MainTitle,geneCount,AUC,P.Value,adj.P.Value,ID,aspect,allNames,rank
mitochondrial protein complex,118,0.234,2.26e-23,1.41e-19,GO:0098798,CC,,1
mitochondrial membrane part,168,0.28,1.14e-22,7.08e-19,GO:0044455,CC,,2
inner mitochondrial membrane protein complex,100,0.222,7.45e-22,4.64e-18,GO:0098800,CC,,3
respiratory chain,74,0.218,5.3e-17,3.3e-13,GO:0070469,CC,,4
mitochondrial translation,108,0.268,1.03e-16,6.44e-13,GO:0032543,BP,,5
ATP synthesis coupled electron transport,77,0.232,4.66e-16,2.9e-12,GO:0042773,BP,,6
mitochondrial respiratory chain,71,0.223,7.12e-16,4.43e-12,GO:0005746,CC,,7
mitochondrial ATP synthesis coupled electron transport,76,0.235,1.53e-15,9.54e-12,GO:0042775,BP,,8
respiratory chain complex,64,0.213,2.06e-15,1.28e-11,GO:0098803,CC,,9
mitochondrial translational termination,77,0.239,2.65e-15,1.65e-11,GO:0070126,BP,,10
mitochondrial translational elongation,76,0.238,3.36e-15,2.09e-11,GO:0070125,BP,,11
cellular respiration,155,0.319,8.05e-15,5.01e-11,GO:0045333,BP,,12
organellar ribosome,77,0.244,8.44e-15,5.25e-11,"GO:0000313,GO:0005761",CC,mitochondrial ribosome,13
oxidative phosphorylation,94,0.272,2.32e-14,1.44e-10,GO:0006119,BP,,14
electron transport chain,92,0.272,4.36e-14,2.71e-10,GO:0022900,BP,,15
respiratory electron transport chain,91,0.274,1e-13,6.23e-10,GO:0022904,BP,,16
regulation of cellular amino acid metabolic process,55,0.215,2.93e-13,1.82e-9,GO:0006521,BP,,17
regulation of cellular amine metabolic process,71,0.25,3.75e-13,2.33e-9,GO:0033238,BP,,18
amine metabolic process,117,0.308,8.23e-13,5.11e-9,GO:0009308,BP,,19
cellular amine metabolic process,112,0.307,1.83e-12,1.14e-8,GO:0044106,BP,,20
electron carrier activity,89,0.286,3.18e-12,1.98e-8,GO:0009055,MF,,21
translational termination,91,0.29,4.57e-12,2.83e-8,GO:0006415,BP,,22
mitochondrial respiratory chain complex assembly,76,0.272,6.15e-12,3.82e-8,GO:0033108,BP,,23
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,67,0.263,1.96e-11,1.22e-7,GO:0031146,BP,,24
translational elongation,122,0.324,2.22e-11,1.37e-7,GO:0006414,BP,,25
oxidoreductase complex,87,0.293,2.64e-11,1.64e-7,GO:1990204,CC,,26
"mitochondrial electron transport, NADH to ubiquinone",41,0.2,3.09e-11,1.91e-7,GO:0006120,BP,,27
NADH dehydrogenase complex assembly,51,0.234,4.78e-11,2.97e-7,"GO:0010257,GO:0032981,GO:0097031",BP,"mitochondrial respiratory chain complex I assembly,mitochondrial respiratory chain complex I biogenesis",28
ribosomal subunit,168,0.355,1.06e-10,6.56e-7,GO:0044391,CC,,29
mitochondrial respiratory chain complex I,39,0.202,1.2e-10,7.42e-7,"GO:0005747,GO:0030964,GO:0045271",CC,"NADH dehydrogenase complex,respiratory chain complex I",30
structural constituent of ribosome,144,0.346,2.1e-10,1.3e-6,GO:0003735,MF,,31
"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor",46,0.232,3.27e-10,2.03e-6,GO:0016655,MF,,32
organellar large ribosomal subunit,47,0.247,2.03e-9,1.26e-5,"GO:0000315,GO:0005762",CC,mitochondrial large ribosomal subunit,33
NADH dehydrogenase activity,36,0.217,4.04e-9,2.5e-5,"GO:0003954,GO:0008137,GO:0050136",MF,"NADH dehydrogenase (ubiquinone) activity,NADH dehydrogenase (quinone) activity",34
"oxidoreductase activity, acting on NAD(P)H",88,0.321,7.39e-9,4.58e-5,GO:0016651,MF,,35
endopeptidase complex,61,0.286,7.6e-9,4.71e-5,GO:1905369,CC,,36
peptidase complex,79,0.312,8.63e-9,5.35e-5,GO:1905368,CC,,37
hydrogen ion transmembrane transport,95,0.33,1.08e-8,6.67e-5,GO:1902600,BP,,38
proteasome complex,60,0.289,1.64e-8,1.02e-4,GO:0000502,CC,,39
proteasome accessory complex,23,0.175,6.58e-8,4.07e-4,GO:0022624,CC,,40
large ribosomal subunit,103,0.348,9.84e-8,6.09e-4,GO:0015934,CC,,41
hydrogen ion transmembrane transporter activity,93,0.341,1.31e-7,8.12e-4,GO:0015078,MF,,42
proteasome regulatory particle,20,0.159,1.32e-7,8.15e-4,GO:0005838,CC,,43
cellular protein complex disassembly,173,0.384,1.57e-7,9.72e-4,GO:0043624,BP,,44
organellar small ribosomal subunit,25,0.197,1.63e-7,0.00101,"GO:0000314,GO:0005763",CC,mitochondrial small ribosomal subunit,45
cellular ketone metabolic process,187,0.392,3.41e-7,0.00211,GO:0042180,BP,,46
proton transport,138,0.375,4.08e-7,0.00252,GO:0015992,BP,,47
hydrogen transport,140,0.378,6.38e-7,0.00394,GO:0006818,BP,,48
cytochrome complex,24,0.21,8.71e-7,0.00538,GO:0070069,CC,,49
negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,65,0.324,9.51e-7,0.00588,GO:0051436,BP,,50
antigen processing and presentation of exogenous antigen,160,0.388,9.87e-7,0.0061,GO:0019884,BP,,51
antigen processing and presentation of exogenous peptide antigen,158,0.387,1.03e-6,0.00637,GO:0002478,BP,,52
regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,66,0.327,1.26e-6,0.00775,GO:0051439,BP,,53
protein localization to mitochondrion,166,0.392,1.51e-6,0.00933,GO:0070585,BP,,54
regulation of transcription from RNA polymerase II promoter in response to hypoxia,73,0.337,1.52e-6,0.00939,GO:0061418,BP,,55
antigen processing and presentation of peptide antigen,171,0.394,1.76e-6,0.0109,GO:0048002,BP,,56
establishment of protein localization to mitochondrion,165,0.393,2.26e-6,0.0139,GO:0072655,BP,,57
positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,69,0.338,3.12e-6,0.0193,GO:0051437,BP,,58
histone demethylase activity,26,0.764,3.19e-6,0.0197,GO:0032452,MF,,59
negative regulation of ubiquitin protein ligase activity,71,0.341,3.54e-6,0.0218,GO:1904667,BP,,60
mitochondrial transmembrane transport,69,0.339,3.59e-6,0.0221,GO:1990542,BP,,61
"transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding",92,0.639,3.93e-6,0.0242,GO:0001078,MF,,62
positive regulation of ubiquitin-protein transferase activity,90,0.36,4.28e-6,0.0264,GO:0051443,BP,,63
voltage-gated potassium channel complex,82,0.354,5.11e-6,0.0315,GO:0008076,CC,,64
histone demethylation,28,0.749,5.14e-6,0.0317,GO:0016577,BP,,65
proton-transporting two-sector ATPase complex,44,0.302,5.3e-6,0.0326,GO:0016469,CC,,66
ensheathment of neurons,108,0.627,5.36e-6,0.033,"GO:0007272,GO:0008366",BP,axon ensheathment,67
anaphase-promoting complex-dependent catabolic process,72,0.345,5.6e-6,0.0345,GO:0031145,BP,,68
positive regulation of ubiquitin protein ligase activity,74,0.35,7.88e-6,0.0485,GO:1904668,BP,,69
potassium channel complex,85,0.361,9.04e-6,0.0557,GO:0034705,CC,,70
transcription corepressor activity,191,0.593,9.14e-6,0.0563,GO:0003714,MF,,71
positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,81,0.359,1.15e-5,0.0707,GO:2000060,BP,,72
protein targeting to mitochondrion,126,0.387,1.19e-5,0.0731,GO:0006626,BP,,73
"transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding",144,0.606,1.23e-5,0.0759,GO:0001227,MF,,74
myelination,105,0.624,1.25e-5,0.0767,GO:0042552,BP,,75
mitochondrial respiratory chain complex III,11,0.123,1.48e-5,0.0909,"GO:0005750,GO:0045275",CC,respiratory chain complex III,76
regulation of ubiquitin-protein transferase activity,109,0.38,1.61e-5,0.0989,GO:0051438,BP,,77
post-embryonic development,76,0.642,1.86e-5,0.114,GO:0009791,BP,,78
organelle envelope lumen,73,0.356,2.22e-5,0.136,GO:0031970,CC,,79
purine nucleoside triphosphate biosynthetic process,57,0.338,2.24e-5,0.138,GO:0009145,BP,,80
cell junction assembly,180,0.592,2.3e-5,0.142,GO:0034329,BP,,81
negative regulation of ubiquitin-protein transferase activity,77,0.361,2.49e-5,0.153,GO:0051444,BP,,82
regulation of cellular ketone metabolic process,140,0.397,2.49e-5,0.153,GO:0010565,BP,,83
regulation of ubiquitin protein ligase activity,82,0.365,2.54e-5,0.156,GO:1904666,BP,,84
cation channel complex,190,0.411,2.65e-5,0.163,GO:0034703,CC,,85
"oxidoreductase activity, acting on a heme group of donors",24,0.252,2.68e-5,0.165,GO:0016675,MF,,86
purine ribonucleoside triphosphate biosynthetic process,56,0.338,2.73e-5,0.168,GO:0009206,BP,,87
nucleoside triphosphate biosynthetic process,73,0.358,2.81e-5,0.173,GO:0009142,BP,,88
mitochondrial ATP synthesis coupled proton transport,18,0.215,2.82e-5,0.173,GO:0042776,BP,,89
"mitochondrial electron transport, ubiquinol to cytochrome c",13,0.166,3.07e-5,0.188,GO:0006122,BP,,90
release of cytochrome c from mitochondria,51,0.332,3.24e-5,0.199,GO:0001836,BP,,91
aerobic respiration,59,0.344,3.34e-5,0.205,GO:0009060,BP,,92
demethylase activity,35,0.703,3.39e-5,0.208,GO:0032451,MF,,93
negative regulation of cell cycle G2/M phase transition,75,0.361,3.41e-5,0.209,GO:1902750,BP,,94
type I interferon signaling pathway,65,0.649,3.47e-5,0.213,"GO:0060337,GO:0071357",BP,cellular response to type I interferon,95
"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors",45,0.678,3.56e-5,0.219,GO:0016706,MF,,96
"Wnt signaling pathway, planar cell polarity pathway",103,0.383,4.07e-5,0.249,GO:0060071,BP,,97
response to type I interferon,69,0.642,4.46e-5,0.273,GO:0034340,BP,,98
DNA packaging complex,59,0.653,4.63e-5,0.284,GO:0044815,CC,,99
PML body,88,0.625,4.83e-5,0.296,GO:0016605,CC,,100
ribonucleoside triphosphate biosynthetic process,62,0.351,5.13e-5,0.314,GO:0009201,BP,,101
histone lysine demethylation,25,0.734,5.3e-5,0.325,GO:0070076,BP,,102
protein demethylation,30,0.713,5.45e-5,0.334,"GO:0006482,GO:0008214",BP,protein dealkylation,103
negative regulation of G2/M transition of mitotic cell cycle,73,0.363,5.5e-5,0.337,GO:0010972,BP,,104
regulation of establishment of planar polarity,104,0.386,5.63e-5,0.345,GO:0090175,BP,,105
tRNA aminoacylation for protein translation,43,0.323,5.9e-5,0.361,GO:0006418,BP,,106
mRNA transport,128,0.603,5.95e-5,0.365,GO:0051028,BP,,107
glycoside metabolic process,14,0.191,6.15e-5,0.377,GO:0016137,BP,,108
"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent",71,0.362,6.2e-5,0.379,GO:0002479,BP,,109
cytochrome-c oxidase activity,23,0.259,6.2e-5,0.38,"GO:0004129,GO:0015002,GO:0016676",MF,"heme-copper terminal oxidase activity,oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor",110
integral component of mitochondrial membrane,51,0.338,6.28e-5,0.385,GO:0032592,CC,,111
establishment of cell polarity,97,0.617,6.54e-5,0.4,GO:0030010,BP,,112
establishment or maintenance of cell polarity,158,0.592,7.17e-5,0.439,GO:0007163,BP,,113
cytochrome complex assembly,28,0.283,7.22e-5,0.442,GO:0017004,BP,,114
tRNA aminoacylation,46,0.331,7.77e-5,0.475,GO:0043039,BP,,115
intrinsic component of mitochondrial membrane,52,0.343,9.2e-5,0.562,GO:0098573,CC,,116
mitochondrial proton-transporting ATP synthase complex,19,0.242,1.01e-4,0.619,GO:0005753,CC,,117
protein sumoylation,80,0.626,1.02e-4,0.624,GO:0016925,BP,,118
"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism",30,0.295,1.06e-4,0.65,GO:0044769,MF,,119
phospholipid translocation,21,0.744,1.11e-4,0.679,GO:0045332,BP,,120
establishment of planar polarity,113,0.395,1.12e-4,0.682,"GO:0001736,GO:0007164",BP,establishment of tissue polarity,121
protein transmembrane import into intracellular organelle,35,0.312,1.15e-4,0.702,GO:0044743,BP,,122
nucleosome,53,0.653,1.16e-4,0.708,GO:0000786,CC,,123
lipid translocation,22,0.737,1.21e-4,0.739,GO:0034204,BP,,124
regulation of G2/M transition of mitotic cell cycle,103,0.39,1.26e-4,0.769,GO:0010389,BP,,125
antigen processing and presentation of exogenous peptide antigen via MHC class I,74,0.372,1.4e-4,0.853,GO:0042590,BP,,126
mitochondrial intermembrane space,65,0.364,1.46e-4,0.893,GO:0005758,CC,,127
iron-sulfur cluster assembly,15,0.217,1.46e-4,0.893,"GO:0016226,GO:0031163",BP,metallo-sulfur cluster assembly,128
early endosome membrane,112,0.604,1.48e-4,0.905,GO:0031901,CC,,129
myelination in peripheral nervous system,22,0.733,1.51e-4,0.922,"GO:0022011,GO:0032292",BP,peripheral nervous system axon ensheathment,130
ficolin-1-rich granule,116,0.398,1.52e-4,0.93,"GO:0101002,GO:1904813",CC,ficolin-1-rich granule lumen,131
transcriptional repressor complex,76,0.625,1.63e-4,0.995,GO:0017053,CC,,132
ATP biosynthetic process,44,0.337,1.8e-4,1,GO:0006754,BP,,133
thiol-dependent ubiquitinyl hydrolase activity,93,0.612,1.89e-4,1,GO:0036459,MF,,134
cell-cell junction assembly,84,0.618,1.89e-4,1,GO:0007043,BP,,135
threonine-type endopeptidase activity,20,0.26,2.07e-4,1,"GO:0004298,GO:0070003",MF,threonine-type peptidase activity,136
proton-transporting ATP synthase complex,20,0.261,2.1e-4,1,GO:0045259,CC,,137
amino acid activation,47,0.344,2.15e-4,1,GO:0043038,BP,,138
small ribosomal subunit,66,0.368,2.18e-4,1,GO:0015935,CC,,139
anterior/posterior pattern specification,152,0.587,2.19e-4,1,GO:0009952,BP,,140
phospholipid-translocating ATPase activity,18,0.75,2.43e-4,1,GO:0004012,MF,,141
cellular detoxification,82,0.383,2.45e-4,1,GO:1990748,BP,,142
detoxification,86,0.386,2.48e-4,1,GO:0098754,BP,,143
aminoacyl-tRNA ligase activity,39,0.331,2.53e-4,1,"GO:0004812,GO:0016875,GO:0016876",MF,"ligase activity, forming carbon-oxygen bonds,ligase activity, forming aminoacyl-tRNA and related compounds",144
demethylation,52,0.646,2.62e-4,1,GO:0070988,BP,,145
protein import into mitochondrial matrix,13,0.208,2.69e-4,1,GO:0030150,BP,,146
mitotic sister chromatid cohesion,21,0.73,2.71e-4,1,GO:0007064,BP,,147
thiol-dependent ubiquitin-specific protease activity,72,0.624,2.94e-4,1,GO:0004843,MF,,148
antioxidant activity,70,0.375,2.95e-4,1,GO:0016209,MF,,149
aldo-keto reductase (NADP) activity,19,0.26,2.95e-4,1,GO:0004033,MF,,150
cell-matrix adhesion,181,0.578,2.97e-4,1,GO:0007160,BP,,151
endothelium development,98,0.606,2.97e-4,1,GO:0003158,BP,,152
apical junction complex,116,0.597,2.98e-4,1,GO:0043296,CC,,153
hexose catabolic process,46,0.346,3.01e-4,1,GO:0019320,BP,,154
neural tube development,140,0.589,3.07e-4,1,GO:0021915,BP,,155
amine transport,73,0.378,3.19e-4,1,GO:0015837,BP,,156
cellular oxidant detoxification,81,0.384,3.21e-4,1,GO:0098869,BP,,157
stimulatory C-type lectin receptor signaling pathway,98,0.395,3.31e-4,1,GO:0002223,BP,,158
regulation of mRNA metabolic process,114,0.597,3.36e-4,1,GO:1903311,BP,,159
positive regulation of protein ubiquitination,160,0.418,3.44e-4,1,GO:0031398,BP,,160
nuclear inner membrane,46,0.653,3.47e-4,1,GO:0005637,CC,,161
regulation of cell cycle G2/M phase transition,111,0.402,3.75e-4,1,GO:1902749,BP,,162
proteasome core complex,19,0.264,3.78e-4,1,GO:0005839,CC,,163
innate immune response activating cell surface receptor signaling pathway,99,0.397,4e-4,1,GO:0002220,BP,,164
ribosomal large subunit biogenesis,51,0.357,4.05e-4,1,GO:0042273,BP,,165
"energy coupled proton transport, down electrochemical gradient",24,0.292,4.14e-4,1,"GO:0015985,GO:0015986",BP,ATP synthesis coupled proton transport,166
positive regulation of actin cytoskeleton reorganization,11,0.193,4.26e-4,1,GO:2000251,BP,,167
regulation of release of cytochrome c from mitochondria,40,0.339,4.26e-4,1,GO:0090199,BP,,168
carbohydrate transport,153,0.583,4.39e-4,1,GO:0008643,BP,,169
hydrogen-exporting ATPase activity,21,0.279,4.48e-4,1,GO:0036442,MF,,170
7-methylguanosine RNA capping,32,0.322,4.84e-4,1,"GO:0009452,GO:0036260",BP,RNA capping,171
"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor",98,0.398,4.89e-4,1,GO:0016616,MF,,172
occluding junction,102,0.6,4.96e-4,1,GO:0070160,CC,,173
delayed rectifier potassium channel activity,18,0.263,4.99e-4,1,GO:0005251,MF,,174
regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,95,0.397,5.08e-4,1,GO:2000058,BP,,175
organic acid binding,144,0.416,5.19e-4,1,GO:0043177,MF,,176
ubiquitinyl hydrolase activity,95,0.603,5.33e-4,1,GO:0101005,MF,,177
voltage-gated potassium channel activity,79,0.387,5.34e-4,1,GO:0005249,MF,,178
histone binding,149,0.582,5.42e-4,1,GO:0042393,MF,,179
bicellular tight junction,100,0.6,5.45e-4,1,GO:0005923,CC,,180
intracellular protein transmembrane transport,44,0.35,5.79e-4,1,GO:0065002,BP,,181
antigen processing and presentation of peptide antigen via MHC class I,89,0.395,5.95e-4,1,GO:0002474,BP,,182
DNA-directed RNA polymerase III complex,15,0.245,6.32e-4,1,GO:0005666,CC,,183
appendage development,139,0.584,6.32e-4,1,"GO:0048736,GO:0060173",BP,limb development,184
cellular pigmentation,48,0.358,6.47e-4,1,GO:0033059,BP,,185
dicarboxylic acid metabolic process,88,0.395,6.48e-4,1,GO:0043648,BP,,186
regulation of actin cytoskeleton reorganization,29,0.317,6.72e-4,1,GO:2000249,BP,,187
carboxylic acid binding,143,0.418,6.79e-4,1,GO:0031406,MF,,188
RNA polymerase III activity,12,0.218,7.07e-4,1,GO:0001056,MF,,189
Schwann cell development,25,0.695,7.31e-4,1,GO:0014044,BP,,190
embryonic limb morphogenesis,101,0.597,7.41e-4,1,"GO:0030326,GO:0035113",BP,embryonic appendage morphogenesis,191
establishment of RNA localization,166,0.576,7.63e-4,1,GO:0051236,BP,,192
somite development,70,0.616,7.82e-4,1,GO:0061053,BP,,193
"2 iron, 2 sulfur cluster binding",21,0.288,7.92e-4,1,GO:0051537,MF,,194
bitter taste receptor activity,10,0.805,8.28e-4,1,GO:0033038,MF,,195
male sex differentiation,128,0.586,8.45e-4,1,GO:0046661,BP,,196
spliceosomal snRNP assembly,33,0.332,8.65e-4,1,GO:0000387,BP,,197
RNA localization to Cajal body,12,0.223,8.78e-4,1,"GO:0090670,GO:0090671,GO:0090672",BP,"telomerase RNA localization to Cajal body,telomerase RNA localization",198
maintenance of location in cell,91,0.601,9.17e-4,1,GO:0051651,BP,,199
nucleic acid transport,164,0.575,9.21e-4,1,"GO:0050657,GO:0050658",BP,RNA transport,200
T cell mediated immunity,61,0.623,9.42e-4,1,GO:0002456,BP,,201
intrinsic component of mitochondrial inner membrane,23,0.302,0.00103,1,"GO:0031304,GO:0031305",CC,integral component of mitochondrial inner membrane,202
positive regulation of cellular response to insulin stimulus,22,0.702,0.00104,1,GO:1900078,BP,,203
potassium channel activity,111,0.41,0.00104,1,GO:0005267,MF,,204
positive regulation of protein depolymerization,13,0.239,0.0011,1,GO:1901881,BP,,205
regulation of membrane lipid distribution,33,0.664,0.00114,1,GO:0097035,BP,,206
SMAD binding,67,0.615,0.00114,1,GO:0046332,MF,,207
antigen processing and presentation of peptide antigen via MHC class II,89,0.4,0.00117,1,GO:0002495,BP,,208
regulation of transcription from RNA polymerase II promoter in response to stress,107,0.409,0.00117,1,GO:0043618,BP,,209
protein-DNA complex,135,0.581,0.00118,1,GO:0032993,CC,,210
regulation of epithelial cell apoptotic process,53,0.629,0.00118,1,GO:1904035,BP,,211
ubiquitin-like protein-specific protease activity,102,0.593,0.00118,1,GO:0019783,MF,,212
basal part of cell,42,0.645,0.00119,1,GO:0045178,CC,,213
membrane budding,96,0.404,0.0012,1,GO:0006900,BP,,214
regulation of epithelial to mesenchymal transition,66,0.615,0.00125,1,GO:0010717,BP,,215
ribonucleoside monophosphate biosynthetic process,76,0.393,0.00125,1,GO:0009156,BP,,216
carbon-carbon lyase activity,46,0.363,0.00128,1,GO:0016830,MF,,217
nuclear periphery,109,0.589,0.00129,1,GO:0034399,CC,,218
regulation of amine transport,66,0.386,0.00134,1,GO:0051952,BP,,219
glial cell differentiation,168,0.572,0.00139,1,GO:0010001,BP,,220
glial cell development,80,0.603,0.00139,1,GO:0021782,BP,,221
Schwann cell differentiation,33,0.66,0.00144,1,GO:0014037,BP,,222
sister chromatid cohesion,108,0.589,0.00145,1,GO:0007062,BP,,223
"mitochondrial electron transport, cytochrome c to oxygen",16,0.27,0.00146,1,GO:0006123,BP,,224
regulation of mitochondrion organization,196,0.434,0.00148,1,GO:0010821,BP,,225
positive regulation of mRNA catabolic process,25,0.683,0.00151,1,GO:0061014,BP,,226
peroxidase activity,39,0.353,0.00152,1,GO:0004601,MF,,227
anterograde synaptic vesicle transport,17,0.278,0.00155,1,"GO:0048490,GO:0099514,GO:0099517",BP,"synaptic vesicle cytoskeletal transport,synaptic vesicle transport along microtubule",228
regulation of RNA splicing,90,0.597,0.00156,1,GO:0043484,BP,,229
"nucleotide-excision repair, DNA damage recognition",19,0.29,0.00157,1,GO:0000715,BP,,230
positive regulation of calcium-mediated signaling,32,0.339,0.00159,1,GO:0050850,BP,,231
antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,90,0.404,0.0016,1,GO:0002504,BP,,232
appendage morphogenesis,118,0.584,0.00163,1,"GO:0035107,GO:0035108",BP,limb morphogenesis,233
membrane assembly,28,0.672,0.00164,1,GO:0071709,BP,,234
antigen processing and presentation of exogenous peptide antigen via MHC class II,86,0.402,0.00165,1,GO:0019886,BP,,235
glutamine family amino acid metabolic process,64,0.386,0.00167,1,GO:0009064,BP,,236
multi-organism membrane organization,29,0.332,0.0017,1,GO:0044803,BP,,237
7-methylguanosine mRNA capping,28,0.329,0.00172,1,GO:0006370,BP,,238
SWI/SNF superfamily-type complex,67,0.611,0.00175,1,GO:0070603,CC,,239
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,15,0.733,0.00176,1,GO:1902043,BP,,240
"oxidoreductase activity, acting on CH-OH group of donors",111,0.414,0.00177,1,GO:0016614,MF,,241
negative regulation of I-kappaB kinase/NF-kappaB signaling,49,0.629,0.0018,1,GO:0043124,BP,,242
protein transmembrane transport,52,0.375,0.00181,1,GO:0071806,BP,,243
monosaccharide transport,130,0.579,0.00182,1,GO:0015749,BP,,244
apoptotic mitochondrial changes,109,0.414,0.00193,1,GO:0008637,BP,,245
negative regulation of protein ubiquitination,123,0.419,0.00194,1,GO:0031397,BP,,246
"proton-transporting ATPase activity, rotational mechanism",19,0.295,0.00194,1,GO:0046961,MF,,247
T cell receptor signaling pathway,154,0.427,0.00194,1,GO:0050852,BP,,248
cysteine-type peptidase activity,160,0.571,0.00195,1,GO:0008234,MF,,249
"oxidoreductase activity, acting on a sulfur group of donors",50,0.373,0.00198,1,GO:0016667,MF,,250
regulation of telomerase RNA localization to Cajal body,11,0.231,0.00202,1,"GO:1904872,GO:1904874",BP,positive regulation of telomerase RNA localization to Cajal body,251
positive regulation of mRNA metabolic process,45,0.633,0.00204,1,GO:1903313,BP,,252
regulation of adherens junction organization,51,0.625,0.00206,1,GO:1903391,BP,,253
alcohol dehydrogenase (NADP+) activity,13,0.254,0.00214,1,GO:0008106,MF,,254
centriole,103,0.588,0.00215,1,GO:0005814,CC,,255
RNA polymerase II transcription factor binding,93,0.592,0.00217,1,GO:0001085,MF,,256
glutathione metabolic process,41,0.362,0.00219,1,GO:0006749,BP,,257
"oxidoreductase activity, acting on peroxide as acceptor",42,0.363,0.00221,1,GO:0016684,MF,,258
ISWI-type complex,10,0.779,0.00225,1,GO:0031010,CC,,259
cell cortex part,109,0.585,0.00225,1,GO:0044448,CC,,260
"transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding",76,0.601,0.0023,1,GO:0003705,MF,,261
lyase activity,148,0.427,0.0023,1,GO:0016829,MF,,262
mRNA 3'-UTR binding,55,0.619,0.00231,1,GO:0003730,MF,,263
arginine metabolic process,15,0.273,0.00231,1,GO:0006525,BP,,264
proteasome assembly,13,0.256,0.00232,1,GO:0043248,BP,,265
amino acid binding,57,0.383,0.00234,1,GO:0016597,MF,,266
polyamine metabolic process,16,0.28,0.00234,1,GO:0006595,BP,,267
skeletal muscle cell differentiation,55,0.618,0.00239,1,GO:0035914,BP,,268
morphogenesis of a polarized epithelium,124,0.421,0.0024,1,GO:0001738,BP,,269
membrane biogenesis,32,0.655,0.00247,1,GO:0044091,BP,,270
phenol-containing compound metabolic process,86,0.406,0.00251,1,GO:0018958,BP,,271
hexose transport,129,0.577,0.00252,1,GO:0008645,BP,,272
segmentation,78,0.599,0.00253,1,GO:0035282,BP,,273
regulation of cell junction assembly,70,0.604,0.00255,1,GO:1901888,BP,,274
catecholamine metabolic process,48,0.374,0.00255,1,"GO:0006584,GO:0009712",BP,catechol-containing compound metabolic process,275
central nervous system myelination,15,0.725,0.00256,1,"GO:0022010,GO:0032291",BP,axon ensheathment in central nervous system,276
nuclear matrix,88,0.593,0.0026,1,GO:0016363,CC,,277
nucleocytoplasmic transporter activity,25,0.674,0.00265,1,GO:0005487,MF,,278
core promoter binding,140,0.574,0.00268,1,GO:0001047,MF,,279
skeletal muscle tissue development,130,0.576,0.00271,1,GO:0007519,BP,,280
cofactor biosynthetic process,176,0.434,0.00272,1,GO:0051188,BP,,281
BLOC complex,20,0.306,0.00273,1,GO:0031082,CC,,282
purine nucleoside monophosphate biosynthetic process,65,0.392,0.00273,1,"GO:0009127,GO:0009168",BP,purine ribonucleoside monophosphate biosynthetic process,283
chromatin DNA binding,74,0.601,0.00274,1,GO:0031490,MF,,284
'de novo' protein folding,31,0.345,0.00276,1,GO:0006458,BP,,285
cellular biogenic amine metabolic process,47,0.374,0.0028,1,GO:0006576,BP,,286
regulation of DNA-templated transcription in response to stress,112,0.418,0.00281,1,GO:0043620,BP,,287
ER membrane protein complex,17,0.291,0.00283,1,GO:0072546,CC,,288
respiratory system development,182,0.564,0.00285,1,GO:0060541,BP,,289
monosaccharide catabolic process,55,0.384,0.00287,1,GO:0046365,BP,,290
viral budding,21,0.313,0.00305,1,"GO:0046755,GO:1902590,GO:1902592",BP,"multi-organism organelle organization,multi-organism membrane budding",291
entry into host cell,108,0.583,0.00306,1,"GO:0030260,GO:0044409,GO:0051806,GO:0051828",BP,"entry into host,entry into cell of other organism involved in symbiotic interaction,entry into other organism involved in symbiotic interaction",292
maintenance of sister chromatid cohesion,11,0.758,0.00308,1,"GO:0034086,GO:0034088",BP,maintenance of mitotic sister chromatid cohesion,293
somitogenesis,53,0.618,0.00308,1,GO:0001756,BP,,294
protein disulfide oxidoreductase activity,19,0.304,0.00309,1,GO:0015035,MF,,295
SUMO transferase activity,14,0.728,0.00313,1,GO:0019789,MF,,296
vesicle transport along microtubule,34,0.354,0.00313,1,GO:0047496,BP,,297
male gonad development,108,0.582,0.00318,1,"GO:0008584,GO:0046546",BP,development of primary male sexual characteristics,298
Fc-epsilon receptor signaling pathway,116,0.421,0.00318,1,GO:0038095,BP,,299
BMP signaling pathway,130,0.575,0.00322,1,GO:0030509,BP,,300
regulation of cellular response to insulin stimulus,60,0.61,0.00324,1,GO:1900076,BP,,301
endothelial cell differentiation,84,0.593,0.00326,1,GO:0045446,BP,,302
spliceosomal tri-snRNP complex,22,0.319,0.00329,1,GO:0097526,CC,,303
maintenance of protein location in cell,76,0.597,0.00335,1,GO:0032507,BP,,304
morphogenesis of a branching structure,170,0.565,0.00336,1,GO:0001763,BP,,305
maintenance of protein location,83,0.593,0.00337,1,GO:0045185,BP,,306
positive regulation of protein modification by small protein conjugation or removal,175,0.436,0.00339,1,GO:1903322,BP,,307
tumor necrosis factor-mediated signaling pathway,142,0.429,0.0034,1,GO:0033209,BP,,308
glutathione derivative metabolic process,18,0.301,0.00349,1,"GO:1901685,GO:1901687",BP,glutathione derivative biosynthetic process,309
transcription cofactor binding,32,0.649,0.00352,1,GO:0001221,MF,,310
"energy coupled proton transmembrane transport, against electrochemical gradient",26,0.335,0.00353,1,"GO:0015988,GO:0015991",BP,ATP hydrolysis coupled proton transport,311
skeletal muscle organ development,137,0.572,0.00353,1,GO:0060538,BP,,312
amine biosynthetic process,23,0.324,0.00357,1,GO:0009309,BP,,313
quinone metabolic process,25,0.332,0.00359,1,GO:1901661,BP,,314
polysaccharide metabolic process,89,0.411,0.00366,1,GO:0005976,BP,,315
positive regulation of epithelial to mesenchymal transition,35,0.642,0.00367,1,GO:0010718,BP,,316
negative regulation of release of cytochrome c from mitochondria,15,0.283,0.00369,1,GO:0090201,BP,,317
regulation of catecholamine secretion,40,0.367,0.0037,1,GO:0050433,BP,,318
negative regulation of axonogenesis,49,0.62,0.00373,1,GO:0050771,BP,,319
"proton-transporting ATP synthase activity, rotational mechanism",15,0.284,0.00376,1,GO:0046933,MF,,320
"negative regulation of gene expression, epigenetic",91,0.588,0.00382,1,GO:0045814,BP,,321
dorsal/ventral pattern formation,81,0.593,0.00383,1,GO:0009953,BP,,322
"proton-transporting two-sector ATPase complex, proton-transporting domain",20,0.313,0.00388,1,GO:0033177,CC,,323
NADH metabolic process,33,0.355,0.00393,1,GO:0006734,BP,,324
Rho protein signal transduction,157,0.567,0.00399,1,GO:0007266,BP,,325
glutathione transferase activity,18,0.304,0.00404,1,GO:0004364,MF,,326
positive regulation of epithelial cell apoptotic process,23,0.673,0.00406,1,GO:1904037,BP,,327
inner mitochondrial membrane organization,17,0.299,0.00406,1,GO:0007007,BP,,328
perikaryon,102,0.418,0.00408,1,GO:0043204,CC,,329
epithelial cell apoptotic process,74,0.597,0.00413,1,GO:1904019,BP,,330
molting cycle,96,0.585,0.00415,1,"GO:0042303,GO:0042633",BP,hair cycle,331
RNA destabilization,20,0.684,0.00431,1,GO:0050779,BP,,332
positive regulation of insulin receptor signaling pathway,10,0.761,0.00431,1,GO:0046628,BP,,333
oxygen transport,12,0.262,0.00435,1,GO:0015671,BP,,334
DNA methylation or demethylation,61,0.605,0.00444,1,GO:0044728,BP,,335
response to BMP,134,0.571,0.00451,1,"GO:0071772,GO:0071773",BP,cellular response to BMP stimulus,336
epithelial tube formation,117,0.576,0.00452,1,GO:0072175,BP,,337
carbohydrate biosynthetic process,171,0.437,0.00456,1,GO:0016051,BP,,338
respiratory chain complex IV assembly,19,0.312,0.00458,1,GO:0008535,BP,,339
microtubule binding,197,0.559,0.0046,1,GO:0008017,MF,,340
ATP transport,10,0.241,0.00463,1,GO:0015867,BP,,341
membrane protein ectodomain proteolysis,38,0.633,0.00464,1,GO:0006509,BP,,342
preribosome,59,0.393,0.00467,1,GO:0030684,CC,,343
NIK/NF-kappaB signaling,108,0.421,0.00468,1,GO:0038061,BP,,344
muscle cell proliferation,148,0.567,0.00471,1,GO:0033002,BP,,345
positive regulation by host of viral transcription,12,0.736,0.00473,1,GO:0043923,BP,,346
"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway",28,0.654,0.00475,1,"GO:0035872,GO:0070423",BP,nucleotide-binding oligomerization domain containing signaling pathway,347
establishment of protein localization to mitochondrial membrane,14,0.282,0.00481,1,GO:0090151,BP,,348
catecholamine secretion,43,0.376,0.00483,1,GO:0050432,BP,,349
voltage-gated cation channel activity,118,0.425,0.00484,1,GO:0022843,MF,,350
glycosphingolipid catabolic process,10,0.243,0.00485,1,"GO:0046479,GO:0046514",BP,ceramide catabolic process,351
cellular biogenic amine biosynthetic process,22,0.326,0.00485,1,GO:0042401,BP,,352
nucleobase-containing compound transport,197,0.558,0.00486,1,GO:0015931,BP,,353
enhancer binding,81,0.59,0.00493,1,GO:0035326,MF,,354
mRNA binding,168,0.563,0.00495,1,GO:0003729,MF,,355
vitamin metabolic process,111,0.423,0.00496,1,GO:0006766,BP,,356
snoRNA binding,23,0.331,0.00499,1,GO:0030515,MF,,357
glucose transport,127,0.572,0.005,1,GO:0015758,BP,,358
embryonic digit morphogenesis,52,0.613,0.00502,1,GO:0042733,BP,,359
coenzyme binding,166,0.437,0.00504,1,GO:0050662,MF,,360
mitochondrion morphogenesis,18,0.309,0.00506,1,GO:0070584,BP,,361
embryonic heart tube development,67,0.599,0.00506,1,GO:0035050,BP,,362
body morphogenesis,41,0.626,0.0051,1,GO:0010171,BP,,363
positive regulation of dendrite extension,17,0.304,0.0051,1,GO:1903861,BP,,364
signal transduction in response to DNA damage,107,0.578,0.00517,1,GO:0042770,BP,,365
adherens junction assembly,74,0.594,0.00519,1,GO:0034333,BP,,366
regulation of non-canonical Wnt signaling pathway,19,0.685,0.00522,1,GO:2000050,BP,,367
vesicle cytoskeletal trafficking,38,0.369,0.00523,1,GO:0099518,BP,,368
morphogenesis of an endothelium,12,0.733,0.00525,1,"GO:0003159,GO:0061154",BP,endothelial tube morphogenesis,369
melanosome,98,0.418,0.00527,1,"GO:0042470,GO:0048770",CC,pigment granule,370
integral component of organelle membrane,148,0.433,0.00528,1,GO:0031301,CC,,371
cell projection cytoplasm,59,0.395,0.00536,1,GO:0032838,CC,,372
nucleoside monophosphate biosynthetic process,83,0.411,0.00537,1,GO:0009124,BP,,373
"proton-transporting ATP synthase complex, coupling factor F(o)",10,0.246,0.00541,1,GO:0045263,CC,,374
monoamine transport,66,0.401,0.0056,1,GO:0015844,BP,,375
axis specification,72,0.594,0.00566,1,GO:0009798,BP,,376
regulation of focal adhesion assembly,49,0.614,0.00569,1,"GO:0051893,GO:0090109",BP,regulation of cell-substrate junction assembly,377
ectodermal placode formation,15,0.706,0.0057,1,"GO:0060788,GO:0071697",BP,ectodermal placode morphogenesis,378
negative regulation of protein modification by small protein conjugation or removal,130,0.43,0.00574,1,GO:1903321,BP,,379
dipeptidase activity,15,0.705,0.00594,1,GO:0016805,MF,,380
negative regulation of canonical Wnt signaling pathway,154,0.436,0.006,1,GO:0090090,BP,,381
glucose catabolic process,28,0.35,0.00603,1,GO:0006007,BP,,382
thiolester hydrolase activity,25,0.342,0.00614,1,GO:0016790,MF,,383
dopamine secretion,23,0.335,0.0062,1,"GO:0014046,GO:0014059",BP,regulation of dopamine secretion,384
tube formation,129,0.57,0.00622,1,GO:0035148,BP,,385
head morphogenesis,29,0.647,0.00624,1,GO:0060323,BP,,386
mRNA destabilization,18,0.686,0.00627,1,GO:0061157,BP,,387
DNA modification,75,0.591,0.00629,1,GO:0006304,BP,,388
platelet-derived growth factor receptor signaling pathway,46,0.617,0.00629,1,GO:0048008,BP,,389
taste receptor activity,14,0.711,0.00633,1,GO:0008527,MF,,390
membrane protein proteolysis,53,0.608,0.00637,1,GO:0033619,BP,,391
"transferase activity, transferring alkyl or aryl (other than methyl) groups",48,0.386,0.00642,1,GO:0016765,MF,,392
protein binding involved in heterotypic cell-cell adhesion,10,0.749,0.00646,1,GO:0086080,MF,,393
apical junction assembly,52,0.609,0.00651,1,GO:0043297,BP,,394
respiratory chain complex IV,11,0.263,0.00653,1,GO:0045277,CC,,395
cation-transporting ATPase activity,55,0.394,0.00653,1,GO:0019829,MF,,396
genetic imprinting,22,0.668,0.00654,1,GO:0071514,BP,,397
RNA export from nucleus,119,0.572,0.00658,1,GO:0006405,BP,,398
copper ion binding,49,0.388,0.00664,1,GO:0005507,MF,,399
mitotic DNA damage checkpoint,83,0.586,0.00694,1,GO:0044773,BP,,400
establishment of protein localization to chromosome,20,0.326,0.00698,1,GO:0070199,BP,,401
dioxygenase activity,83,0.586,0.00701,1,GO:0051213,MF,,402
virion assembly,32,0.362,0.00703,1,GO:0019068,BP,,403
nuclear pore organization,15,0.701,0.00706,1,GO:0006999,BP,,404
caveola,70,0.593,0.00708,1,GO:0005901,CC,,405
DNA damage checkpoint,131,0.568,0.00713,1,GO:0000077,BP,,406
glutathione peroxidase activity,17,0.312,0.00718,1,GO:0004602,MF,,407
oxygen transporter activity,11,0.266,0.00722,1,GO:0005344,MF,,408
regulation of cardiac muscle cell action potential,25,0.655,0.00723,1,GO:0098901,BP,,409
ATP hydrolysis coupled cation transmembrane transport,51,0.391,0.00728,1,GO:0099132,BP,,410
coronary vasculature morphogenesis,12,0.724,0.00729,1,GO:0060977,BP,,411
cardiac septum development,85,0.584,0.00732,1,GO:0003279,BP,,412
adenylyltransferase activity,23,0.661,0.00736,1,GO:0070566,MF,,413
viral entry into host cell,94,0.58,0.00738,1,GO:0046718,BP,,414
regulation of embryonic development,105,0.576,0.0074,1,GO:0045995,BP,,415
steroid hormone mediated signaling pathway,161,0.561,0.0076,1,GO:0043401,BP,,416
BLOC-1 complex,15,0.301,0.00761,1,GO:0031083,CC,,417
potassium ion transmembrane transporter activity,138,0.434,0.00764,1,GO:0015079,MF,,418
nuclear pore,69,0.593,0.00786,1,GO:0005643,CC,,419
water-soluble vitamin metabolic process,78,0.413,0.00791,1,GO:0006767,BP,,420
negative regulation of sodium ion transmembrane transport,11,0.269,0.00791,1,GO:1902306,BP,,421
glycolipid catabolic process,11,0.269,0.00794,1,GO:0019377,BP,,422
MAP kinase kinase kinase activity,20,0.671,0.00795,1,GO:0004709,MF,,423
cell-cell adhesion mediated by integrin,10,0.742,0.00805,1,GO:0033631,BP,,424
nitrogen cycle metabolic process,12,0.279,0.00808,1,GO:0071941,BP,,425
"proton-transporting two-sector ATPase complex, catalytic domain",16,0.309,0.00817,1,GO:0033178,CC,,426
monocarboxylic acid binding,44,0.385,0.00817,1,GO:0033293,MF,,427
activating transcription factor binding,56,0.602,0.00825,1,GO:0033613,MF,,428
molting cycle process,79,0.586,0.00827,1,"GO:0022404,GO:0022405",BP,hair cycle process,429
peripheral nervous system development,64,0.595,0.00845,1,GO:0007422,BP,,430
muscle filament sliding,30,0.361,0.00847,1,"GO:0030049,GO:0033275",BP,actin-myosin filament sliding,431
negative regulation of mitochondrion organization,43,0.384,0.00848,1,GO:0010823,BP,,432
"synaptic transmission, dopaminergic",25,0.348,0.0085,1,GO:0001963,BP,,433
striated muscle cell proliferation,49,0.609,0.00853,1,GO:0014855,BP,,434
neuronal cell body membrane,19,0.326,0.00857,1,"GO:0032809,GO:0044298",CC,cell body membrane,435
adipose tissue development,32,0.634,0.00865,1,GO:0060612,BP,,436
axonal transport,37,0.375,0.00867,1,GO:0098930,BP,,437
myeloid cell homeostasis,107,0.574,0.0087,1,GO:0002262,BP,,438
mRNA export from nucleus,95,0.578,0.00872,1,"GO:0006406,GO:0071427",BP,mRNA-containing ribonucleoprotein complex export from nucleus,439
basal plasma membrane,28,0.643,0.00881,1,GO:0009925,CC,,440
carboxy-lyase activity,33,0.368,0.00888,1,GO:0016831,MF,,441
homeostasis of number of cells,195,0.554,0.00898,1,GO:0048872,BP,,442
cytoplasmic pattern recognition receptor signaling pathway,46,0.611,0.00903,1,GO:0002753,BP,,443
myelin assembly,18,0.678,0.00909,1,GO:0032288,BP,,444
carbohydrate derivative catabolic process,154,0.439,0.00914,1,GO:1901136,BP,,445
ventricular septum development,55,0.602,0.0092,1,GO:0003281,BP,,446
mitotic nuclear envelope disassembly,38,0.622,0.00922,1,GO:0007077,BP,,447
positive regulation of protein complex disassembly,19,0.328,0.00928,1,GO:0043243,BP,,448
epithelial cell development,171,0.558,0.00931,1,GO:0002064,BP,,449
dendrite development,188,0.555,0.00939,1,GO:0016358,BP,,450
regulation of endothelial cell differentiation,26,0.647,0.0094,1,GO:0045601,BP,,451
positive regulation of mitochondrion organization,148,0.438,0.00961,1,GO:0010822,BP,,452
phagosome acidification,25,0.35,0.00962,1,GO:0090383,BP,,453
cullin family protein binding,13,0.293,0.00964,1,GO:0097602,MF,,454
mitotic DNA integrity checkpoint,89,0.579,0.00967,1,GO:0044774,BP,,455
positive regulation of protein dephosphorylation,32,0.368,0.00968,1,GO:0035307,BP,,456
smooth muscle tissue development,16,0.687,0.00969,1,GO:0048745,BP,,457
antigen receptor-mediated signaling pathway,185,0.445,0.00973,1,GO:0050851,BP,,458
cell-substrate junction assembly,81,0.583,0.00976,1,GO:0007044,BP,,459
endothelial cell development,49,0.607,0.00977,1,GO:0001885,BP,,460
bleb assembly,10,0.736,0.00983,1,GO:0032060,BP,,461
axon cytoplasm,37,0.377,0.00983,1,GO:1904115,CC,,462
RNA localization,190,0.554,0.00992,1,GO:0006403,BP,,463
adherens junction organization,111,0.571,0.00997,1,GO:0034332,BP,,464
regulation of dendritic spine morphogenesis,33,0.63,0.01,1,GO:0061001,BP,,465
transepithelial transport,15,0.692,0.0101,1,GO:0070633,BP,,466
anterior/posterior axis specification,38,0.621,0.0102,1,GO:0009948,BP,,467
humoral immune response,132,0.435,0.0102,1,GO:0006959,BP,,468
epithelial to mesenchymal transition,114,0.57,0.0102,1,GO:0001837,BP,,469
response to xenobiotic stimulus,79,0.416,0.0103,1,GO:0009410,BP,,470
regulation of calcium-mediated signaling,70,0.411,0.0103,1,GO:0050848,BP,,471
tertiary granule lumen,45,0.389,0.0103,1,GO:1904724,CC,,472
"DNA damage response, signal transduction by p53 class mediator",94,0.577,0.0104,1,GO:0030330,BP,,473
negative regulation of cell-matrix adhesion,27,0.643,0.0104,1,GO:0001953,BP,,474
hair follicle development,77,0.584,0.0105,1,GO:0001942,BP,,475
dorsal/ventral neural tube patterning,20,0.665,0.0105,1,GO:0021904,BP,,476
SMN-Sm protein complex,14,0.303,0.0106,1,GO:0034719,CC,,477
"DNA catabolic process, endonucleolytic",19,0.669,0.0106,1,GO:0000737,BP,,478
endolysosome,19,0.331,0.0106,1,GO:0036019,CC,,479
regulation of translational fidelity,16,0.316,0.0107,1,GO:0006450,BP,,480
NADH regeneration,23,0.346,0.0108,1,"GO:0006735,GO:0061621,GO:0061718",BP,"canonical glycolysis,glucose catabolic process to pyruvate",481
pyridoxal phosphate binding,48,0.394,0.0108,1,"GO:0030170,GO:0070279",MF,vitamin B6 binding,482
maintenance of protein location in nucleus,14,0.697,0.0109,1,GO:0051457,BP,,483
branching morphogenesis of an epithelial tube,132,0.564,0.0109,1,GO:0048754,BP,,484
nucleus localization,21,0.66,0.0111,1,GO:0051647,BP,,485
regulation of mRNA catabolic process,30,0.634,0.0112,1,GO:0061013,BP,,486
pigment granule organization,25,0.353,0.0112,1,GO:0048753,BP,,487
regulation of T cell mediated immunity,41,0.614,0.0114,1,GO:0002709,BP,,488
intrinsic component of organelle membrane,156,0.441,0.0114,1,GO:0031300,CC,,489
hippo signaling,32,0.629,0.0114,1,GO:0035329,BP,,490
"preribosome, large subunit precursor",17,0.323,0.0114,1,GO:0030687,CC,,491
regulation of adaptive immune response,99,0.574,0.0114,1,GO:0002819,BP,,492
neuroblast proliferation,49,0.604,0.0116,1,GO:0007405,BP,,493
negative regulation of DNA recombination,19,0.667,0.0116,1,GO:0045910,BP,,494
collateral sprouting,24,0.649,0.0116,1,GO:0048668,BP,,495
transmembrane receptor protein serine/threonine kinase activity,15,0.688,0.0116,1,GO:0004675,MF,,496
protein targeting to lysosome,17,0.677,0.0116,1,GO:0006622,BP,,497
histone H3-K9 demethylation,11,0.72,0.0117,1,GO:0033169,BP,,498
glycerophospholipid biosynthetic process,199,0.552,0.0117,1,GO:0046474,BP,,499
chromatin silencing,78,0.583,0.0117,1,GO:0006342,BP,,500
ribonucleoprotein complex export from nucleus,109,0.57,0.0117,1,GO:0071426,BP,,501
miRNA mediated inhibition of translation,12,0.71,0.0117,1,"GO:0035278,GO:0040033,GO:0045974",BP,"negative regulation of translation, ncRNA-mediated,regulation of translation, ncRNA-mediated",502
hormone-mediated signaling pathway,187,0.554,0.0118,1,GO:0009755,BP,,503
nucleoside diphosphate kinase activity,18,0.328,0.0118,1,GO:0004550,MF,,504
cellular amino acid catabolic process,102,0.428,0.0118,1,GO:0009063,BP,,505
microtubule organizing center localization,23,0.652,0.0119,1,GO:0061842,BP,,506
NAD metabolic process,64,0.409,0.0121,1,GO:0019674,BP,,507
cell-substrate adherens junction assembly,66,0.589,0.0121,1,"GO:0007045,GO:0048041",BP,focal adhesion assembly,508
nucleoside diphosphate metabolic process,101,0.428,0.0122,1,GO:0009132,BP,,509
positive regulation of canonical Wnt signaling pathway,113,0.432,0.0122,1,GO:0090263,BP,,510
exocytic vesicle,146,0.44,0.0122,1,GO:0070382,CC,,511
cranial skeletal system development,55,0.597,0.0125,1,GO:1904888,BP,,512
regulation of mRNA processing,85,0.578,0.0125,1,GO:0050684,BP,,513
embryonic cranial skeleton morphogenesis,42,0.611,0.0125,1,GO:0048701,BP,,514
plasma membrane raft,83,0.579,0.0125,1,GO:0044853,CC,,515
regulation of gene expression by genetic imprinting,13,0.7,0.0127,1,GO:0006349,BP,,516
DNA alkylation,50,0.602,0.0127,1,"GO:0006305,GO:0006306",BP,DNA methylation,517
neuron projection terminus,120,0.434,0.0129,1,GO:0044306,CC,,518
single-stranded RNA binding,63,0.59,0.0131,1,GO:0003727,MF,,519
cellular response to hypoxia,171,0.445,0.0131,1,GO:0071456,BP,,520
cellular response to decreased oxygen levels,178,0.446,0.0132,1,GO:0036294,BP,,521
catecholamine transport,55,0.404,0.0135,1,GO:0051937,BP,,522
embryonic heart tube morphogenesis,58,0.594,0.0135,1,GO:0003143,BP,,523
establishment of protein localization to telomere,13,0.302,0.0136,1,GO:0070200,BP,,524
carboxylic ester hydrolase activity,113,0.433,0.0136,1,GO:0052689,MF,,525
histone H3-K9 modification,34,0.622,0.0139,1,GO:0061647,BP,,526
transferrin transport,33,0.376,0.014,1,GO:0033572,BP,,527
alpha-amino acid metabolic process,196,0.449,0.014,1,GO:1901605,BP,,528
oxygen binding,30,0.37,0.0141,1,GO:0019825,MF,,529
"transcriptional repressor activity, RNA polymerase II transcription factor binding",76,0.581,0.0142,1,GO:0001191,MF,,530
negative regulation of cell morphogenesis involved in differentiation,75,0.582,0.0142,1,GO:0010771,BP,,531
transcription from RNA polymerase III promoter,48,0.398,0.0143,1,GO:0006383,BP,,532
morphogenesis of a branching epithelium,157,0.557,0.0144,1,GO:0061138,BP,,533
U4/U6 x U5 tri-snRNP complex,18,0.333,0.0144,1,GO:0046540,CC,,534
glycolytic process through fructose-6-phosphate,24,0.356,0.0145,1,"GO:0061615,GO:0061620",BP,glycolytic process through glucose-6-phosphate,535
acrosomal membrane,19,0.662,0.0146,1,GO:0002080,CC,,536
transcription coactivator binding,17,0.671,0.0146,1,GO:0001223,MF,,537
mesenchymal cell differentiation,166,0.555,0.0146,1,GO:0048762,BP,,538
skin epidermis development,83,0.578,0.0147,1,GO:0098773,BP,,539
melanosome organization,24,0.356,0.0147,1,GO:0032438,BP,,540
xenobiotic metabolic process,70,0.416,0.0148,1,GO:0006805,BP,,541
cytoskeleton-dependent cytokinesis,41,0.61,0.0148,1,GO:0061640,BP,,542
solute:cation symporter activity,78,0.58,0.015,1,GO:0015294,MF,,543
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,90,0.574,0.015,1,GO:0002822,BP,,544
transforming growth factor beta receptor signaling pathway,156,0.557,0.015,1,GO:0007179,BP,,545
magnesium ion transport,17,0.67,0.015,1,GO:0015693,BP,,546
nuclear envelope organization,77,0.58,0.015,1,GO:0006998,BP,,547
MHC class II protein complex,16,0.325,0.0151,1,GO:0042613,CC,,548
proton-transporting V-type ATPase complex,22,0.35,0.0152,1,GO:0033176,CC,,549
guanosine-containing compound biosynthetic process,14,0.313,0.0152,1,GO:1901070,BP,,550
histone deacetylase binding,89,0.574,0.0153,1,GO:0042826,MF,,551
multicellular organism growth,123,0.563,0.0153,1,GO:0035264,BP,,552
metanephric nephron morphogenesis,24,0.643,0.0154,1,GO:0072273,BP,,553
mitochondrial respiratory chain complex IV,10,0.279,0.0154,1,GO:0005751,CC,,554
cargo loading into vesicle,10,0.721,0.0154,1,GO:0035459,BP,,555
ligand-dependent nuclear receptor binding,20,0.656,0.0156,1,GO:0016922,MF,,556
SMN complex,11,0.29,0.0159,1,GO:0032797,CC,,557
extracellular matrix assembly,26,0.636,0.016,1,GO:0085029,BP,,558
negative regulation of cell junction assembly,20,0.656,0.016,1,GO:1901889,BP,,559
branching involved in blood vessel morphogenesis,25,0.639,0.0161,1,GO:0001569,BP,,560
nucleotide-binding oligomerization domain containing 2 signaling pathway,11,0.709,0.0162,1,GO:0070431,BP,,561
ribonucleoprotein complex localization,110,0.566,0.0164,1,GO:0071166,BP,,562
negative regulation of G1/S transition of mitotic cell cycle,83,0.576,0.0164,1,GO:2000134,BP,,563
negative regulation of lipid localization,30,0.627,0.0164,1,GO:1905953,BP,,564
nuclear pore complex assembly,10,0.719,0.0164,1,GO:0051292,BP,,565
collagen binding,57,0.592,0.0164,1,GO:0005518,MF,,566
negative regulation of gene silencing,19,0.659,0.0165,1,GO:0060969,BP,,567
axon terminus,105,0.432,0.0165,1,GO:0043679,CC,,568
DNA integrity checkpoint,139,0.559,0.0166,1,GO:0031570,BP,,569
positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,26,0.636,0.0167,1,GO:1901522,BP,,570
negative regulation of Wnt signaling pathway,183,0.449,0.0167,1,GO:0030178,BP,,571
cellular potassium ion transport,173,0.447,0.0167,1,"GO:0071804,GO:0071805",BP,potassium ion transmembrane transport,572
filamin binding,13,0.308,0.0168,1,GO:0031005,MF,,573
COPII-coated vesicle budding,56,0.408,0.0169,1,GO:0090114,BP,,574
anterograde axonal transport,29,0.372,0.017,1,GO:0008089,BP,,575
regulation of glucose transport,90,0.573,0.017,1,GO:0010827,BP,,576
cellular response to oxygen radical,21,0.35,0.017,1,"GO:0071450,GO:0071451",BP,cellular response to superoxide,577
T cell mediated cytotoxicity,24,0.641,0.0172,1,GO:0001913,BP,,578
positive regulation of histone methylation,29,0.628,0.0172,1,GO:0031062,BP,,579
negative regulation of amine transport,22,0.353,0.0173,1,GO:0051953,BP,,580
paranode region of axon,11,0.707,0.0173,1,GO:0033270,CC,,581
protein kinase complex,90,0.573,0.0174,1,GO:1902911,CC,,582
cellular response to oxygen levels,185,0.449,0.0175,1,GO:0071453,BP,,583
MCM complex,11,0.707,0.0177,1,GO:0042555,CC,,584
outer mitochondrial membrane protein complex,12,0.302,0.0178,1,GO:0098799,CC,,585
DNA catabolic process,26,0.634,0.0178,1,GO:0006308,BP,,586
neural tube formation,92,0.572,0.0178,1,GO:0001841,BP,,587
ATPase coupled ion transmembrane transporter activity,66,0.416,0.0178,1,GO:0042625,MF,,588
cell cycle checkpoint,190,0.55,0.0178,1,GO:0000075,BP,,589
response to mineralocorticoid,30,0.375,0.018,1,GO:0051385,BP,,590
negative regulation of cell cycle G1/S phase transition,85,0.574,0.018,1,GO:1902807,BP,,591
alpha-amino acid catabolic process,88,0.427,0.018,1,GO:1901606,BP,,592
nuclear membrane part,13,0.689,0.018,1,GO:0044453,CC,,593
nucleus organization,124,0.562,0.018,1,GO:0006997,BP,,594
N-glycan processing,17,0.666,0.0181,1,GO:0006491,BP,,595
regulation of protein dephosphorylation,60,0.412,0.0181,1,GO:0035304,BP,,596
lateral plasma membrane,49,0.598,0.0182,1,GO:0016328,CC,,597
artery morphogenesis,52,0.595,0.0183,1,GO:0048844,BP,,598
polyamine biosynthetic process,13,0.311,0.0184,1,GO:0006596,BP,,599
transport vesicle membrane,159,0.446,0.0185,1,GO:0030658,CC,,600
insulin receptor substrate binding,11,0.705,0.0186,1,GO:0043560,MF,,601
metanephric renal vesicle morphogenesis,14,0.682,0.0186,1,GO:0072283,BP,,602
lactate metabolic process,12,0.304,0.0187,1,GO:0006089,BP,,603
regulation of cellular respiration,21,0.352,0.0187,1,GO:0043457,BP,,604
detection of chemical stimulus involved in sensory perception of bitter taste,17,0.665,0.0187,1,GO:0001580,BP,,605
RNA polyadenylation,35,0.615,0.0187,1,GO:0043631,BP,,606
90S preribosome,25,0.364,0.0188,1,GO:0030686,CC,,607
transforming growth factor beta binding,17,0.665,0.0188,1,GO:0050431,MF,,608
histone lysine methylation,89,0.572,0.0188,1,GO:0034968,BP,,609
neural tube closure,79,0.576,0.0189,1,GO:0001843,BP,,610
Rho guanyl-nucleotide exchange factor activity,76,0.578,0.0189,1,GO:0005089,MF,,611
synaptic vesicle,133,0.441,0.019,1,GO:0008021,CC,,612
centriole assembly,28,0.628,0.019,1,GO:0098534,BP,,613
cellular polysaccharide metabolic process,77,0.423,0.0192,1,GO:0044264,BP,,614
CCR4-NOT complex,13,0.687,0.0193,1,GO:0030014,CC,,615
embryonic epithelial tube formation,109,0.565,0.0193,1,GO:0001838,BP,,616
mitogen-activated protein kinase binding,22,0.644,0.0197,1,GO:0051019,MF,,617
protein targeting to ER,94,0.43,0.0197,1,GO:0045047,BP,,618
negative regulation of morphogenesis of an epithelium,16,0.668,0.0198,1,GO:1905331,BP,,619
gonad development,169,0.552,0.0198,1,GO:0008406,BP,,620
regulation of sister chromatid cohesion,20,0.65,0.0198,1,GO:0007063,BP,,621
disulfide oxidoreductase activity,35,0.386,0.0199,1,GO:0015036,MF,,622
SMAD protein import into nucleus,22,0.643,0.0199,1,GO:0007184,BP,,623
"oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor",13,0.314,0.02,1,GO:0016668,MF,,624
dopamine transport,34,0.385,0.0201,1,GO:0015872,BP,,625
centrosome localization,22,0.643,0.0202,1,GO:0051642,BP,,626
negative regulation of viral process,91,0.57,0.0204,1,GO:0048525,BP,,627
T cell cytokine production,20,0.65,0.0204,1,GO:0002369,BP,,628
stem cell proliferation,98,0.568,0.0204,1,GO:0072089,BP,,629
ATP hydrolysis coupled ion transmembrane transport,62,0.415,0.0205,1,GO:0099131,BP,,630
heart looping,53,0.592,0.0205,1,GO:0001947,BP,,631
striated muscle thin filament,13,0.315,0.0208,1,GO:0005865,CC,,632
nucleoside diphosphate phosphorylation,78,0.424,0.0209,1,GO:0006165,BP,,633
structural constituent of nuclear pore,16,0.667,0.0209,1,GO:0017056,MF,,634
cofactor catabolic process,17,0.338,0.0209,1,GO:0051187,BP,,635
tube closure,80,0.575,0.0209,1,GO:0060606,BP,,636
phospholipase C-activating G-protein coupled receptor signaling pathway,80,0.425,0.021,1,GO:0007200,BP,,637
regulation of ventricular cardiac muscle cell action potential,13,0.685,0.021,1,GO:0098911,BP,,638
symporter activity,112,0.563,0.0211,1,GO:0015293,MF,,639
"nucleotide-excision repair, DNA duplex unwinding",20,0.351,0.0212,1,GO:0000717,BP,,640
regulation of histone methylation,49,0.595,0.0213,1,GO:0031060,BP,,641
epidermis morphogenesis,26,0.63,0.0213,1,GO:0048730,BP,,642
nucleosome assembly,88,0.571,0.0214,1,GO:0006334,BP,,643
negative regulation of sodium ion transmembrane transporter activity,10,0.29,0.0214,1,GO:2000650,BP,,644
"nucleotide-excision repair, preincision complex assembly",26,0.37,0.0214,1,GO:0006294,BP,,645
regulation of cGMP biosynthetic process,19,0.348,0.0215,1,GO:0030826,BP,,646
synaptic cleft,10,0.29,0.0216,1,GO:0043083,CC,,647
respiratory tube development,162,0.552,0.0216,1,GO:0030323,BP,,648
1-acylglycerol-3-phosphate O-acyltransferase activity,18,0.656,0.0216,1,"GO:0003841,GO:0042171,GO:0071617",MF,"lysophosphatidic acid acyltransferase activity,lysophospholipid acyltransferase activity",649
response to toxic substance,187,0.451,0.0218,1,GO:0009636,BP,,650
positive regulation of cellular protein catabolic process,176,0.45,0.0218,1,GO:1903364,BP,,651
single-organism carbohydrate catabolic process,125,0.44,0.0218,1,GO:0044724,BP,,652
vesicle coating,54,0.41,0.0221,1,GO:0006901,BP,,653
signal transduction involved in DNA integrity checkpoint,56,0.588,0.0222,1,"GO:0072401,GO:0072422",BP,signal transduction involved in DNA damage checkpoint,654
regulation of cell-matrix adhesion,90,0.57,0.0223,1,GO:0001952,BP,,655
regulation of oxidative phosphorylation,16,0.335,0.0223,1,GO:0002082,BP,,656
multivesicular body assembly,26,0.371,0.0223,1,GO:0036258,BP,,657
catechol-containing compound biosynthetic process,19,0.349,0.0223,1,"GO:0009713,GO:0042423",BP,catecholamine biosynthetic process,658
cellular modified amino acid catabolic process,21,0.356,0.0224,1,GO:0042219,BP,,659
core promoter sequence-specific DNA binding,95,0.568,0.0224,1,GO:0001046,MF,,660
chromatin assembly or disassembly,128,0.559,0.0224,1,GO:0006333,BP,,661
miRNA metabolic process,17,0.66,0.0225,1,GO:0010586,BP,,662
signal transduction involved in mitotic cell cycle checkpoint,54,0.59,0.0225,1,"GO:0072413,GO:1902402,GO:1902403",BP,"signal transduction involved in mitotic DNA damage checkpoint,signal transduction involved in mitotic DNA integrity checkpoint",663
growth factor binding,119,0.561,0.0226,1,GO:0019838,MF,,664
cardiac ventricle development,101,0.566,0.0227,1,GO:0003231,BP,,665
myelin maintenance,12,0.69,0.0228,1,GO:0043217,BP,,666
regulation of bicellular tight junction assembly,14,0.676,0.0229,1,GO:2000810,BP,,667
microtubule organizing center part,143,0.555,0.0229,1,GO:0044450,CC,,668
carbohydrate catabolic process,130,0.442,0.0229,1,GO:0016052,BP,,669
UTP biosynthetic process,11,0.302,0.0229,1,GO:0006228,BP,,670
dendrite morphogenesis,114,0.562,0.023,1,GO:0048813,BP,,671
embryonic eye morphogenesis,28,0.624,0.023,1,GO:0048048,BP,,672
phospholipid transporter activity,44,0.599,0.0231,1,GO:0005548,MF,,673
artery development,72,0.577,0.0232,1,GO:0060840,BP,,674
"Wnt signaling pathway, calcium modulating pathway",37,0.608,0.0232,1,GO:0007223,BP,,675
regulation of dendrite morphogenesis,70,0.579,0.0233,1,GO:0048814,BP,,676
tRNA export from nucleus,30,0.62,0.0233,1,"GO:0006409,GO:0071431",BP,tRNA-containing ribonucleoprotein complex export from nucleus,677
ectodermal placode development,16,0.664,0.0233,1,GO:0071696,BP,,678
regulation of glutamate receptor signaling pathway,34,0.388,0.0234,1,GO:1900449,BP,,679
endolysosome membrane,13,0.319,0.0236,1,GO:0036020,CC,,680
nucleotide-sugar biosynthetic process,21,0.357,0.0237,1,GO:0009226,BP,,681
negative regulation of cell projection organization,138,0.556,0.0237,1,GO:0031345,BP,,682
regulation of respiratory gaseous exchange,19,0.65,0.0237,1,GO:0043576,BP,,683
pigment granule localization,25,0.369,0.0237,1,GO:0051875,BP,,684
endosome organization,65,0.419,0.0237,1,GO:0007032,BP,,685
amino sugar metabolic process,32,0.384,0.0238,1,GO:0006040,BP,,686
serine/threonine protein kinase complex,76,0.575,0.0238,1,GO:1902554,CC,,687
axo-dendritic transport,43,0.4,0.0238,1,GO:0008088,BP,,688
establishment or maintenance of apical/basal cell polarity,36,0.609,0.0239,1,"GO:0035088,GO:0061245",BP,establishment or maintenance of bipolar cell polarity,689
post-embryonic animal morphogenesis,10,0.706,0.024,1,GO:0009886,BP,,690
stem cell population maintenance,132,0.557,0.024,1,GO:0019827,BP,,691
regulation of nuclear-transcribed mRNA poly(A) tail shortening,11,0.697,0.024,1,"GO:0060211,GO:0060213",BP,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,692
sterol biosynthetic process,49,0.407,0.024,1,GO:0016126,BP,,693
ventricular trabecula myocardium morphogenesis,15,0.668,0.024,1,GO:0003222,BP,,694
urea cycle,10,0.294,0.024,1,"GO:0000050,GO:0019627",BP,urea metabolic process,695
apoptotic process involved in morphogenesis,20,0.646,0.024,1,GO:0060561,BP,,696
activation of MAPKK activity,46,0.596,0.0242,1,GO:0000186,BP,,697
negative regulation of neuron projection development,115,0.561,0.0243,1,GO:0010977,BP,,698
cardiac right ventricle morphogenesis,14,0.674,0.0243,1,GO:0003215,BP,,699
dicarboxylic acid catabolic process,14,0.326,0.0244,1,GO:0043649,BP,,700
removal of superoxide radicals,20,0.355,0.0244,1,GO:0019430,BP,,701
protein targeting to membrane,173,0.45,0.0245,1,GO:0006612,BP,,702
regulation of dendrite extension,19,0.351,0.0246,1,GO:1903859,BP,,703
voltage-gated ion channel activity,175,0.451,0.0247,1,"GO:0005244,GO:0022832",MF,voltage-gated channel activity,704
nucleotide-sugar metabolic process,33,0.387,0.0248,1,GO:0009225,BP,,705
embryonic axis specification,28,0.623,0.0248,1,GO:0000578,BP,,706
synaptic vesicle transport,123,0.441,0.025,1,"GO:0048489,GO:0097480,GO:0099003",BP,"establishment of synaptic vesicle localization,vesicle-mediated transport in synapse",707
"transcription factor activity, RNA polymerase II transcription factor binding",131,0.557,0.025,1,GO:0001076,MF,,708
lysosome localization,57,0.414,0.025,1,GO:0032418,BP,,709
AP-3 adaptor complex,10,0.295,0.0251,1,GO:0030123,CC,,710
"vesicle targeting, rough ER to cis-Golgi",53,0.411,0.0252,1,"GO:0048207,GO:0048208",BP,COPII vesicle coating,711
integral component of mitochondrial outer membrane,21,0.359,0.0253,1,GO:0031307,CC,,712
histone demethylase activity (H3-K9 specific),10,0.704,0.0253,1,GO:0032454,MF,,713
mRNA polyadenylation,34,0.611,0.0253,1,GO:0006378,BP,,714
miRNA binding,14,0.673,0.0254,1,GO:0035198,MF,,715
amino-acid betaine metabolic process,17,0.344,0.0255,1,GO:0006577,BP,,716
positive regulation of T cell mediated immunity,24,0.632,0.0257,1,GO:0002711,BP,,717
calcium-dependent phospholipid binding,37,0.394,0.0258,1,GO:0005544,MF,,718
development of primary sexual characteristics,173,0.549,0.0259,1,GO:0045137,BP,,719
structural constituent of myelin sheath,10,0.703,0.026,1,GO:0019911,MF,,720
lung development,158,0.551,0.026,1,GO:0030324,BP,,721
erythrocyte homeostasis,88,0.569,0.026,1,GO:0034101,BP,,722
pore complex assembly,15,0.666,0.026,1,GO:0046931,BP,,723
morphogenesis of embryonic epithelium,132,0.556,0.0262,1,GO:0016331,BP,,724
phenol-containing compound biosynthetic process,37,0.394,0.0262,1,GO:0046189,BP,,725
cellular response to xenobiotic stimulus,74,0.425,0.0263,1,GO:0071466,BP,,726
face morphogenesis,25,0.628,0.0263,1,GO:0060325,BP,,727
negative regulation of neuron differentiation,175,0.549,0.0263,1,GO:0045665,BP,,728
response to UV,115,0.56,0.0263,1,GO:0009411,BP,,729
phosphatidylinositol binding,196,0.546,0.0264,1,GO:0035091,MF,,730
microvillus membrane,17,0.656,0.0264,1,GO:0031528,CC,,731
RNA polymerase II distal enhancer sequence-specific DNA binding,55,0.587,0.0266,1,GO:0000980,MF,,732
positive regulation of endoplasmic reticulum unfolded protein response,12,0.685,0.0266,1,GO:1900103,BP,,733
tRNA transport,31,0.615,0.0266,1,GO:0051031,BP,,734
clathrin binding,55,0.414,0.0267,1,GO:0030276,MF,,735
regulation of PERK-mediated unfolded protein response,10,0.702,0.0268,1,GO:1903897,BP,,736
inositol lipid-mediated signaling,185,0.547,0.0268,1,GO:0048017,BP,,737
response to fluid shear stress,32,0.613,0.0268,1,GO:0034405,BP,,738
synaptic vesicle membrane,66,0.421,0.0269,1,"GO:0030672,GO:0099501",CC,exocytic vesicle membrane,739
respiratory burst,23,0.367,0.0271,1,GO:0045730,BP,,740
ribosome assembly,47,0.407,0.0273,1,GO:0042255,BP,,741
mitotic spindle pole,11,0.692,0.0273,1,GO:0097431,CC,,742
positive regulation of response to endoplasmic reticulum stress,33,0.611,0.0273,1,GO:1905898,BP,,743
regulation of mitochondrial translation,15,0.335,0.0274,1,GO:0070129,BP,,744
negative regulation of sodium ion transport,13,0.323,0.0274,1,GO:0010766,BP,,745
cortical cytoskeleton organization,32,0.613,0.0274,1,GO:0030865,BP,,746
regulation of cardiac muscle cell contraction,32,0.613,0.0274,1,GO:0086004,BP,,747
protein folding,199,0.455,0.0275,1,GO:0006457,BP,,748
positive regulation of acute inflammatory response,22,0.364,0.0276,1,GO:0002675,BP,,749
nucleotide phosphorylation,82,0.43,0.0277,1,GO:0046939,BP,,750
cortical actin cytoskeleton organization,28,0.62,0.0277,1,GO:0030866,BP,,751
signal transduction involved in mitotic G1 DNA damage checkpoint,53,0.587,0.0278,1,"GO:0072431,GO:1902400",BP,intracellular signal transduction involved in G1 DNA damage checkpoint,752
regulation of glial cell differentiation,50,0.59,0.0278,1,GO:0045685,BP,,753
negative regulation of reactive oxygen species biosynthetic process,17,0.654,0.0279,1,GO:1903427,BP,,754
negative regulation of bone mineralization,14,0.33,0.0279,1,GO:0030502,BP,,755
positive regulation of monooxygenase activity,23,0.368,0.028,1,GO:0032770,BP,,756
regulation of mesenchymal cell proliferation,33,0.611,0.028,1,GO:0010464,BP,,757
ubiquitin-like protein ligase activity,180,0.548,0.028,1,GO:0061659,MF,,758
isomerase activity,128,0.444,0.0281,1,GO:0016853,MF,,759
enhancer sequence-specific DNA binding,68,0.577,0.0282,1,GO:0001158,MF,,760
interaction with host,165,0.55,0.0282,1,GO:0051701,BP,,761
apoptotic nuclear changes,23,0.632,0.0283,1,GO:0030262,BP,,762
spindle localization,30,0.616,0.0283,1,GO:0051653,BP,,763
erythrocyte differentiation,80,0.571,0.0284,1,GO:0030218,BP,,764
maturation of LSU-rRNA,18,0.351,0.0284,1,GO:0000470,BP,,765
cytoplasmic side of plasma membrane,146,0.553,0.0284,1,GO:0009898,CC,,766
linoleic acid metabolic process,17,0.653,0.0285,1,GO:0043651,BP,,767
monocyte chemotactic protein-1 production,11,0.691,0.0285,1,"GO:0071605,GO:0071637",BP,regulation of monocyte chemotactic protein-1 production,768
microglial cell activation,14,0.331,0.0286,1,GO:0001774,BP,,769
neural tube patterning,33,0.61,0.0287,1,GO:0021532,BP,,770
alcohol biosynthetic process,89,0.433,0.029,1,GO:0046165,BP,,771
polysaccharide biosynthetic process,62,0.42,0.0292,1,GO:0000271,BP,,772
negative regulation of viral life cycle,71,0.575,0.0295,1,GO:1903901,BP,,773
viral budding via host ESCRT complex,18,0.352,0.0295,1,GO:0039702,BP,,774
"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",52,0.587,0.0297,1,GO:0006977,BP,,775
sphingolipid biosynthetic process,77,0.572,0.0297,1,GO:0030148,BP,,776
phosphatidylinositol-mediated signaling,182,0.547,0.0298,1,GO:0048015,BP,,777
response to oxygen radical,27,0.379,0.0299,1,GO:0000305,BP,,778
mRNA splice site selection,23,0.631,0.0299,1,GO:0006376,BP,,779
antimicrobial humoral response,48,0.409,0.0301,1,GO:0019730,BP,,780
MHC class II receptor activity,10,0.302,0.0302,1,GO:0032395,MF,,781
keratan sulfate metabolic process,30,0.386,0.0306,1,GO:0042339,BP,,782
"vesicle targeting, to, from or within Golgi",57,0.417,0.0306,1,GO:0048199,BP,,783
presynaptic membrane organization,10,0.697,0.0307,1,GO:0097090,BP,,784
transcription-coupled nucleotide-excision repair,60,0.419,0.0308,1,GO:0006283,BP,,785
embryonic pattern specification,52,0.587,0.0308,1,GO:0009880,BP,,786
vascular process in circulatory system,136,0.446,0.0309,1,GO:0003018,BP,,787
exocyst,18,0.647,0.031,1,GO:0000145,CC,,788
AMPA glutamate receptor complex,26,0.378,0.031,1,GO:0032281,CC,,789
phosphatidylinositol-3-phosphatase activity,14,0.666,0.031,1,"GO:0004438,GO:0052744",MF,phosphatidylinositol monophosphate phosphatase activity,790
nuclear export,174,0.548,0.031,1,GO:0051168,BP,,791
chromatin assembly,104,0.561,0.0311,1,GO:0031497,BP,,792
positive regulation of proteolysis involved in cellular protein catabolic process,161,0.451,0.0311,1,GO:1903052,BP,,793
microvillus,65,0.577,0.0312,1,GO:0005902,CC,,794
regulation of smoothened signaling pathway,62,0.579,0.0313,1,GO:0008589,BP,,795
neuron projection membrane,36,0.396,0.0313,1,GO:0032589,CC,,796
primary neural tube formation,85,0.568,0.0313,1,GO:0014020,BP,,797
regulation of morphogenesis of an epithelium,159,0.45,0.0313,1,GO:1905330,BP,,798
endocardial cushion morphogenesis,28,0.617,0.0315,1,GO:0003203,BP,,799
regulation of dopamine metabolic process,17,0.349,0.0316,1,"GO:0042053,GO:0042069",BP,regulation of catecholamine metabolic process,800
magnesium ion transmembrane transport,16,0.655,0.0316,1,"GO:1903830,GO:0015095",BP,magnesium ion transmembrane transporter activity,801
"synaptic transmission, cholinergic",31,0.388,0.0317,1,GO:0007271,BP,,802
macromitophagy,17,0.35,0.0318,1,GO:0000423,BP,,803
quinone binding,17,0.35,0.0318,1,GO:0048038,MF,,804
metaphase plate congression,41,0.403,0.0319,1,GO:0051310,BP,,805
regulation of endoplasmic reticulum unfolded protein response,22,0.632,0.0319,1,GO:1900101,BP,,806
cell-cell contact zone,61,0.579,0.032,1,GO:0044291,CC,,807
"DNA damage response, detection of DNA damage",31,0.389,0.032,1,GO:0042769,BP,,808
signal transduction involved in cell cycle checkpoint,57,0.582,0.0321,1,GO:0072395,BP,,809
RNA polymerase II activating transcription factor binding,32,0.609,0.0324,1,GO:0001102,MF,,810
node of Ranvier,14,0.665,0.0325,1,GO:0033268,CC,,811
circadian regulation of gene expression,52,0.586,0.0326,1,GO:0032922,BP,,812
inward rectifier potassium channel activity,21,0.365,0.0326,1,GO:0005242,MF,,813
histone methylation,109,0.559,0.0328,1,GO:0016571,BP,,814
short-chain fatty acid metabolic process,13,0.329,0.0329,1,GO:0046459,BP,,815
nitric oxide mediated signal transduction,20,0.362,0.0329,1,GO:0007263,BP,,816
regulation of respiratory system process,13,0.671,0.0329,1,GO:0044065,BP,,817
regulation of monooxygenase activity,48,0.411,0.033,1,GO:0032768,BP,,818
regulation of smooth muscle cell proliferation,101,0.561,0.033,1,GO:0048660,BP,,819
polysaccharide catabolic process,26,0.379,0.033,1,GO:0000272,BP,,820
smoothened signaling pathway involved in dorsal/ventral neural tube patterning,14,0.665,0.033,1,GO:0060831,BP,,821
cytoplasmic side of membrane,160,0.549,0.0331,1,GO:0098562,CC,,822
regulation of dendrite development,117,0.557,0.0332,1,GO:0050773,BP,,823
guanyl-nucleotide exchange factor complex,13,0.671,0.0332,1,GO:0032045,CC,,824
pH reduction,46,0.409,0.0333,1,GO:0045851,BP,,825
positive regulation of oxidoreductase activity,37,0.399,0.0334,1,GO:0051353,BP,,826
axis elongation,27,0.618,0.0337,1,GO:0003401,BP,,827
cell-cell adhesion via plasma-membrane adhesion molecules,186,0.545,0.0337,1,GO:0098742,BP,,828
epithelial cell differentiation involved in kidney development,42,0.595,0.0337,1,GO:0035850,BP,,829
1-phosphatidylinositol-3-kinase activity,38,0.6,0.0338,1,GO:0016303,MF,,830
mesenchymal cell proliferation,44,0.593,0.0338,1,GO:0010463,BP,,831
cellular component disassembly involved in execution phase of apoptosis,25,0.623,0.0339,1,GO:0006921,BP,,832
spindle organization,131,0.554,0.034,1,GO:0007051,BP,,833
dendritic spine morphogenesis,45,0.591,0.0344,1,GO:0060997,BP,,834
GTP-dependent protein binding,21,0.367,0.0348,1,GO:0030742,MF,,835
synaptic vesicle localization,130,0.446,0.0348,1,GO:0097479,BP,,836
nucleosome organization,112,0.558,0.0348,1,GO:0034728,BP,,837
mitotic G1 DNA damage checkpoint,60,0.579,0.0349,1,"GO:0031571,GO:0044819",BP,mitotic G1/S transition checkpoint,838
nuclear localization sequence binding,22,0.63,0.0349,1,GO:0008139,MF,,839
NLS-bearing protein import into nucleus,21,0.633,0.0349,1,GO:0006607,BP,,840
cellular response to transforming growth factor beta stimulus,200,0.543,0.0349,1,GO:0071560,BP,,841
regulation of cell shape,134,0.553,0.0349,1,GO:0008360,BP,,842
renal vesicle morphogenesis,17,0.648,0.035,1,GO:0072077,BP,,843
non-canonical Wnt signaling pathway,139,0.448,0.0351,1,GO:0035567,BP,,844
response to fungus,29,0.387,0.0351,1,GO:0009620,BP,,845
apoptotic DNA fragmentation,15,0.657,0.0351,1,GO:0006309,BP,,846
integral component of nuclear inner membrane,12,0.676,0.0351,1,"GO:0005639,GO:0031229",CC,intrinsic component of nuclear inner membrane,847
anion:cation symporter activity,36,0.602,0.0352,1,GO:0015296,MF,,848
intrinsic component of mitochondrial outer membrane,22,0.37,0.0353,1,GO:0031306,CC,,849
negative regulation of cell adhesion,195,0.544,0.0353,1,GO:0007162,BP,,850
positive regulation of release of cytochrome c from mitochondria,26,0.381,0.0353,1,GO:0090200,BP,,851
smoothened signaling pathway,112,0.558,0.0354,1,GO:0007224,BP,,852
COP9 signalosome,30,0.389,0.0355,1,GO:0008180,CC,,853
regulation of epithelial cell differentiation,105,0.559,0.0355,1,GO:0030856,BP,,854
mismatch repair complex,10,0.692,0.0356,1,GO:0032300,CC,,855
regulation of insulin receptor signaling pathway,45,0.591,0.0357,1,GO:0046626,BP,,856
intramolecular transferase activity,24,0.376,0.0357,1,GO:0016866,MF,,857
Fc receptor signaling pathway,174,0.454,0.0357,1,GO:0038093,BP,,858
protein hydroxylation,20,0.636,0.0358,1,GO:0018126,BP,,859
cytokinetic process,18,0.643,0.0362,1,GO:0032506,BP,,860
cellular lipid catabolic process,157,0.451,0.0364,1,GO:0044242,BP,,861
cytosolic ribosome,104,0.441,0.0364,1,GO:0022626,CC,,862
skeletal muscle cell proliferation,11,0.682,0.0365,1,GO:0014856,BP,,863
melanosome localization,24,0.377,0.0365,1,GO:0032400,BP,,864
skeletal muscle satellite cell proliferation,10,0.691,0.0365,1,GO:0014841,BP,,865
protein homotetramerization,60,0.422,0.0366,1,GO:0051289,BP,,866
positive regulation of cGMP metabolic process,19,0.362,0.0367,1,GO:0030825,BP,,867
maintenance of cell number,135,0.552,0.0368,1,GO:0098727,BP,,868
regulation of histone phosphorylation,12,0.326,0.0368,1,GO:0033127,BP,,869
unfolded protein binding,91,0.437,0.0369,1,GO:0051082,MF,,870
secondary metabolic process,41,0.406,0.037,1,GO:0019748,BP,,871
palmitoyltransferase complex,11,0.681,0.0372,1,GO:0002178,CC,,872
multivesicular body organization,27,0.384,0.0373,1,GO:0036257,BP,,873
peptide hormone binding,32,0.606,0.0373,1,GO:0017046,MF,,874
mitochondrial respiratory chain complex IV biogenesis,15,0.345,0.0373,1,GO:0097034,BP,,875
phosphatidic acid biosynthetic process,32,0.606,0.0375,1,"GO:0006654,GO:0046473",BP,phosphatidic acid metabolic process,876
lung alveolus development,29,0.611,0.0378,1,GO:0048286,BP,,877
positive regulation of mitophagy,20,0.366,0.0378,1,GO:1903599,BP,,878
ATP hydrolysis coupled transmembrane transport,67,0.427,0.0379,1,GO:0090662,BP,,879
protein export from nucleus,159,0.548,0.038,1,GO:0006611,BP,,880
polarized epithelial cell differentiation,11,0.681,0.038,1,GO:0030859,BP,,881
regulation of mRNA stability,127,0.447,0.038,1,GO:0043488,BP,,882
negative regulation of adherens junction organization,16,0.65,0.038,1,GO:1903392,BP,,883
"negative regulation of CD4-positive, alpha-beta T cell activation",14,0.66,0.0381,1,GO:2000515,BP,,884
establishment or maintenance of epithelial cell apical/basal polarity,30,0.609,0.0382,1,GO:0045197,BP,,885
embryonic skeletal system morphogenesis,71,0.571,0.0382,1,GO:0048704,BP,,886
vitamin binding,117,0.444,0.0382,1,GO:0019842,MF,,887
transcription initiation from RNA polymerase I promoter,30,0.391,0.0383,1,GO:0006361,BP,,888
positive regulation of endothelial cell differentiation,14,0.66,0.0384,1,GO:0045603,BP,,889
regulation of RNA stability,134,0.448,0.0386,1,GO:0043487,BP,,890
outflow tract morphogenesis,64,0.575,0.0388,1,GO:0003151,BP,,891
phosphatidylinositol phosphorylation,87,0.564,0.0388,1,GO:0046854,BP,,892
sister chromatid segregation,186,0.544,0.0388,1,GO:0000819,BP,,893
regulation of extrinsic apoptotic signaling pathway via death domain receptors,47,0.587,0.0389,1,GO:1902041,BP,,894
positive regulation of striated muscle contraction,13,0.335,0.0389,1,GO:0045989,BP,,895
centriole replication,26,0.617,0.0389,1,GO:0007099,BP,,896
regulation of stem cell population maintenance,19,0.637,0.0391,1,GO:2000036,BP,,897
ketone body metabolic process,11,0.32,0.0391,1,GO:1902224,BP,,898
coenzyme biosynthetic process,142,0.45,0.0391,1,GO:0009108,BP,,899
mitophagy,72,0.43,0.0392,1,"GO:0000422,GO:0061726",BP,mitochondrion disassembly,900
maintenance of organelle location,10,0.688,0.0393,1,GO:0051657,BP,,901
postsynaptic density organization,13,0.665,0.0393,1,"GO:0097106,GO:0099084",BP,postsynaptic specialization organization,902
cellular response to prostaglandin stimulus,18,0.36,0.0394,1,GO:0071379,BP,,903
potassium ion transport,199,0.458,0.0395,1,GO:0006813,BP,,904
regulation of cellular response to heat,70,0.571,0.0396,1,GO:1900034,BP,,905
compact myelin,14,0.659,0.0396,1,GO:0043218,CC,,906
cardiac septum morphogenesis,55,0.58,0.04,1,GO:0060411,BP,,907
oxaloacetate metabolic process,12,0.329,0.04,1,GO:0006107,BP,,908
osteoblast proliferation,23,0.624,0.04,1,GO:0033687,BP,,909
bicarbonate transmembrane transporter activity,18,0.64,0.0401,1,GO:0015106,MF,,910
smooth muscle cell proliferation,104,0.558,0.0402,1,GO:0048659,BP,,911
sulfur compound catabolic process,45,0.412,0.0403,1,GO:0044273,BP,,912
rRNA binding,50,0.416,0.0403,1,GO:0019843,MF,,913
secondary active transmembrane transporter activity,188,0.543,0.0405,1,GO:0015291,MF,,914
regulation of lymphocyte mediated immunity,90,0.563,0.0406,1,GO:0002706,BP,,915
positive regulation of nucleocytoplasmic transport,105,0.558,0.0406,1,GO:0046824,BP,,916
positive regulation of dendrite morphogenesis,30,0.608,0.0406,1,GO:0050775,BP,,917
regulation of gene silencing,53,0.581,0.0407,1,GO:0060968,BP,,918
maintenance of protein localization in organelle,27,0.614,0.0407,1,GO:0072595,BP,,919
glutamine family amino acid catabolic process,23,0.377,0.0408,1,GO:0009065,BP,,920
azurophil granule lumen,73,0.431,0.0408,1,GO:0035578,CC,,921
"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen",127,0.553,0.0408,1,GO:0016705,MF,,922
positive regulation of I-kappaB kinase/NF-kappaB signaling,156,0.548,0.0409,1,GO:0043123,BP,,923
aminoacyl-tRNA editing activity,12,0.33,0.041,1,GO:0002161,MF,,924
"negative regulation of CD4-positive, alpha-beta T cell differentiation",11,0.678,0.0412,1,GO:0043371,BP,,925
regulation of nephron tubule epithelial cell differentiation,11,0.678,0.0412,1,GO:0072182,BP,,926
detection of chemical stimulus involved in sensory perception of taste,21,0.628,0.0416,1,GO:0050912,BP,,927
amine catabolic process,23,0.377,0.0418,1,GO:0009310,BP,,928
oxidoreduction coenzyme metabolic process,135,0.449,0.0418,1,GO:0006733,BP,,929
adenyl-nucleotide exchange factor activity,10,0.314,0.0419,1,GO:0000774,MF,,930
bicellular tight junction assembly,43,0.59,0.0422,1,GO:0070830,BP,,931
regulation of triglyceride metabolic process,23,0.378,0.0422,1,GO:0090207,BP,,932
oligodendrocyte development,35,0.599,0.0423,1,GO:0014003,BP,,933
protein localization to Golgi apparatus,23,0.622,0.0423,1,GO:0034067,BP,,934
recombinational repair,84,0.564,0.0425,1,GO:0000725,BP,,935
regulation of neurotransmitter receptor activity,34,0.399,0.0426,1,GO:0099601,BP,,936
negative regulation of viral genome replication,42,0.59,0.0427,1,GO:0045071,BP,,937
negative regulation of translation,141,0.55,0.0428,1,GO:0017148,BP,,938
cell-cell adherens junction,79,0.566,0.0428,1,GO:0005913,CC,,939
promoter-specific chromatin binding,25,0.617,0.0429,1,GO:1990841,MF,,940
negative regulation of developmental growth,69,0.571,0.043,1,GO:0048640,BP,,941
sphingolipid catabolic process,17,0.358,0.0431,1,GO:0030149,BP,,942
actin-based cell projection,166,0.546,0.0431,1,GO:0098858,CC,,943
negative regulation of autophagosome assembly,10,0.315,0.0432,1,GO:1902902,BP,,944
protein deglycosylation,30,0.607,0.0432,1,GO:0006517,BP,,945
mitotic spindle,58,0.577,0.0433,1,GO:0072686,CC,,946
nephron morphogenesis,67,0.571,0.0433,1,GO:0072028,BP,,947
ferric iron transport,36,0.403,0.0435,1,"GO:0015682,GO:0072512",BP,trivalent inorganic cation transport,948
neuropeptide receptor activity,34,0.4,0.0437,1,GO:0008188,MF,,949
establishment of pigment granule localization,23,0.379,0.0438,1,GO:0051905,BP,,950
aorta development,48,0.584,0.044,1,GO:0035904,BP,,951
negative regulation of smoothened signaling pathway,25,0.616,0.044,1,GO:0045879,BP,,952
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,171,0.545,0.0442,1,GO:0002460,BP,,953
secondary alcohol biosynthetic process,45,0.413,0.0443,1,GO:1902653,BP,,954
PcG protein complex,36,0.597,0.0444,1,GO:0031519,CC,,955
membrane lipid catabolic process,19,0.367,0.0447,1,GO:0046466,BP,,956
otic vesicle development,13,0.661,0.0447,1,GO:0071599,BP,,957
regulation of macromitophagy,14,0.345,0.0447,1,GO:1901524,BP,,958
cellular response to heat,99,0.558,0.0448,1,GO:0034605,BP,,959
helicase activity,136,0.55,0.0448,1,GO:0004386,MF,,960
DNA-dependent DNA replication maintenance of fidelity,28,0.609,0.045,1,GO:0045005,BP,,961
determination of heart left/right asymmetry,57,0.577,0.045,1,GO:0061371,BP,,962
monocyte chemotaxis,37,0.405,0.0451,1,GO:0002548,BP,,963
negative regulation of axon regeneration,12,0.667,0.0451,1,GO:0048681,BP,,964
RNA polymerase II transcription corepressor activity,25,0.616,0.0452,1,GO:0001106,MF,,965
aggresome,37,0.595,0.0453,1,GO:0016235,CC,,966
response to superoxide,24,0.382,0.0453,1,GO:0000303,BP,,967
regulation of axonogenesis,147,0.548,0.0453,1,GO:0050770,BP,,968
positive regulation of humoral immune response,12,0.333,0.0454,1,GO:0002922,BP,,969
purine deoxyribonucleotide metabolic process,11,0.326,0.0454,1,GO:0009151,BP,,970
regulation of establishment of protein localization to mitochondrion,109,0.444,0.0455,1,GO:1903747,BP,,971
lung morphogenesis,48,0.583,0.0455,1,GO:0060425,BP,,972
intracellular estrogen receptor signaling pathway,40,0.591,0.0456,1,GO:0030520,BP,,973
positive regulation of protein binding,70,0.569,0.0456,1,GO:0032092,BP,,974
pericentriolar material,20,0.629,0.0456,1,GO:0000242,CC,,975
establishment of spindle localization,25,0.615,0.0459,1,GO:0051293,BP,,976
pseudouridine synthesis,17,0.36,0.046,1,GO:0001522,BP,,977
second-messenger-mediated signaling,194,0.458,0.046,1,GO:0019932,BP,,978
mitotic metaphase plate congression,34,0.401,0.0461,1,GO:0007080,BP,,979
ESCRT III complex,10,0.318,0.0462,1,GO:0000815,CC,,980
Sertoli cell differentiation,18,0.636,0.0465,1,GO:0060008,BP,,981
aromatic amino acid family metabolic process,24,0.383,0.0466,1,GO:0009072,BP,,982
disordered domain specific binding,29,0.607,0.0466,1,GO:0097718,MF,,983
cellular response to dsRNA,48,0.583,0.047,1,GO:0071359,BP,,984
monocarboxylic acid catabolic process,99,0.442,0.047,1,GO:0072329,BP,,985
regulation of heart morphogenesis,30,0.605,0.0473,1,GO:2000826,BP,,986
sarcolemma,112,0.554,0.0473,1,GO:0042383,CC,,987
phosphatidylcholine metabolic process,67,0.57,0.0474,1,GO:0046470,BP,,988
dopamine metabolic process,33,0.4,0.0476,1,GO:0042417,BP,,989
killing of cells of other organism,13,0.341,0.0477,1,"GO:0031640,GO:0044364",BP,disruption of cells of other organism,990
acute inflammatory response to antigenic stimulus,18,0.365,0.0477,1,GO:0002438,BP,,991
adenine nucleotide transport,12,0.335,0.0478,1,GO:0051503,BP,,992
vasculogenesis,61,0.573,0.048,1,GO:0001570,BP,,993
positive regulation of ERK1 and ERK2 cascade,144,0.452,0.0481,1,GO:0070374,BP,,994
hair follicle morphogenesis,23,0.619,0.0481,1,GO:0031069,BP,,995
glucose import in response to insulin stimulus,18,0.635,0.0482,1,GO:0044381,BP,,996
carboxypeptidase activity,38,0.593,0.0482,1,GO:0004180,MF,,997
vacuolar proton-transporting V-type ATPase complex,15,0.353,0.0483,1,GO:0016471,CC,,998
positive regulation of protein targeting to mitochondrion,70,0.432,0.0485,1,GO:1903955,BP,,999
mRNA 3'-UTR AU-rich region binding,11,0.672,0.0485,1,GO:0035925,MF,,1000
neutral lipid catabolic process,28,0.392,0.0486,1,"GO:0046461,GO:0046464",BP,acylglycerol catabolic process,1001
strand displacement,20,0.627,0.0487,1,GO:0000732,BP,,1002
dendritic spine development,79,0.564,0.0487,1,GO:0060996,BP,,1003
protein neddylation,13,0.342,0.0487,1,GO:0045116,BP,,1004
endoplasmic reticulum lumen,177,0.543,0.0488,1,GO:0005788,CC,,1005
kidney morphogenesis,81,0.563,0.0489,1,GO:0060993,BP,,1006
purinergic receptor activity,17,0.362,0.0489,1,GO:0035586,MF,,1007
G1 DNA damage checkpoint,61,0.573,0.049,1,GO:0044783,BP,,1008
establishment of protein localization to endoplasmic reticulum,98,0.442,0.0491,1,GO:0072599,BP,,1009
phosphatidylinositol metabolic process,190,0.542,0.0491,1,GO:0046488,BP,,1010
transcriptionally active chromatin,18,0.634,0.0492,1,GO:0035327,CC,,1011
protein binding involved in cell adhesion,36,0.595,0.0492,1,GO:0098631,MF,,1012
myofilament,15,0.353,0.0493,1,GO:0036379,CC,,1013
developmental induction,26,0.611,0.0494,1,GO:0031128,BP,,1014
gastrulation with mouth forming second,26,0.611,0.0494,1,GO:0001702,BP,,1015
pigment granule transport,22,0.379,0.0494,1,GO:0051904,BP,,1016
3'-5' exonuclease activity,44,0.586,0.0495,1,GO:0008408,MF,,1017
nephron tubule epithelial cell differentiation,13,0.657,0.0496,1,GO:0072160,BP,,1018
positive regulation of sequence-specific DNA binding transcription factor activity,198,0.541,0.0496,1,GO:0051091,BP,,1019
hypothalamus development,17,0.362,0.0497,1,GO:0021854,BP,,1020
membrane disassembly,42,0.588,0.0497,1,"GO:0030397,GO:0051081",BP,nuclear envelope disassembly,1021
positive regulation of NF-kappaB transcription factor activity,114,0.553,0.0497,1,GO:0051092,BP,,1022
nephron epithelium development,98,0.557,0.0501,1,GO:0072009,BP,,1023
methylated histone binding,47,0.583,0.0502,1,GO:0035064,MF,,1024
mitotic cytokinesis,33,0.599,0.0503,1,GO:0000281,BP,,1025
aminoacyl-tRNA synthetase multienzyme complex,10,0.321,0.0503,1,GO:0017101,CC,,1026
positive regulation of protein import into nucleus,86,0.561,0.0504,1,GO:0042307,BP,,1027
replication fork processing,25,0.613,0.0505,1,GO:0031297,BP,,1028
DNA double-strand break processing,19,0.63,0.0505,1,GO:0000729,BP,,1029
positive regulation of receptor activity,45,0.416,0.0506,1,GO:2000273,BP,,1030
response to muramyl dipeptide,14,0.651,0.0508,1,GO:0032495,BP,,1031
positive regulation of nitric-oxide synthase activity,17,0.363,0.0509,1,GO:0051000,BP,,1032
damaged DNA binding,50,0.58,0.0509,1,GO:0003684,MF,,1033
regulation of cell-substrate adhesion,164,0.544,0.0509,1,GO:0010810,BP,,1034
"UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity",13,0.344,0.0509,1,GO:0008499,MF,,1035
positive regulation of muscle contraction,37,0.407,0.0511,1,GO:0045933,BP,,1036
keratan sulfate biosynthetic process,26,0.39,0.0512,1,GO:0018146,BP,,1037
organelle disassembly,90,0.44,0.0513,1,GO:1903008,BP,,1038
transmitter-gated ion channel activity,41,0.412,0.0514,1,"GO:0022824,GO:0022835",MF,transmitter-gated channel activity,1039
positive regulation of glucose import,34,0.597,0.0515,1,GO:0046326,BP,,1040
"condensed nuclear chromosome, centromeric region",17,0.636,0.0516,1,GO:0000780,CC,,1041
pore complex,12,0.338,0.0518,1,GO:0046930,CC,,1042
regulation of osteoblast proliferation,21,0.623,0.0518,1,GO:0033688,BP,,1043
negative regulation of dendritic spine development,12,0.662,0.052,1,GO:0061000,BP,,1044
small nucleolar ribonucleoprotein complex,16,0.36,0.0521,1,GO:0005732,CC,,1045
negative regulation of cellular senescence,10,0.677,0.0521,1,GO:2000773,BP,,1046
cellular polysaccharide biosynthetic process,53,0.423,0.0523,1,GO:0033692,BP,,1047
microvillus organization,22,0.619,0.0525,1,GO:0032528,BP,,1048
dorsal/ventral axis specification,15,0.645,0.0526,1,GO:0009950,BP,,1049
regulation of DNA recombination,53,0.577,0.0526,1,GO:0000018,BP,,1050
endocardial cushion development,36,0.593,0.0528,1,GO:0003197,BP,,1051
actin crosslink formation,11,0.332,0.0533,1,GO:0051764,BP,,1052
membrane coat,86,0.44,0.0533,1,"GO:0030117,GO:0048475",CC,coated membrane,1053
establishment of endothelial barrier,35,0.594,0.0537,1,GO:0061028,BP,,1054
regulation of microtubule cytoskeleton organization,122,0.551,0.053900000000000003,1,GO:0070507,BP,,1055
adaptive thermogenesis,10,0.676,0.053900000000000003,1,GO:1990845,BP,,1056
lipid phosphorylation,99,0.556,0.053900000000000003,1,GO:0046834,BP,,1057
centrosome duplication,60,0.572,0.0541,1,GO:0051298,BP,,1058
regulation of amino acid transport,27,0.393,0.0542,1,GO:0051955,BP,,1059
K63-linked polyubiquitin binding,17,0.635,0.0543,1,GO:0070530,MF,,1060
phosphatidylinositol-3-phosphate biosynthetic process,45,0.583,0.0544,1,GO:0036092,BP,,1061
cortical actin cytoskeleton,49,0.579,0.0544,1,GO:0030864,CC,,1062
positive regulation of endothelial cell apoptotic process,13,0.654,0.0546,1,GO:2000353,BP,,1063
integral component of endoplasmic reticulum membrane,127,0.451,0.0547,1,GO:0030176,CC,,1064
Rac guanyl-nucleotide exchange factor activity,15,0.643,0.0548,1,GO:0030676,MF,,1065
phagosome maturation,39,0.411,0.055,1,GO:0090382,BP,,1066
intracellular pH reduction,45,0.417,0.0554,1,GO:0051452,BP,,1067
alpha-mannosidase activity,13,0.653,0.0558,1,GO:0004559,MF,,1068
response to mitochondrial depolarisation,17,0.366,0.0559,1,GO:0098780,BP,,1069
detection of chemical stimulus involved in sensory perception,144,0.546,0.0561,1,GO:0050907,BP,,1070
positive regulation of peptidyl-threonine phosphorylation,24,0.387,0.0562,1,GO:0010800,BP,,1071
pyruvate metabolic process,93,0.443,0.0562,1,GO:0006090,BP,,1072
glycosyl compound catabolic process,34,0.405,0.0563,1,GO:1901658,BP,,1073
regulation of regulated secretory pathway,100,0.445,0.0564,1,GO:1903305,BP,,1074
catecholamine binding,12,0.341,0.0564,1,GO:1901338,MF,,1075
positive regulation of T cell cytokine production,10,0.674,0.0564,1,GO:0002726,BP,,1076
mesenchymal to epithelial transition involved in metanephros morphogenesis,11,0.666,0.0567,1,GO:0003337,BP,,1077
positive regulation of response to DNA damage stimulus,66,0.568,0.0568,1,GO:2001022,BP,,1078
positive regulation of adaptive immune response,59,0.572,0.0568,1,GO:0002821,BP,,1079
ubiquitin conjugating enzyme binding,32,0.597,0.0568,1,GO:0031624,MF,,1080
regulation of gonad development,13,0.653,0.0569,1,GO:1905939,BP,,1081
nucleosomal DNA binding,28,0.604,0.057,1,GO:0031492,MF,,1082
peptidyl-lysine methylation,99,0.555,0.0571,1,GO:0018022,BP,,1083
channel regulator activity,118,0.449,0.0572,1,GO:0016247,MF,,1084
endothelial cell proliferation,102,0.555,0.0573,1,GO:0001935,BP,,1085
tricarboxylic acid cycle,29,0.398,0.0574,1,GO:0006099,BP,,1086
regulation of intracellular estrogen receptor signaling pathway,27,0.606,0.0575,1,GO:0033146,BP,,1087
mitotic spindle organization,80,0.562,0.0575,1,"GO:0007052,GO:1902850",BP,microtubule cytoskeleton organization involved in mitosis,1088
"translation regulator activity, nucleic acid binding",18,0.629,0.0576,1,GO:0090079,MF,,1089
regulation of ruffle assembly,20,0.623,0.0576,1,GO:1900027,BP,,1090
neuromuscular junction,53,0.575,0.0577,1,GO:0031594,CC,,1091
modified amino acid binding,63,0.431,0.0578,1,GO:0072341,MF,,1092
estrogen receptor binding,40,0.587,0.0579,1,GO:0030331,MF,,1093
leukotriene biosynthetic process,15,0.359,0.0581,1,GO:0019370,BP,,1094
axon part,169,0.458,0.0581,1,GO:0033267,CC,,1095
glycine binding,11,0.335,0.0582,1,GO:0016594,MF,,1096
regulation of chromatin silencing,18,0.629,0.0582,1,GO:0031935,BP,,1097
regulation of angiogenesis,190,0.54,0.0583,1,GO:0045765,BP,,1098
CXCR chemokine receptor binding,10,0.673,0.0583,1,GO:0045236,MF,,1099
inositol phosphate phosphatase activity,19,0.625,0.0584,1,GO:0052745,MF,,1100
palate development,78,0.562,0.0584,1,GO:0060021,BP,,1101
steroid hormone receptor activity,52,0.576,0.0585,1,GO:0003707,MF,,1102
dendrite extension,28,0.397,0.0586,1,GO:0097484,BP,,1103
cellular component maintenance,27,0.395,0.0586,1,GO:0043954,BP,,1104
response to isoquinoline alkaloid,28,0.397,0.0591,1,"GO:0014072,GO:0043278",BP,response to morphine,1105
cellular biogenic amine catabolic process,22,0.384,0.0591,1,GO:0042402,BP,,1106
intercalated disc,44,0.582,0.0592,1,GO:0014704,CC,,1107
stereocilium,35,0.592,0.0592,1,GO:0032420,CC,,1108
renal tubule morphogenesis,68,0.566,0.0594,1,GO:0061333,BP,,1109
ubiquitin protein ligase activity,176,0.541,0.0595,1,GO:0061630,MF,,1110
cardiac chamber development,138,0.547,0.0595,1,GO:0003205,BP,,1111
double-strand break repair via homologous recombination,83,0.56,0.0596,1,GO:0000724,BP,,1112
GTP biosynthetic process,12,0.343,0.0597,1,GO:0006183,BP,,1113
regulation of osteoblast differentiation,101,0.554,0.0597,1,GO:0045667,BP,,1114
protein transporter activity,89,0.442,0.0597,1,GO:0008565,MF,,1115
actomyosin structure organization,153,0.544,0.0599,1,GO:0031032,BP,,1116
mononuclear cell migration,51,0.424,0.0599,1,GO:0071674,BP,,1117
Golgi transport complex,12,0.343,0.06,1,GO:0017119,CC,,1118
regulation of centriole replication,14,0.645,0.06,1,GO:0046599,BP,,1119
regulation of ATP metabolic process,50,0.423,0.0601,1,GO:1903578,BP,,1120
mannosidase activity,14,0.645,0.0601,1,GO:0015923,MF,,1121
embryonic skeletal system development,93,0.556,0.0602,1,GO:0048706,BP,,1122
macrophage migration,22,0.384,0.0604,1,GO:1905517,BP,,1123
neuropeptide signaling pathway,79,0.439,0.0606,1,GO:0007218,BP,,1124
desmosome,20,0.621,0.0606,1,GO:0030057,CC,,1125
cullin-RING ubiquitin ligase complex,152,0.456,0.0607,1,GO:0031461,CC,,1126
regulation of inflammatory response to antigenic stimulus,18,0.372,0.0607,1,GO:0002861,BP,,1127
regulation of establishment of cell polarity,19,0.624,0.0607,1,GO:2000114,BP,,1128
tRNA metabolic process,147,0.455,0.0608,1,GO:0006399,BP,,1129
nephron epithelium morphogenesis,65,0.567,0.0608,1,GO:0072088,BP,,1130
glial cell apoptotic process,14,0.645,0.0608,1,GO:0034349,BP,,1131
tRNA modification,53,0.574,0.0608,1,GO:0006400,BP,,1132
nose development,14,0.645,0.061,1,GO:0043584,BP,,1133
positive regulation of establishment of protein localization to mitochondrion,97,0.445,0.061,1,GO:1903749,BP,,1134
cellular response to glucose stimulus,99,0.445,0.0611,1,GO:0071333,BP,,1135
bHLH transcription factor binding,26,0.606,0.0613,1,GO:0043425,MF,,1136
GTPase inhibitor activity,12,0.656,0.0614,1,GO:0005095,MF,,1137
Arp2/3 complex-mediated actin nucleation,33,0.406,0.0615,1,GO:0034314,BP,,1138
piRNA metabolic process,12,0.344,0.0615,1,GO:0034587,BP,,1139
regulation of behavior,50,0.576,0.0615,1,GO:0050795,BP,,1140
positive regulation of dephosphorylation,43,0.418,0.0615,1,GO:0035306,BP,,1141
Sertoli cell development,12,0.656,0.0616,1,GO:0060009,BP,,1142
membrane lipid biosynthetic process,108,0.552,0.0617,1,GO:0046467,BP,,1143
negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,97,0.555,0.0618,1,GO:0090101,BP,,1144
circadian rhythm,177,0.541,0.0622,1,GO:0007623,BP,,1145
positive regulation of gliogenesis,40,0.585,0.0623,1,GO:0014015,BP,,1146
embryonic camera-type eye development,33,0.594,0.0624,1,GO:0031076,BP,,1147
Rho GTPase binding,82,0.56,0.0624,1,GO:0017048,MF,,1148
DNA-directed 5'-3' RNA polymerase activity,33,0.406,0.0625,1,GO:0003899,MF,,1149
repressing transcription factor binding,51,0.575,0.0626,1,GO:0070491,MF,,1150
chromatin silencing at rDNA,20,0.62,0.0626,1,GO:0000183,BP,,1151
embryonic camera-type eye morphogenesis,21,0.617,0.0629,1,GO:0048596,BP,,1152
negative regulation of BMP signaling pathway,43,0.582,0.063,1,GO:0030514,BP,,1153
positive regulation of cGMP biosynthetic process,17,0.37,0.0633,1,GO:0030828,BP,,1154
aorta morphogenesis,29,0.6,0.0634,1,GO:0035909,BP,,1155
odontogenesis of dentin-containing tooth,69,0.565,0.0635,1,GO:0042475,BP,,1156
mRNA 3'-end processing,76,0.562,0.0636,1,GO:0031124,BP,,1157
outer dynein arm assembly,14,0.357,0.0636,1,GO:0036158,BP,,1158
glycogen catabolic process,25,0.393,0.0636,1,"GO:0005980,GO:0009251,GO:0044247",BP,"glucan catabolic process,cellular polysaccharide catabolic process",1159
bicarbonate transport,40,0.585,0.064,1,GO:0015701,BP,,1160
phosphatidylinositol-3-phosphate binding,28,0.601,0.0641,1,GO:0032266,MF,,1161
negative regulation of viral entry into host cell,15,0.638,0.0643,1,GO:0046597,BP,,1162
response to heat,141,0.545,0.0643,1,GO:0009408,BP,,1163
positive regulation of transcription initiation from RNA polymerase II promoter,15,0.362,0.0643,1,GO:0060261,BP,,1164
response to amine,36,0.411,0.0644,1,GO:0014075,BP,,1165
cellular component assembly involved in morphogenesis,85,0.558,0.0646,1,GO:0010927,BP,,1166
basolateral plasma membrane,181,0.54,0.0647,1,GO:0016323,CC,,1167
regulation of calcium ion import,88,0.443,0.0647,1,GO:0090279,BP,,1168
reflex,16,0.633,0.065,1,GO:0060004,BP,,1169
positive regulation of cardiac muscle cell proliferation,18,0.626,0.065,1,GO:0060045,BP,,1170
regulation of cytokine secretion involved in immune response,10,0.331,0.065,1,GO:0002739,BP,,1171
coenzyme A metabolic process,14,0.358,0.0651,1,GO:0015936,BP,,1172
protein deacetylation,89,0.557,0.0652,1,GO:0006476,BP,,1173
regulation of cell proliferation involved in heart morphogenesis,14,0.642,0.0652,1,GO:2000136,BP,,1174
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,55,0.572,0.0655,1,GO:0002824,BP,,1175
histone H3-K9 methylation,27,0.602,0.0656,1,GO:0051567,BP,,1176
lamin binding,15,0.637,0.0657,1,GO:0005521,MF,,1177
pigmentation,87,0.443,0.0658,1,GO:0043473,BP,,1178
ER to Golgi vesicle-mediated transport,149,0.456,0.0659,1,GO:0006888,BP,,1179
collagen fibril organization,37,0.587,0.0659,1,GO:0030199,BP,,1180
cholesterol biosynthetic process,44,0.42,0.066,1,GO:0006695,BP,,1181
sex chromosome,21,0.616,0.066,1,GO:0000803,CC,,1182
purine nucleotide transmembrane transporter activity,11,0.34,0.0663,1,GO:0015216,MF,,1183
regulation of non-motile cilium assembly,11,0.66,0.0664,1,GO:1902855,BP,,1184
positive regulation of peptide secretion,189,0.461,0.0666,1,GO:0002793,BP,,1185
establishment of melanosome localization,22,0.387,0.0666,1,GO:0032401,BP,,1186
negative regulation of transcription from RNA polymerase II promoter in response to stress,13,0.647,0.0666,1,GO:0097201,BP,,1187
digestion,109,0.449,0.0668,1,GO:0007586,BP,,1188
vacuolar lumen,143,0.455,0.0668,1,GO:0005775,CC,,1189
cellular response to hexose stimulus,102,0.447,0.0669,1,GO:0071331,BP,,1190
establishment of apical/basal cell polarity,11,0.66,0.0669,1,GO:0035089,BP,,1191
transcription corepressor binding,10,0.667,0.0671,1,GO:0001222,MF,,1192
phosphatidylserine metabolic process,26,0.604,0.0672,1,GO:0006658,BP,,1193
protein heterotrimerization,13,0.646,0.0675,1,GO:0070208,BP,,1194
negative regulation of cation transmembrane transport,57,0.43,0.0675,1,GO:1904063,BP,,1195
establishment of protein localization to Golgi,17,0.628,0.0676,1,GO:0072600,BP,,1196
purinergic nucleotide receptor activity,13,0.354,0.0677,1,"GO:0001614,GO:0016502",MF,nucleotide receptor activity,1197
mismatch repair,31,0.595,0.0678,1,GO:0006298,BP,,1198
hydrogen peroxide metabolic process,38,0.414,0.0679,1,GO:0042743,BP,,1199
C-terminal protein amino acid modification,63,0.433,0.0679,1,GO:0018410,BP,,1200
Schmidt-Lanterman incisure,11,0.659,0.068,1,GO:0043220,CC,,1201
regulation of glucose import in response to insulin stimulus,16,0.632,0.068,1,GO:2001273,BP,,1202
dystrophin-associated glycoprotein complex,21,0.615,0.068,1,"GO:0016010,GO:0090665",CC,glycoprotein complex,1203
BAF-type complex,23,0.61,0.068,1,GO:0090544,CC,,1204
regulation of ossification,166,0.541,0.0681,1,GO:0030278,BP,,1205
mitochondrial respiratory chain complex IV assembly,14,0.359,0.0682,1,GO:0033617,BP,,1206
ligand-gated ion channel activity,121,0.452,0.0682,1,"GO:0015276,GO:0022834",MF,ligand-gated channel activity,1207
response to muscle stretch,17,0.628,0.0688,1,GO:0035994,BP,,1208
tRNA methyltransferase activity,22,0.612,0.0689,1,GO:0008175,MF,,1209
astrocyte projection,10,0.334,0.069,1,GO:0097449,CC,,1210
regulation of oxidoreductase activity,72,0.438,0.069,1,GO:0051341,BP,,1211
negative regulation of blood pressure,37,0.414,0.069,1,GO:0045776,BP,,1212
C-terminal protein lipidation,56,0.43,0.0691,1,GO:0006501,BP,,1213
activated T cell proliferation,34,0.59,0.0691,1,GO:0050798,BP,,1214
regulation of cell growth involved in cardiac muscle cell development,10,0.334,0.0692,1,GO:0061050,BP,,1215
"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor",23,0.391,0.0693,1,GO:0016628,MF,,1216
positive regulation of glucose import in response to insulin stimulus,12,0.651,0.0693,1,GO:2001275,BP,,1217
"transferase activity, transferring pentosyl groups",41,0.582,0.0694,1,GO:0016763,MF,,1218
regulation of cellular response to hypoxia,10,0.334,0.0695,1,GO:1900037,BP,,1219
regulation of protein glycosylation,17,0.627,0.0697,1,GO:0060049,BP,,1220
negative regulation of cellular amide metabolic process,153,0.543,0.0697,1,GO:0034249,BP,,1221
lipid transporter activity,96,0.554,0.0698,1,GO:0005319,MF,,1222
"phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity",11,0.658,0.0698,1,GO:0052629,MF,,1223
calcium ion-regulated exocytosis of neurotransmitter,28,0.401,0.0699,1,GO:0048791,BP,,1224
positive regulation of hair follicle development,10,0.334,0.0699,1,GO:0051798,BP,,1225
neuronal stem cell population maintenance,19,0.62,0.0699,1,GO:0097150,BP,,1226
response to lithium ion,22,0.388,0.0703,1,GO:0010226,BP,,1227
peptidyl-lysine trimethylation,35,0.588,0.0704,1,GO:0018023,BP,,1228
response to testosterone,36,0.587,0.0706,1,GO:0033574,BP,,1229
vacuole fusion,33,0.409,0.0706,1,GO:0097576,BP,,1230
myelin sheath,160,0.458,0.0706,1,GO:0043209,CC,,1231
vesicle targeting,68,0.437,0.0707,1,GO:0006903,BP,,1232
regulation of transmembrane transporter activity,181,0.461,0.0709,1,GO:0022898,BP,,1233
response to dsRNA,69,0.563,0.0709,1,GO:0043331,BP,,1234
adenylate cyclase binding,12,0.349,0.0711,1,GO:0008179,MF,,1235
glycosaminoglycan biosynthetic process,103,0.448,0.0711,1,GO:0006024,BP,,1236
regulation of endothelial cell apoptotic process,32,0.592,0.0715,1,GO:2000351,BP,,1237
double-strand break repair,167,0.541,0.0716,1,GO:0006302,BP,,1238
organelle inheritance,12,0.35,0.0717,1,"GO:0048308,GO:0048313",BP,Golgi inheritance,1239
UTP metabolic process,12,0.35,0.0718,1,GO:0046051,BP,,1240
positive regulation of glucose transport,37,0.586,0.0718,1,GO:0010828,BP,,1241
triglyceride catabolic process,23,0.392,0.0718,1,GO:0019433,BP,,1242
cardiac left ventricle morphogenesis,12,0.65,0.0718,1,GO:0003214,BP,,1243
respiratory system process,27,0.6,0.0718,1,GO:0003016,BP,,1244
Golgi stack,115,0.451,0.0719,1,GO:0005795,CC,,1245
positive regulation of extrinsic apoptotic signaling pathway,48,0.575,0.072,1,GO:2001238,BP,,1246
eating behavior,25,0.396,0.0722,1,GO:0042755,BP,,1247
negative regulation of cell-substrate adhesion,46,0.577,0.0722,1,GO:0010812,BP,,1248
metanephros morphogenesis,31,0.593,0.0725,1,GO:0003338,BP,,1249
positive regulation of cell cycle arrest,74,0.56,0.0725,1,GO:0071158,BP,,1250
"translation repressor activity, nucleic acid binding",13,0.644,0.0726,1,GO:0000900,MF,,1251
positive regulation of epithelial cell differentiation,48,0.575,0.0727,1,GO:0030858,BP,,1252
establishment of mitotic spindle orientation,15,0.634,0.0728,1,GO:0000132,BP,,1253
placenta development,125,0.547,0.0729,1,GO:0001890,BP,,1254
structural constituent of cytoskeleton,94,0.446,0.0729,1,GO:0005200,MF,,1255
renal tubule development,83,0.557,0.0731,1,GO:0061326,BP,,1256
gamma-catenin binding,10,0.664,0.0731,1,GO:0045295,MF,,1257
cellular response to prostaglandin E stimulus,15,0.366,0.0733,1,GO:0071380,BP,,1258
"positive regulation of protein import into nucleus, translocation",10,0.664,0.0733,1,GO:0033160,BP,,1259
thioesterase binding,12,0.351,0.0733,1,GO:0031996,MF,,1260
signal peptide processing,16,0.371,0.0734,1,GO:0006465,BP,,1261
calcium-release channel activity,16,0.629,0.0734,1,"GO:0015278,GO:0099604",MF,ligand-gated calcium channel activity,1262
termination of RNA polymerase I transcription,27,0.4,0.0735,1,GO:0006363,BP,,1263
glial cell projection,16,0.371,0.0738,1,GO:0097386,CC,,1264
regulation of BMP signaling pathway,73,0.561,0.0739,1,GO:0030510,BP,,1265
entry of bacterium into host cell,16,0.629,0.0741,1,GO:0035635,BP,,1266
cis-trans isomerase activity,33,0.41,0.0741,1,GO:0016859,MF,,1267
negative regulation of intracellular estrogen receptor signaling pathway,10,0.663,0.0742,1,GO:0033147,BP,,1268
visual perception,162,0.459,0.0742,1,GO:0007601,BP,,1269
pyrimidine ribonucleoside triphosphate biosynthetic process,16,0.371,0.0743,1,GO:0009209,BP,,1270
organelle fusion,187,0.462,0.0743,1,GO:0048284,BP,,1271
regulation of sodium ion transmembrane transporter activity,44,0.422,0.0744,1,GO:2000649,BP,,1272
organic hydroxy compound biosynthetic process,172,0.46,0.0744,1,GO:1901617,BP,,1273
regulation of nucleotide metabolic process,184,0.462,0.0746,1,GO:0006140,BP,,1274
DNA integration,10,0.663,0.0749,1,GO:0015074,BP,,1275
positive regulation of glycoprotein biosynthetic process,16,0.629,0.0749,1,GO:0010560,BP,,1276
negative regulation of T-helper cell differentiation,10,0.663,0.075,1,GO:0045623,BP,,1277
negative regulation of calcium-mediated signaling,18,0.379,0.075,1,GO:0050849,BP,,1278
negative regulation of smooth muscle cell proliferation,34,0.588,0.0751,1,GO:0048662,BP,,1279
regulation of T cell mediated cytotoxicity,18,0.621,0.0751,1,GO:0001914,BP,,1280
regulation of T cell cytokine production,15,0.633,0.0752,1,GO:0002724,BP,,1281
fatty acid binding,22,0.39,0.0752,1,GO:0005504,MF,,1282
melanosome transport,21,0.388,0.0753,1,GO:0032402,BP,,1283
negative regulation of lipid storage,15,0.633,0.0754,1,GO:0010888,BP,,1284
cytokine receptor binding,182,0.538,0.0757,1,GO:0005126,MF,,1285
"retrograde transport, vesicle recycling within Golgi",19,0.618,0.0757,1,GO:0000301,BP,,1286
apicolateral plasma membrane,17,0.624,0.0757,1,GO:0016327,CC,,1287
mRNA stabilization,28,0.597,0.0758,1,GO:0048255,BP,,1288
establishment of monopolar cell polarity,13,0.642,0.0758,1,GO:0061162,BP,,1289
protein K11-linked ubiquitination,21,0.388,0.0758,1,GO:0070979,BP,,1290
beta-catenin binding,76,0.559,0.076,1,GO:0008013,MF,,1291
skeletal system morphogenesis,165,0.54,0.076,1,GO:0048705,BP,,1292
ceramide biosynthetic process,46,0.576,0.0761,1,GO:0046513,BP,,1293
positive regulation of multi-organism process,134,0.456,0.0762,1,GO:0043902,BP,,1294
regulation of action potential,43,0.578,0.0764,1,GO:0098900,BP,,1295
organic hydroxy compound transmembrane transporter activity,29,0.595,0.0764,1,GO:1901618,MF,,1296
regulation of bone development,18,0.379,0.0765,1,GO:1903010,BP,,1297
positive regulation of cardiocyte differentiation,18,0.379,0.0767,1,GO:1905209,BP,,1298
adenine nucleotide transmembrane transporter activity,10,0.338,0.0768,1,"GO:0000295,GO:0005346",MF,purine ribonucleotide transmembrane transporter activity,1299
glucose import,65,0.564,0.0768,1,GO:0046323,BP,,1300
detection of chemical stimulus,172,0.539,0.0772,1,GO:0009593,BP,,1301
cell redox homeostasis,63,0.436,0.0772,1,GO:0045454,BP,,1302
gas transport,16,0.372,0.0773,1,GO:0015669,BP,,1303
posttranscriptional gene silencing,62,0.565,0.0774,1,GO:0016441,BP,,1304
beta-amyloid binding,33,0.411,0.0774,1,GO:0001540,MF,,1305
cytosolic large ribosomal subunit,54,0.43,0.0774,1,GO:0022625,CC,,1306
modulation by host of viral transcription,20,0.614,0.0774,1,"GO:0043921,GO:0052472",BP,modulation by host of symbiont transcription,1307
AU-rich element binding,22,0.609,0.0775,1,GO:0017091,MF,,1308
protein transmembrane transporter activity,16,0.373,0.0777,1,GO:0008320,MF,,1309
maturation of SSU-rRNA,46,0.425,0.0777,1,GO:0030490,BP,,1310
metanephric nephron development,38,0.583,0.0777,1,GO:0072210,BP,,1311
positive regulation of protein secretion,177,0.461,0.0779,1,GO:0050714,BP,,1312
negative T cell selection,11,0.347,0.0781,1,GO:0043383,BP,,1313
regulation of triglyceride biosynthetic process,15,0.369,0.0783,1,GO:0010866,BP,,1314
glycosyl compound metabolic process,131,0.455,0.0785,1,GO:1901657,BP,,1315
axolemma,16,0.373,0.0787,1,GO:0030673,CC,,1316
negative regulation of focal adhesion assembly,15,0.631,0.0788,1,GO:0051895,BP,,1317
lymphocyte activation involved in immune response,106,0.549,0.0789,1,GO:0002285,BP,,1318
aminoglycan biosynthetic process,104,0.45,0.079,1,GO:0006023,BP,,1319
intracellular mRNA localization,11,0.653,0.0791,1,GO:0008298,BP,,1320
smooth muscle cell migration,56,0.568,0.0792,1,GO:0014909,BP,,1321
negative regulation of protein processing,28,0.596,0.0793,1,"GO:0010955,GO:1903318",BP,negative regulation of protein maturation,1322
cytoskeletal anchoring at plasma membrane,10,0.66,0.0793,1,GO:0007016,BP,,1323
positive regulation of insulin secretion,54,0.431,0.0796,1,GO:0032024,BP,,1324
exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,29,0.406,0.0797,1,GO:0043928,BP,,1325
response to interferon-alpha,14,0.635,0.0798,1,GO:0035455,BP,,1326
nuclear-transcribed mRNA poly(A) tail shortening,32,0.589,0.0801,1,GO:0000289,BP,,1327
positive regulation of insulin secretion involved in cellular response to glucose stimulus,20,0.387,0.0801,1,GO:0035774,BP,,1328
late endosome to vacuole transport,14,0.365,0.0801,1,GO:0045324,BP,,1329
regulation of superoxide metabolic process,22,0.392,0.0803,1,GO:0090322,BP,,1330
positive regulation of dendrite development,61,0.565,0.0803,1,GO:1900006,BP,,1331
glucose binding,10,0.34,0.0805,1,GO:0005536,MF,,1332
regulation of mitophagy in response to mitochondrial depolarization,14,0.365,0.0805,1,"GO:1904923,GO:1904925",BP,positive regulation of mitophagy in response to mitochondrial depolarization,1333
RNA 3'-end processing,96,0.552,0.0807,1,GO:0031123,BP,,1334
transcription elongation from RNA polymerase I promoter,27,0.403,0.0808,1,GO:0006362,BP,,1335
positive regulation of neuron death,60,0.435,0.081,1,GO:1901216,BP,,1336
establishment of mitotic spindle localization,18,0.619,0.081,1,GO:0040001,BP,,1337
positive regulation of interferon-alpha production,13,0.64,0.0811,1,GO:0032727,BP,,1338
pharyngeal system development,23,0.605,0.0814,1,GO:0060037,BP,,1339
response to inactivity,12,0.645,0.0814,1,GO:0014854,BP,,1340
negative regulation of DNA biosynthetic process,29,0.407,0.0815,1,GO:2000279,BP,,1341
positive regulation of mitochondrial fission,14,0.366,0.0816,1,GO:0090141,BP,,1342
tricarboxylic acid metabolic process,37,0.417,0.0817,1,GO:0072350,BP,,1343
cellular response to monosaccharide stimulus,103,0.45,0.0817,1,GO:0071326,BP,,1344
nitric-oxide synthase biosynthetic process,16,0.626,0.082,1,"GO:0051767,GO:0051769",BP,regulation of nitric-oxide synthase biosynthetic process,1345
cellular carbohydrate catabolic process,39,0.42,0.0823,1,GO:0044275,BP,,1346
glycogen metabolic process,65,0.438,0.0824,1,"GO:0005977,GO:0006073,GO:0044042",BP,"cellular glucan metabolic process,glucan metabolic process",1347
positive regulation of organelle assembly,52,0.57,0.0824,1,GO:1902117,BP,,1348
fatty acid elongation,10,0.659,0.0825,1,"GO:0030497,GO:0042761",BP,very long-chain fatty acid biosynthetic process,1349
cysteine-type endopeptidase activity,78,0.557,0.0825,1,GO:0004197,MF,,1350
lipid digestion,16,0.375,0.0826,1,GO:0044241,BP,,1351
sphingoid metabolic process,12,0.645,0.0826,1,GO:0046519,BP,,1352
positive regulation of vascular associated smooth muscle cell migration,11,0.651,0.0827,1,GO:1904754,BP,,1353
telomerase RNA binding,15,0.371,0.0827,1,GO:0070034,MF,,1354
muscle cell migration,66,0.562,0.0828,1,GO:0014812,BP,,1355
regulation of protein deacetylation,33,0.587,0.0829,1,GO:0090311,BP,,1356
extracellular ligand-gated ion channel activity,60,0.435,0.0832,1,GO:0005230,MF,,1357
negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,19,0.385,0.0834,1,GO:1902176,BP,,1358
protein disulfide isomerase activity,20,0.612,0.0835,1,"GO:0003756,GO:0016864",MF,"intramolecular oxidoreductase activity, transposing S-S bonds",1359
clathrin coat of endocytic vesicle,14,0.634,0.0835,1,GO:0030128,CC,,1360
cell differentiation involved in kidney development,51,0.57,0.084,1,GO:0061005,BP,,1361
calmodulin-dependent protein kinase activity,28,0.406,0.0842,1,GO:0004683,MF,,1362
activin receptor signaling pathway,32,0.588,0.0842,1,GO:0032924,BP,,1363
extracellular matrix component,109,0.548,0.0842,1,GO:0044420,CC,,1364
chromatin remodeling,127,0.544,0.0843,1,GO:0006338,BP,,1365
post-embryonic animal organ development,12,0.644,0.0843,1,GO:0048569,BP,,1366
phosphatidylinositol 3-kinase activity,64,0.562,0.0843,1,GO:0035004,MF,,1367
protein serine/threonine kinase inhibitor activity,32,0.412,0.0844,1,GO:0030291,MF,,1368
regulation of protein targeting to mitochondrion,79,0.444,0.0846,1,GO:1903214,BP,,1369
terpenoid metabolic process,82,0.445,0.0847,1,GO:0006721,BP,,1370
ligase activity,160,0.46,0.0847,1,GO:0016874,MF,,1371
glomerular mesangium development,13,0.638,0.0847,1,GO:0072109,BP,,1372
histone H3-K4 methylation,42,0.577,0.0848,1,GO:0051568,BP,,1373
positive regulation of mesenchymal cell proliferation,25,0.6,0.0848,1,GO:0002053,BP,,1374
gene silencing by miRNA,57,0.566,0.0848,1,GO:0035195,BP,,1375
regulation of actin filament-based movement,35,0.584,0.0849,1,GO:1903115,BP,,1376
neurotransmitter receptor activity,73,0.442,0.085,1,GO:0030594,MF,,1377
defense response to fungus,17,0.379,0.0854,1,GO:0050832,BP,,1378
macrophage chemotaxis,19,0.386,0.0855,1,GO:0048246,BP,,1379
neuron cell-cell adhesion,15,0.628,0.0856,1,GO:0007158,BP,,1380
oligodendrocyte differentiation,77,0.557,0.0856,1,GO:0048709,BP,,1381
negative regulation of multi-organism process,128,0.544,0.0857,1,GO:0043901,BP,,1382
negative regulation of lymphocyte differentiation,31,0.589,0.0858,1,GO:0045620,BP,,1383
fascia adherens,10,0.657,0.0858,1,GO:0005916,CC,,1384
regulation of glycoprotein biosynthetic process,35,0.584,0.0858,1,GO:0010559,BP,,1385
positive regulation of protein import,88,0.553,0.0858,1,GO:1904591,BP,,1386
establishment of spindle orientation,17,0.62,0.086,1,GO:0051294,BP,,1387
sulfur compound biosynthetic process,197,0.464,0.0861,1,GO:0044272,BP,,1388
manganese ion binding,48,0.428,0.0864,1,GO:0030145,MF,,1389
pattern recognition receptor signaling pathway,141,0.542,0.0868,1,GO:0002221,BP,,1390
recycling endosome membrane,56,0.566,0.087,1,GO:0055038,CC,,1391
SMAD protein signal transduction,44,0.575,0.0871,1,GO:0060395,BP,,1392
adenylate cyclase-activating adrenergic receptor signaling pathway,13,0.363,0.0871,1,GO:0071880,BP,,1393
cell migration in hindbrain,13,0.637,0.0871,1,GO:0021535,BP,,1394
regulation of synaptic vesicle transport,38,0.42,0.0872,1,GO:1902803,BP,,1395
regulation of defense response to virus by virus,25,0.401,0.0873,1,GO:0050690,BP,,1396
peptidase regulator activity,163,0.539,0.0874,1,GO:0061134,MF,,1397
negative regulation of neuron projection regeneration,13,0.637,0.0875,1,GO:0070571,BP,,1398
dsRNA fragmentation,33,0.586,0.0875,1,"GO:0031050,GO:0070918",BP,production of small RNA involved in gene silencing by RNA,1399
fatty acid catabolic process,81,0.445,0.0876,1,GO:0009062,BP,,1400
virus receptor activity,54,0.567,0.0878,1,GO:0001618,MF,,1401
"regulation of mRNA splicing, via spliceosome",56,0.566,0.0881,1,GO:0048024,BP,,1402
regulation of cytokine-mediated signaling pathway,109,0.547,0.0882,1,GO:0001959,BP,,1403
epithelial tube branching involved in lung morphogenesis,26,0.597,0.0885,1,GO:0060441,BP,,1404
cellular response to fatty acid,43,0.425,0.0887,1,GO:0071398,BP,,1405
positive regulation of muscle cell apoptotic process,15,0.373,0.0888,1,GO:0010661,BP,,1406
positive regulation of glial cell differentiation,27,0.595,0.0888,1,GO:0045687,BP,,1407
cholesterol homeostasis,56,0.566,0.089,1,"GO:0042632,GO:0055092",BP,sterol homeostasis,1408
regulation of establishment or maintenance of cell polarity,21,0.607,0.0891,1,GO:0032878,BP,,1409
regulation of guanylate cyclase activity,10,0.345,0.0891,1,GO:0031282,BP,,1410
intrinsic apoptotic signaling pathway in response to oxidative stress,43,0.425,0.0892,1,GO:0008631,BP,,1411
protein refolding,24,0.6,0.0892,1,GO:0042026,BP,,1412
branched-chain amino acid catabolic process,19,0.387,0.0892,1,GO:0009083,BP,,1413
cranial nerve development,41,0.577,0.0895,1,GO:0021545,BP,,1414
regulation of monocyte chemotaxis,16,0.377,0.0896,1,GO:0090025,BP,,1415
NAD biosynthesis via nicotinamide riboside salvage pathway,13,0.636,0.0897,1,GO:0034356,BP,,1416
nuclease activity,166,0.538,0.0897,1,GO:0004518,MF,,1417
L-phenylalanine metabolic process,10,0.345,0.0897,1,"GO:0006558,GO:0006559,GO:1902221,GO:1902222",BP,"L-phenylalanine catabolic process,erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process,erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process",1418
phosphatidylinositol biosynthetic process,123,0.544,0.0898,1,GO:0006661,BP,,1419
cytokine secretion involved in immune response,12,0.359,0.0899,1,GO:0002374,BP,,1420
autophagosome maturation,31,0.412,0.09,1,GO:0097352,BP,,1421
regulation of B cell receptor signaling pathway,12,0.359,0.0901,1,GO:0050855,BP,,1422
regulation of epithelial tube formation,16,0.622,0.0901,1,GO:1905276,BP,,1423
multi-organism transport,68,0.559,0.0902,1,"GO:0044766,GO:1902579",BP,multi-organism localization,1424
pyridine-containing compound metabolic process,126,0.456,0.0902,1,GO:0072524,BP,,1425
"signal transducer, downstream of receptor, with serine/threonine kinase activity",84,0.554,0.0903,1,GO:0004702,MF,,1426
neurotransmitter receptor complex,45,0.427,0.0903,1,GO:0098878,CC,,1427
regulation of protein sumoylation,19,0.612,0.0904,1,GO:0033233,BP,,1428
regulation of growth of symbiont in host,10,0.345,0.0904,1,"GO:0044126,GO:0044144",BP,modulation of growth of symbiont involved in interaction with host,1429
regulation of mitochondrial membrane potential,57,0.435,0.0904,1,GO:0051881,BP,,1430
cellular response to carbohydrate stimulus,110,0.453,0.0904,1,GO:0071322,BP,,1431
regulation of NIK/NF-kappaB signaling,46,0.572,0.0905,1,GO:1901222,BP,,1432
pallium development,153,0.54,0.0906,1,GO:0021543,BP,,1433
production of miRNAs involved in gene silencing by miRNA,32,0.586,0.0906,1,GO:0035196,BP,,1434
IkappaB kinase complex,10,0.654,0.0907,1,GO:0008385,CC,,1435
G-protein alpha-subunit binding,18,0.385,0.091,1,GO:0001965,MF,,1436
ERBB signaling pathway,134,0.542,0.0911,1,GO:0038127,BP,,1437
atrioventricular valve morphogenesis,19,0.612,0.0911,1,GO:0003181,BP,,1438
positive regulation of DNA replication,47,0.429,0.0913,1,GO:0045740,BP,,1439
regulation of short-term neuronal synaptic plasticity,14,0.37,0.0913,1,GO:0048172,BP,,1440
"negative regulation of DNA-templated transcription, elongation",10,0.346,0.0915,1,GO:0032785,BP,,1441
late endosome,197,0.465,0.0916,1,GO:0005770,CC,,1442
norepinephrine metabolic process,11,0.353,0.0916,1,GO:0042415,BP,,1443
ribosomal small subunit assembly,15,0.374,0.0918,1,GO:0000028,BP,,1444
mitochondrial membrane organization,95,0.45,0.0918,1,GO:0007006,BP,,1445
clathrin coat assembly,16,0.622,0.092,1,GO:0048268,BP,,1446
somatic diversification of immune receptors,45,0.573,0.0922,1,GO:0002200,BP,,1447
"transferase activity, transferring amino-acyl groups",18,0.385,0.0923,1,GO:0016755,MF,,1448
renal vesicle development,18,0.615,0.0923,1,GO:0072087,BP,,1449
protein insertion into membrane,41,0.424,0.0924,1,GO:0051205,BP,,1450
execution phase of apoptosis,70,0.558,0.0925,1,GO:0097194,BP,,1451
cellular carbohydrate biosynthetic process,66,0.44,0.0925,1,GO:0034637,BP,,1452
negative regulation of stress fiber assembly,17,0.618,0.0929,1,GO:0051497,BP,,1453
ventricular septum morphogenesis,34,0.583,0.0931,1,GO:0060412,BP,,1454
positive regulation of calcium ion import,43,0.426,0.0931,1,GO:0090280,BP,,1455
metalloendopeptidase inhibitor activity,14,0.63,0.0932,1,GO:0008191,MF,,1456
wide pore channel activity,17,0.382,0.0933,1,GO:0022829,MF,,1457
distal tubule development,11,0.646,0.0933,1,GO:0072017,BP,,1458
telomere cap complex,11,0.354,0.0937,1,"GO:0000782,GO:0000783",CC,nuclear telomere cap complex,1459
cellular ketone body metabolic process,10,0.347,0.0937,1,GO:0046950,BP,,1460
white fat cell differentiation,11,0.354,0.0937,1,GO:0050872,BP,,1461
fatty acid beta-oxidation,64,0.439,0.0937,1,GO:0006635,BP,,1462
nephron tubule morphogenesis,64,0.561,0.0944,1,GO:0072078,BP,,1463
gene silencing by RNA,130,0.543,0.0945,1,GO:0031047,BP,,1464
vascular associated smooth muscle cell migration,13,0.634,0.0945,1,"GO:1904738,GO:1904752",BP,regulation of vascular associated smooth muscle cell migration,1465
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,17,0.617,0.0946,1,GO:0016338,BP,,1466
vacuolar acidification,18,0.386,0.0947,1,GO:0007035,BP,,1467
regulation of neuroblast proliferation,24,0.599,0.0947,1,GO:1902692,BP,,1468
"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",32,0.415,0.0948,1,GO:0000462,BP,,1469
lipoxygenase pathway,14,0.371,0.0948,1,GO:0019372,BP,,1470
regulation of skeletal muscle cell proliferation,10,0.653,0.0949,1,GO:0014857,BP,,1471
histone deacetylation,77,0.555,0.095,1,GO:0016575,BP,,1472
lysine-acetylated histone binding,17,0.617,0.0952,1,GO:0070577,MF,,1473
SNARE complex,44,0.427,0.0953,1,GO:0031201,CC,,1474
cardiac conduction,129,0.457,0.0953,1,GO:0061337,BP,,1475
protein localization to endoplasmic reticulum,117,0.455,0.0954,1,GO:0070972,BP,,1476
regulation of attachment of spindle microtubules to kinetochore,11,0.355,0.0955,1,GO:0051988,BP,,1477
protein targeting to Golgi,14,0.629,0.0956,1,GO:0000042,BP,,1478
negative regulation of epithelial cell apoptotic process,27,0.593,0.0962,1,GO:1904036,BP,,1479
SH3 domain binding,114,0.545,0.0963,1,GO:0017124,MF,,1480
negative regulation of endothelial cell proliferation,27,0.592,0.0966,1,GO:0001937,BP,,1481
deoxyribonucleoside triphosphate metabolic process,16,0.38,0.0969,1,GO:0009200,BP,,1482
cardiac muscle cell proliferation,39,0.577,0.0971,1,GO:0060038,BP,,1483
regulation of glucose import,53,0.566,0.0971,1,GO:0046324,BP,,1484
axonal fasciculation,21,0.395,0.0971,1,GO:0007413,BP,,1485
positive regulation of SMAD protein import into nucleus,12,0.638,0.0972,1,GO:0060391,BP,,1486
pyrimidine nucleoside triphosphate biosynthetic process,20,0.393,0.0974,1,GO:0009148,BP,,1487
regulation of mononuclear cell migration,30,0.413,0.0975,1,GO:0071675,BP,,1488
HMG box domain binding,13,0.633,0.0976,1,GO:0071837,MF,,1489
3'-UTR-mediated mRNA destabilization,11,0.644,0.0977,1,GO:0061158,BP,,1490
positive regulation of cardiac muscle cell differentiation,16,0.38,0.0977,1,GO:2000727,BP,,1491
positive regulation of hair cycle,11,0.356,0.0978,1,GO:0042635,BP,,1492
V(D)J recombination,12,0.638,0.0979,1,GO:0033151,BP,,1493
regulation of purine nucleotide metabolic process,179,0.464,0.098,1,GO:1900542,BP,,1494
mRNA catabolic process,200,0.534,0.098,1,GO:0006402,BP,,1495
regulation of cGMP metabolic process,25,0.404,0.0981,1,GO:0030823,BP,,1496
citrate metabolic process,33,0.417,0.0982,1,GO:0006101,BP,,1497
fibronectin binding,23,0.6,0.0982,1,GO:0001968,MF,,1498
carnitine metabolic process,13,0.368,0.0984,1,GO:0009437,BP,,1499
insulin receptor signaling pathway,116,0.544,0.0985,1,GO:0008286,BP,,1500
regulation of polysaccharide metabolic process,32,0.416,0.0986,1,GO:0032881,BP,,1501
regulation of nuclease activity,25,0.595,0.0986,1,GO:0032069,BP,,1502
muscle atrophy,11,0.644,0.0987,1,GO:0014889,BP,,1503
ubiquitin-like protein conjugating enzyme binding,37,0.578,0.0987,1,GO:0044390,MF,,1504
regulation of nitric-oxide synthase activity,40,0.425,0.099,1,GO:0050999,BP,,1505
posttranscriptional gene silencing by RNA,61,0.561,0.0991,1,GO:0035194,BP,,1506
positive regulation of lymphocyte mediated immunity,53,0.566,0.0991,1,GO:0002708,BP,,1507
negative regulation of protein tyrosine kinase activity,22,0.602,0.0992,1,GO:0061099,BP,,1508
negative regulation of ATPase activity,11,0.356,0.0992,1,GO:0032780,BP,,1509
positive regulation of pathway-restricted SMAD protein phosphorylation,37,0.578,0.0992,1,GO:0010862,BP,,1510
phosphorylated carbohydrate dephosphorylation,10,0.651,0.0993,1,GO:0046838,BP,,1511
"exoribonuclease activity, producing 5'-phosphomonoesters",29,0.588,0.0994,1,GO:0016896,MF,,1512
methylation-dependent chromatin silencing,16,0.619,0.0995,1,GO:0006346,BP,,1513
response to nitric oxide,17,0.615,0.0995,1,GO:0071731,BP,,1514
exonuclease activity,69,0.557,0.0996,1,GO:0004527,MF,,1515
heart formation,21,0.604,0.0997,1,GO:0060914,BP,,1516
integrator complex,12,0.637,0.0998,1,GO:0032039,CC,,1517
purine nucleotide transport,14,0.373,0.0998,1,GO:0015865,BP,,1518
regulation of collateral sprouting,18,0.612,0.0999,1,GO:0048670,BP,,1519
positive regulation of synaptic transmission,115,0.456,0.0999,1,GO:0050806,BP,,1520
asymmetric protein localization,18,0.612,0.1,1,GO:0008105,BP,,1521
positive regulation of peptide hormone secretion,66,0.441,0.1,1,GO:0090277,BP,,1522
nuclear heterochromatin,27,0.591,0.1,1,GO:0005720,CC,,1523
kidney epithelium development,127,0.542,0.101,1,GO:0072073,BP,,1524
aromatic amino acid family catabolic process,18,0.388,0.101,1,GO:0009074,BP,,1525
response to stimulus involved in regulation of muscle adaptation,16,0.619,0.101,1,GO:0014874,BP,,1526
B cell differentiation,86,0.551,0.101,1,GO:0030183,BP,,1527
ventricular cardiac muscle tissue development,43,0.572,0.101,1,GO:0003229,BP,,1528
negative regulation of epithelial cell proliferation,105,0.546,0.102,1,GO:0050680,BP,,1529
digestive system development,114,0.544,0.102,1,GO:0055123,BP,,1530
protein peptidyl-prolyl isomerization,31,0.415,0.102,1,"GO:0000413,GO:0003755",BP,peptidyl-prolyl cis-trans isomerase activity,1531
regulation of response to DNA damage stimulus,145,0.539,0.102,1,GO:2001020,BP,,1532
androgen metabolic process,19,0.608,0.102,1,GO:0008209,BP,,1533
regulation of ion transmembrane transporter activity,177,0.464,0.103,1,GO:0032412,BP,,1534
somatic diversification of immune receptors via germline recombination within a single locus,41,0.574,0.103,1,"GO:0002562,GO:0016444",BP,somatic cell DNA recombination,1535
I-SMAD binding,11,0.642,0.103,1,GO:0070411,MF,,1536
growth hormone receptor signaling pathway,19,0.608,0.103,1,GO:0060396,BP,,1537
substrate-independent telencephalic tangential migration,10,0.351,0.103,1,"GO:0021826,GO:0021843",BP,substrate-independent telencephalic tangential interneuron migration,1538
RNA polymerase II repressing transcription factor binding,25,0.594,0.103,1,GO:0001103,MF,,1539
regulation of calcium ion-dependent exocytosis,64,0.441,0.103,1,GO:0017158,BP,,1540
mitotic G2 DNA damage checkpoint,15,0.622,0.103,1,GO:0007095,BP,,1541
phosphatidylserine acyl-chain remodeling,17,0.614,0.103,1,GO:0036150,BP,,1542
small-subunit processome,26,0.408,0.103,1,GO:0032040,CC,,1543
racemase and epimerase activity,14,0.374,0.103,1,GO:0016854,MF,,1544
leukotriene metabolic process,21,0.397,0.103,1,GO:0006691,BP,,1545
mast cell granule,20,0.395,0.103,1,GO:0042629,CC,,1546
positive regulation of autophagy,92,0.549,0.104,1,GO:0010508,BP,,1547
regulation of JUN kinase activity,74,0.555,0.104,1,GO:0043506,BP,,1548
G2 DNA damage checkpoint,32,0.583,0.104,1,GO:0031572,BP,,1549
regulation of double-strand break repair via homologous recombination,17,0.614,0.104,1,GO:0010569,BP,,1550
DNA dealkylation,19,0.608,0.104,1,GO:0035510,BP,,1551
"G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger",141,0.46,0.104,1,GO:0007187,BP,,1552
establishment of epithelial cell polarity,20,0.605,0.104,1,GO:0090162,BP,,1553
intrinsic component of endoplasmic reticulum membrane,132,0.459,0.104,1,GO:0031227,CC,,1554
positive regulation of epidermal growth factor-activated receptor activity,11,0.359,0.105,1,GO:0045741,BP,,1555
animal organ formation,50,0.566,0.105,1,GO:0048645,BP,,1556
neuron recognition,34,0.42,0.105,1,GO:0008038,BP,,1557
regulation of phosphoprotein phosphatase activity,37,0.423,0.105,1,GO:0043666,BP,,1558
regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,181,0.535,0.105,1,GO:0090092,BP,,1559
regulation of tolerance induction,16,0.617,0.106,1,GO:0002643,BP,,1560
"retrograde vesicle-mediated transport, Golgi to ER",70,0.444,0.106,1,GO:0006890,BP,,1561
growth factor receptor binding,104,0.546,0.106,1,GO:0070851,MF,,1562
protein binding involved in cell-cell adhesion,29,0.587,0.106,1,GO:0098632,MF,,1563
neurotransmitter transporter activity,23,0.597,0.106,1,GO:0005326,MF,,1564
exoribonuclease activity,31,0.584,0.106,1,GO:0004532,MF,,1565
homophilic cell adhesion via plasma membrane adhesion molecules,125,0.542,0.106,1,GO:0007156,BP,,1566
positive regulation of leukocyte mediated immunity,65,0.558,0.107,1,GO:0002705,BP,,1567
CTP biosynthetic process,15,0.38,0.107,1,"GO:0006241,GO:0046036",BP,CTP metabolic process,1568
negative regulation of biomineral tissue development,16,0.384,0.107,1,GO:0070168,BP,,1569
T cell differentiation,178,0.535,0.107,1,GO:0030217,BP,,1570
"wound healing, spreading of epidermal cells",12,0.634,0.107,1,GO:0035313,BP,,1571
nephron development,124,0.542,0.108,1,GO:0072006,BP,,1572
cerebral cortex development,102,0.546,0.108,1,GO:0021987,BP,,1573
nephron tubule development,81,0.552,0.108,1,GO:0072080,BP,,1574
positive regulation of CREB transcription factor activity,14,0.624,0.108,1,GO:0032793,BP,,1575
keratinocyte differentiation,168,0.536,0.108,1,GO:0030216,BP,,1576
regulation of neurotransmitter levels,178,0.465,0.108,1,GO:0001505,BP,,1577
regulation of acute inflammatory response to antigenic stimulus,12,0.366,0.108,1,GO:0002864,BP,,1578
pre-mRNA binding,25,0.593,0.108,1,GO:0036002,MF,,1579
cellular response to UV,64,0.558,0.108,1,GO:0034644,BP,,1580
multicellular organism metabolic process,111,0.544,0.109,1,GO:0044236,BP,,1581
isoprenoid metabolic process,99,0.453,0.109,1,GO:0006720,BP,,1582
pyridine nucleotide metabolic process,121,0.458,0.109,1,"GO:0019362,GO:0046496",BP,nicotinamide nucleotide metabolic process,1583
DNA packaging,136,0.54,0.109,1,GO:0006323,BP,,1584
response to amphetamine,25,0.407,0.109,1,GO:0001975,BP,,1585
heart valve morphogenesis,28,0.588,0.109,1,GO:0003179,BP,,1586
mitotic cell cycle checkpoint,129,0.541,0.109,1,GO:0007093,BP,,1587
positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,10,0.646,0.109,1,GO:1902237,BP,,1588
positive regulation of multicellular organism growth,27,0.589,0.11,1,GO:0040018,BP,,1589
growth involved in symbiotic interaction,11,0.361,0.11,1,"GO:0044110,GO:0044116,GO:0044117",BP,"growth of symbiont involved in interaction with host,growth of symbiont in host",1590
lymphocyte costimulation,62,0.441,0.11,1,"GO:0031294,GO:0031295",BP,T cell costimulation,1591
non-motile cilium assembly,45,0.569,0.11,1,GO:1905515,BP,,1592
mating behavior,20,0.397,0.11,1,GO:0007617,BP,,1593
ubiquinone metabolic process,14,0.377,0.11,1,GO:0006743,BP,,1594
regulation of generation of precursor metabolites and energy,75,0.447,0.111,1,GO:0043467,BP,,1595
ciliary base,26,0.59,0.111,1,GO:0097546,CC,,1596
Gemini of coiled bodies,10,0.354,0.111,1,GO:0097504,CC,,1597
Golgi cisterna membrane,70,0.445,0.111,1,GO:0032580,CC,,1598
activin binding,12,0.633,0.111,1,GO:0048185,MF,,1599
mismatched DNA binding,12,0.633,0.111,1,GO:0030983,MF,,1600
regulation of exocytosis,148,0.462,0.111,1,GO:0017157,BP,,1601
basement membrane organization,18,0.608,0.111,1,GO:0071711,BP,,1602
positive regulation of osteoblast proliferation,10,0.645,0.111,1,GO:0033690,BP,,1603
response to calcium ion,102,0.546,0.111,1,GO:0051592,BP,,1604
specification of animal organ identity,27,0.589,0.111,1,GO:0010092,BP,,1605
regulation of dendritic spine development,58,0.56,0.112,1,GO:0060998,BP,,1606
lipid particle organization,12,0.367,0.112,1,GO:0034389,BP,,1607
positive regulation of RNA splicing,24,0.594,0.112,1,GO:0033120,BP,,1608
ventricular cardiac muscle tissue morphogenesis,40,0.573,0.112,1,GO:0055010,BP,,1609
phospholipid scrambling,10,0.645,0.112,1,GO:0017121,BP,,1610
muscle cell fate commitment,13,0.627,0.112,1,GO:0042693,BP,,1611
nucleoside kinase activity,14,0.377,0.112,1,GO:0019206,MF,,1612
purine nucleoside diphosphate metabolic process,80,0.449,0.112,1,"GO:0009135,GO:0009179",BP,purine ribonucleoside diphosphate metabolic process,1613
intracellular steroid hormone receptor signaling pathway,113,0.543,0.112,1,GO:0030518,BP,,1614
organelle transport along microtubule,64,0.442,0.112,1,GO:0072384,BP,,1615
regulation of cellular carbohydrate catabolic process,10,0.355,0.112,1,GO:0043471,BP,,1616
regulation of phagocytosis,54,0.437,0.112,1,GO:0050764,BP,,1617
regulation of stem cell proliferation,53,0.563,0.112,1,GO:0072091,BP,,1618
cristae formation,11,0.362,0.112,1,GO:0042407,BP,,1619
positive regulation of gluconeogenesis,10,0.645,0.112,1,GO:0045722,BP,,1620
cellular response to reactive oxygen species,135,0.46,0.112,1,GO:0034614,BP,,1621
dendrite membrane,21,0.4,0.112,1,GO:0032590,CC,,1622
pri-miRNA transcription from RNA polymerase II promoter,28,0.587,0.113,1,GO:0061614,BP,,1623
DNA-directed DNA polymerase activity,23,0.596,0.113,1,GO:0003887,MF,,1624
acyl-CoA hydrolase activity,14,0.378,0.113,1,GO:0047617,MF,,1625
actin filament binding,129,0.541,0.113,1,GO:0051015,MF,,1626
negative regulation of T cell differentiation,25,0.592,0.113,1,GO:0045581,BP,,1627
positive regulation of glucose metabolic process,30,0.584,0.113,1,GO:0010907,BP,,1628
Arp2/3 protein complex,10,0.355,0.113,1,GO:0005885,CC,,1629
response to corticosterone,19,0.395,0.114,1,GO:0051412,BP,,1630
nucleoside-diphosphatase activity,10,0.356,0.114,1,GO:0017110,MF,,1631
leukocyte chemotaxis,137,0.461,0.114,1,GO:0030595,BP,,1632
positive regulation of protein complex assembly,195,0.467,0.114,1,GO:0031334,BP,,1633
solute:sodium symporter activity,40,0.572,0.114,1,GO:0015370,MF,,1634
regulation of establishment of protein localization to chromosome,10,0.356,0.114,1,GO:0070202,BP,,1635
MHC protein complex binding,18,0.393,0.114,1,GO:0023023,MF,,1636
U2 snRNP,14,0.378,0.115,1,GO:0005686,CC,,1637
hindbrain radial glia guided cell migration,10,0.644,0.115,1,GO:0021932,BP,,1638
tRNA methylation,22,0.597,0.115,1,GO:0030488,BP,,1639
carbohydrate transmembrane transporter activity,31,0.582,0.115,1,"GO:0015144,GO:1901476",MF,carbohydrate transporter activity,1640
transport of virus,64,0.557,0.115,1,GO:0046794,BP,,1641
growth factor activity,126,0.459,0.115,1,GO:0008083,MF,,1642
vocalization behavior,16,0.614,0.115,1,GO:0071625,BP,,1643
endoplasmic reticulum subcompartment,19,0.396,0.115,1,GO:0098827,CC,,1644
negative regulation of ion transmembrane transporter activity,48,0.434,0.116,1,GO:0032413,BP,,1645
recycling endosome,132,0.54,0.116,1,GO:0055037,CC,,1646
mucus secretion,10,0.357,0.116,1,GO:0070254,BP,,1647
purine ribonucleotide transport,13,0.374,0.116,1,GO:0015868,BP,,1648
dendritic spine organization,57,0.56,0.116,1,GO:0097061,BP,,1649
regulation of translational initiation,62,0.442,0.116,1,GO:0006446,BP,,1650
receptor signaling complex scaffold activity,24,0.593,0.117,1,GO:0030159,MF,,1651
regulation of cation channel activity,115,0.458,0.117,1,GO:2001257,BP,,1652
pigment accumulation,10,0.357,0.117,1,"GO:0043476,GO:0043482",BP,cellular pigment accumulation,1653
nucleobase-containing compound kinase activity,46,0.433,0.117,1,GO:0019205,MF,,1654
astrocyte differentiation,57,0.56,0.117,1,GO:0048708,BP,,1655
negative regulation of cell aging,13,0.626,0.117,1,GO:0090344,BP,,1656
"hydrolase activity, hydrolyzing N-glycosyl compounds",16,0.613,0.117,1,GO:0016799,MF,,1657
"transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding",23,0.594,0.117,1,GO:0001205,MF,,1658
endothelial cell apoptotic process,38,0.573,0.117,1,GO:0072577,BP,,1659
regulation of macroautophagy,125,0.459,0.118,1,GO:0016241,BP,,1660
sensory perception of chemical stimulus,182,0.534,0.118,1,GO:0007606,BP,,1661
cell differentiation involved in metanephros development,24,0.592,0.118,1,GO:0072202,BP,,1662
chaperone-mediated protein folding,56,0.44,0.118,1,GO:0061077,BP,,1663
phosphatidylethanolamine acyl-chain remodeling,21,0.599,0.118,1,GO:0036152,BP,,1664
microfilament motor activity,18,0.606,0.118,1,GO:0000146,MF,,1665
positive regulation of microtubule polymerization,18,0.606,0.118,1,GO:0031116,BP,,1666
cardiac ventricle morphogenesis,60,0.558,0.119,1,GO:0003208,BP,,1667
alpha-linolenic acid metabolic process,13,0.625,0.119,1,GO:0036109,BP,,1668
protein localization to synapse,30,0.418,0.119,1,GO:0035418,BP,,1669
regulation of multicellular organism growth,58,0.559,0.12,1,GO:0040014,BP,,1670
prostate gland morphogenesis,22,0.596,0.12,1,GO:0060512,BP,,1671
MHC class II protein complex binding,15,0.384,0.12,1,GO:0023026,MF,,1672
vacuole organization,151,0.463,0.12,1,GO:0007033,BP,,1673
negative regulation of embryonic development,25,0.59,0.12,1,GO:0045992,BP,,1674
adenylate cyclase-modulating G-protein coupled receptor signaling pathway,122,0.459,0.12,1,GO:0007188,BP,,1675
neural retina development,51,0.437,0.12,1,GO:0003407,BP,,1676
response to UV-C,10,0.642,0.12,1,GO:0010225,BP,,1677
JAK-STAT cascade,118,0.541,0.12,1,"GO:0007259,GO:0097696",BP,STAT cascade,1678
regulation of gliogenesis,82,0.55,0.12,1,GO:0014013,BP,,1679
"nuclear-transcribed mRNA catabolic process, exonucleolytic",31,0.419,0.12,1,GO:0000291,BP,,1680
liver morphogenesis,17,0.609,0.121,1,GO:0072576,BP,,1681
deoxyribose phosphate catabolic process,18,0.394,0.121,1,GO:0046386,BP,,1682
Golgi to endosome transport,17,0.609,0.121,1,GO:0006895,BP,,1683
regulation of heart rate,84,0.549,0.121,1,GO:0002027,BP,,1684
positive regulation of transcription from RNA polymerase II promoter in response to stress,23,0.593,0.121,1,GO:0036003,BP,,1685
DNA helicase activity,43,0.568,0.121,1,GO:0003678,MF,,1686
apoptotic process involved in development,26,0.588,0.122,1,GO:1902742,BP,,1687
regulation of acute inflammatory response,55,0.44,0.122,1,GO:0002673,BP,,1688
phospholipid transport,48,0.565,0.122,1,GO:0015914,BP,,1689
convergent extension,15,0.615,0.122,1,GO:0060026,BP,,1690
excitatory synapse,25,0.589,0.122,1,GO:0060076,CC,,1691
physiological muscle hypertrophy,16,0.388,0.122,1,"GO:0003298,GO:0003301,GO:0061049",BP,"physiological cardiac muscle hypertrophy,cell growth involved in cardiac muscle cell development",1692
peptide transporter activity,99,0.455,0.122,1,GO:0015197,MF,,1693
regulation of AMPA receptor activity,19,0.398,0.123,1,GO:2000311,BP,,1694
R-SMAD binding,20,0.6,0.123,1,GO:0070412,MF,,1695
"RNA phosphodiester bond hydrolysis, exonucleolytic",33,0.578,0.123,1,GO:0090503,BP,,1696
endocardial cushion formation,21,0.597,0.123,1,GO:0003272,BP,,1697
RNA polymerase II core promoter sequence-specific DNA binding,50,0.563,0.123,1,GO:0000979,MF,,1698
regulation of steroid biosynthetic process,42,0.569,0.124,1,GO:0050810,BP,,1699
osteoblast differentiation,187,0.533,0.124,1,GO:0001649,BP,,1700
positive regulation of actin filament polymerization,79,0.45,0.124,1,GO:0030838,BP,,1701
negative regulation of cellular response to growth factor stimulus,116,0.541,0.124,1,GO:0090288,BP,,1702
negative regulation of chromatin organization,41,0.569,0.124,1,GO:1905268,BP,,1703
ribosomal small subunit biogenesis,58,0.442,0.124,1,GO:0042274,BP,,1704
WW domain binding,19,0.602,0.124,1,GO:0050699,MF,,1705
pathway-restricted SMAD protein phosphorylation,52,0.562,0.124,1,GO:0060389,BP,,1706
ovulation,19,0.602,0.124,1,GO:0030728,BP,,1707
mesenchymal to epithelial transition,16,0.611,0.124,1,GO:0060231,BP,,1708
CoA hydrolase activity,16,0.389,0.124,1,GO:0016289,MF,,1709
response to temperature stimulus,194,0.532,0.124,1,GO:0009266,BP,,1710
cell volume homeostasis,16,0.611,0.124,1,GO:0006884,BP,,1711
glomerular visceral epithelial cell development,11,0.634,0.124,1,GO:0072015,BP,,1712
atrioventricular valve development,20,0.599,0.125,1,GO:0003171,BP,,1713
synaptic vesicle endocytosis,29,0.418,0.125,1,GO:0048488,BP,,1714
face development,43,0.568,0.125,1,GO:0060324,BP,,1715
lung cell differentiation,24,0.59,0.125,1,GO:0060479,BP,,1716
O-methyltransferase activity,17,0.393,0.125,1,GO:0008171,MF,,1717
cortical cytoskeleton,70,0.553,0.125,1,GO:0030863,CC,,1718
neuropeptide hormone activity,25,0.411,0.125,1,GO:0005184,MF,,1719
regulation of platelet-derived growth factor receptor signaling pathway,21,0.597,0.125,1,GO:0010640,BP,,1720
vitamin biosynthetic process,19,0.398,0.125,1,GO:0009110,BP,,1721
left/right axis specification,12,0.628,0.125,1,GO:0070986,BP,,1722
activation of protein kinase B activity,25,0.411,0.125,1,GO:0032148,BP,,1723
pigment metabolic process,56,0.441,0.126,1,GO:0042440,BP,,1724
ionotropic glutamate receptor complex,43,0.432,0.126,1,GO:0008328,CC,,1725
integral component of peroxisomal membrane,13,0.377,0.126,1,"GO:0005779,GO:0031231",CC,intrinsic component of peroxisomal membrane,1726
transmembrane receptor protein kinase activity,76,0.551,0.126,1,GO:0019199,MF,,1727
epidermal growth factor receptor signaling pathway,114,0.542,0.126,1,GO:0007173,BP,,1728
aminoglycan metabolic process,148,0.464,0.126,1,GO:0006022,BP,,1729
lymph vessel morphogenesis,17,0.607,0.126,1,GO:0036303,BP,,1730
protein demannosylation,20,0.599,0.127,1,"GO:0036507,GO:0036508",BP,"protein alpha-1,2-demannosylation",1731
protein phosphatase 2A binding,24,0.41,0.127,1,GO:0051721,MF,,1732
sulfotransferase activity,42,0.432,0.127,1,GO:0008146,MF,,1733
establishment of nucleus localization,13,0.622,0.127,1,GO:0040023,BP,,1734
pyrimidine ribonucleoside biosynthetic process,22,0.406,0.127,1,GO:0046132,BP,,1735
regulation of double-strand break repair,37,0.573,0.127,1,GO:2000779,BP,,1736
peptidyl-arginine methylation,12,0.373,0.127,1,GO:0018216,BP,,1737
peptidyl-proline hydroxylation,14,0.618,0.127,1,GO:0019511,BP,,1738
cell proliferation involved in heart morphogenesis,14,0.618,0.127,1,GO:0061323,BP,,1739
interleukin-8 secretion,20,0.402,0.127,1,GO:0072606,BP,,1740
negative regulation of neurotransmitter transport,15,0.614,0.127,1,GO:0051589,BP,,1741
nucleolar part,146,0.463,0.128,1,GO:0044452,CC,,1742
endopeptidase inhibitor activity,124,0.54,0.128,1,GO:0004866,MF,,1743
nucleobase-containing small molecule interconversion,22,0.406,0.128,1,GO:0015949,BP,,1744
regulation of Rho protein signal transduction,115,0.541,0.128,1,GO:0035023,BP,,1745
odontogenesis,98,0.545,0.128,1,GO:0042476,BP,,1746
cerebellar cortex development,46,0.435,0.128,1,GO:0021695,BP,,1747
fluid transport,19,0.601,0.129,1,GO:0042044,BP,,1748
peptidase inhibitor activity,129,0.539,0.129,1,GO:0030414,MF,,1749
cellular response to interferon-beta,13,0.378,0.129,1,GO:0035458,BP,,1750
histone H3 deacetylation,19,0.6,0.13,1,GO:0070932,BP,,1751
glomerular epithelial cell development,12,0.626,0.13,1,GO:0072310,BP,,1752
negative regulation of alpha-beta T cell differentiation,13,0.621,0.13,1,GO:0046639,BP,,1753
terminal bouton,59,0.443,0.13,1,GO:0043195,CC,,1754
behavioral response to cocaine,13,0.379,0.13,1,GO:0048148,BP,,1755
RNA methylation,51,0.561,0.13,1,GO:0001510,BP,,1756
acylglycerol O-acyltransferase activity,23,0.591,0.13,1,GO:0016411,MF,,1757
negative regulation of calcium ion-dependent exocytosis,11,0.632,0.13,1,GO:0045955,BP,,1758
coenzyme A biosynthetic process,10,0.362,0.131,1,GO:0015937,BP,,1759
polyol catabolic process,16,0.609,0.131,1,GO:0046174,BP,,1760
cellular response to starvation,110,0.542,0.131,1,GO:0009267,BP,,1761
thymocyte apoptotic process,15,0.613,0.131,1,GO:0070242,BP,,1762
3'-5'-exoribonuclease activity,27,0.584,0.131,1,GO:0000175,MF,,1763
basement membrane,85,0.547,0.131,1,GO:0005604,CC,,1764
histone acetylation,129,0.539,0.131,1,GO:0016573,BP,,1765
nucleotide transmembrane transporter activity,15,0.388,0.132,1,GO:0015215,MF,,1766
histone H4-K16 acetylation,18,0.603,0.132,1,GO:0043984,BP,,1767
deoxyribonucleotide catabolic process,17,0.394,0.132,1,GO:0009264,BP,,1768
ammonium ion binding,53,0.44,0.132,1,GO:0070405,MF,,1769
regulation of fatty acid biosynthetic process,30,0.579,0.132,1,GO:0042304,BP,,1770
spongiotrophoblast layer development,13,0.38,0.133,1,GO:0060712,BP,,1771
energy homeostasis,30,0.579,0.133,1,GO:0097009,BP,,1772
ectoderm development,15,0.612,0.133,1,GO:0007398,BP,,1773
negative regulation of kidney development,14,0.616,0.133,1,GO:0090185,BP,,1774
rhodopsin mediated signaling pathway,25,0.413,0.133,1,GO:0016056,BP,,1775
negative regulation of amino acid transport,10,0.363,0.133,1,GO:0051956,BP,,1776
receptor activator activity,33,0.424,0.133,1,GO:0030546,MF,,1777
sensory perception of bitter taste,21,0.595,0.133,1,GO:0050913,BP,,1778
negative regulation of mRNA metabolic process,32,0.577,0.133,1,GO:1903312,BP,,1779
positive regulation of cardiac muscle contraction,10,0.363,0.133,1,GO:0060452,BP,,1780
steroid binding,69,0.552,0.134,1,GO:0005496,MF,,1781
cell fate commitment,190,0.532,0.134,1,GO:0045165,BP,,1782
synaptic vesicle recycling,39,0.431,0.134,1,GO:0036465,BP,,1783
organic cation transport,20,0.403,0.134,1,GO:0015695,BP,,1784
regulation of isotype switching,21,0.594,0.134,1,GO:0045191,BP,,1785
T cell receptor complex,17,0.395,0.134,1,GO:0042101,CC,,1786
negative regulation of posttranscriptional gene silencing,11,0.63,0.135,1,"GO:0060149,GO:0060967",BP,negative regulation of gene silencing by RNA,1787
neutrophil homeostasis,11,0.63,0.135,1,GO:0001780,BP,,1788
nerve development,64,0.554,0.135,1,GO:0021675,BP,,1789
"CD4-positive, alpha-beta T cell activation",52,0.56,0.135,1,GO:0035710,BP,,1790
negative regulation of gene silencing by miRNA,10,0.636,0.136,1,GO:0060965,BP,,1791
regulation of cytoplasmic translation,13,0.62,0.136,1,GO:2000765,BP,,1792
C2H2 zinc finger domain binding,12,0.624,0.136,1,GO:0070742,MF,,1793
protein deacylation,93,0.545,0.136,1,GO:0035601,BP,,1794
negative regulation of cellular response to transforming growth factor beta stimulus,63,0.554,0.136,1,GO:1903845,BP,,1795
plasma membrane tubulation,17,0.604,0.136,1,GO:0097320,BP,,1796
atrial septum development,14,0.615,0.136,1,GO:0003283,BP,,1797
receptor tyrosine kinase binding,50,0.561,0.136,1,GO:0030971,MF,,1798
divalent inorganic cation transmembrane transporter activity,155,0.535,0.136,1,GO:0072509,MF,,1799
vinculin binding,10,0.636,0.136,1,GO:0017166,MF,,1800
cardiac muscle tissue morphogenesis,50,0.561,0.136,1,GO:0055008,BP,,1801
positive regulation of ion transport,198,0.469,0.136,1,GO:0043270,BP,,1802
regulation of tube size,119,0.46,0.136,1,GO:0035150,BP,,1803
"transforming growth factor beta receptor, cytoplasmic mediator activity",10,0.636,0.136,1,GO:0005072,MF,,1804
regulation of superoxide anion generation,11,0.37,0.137,1,GO:0032928,BP,,1805
iron-sulfur cluster binding,57,0.443,0.137,1,"GO:0051536,GO:0051540",MF,metal cluster binding,1806
negative regulation of mRNA processing,24,0.588,0.137,1,GO:0050686,BP,,1807
regulation of nucleocytoplasmic transport,189,0.531,0.137,1,GO:0046822,BP,,1808
cellular aldehyde metabolic process,81,0.452,0.137,1,GO:0006081,BP,,1809
5'-3' RNA polymerase activity,35,0.427,0.137,1,"GO:0034062,GO:0097747",MF,RNA polymerase activity,1810
SNAP receptor activity,33,0.425,0.137,1,GO:0005484,MF,,1811
peroxisome organization,27,0.417,0.137,1,GO:0007031,BP,,1812
icosanoid metabolic process,82,0.452,0.137,1,"GO:0006690,GO:1901568",BP,fatty acid derivative metabolic process,1813
tyrosine phosphorylation of Stat5 protein,13,0.619,0.137,1,GO:0042506,BP,,1814
negative regulation of production of molecular mediator of immune response,24,0.588,0.138,1,GO:0002701,BP,,1815
membrane depolarization during action potential,45,0.564,0.138,1,GO:0086010,BP,,1816
cotranslational protein targeting to membrane,90,0.455,0.138,1,GO:0006613,BP,,1817
hydrogen peroxide catabolic process,20,0.404,0.138,1,GO:0042744,BP,,1818
regulation of Notch signaling pathway,62,0.445,0.138,1,GO:0008593,BP,,1819
response to redox state,12,0.376,0.138,1,GO:0051775,BP,,1820
DNA replication-independent nucleosome organization,36,0.571,0.138,1,GO:0034724,BP,,1821
regulation of myeloid leukocyte mediated immunity,32,0.424,0.138,1,GO:0002886,BP,,1822
external side of plasma membrane,178,0.532,0.139,1,GO:0009897,CC,,1823
positive regulation of glycoprotein metabolic process,17,0.604,0.139,1,GO:1903020,BP,,1824
positive regulation of smooth muscle cell migration,28,0.581,0.139,1,GO:0014911,BP,,1825
P granule,13,0.382,0.139,1,"GO:0043186,GO:0045495,GO:0060293",CC,"pole plasm,germ plasm",1826
organic anion transmembrane transporter activity,156,0.534,0.139,1,GO:0008514,MF,,1827
dynein complex binding,22,0.409,0.139,1,GO:0070840,MF,,1828
B cell homeostasis,25,0.585,0.139,1,GO:0001782,BP,,1829
regulation of cell fate specification,12,0.377,0.14,1,GO:0042659,BP,,1830
protein ubiquitination involved in ubiquitin-dependent protein catabolic process,188,0.469,0.14,1,GO:0042787,BP,,1831
G-protein coupled amine receptor activity,38,0.431,0.14,1,GO:0008227,MF,,1832
positive regulation of cation transmembrane transport,94,0.456,0.14,1,GO:1904064,BP,,1833
detection of mechanical stimulus,37,0.57,0.14,1,GO:0050982,BP,,1834
negative regulation of establishment of protein localization to plasma membrane,10,0.635,0.14,1,GO:0090005,BP,,1835
epidermal growth factor receptor binding,28,0.581,0.14,1,GO:0005154,MF,,1836
serotonin secretion,10,0.365,0.141,1,GO:0001820,BP,,1837
negative regulation of epithelial cell differentiation,30,0.578,0.141,1,GO:0030857,BP,,1838
histone H3-K36 methylation,10,0.635,0.141,1,GO:0010452,BP,,1839
"regulation of CD4-positive, alpha-beta T cell activation",31,0.576,0.141,1,GO:2000514,BP,,1840
diol metabolic process,10,0.634,0.141,1,GO:0034311,BP,,1841
phosphatidylinositol kinase activity,44,0.564,0.141,1,GO:0052742,MF,,1842
regulation of blood vessel size,118,0.461,0.141,1,GO:0050880,BP,,1843
B cell activation,178,0.532,0.141,1,GO:0042113,BP,,1844
nephric duct development,13,0.618,0.141,1,GO:0072176,BP,,1845
microvillus assembly,16,0.606,0.142,1,GO:0030033,BP,,1846
positive regulation of biomineral tissue development,34,0.573,0.142,1,GO:0070169,BP,,1847
copper ion homeostasis,14,0.387,0.142,1,GO:0055070,BP,,1848
deoxyribose phosphate metabolic process,29,0.421,0.142,1,GO:0019692,BP,,1849
mitochondrial calcium ion homeostasis,22,0.41,0.142,1,GO:0051560,BP,,1850
regulation of cell cycle arrest,97,0.543,0.143,1,GO:0071156,BP,,1851
platelet-derived growth factor receptor-beta signaling pathway,12,0.622,0.143,1,GO:0035791,BP,,1852
global genome nucleotide-excision repair,29,0.421,0.143,1,GO:0070911,BP,,1853
regulation of transporter activity,192,0.469,0.143,1,GO:0032409,BP,,1854
neutrophil chemotaxis,60,0.445,0.143,1,GO:0030593,BP,,1855
defense response to Gram-negative bacterium,23,0.412,0.144,1,GO:0050829,BP,,1856
positive regulation of macromitophagy in response to mitochondrial depolarization,10,0.366,0.144,1,"GO:0098779,GO:1901526",BP,positive regulation of macromitophagy,1857
regulation of establishment of planar polarity involved in neural tube closure,13,0.617,0.144,1,GO:0090178,BP,,1858
positive regulation of dendritic spine morphogenesis,16,0.605,0.144,1,GO:0061003,BP,,1859
interleukin-1-mediated signaling pathway,14,0.613,0.144,1,GO:0070498,BP,,1860
"mRNA cis splicing, via spliceosome",14,0.613,0.144,1,GO:0045292,BP,,1861
regulation of microtubule-based process,143,0.535,0.145,1,GO:0032886,BP,,1862
digestive system process,67,0.449,0.146,1,GO:0022600,BP,,1863
hemoglobin metabolic process,11,0.627,0.146,1,GO:0020027,BP,,1864
regulation of leukocyte mediated cytotoxicity,39,0.567,0.146,1,GO:0001910,BP,,1865
late endosome membrane,101,0.458,0.146,1,GO:0031902,CC,,1866
channel inhibitor activity,33,0.427,0.146,1,GO:0016248,MF,,1867
"regulation of Wnt signaling pathway, planar cell polarity pathway",12,0.621,0.146,1,GO:2000095,BP,,1868
DNA demethylation,14,0.612,0.146,1,GO:0080111,BP,,1869
regulation of endothelial cell proliferation,86,0.545,0.146,1,GO:0001936,BP,,1870
RNAi effector complex,11,0.626,0.147,1,GO:0031332,CC,,1871
cellular response to insulin stimulus,183,0.531,0.147,1,GO:0032869,BP,,1872
synaptic vesicle cycle,115,0.461,0.147,1,GO:0099504,BP,,1873
negative regulation of Ras protein signal transduction,40,0.566,0.147,1,GO:0046580,BP,,1874
syncytium formation,41,0.565,0.147,1,GO:0006949,BP,,1875
multi-organism cellular localization,62,0.553,0.147,1,"GO:1902581,GO:1902583",BP,multi-organism intracellular transport,1876
GTP-Rho binding,17,0.601,0.148,1,GO:0017049,MF,,1877
mast cell mediated immunity,42,0.435,0.148,1,GO:0002448,BP,,1878
exopeptidase activity,93,0.543,0.148,1,GO:0008238,MF,,1879
purine nucleoside biosynthetic process,21,0.409,0.148,1,"GO:0042451,GO:0046129",BP,purine ribonucleoside biosynthetic process,1880
blastocyst growth,14,0.388,0.148,1,GO:0001832,BP,,1881
coronary vasculature development,40,0.566,0.148,1,GO:0060976,BP,,1882
energy reserve metabolic process,78,0.453,0.148,1,GO:0006112,BP,,1883
negative regulation of Notch signaling pathway,28,0.421,0.149,1,GO:0045746,BP,,1884
negative regulation of neurotransmitter secretion,12,0.62,0.149,1,GO:0046929,BP,,1885
snRNA processing,15,0.608,0.149,1,GO:0016180,BP,,1886
regulation of ERAD pathway,26,0.582,0.149,1,GO:1904292,BP,,1887
chemosensory behavior,13,0.616,0.149,1,GO:0007635,BP,,1888
regulation of smooth muscle cell migration,49,0.56,0.149,1,GO:0014910,BP,,1889
membrane raft organization,23,0.587,0.149,1,GO:0031579,BP,,1890
centrosome cycle,79,0.547,0.149,1,GO:0007098,BP,,1891
secretion by tissue,30,0.424,0.149,1,GO:0032941,BP,,1892
biotin metabolic process,11,0.374,0.15,1,GO:0006768,BP,,1893
regulation of muscle cell differentiation,146,0.535,0.15,1,GO:0051147,BP,,1894
regulation of membrane protein ectodomain proteolysis,20,0.593,0.15,1,GO:0051043,BP,,1895
glutamine family amino acid biosynthetic process,17,0.399,0.15,1,GO:0009084,BP,,1896
cerebellar granular layer development,12,0.38,0.15,1,GO:0021681,BP,,1897
negative regulation of immune effector process,84,0.546,0.15,1,GO:0002698,BP,,1898
Sin3 complex,13,0.615,0.15,1,GO:0016580,CC,,1899
response to follicle-stimulating hormone,15,0.393,0.15,1,GO:0032354,BP,,1900
cerebral cortex neuron differentiation,22,0.411,0.151,1,GO:0021895,BP,,1901
hormone biosynthetic process,52,0.442,0.151,1,GO:0042446,BP,,1902
negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,12,0.62,0.151,1,GO:2000059,BP,,1903
galactose metabolic process,12,0.38,0.151,1,GO:0006012,BP,,1904
modulation of transcription in other organism involved in symbiotic interaction,21,0.591,0.151,1,GO:0052312,BP,,1905
mesenchyme morphogenesis,45,0.562,0.151,1,GO:0072132,BP,,1906
regulation of brown fat cell differentiation,10,0.631,0.151,1,GO:0090335,BP,,1907
regulation of SMAD protein import into nucleus,16,0.604,0.151,1,GO:0060390,BP,,1908
sensory perception of light stimulus,166,0.468,0.152,1,GO:0050953,BP,,1909
response to muscle inactivity,10,0.631,0.152,1,"GO:0014870,GO:0014877,GO:0014894",BP,"response to muscle inactivity involved in regulation of muscle adaptation,response to denervation involved in regulation of muscle adaptation",1910
inorganic anion transmembrane transporter activity,109,0.54,0.152,1,GO:0015103,MF,,1911
protein activation cascade,61,0.447,0.152,1,GO:0072376,BP,,1912
sugar transmembrane transporter activity,26,0.581,0.152,1,GO:0051119,MF,,1913
DNA polymerase activity,30,0.576,0.152,1,GO:0034061,MF,,1914
microtubule organizing center organization,111,0.539,0.152,1,GO:0031023,BP,,1915
lamellipodium morphogenesis,13,0.615,0.152,1,GO:0072673,BP,,1916
negative regulation of JAK-STAT cascade,43,0.563,0.152,1,"GO:0046426,GO:1904893",BP,negative regulation of STAT cascade,1917
C21-steroid hormone metabolic process,27,0.42,0.152,1,GO:0008207,BP,,1918
integral component of synaptic vesicle membrane,14,0.39,0.153,1,GO:0030285,CC,,1919
epithelial cell morphogenesis,26,0.581,0.153,1,GO:0003382,BP,,1920
positive regulation of JUN kinase activity,59,0.554,0.153,1,GO:0043507,BP,,1921
primary lysosome,124,0.463,0.153,1,"GO:0005766,GO:0042582",CC,azurophil granule,1922
germinal center formation,15,0.607,0.153,1,GO:0002467,BP,,1923
regulation of Ras protein signal transduction,187,0.53,0.153,1,GO:0046578,BP,,1924
establishment of planar polarity involved in neural tube closure,14,0.61,0.153,1,GO:0090177,BP,,1925
response to ammonium ion,109,0.46,0.154,1,GO:0060359,BP,,1926
negative regulation of cell-cell adhesion,111,0.539,0.154,1,GO:0022408,BP,,1927
positive regulation of bone mineralization,32,0.573,0.154,1,GO:0030501,BP,,1928
negative regulation of intracellular steroid hormone receptor signaling pathway,28,0.578,0.154,1,GO:0033144,BP,,1929
mitochondrion localization,37,0.568,0.154,1,GO:0051646,BP,,1930
regulation of transcription from RNA polymerase II promoter involved in heart development,11,0.624,0.154,1,GO:1901213,BP,,1931
protein acylation,184,0.531,0.154,1,GO:0043543,BP,,1932
regulation of G-protein coupled receptor protein signaling pathway,113,0.461,0.154,1,GO:0008277,BP,,1933
"regulation of protein localization to chromosome, telomeric region",12,0.381,0.154,1,GO:1904814,BP,,1934
positive regulation of NIK/NF-kappaB signaling,34,0.571,0.154,1,GO:1901224,BP,,1935
response to tumor cell,15,0.606,0.154,1,GO:0002347,BP,,1936
inorganic anion transport,136,0.535,0.155,1,GO:0015698,BP,,1937
sperm principal piece,18,0.403,0.155,1,GO:0097228,CC,,1938
ESCRT complex,23,0.414,0.155,1,GO:0036452,CC,,1939
fatty-acyl-CoA binding,14,0.39,0.155,1,GO:0000062,MF,,1940
regulation of organelle assembly,134,0.536,0.155,1,GO:1902115,BP,,1941
multicellular organismal signaling,176,0.469,0.155,1,GO:0035637,BP,,1942
negative regulation of anoikis,16,0.603,0.155,1,GO:2000811,BP,,1943
regulation of stress fiber assembly,67,0.55,0.156,1,GO:0051492,BP,,1944
negative regulation of lipid transport,19,0.594,0.156,1,GO:0032369,BP,,1945
NAD binding,51,0.443,0.156,1,GO:0051287,MF,,1946
detection of stimulus involved in sensory perception,189,0.53,0.156,1,GO:0050906,BP,,1947
ribonucleoside diphosphate metabolic process,82,0.455,0.157,1,GO:0009185,BP,,1948
inorganic anion exchanger activity,21,0.589,0.157,1,GO:0005452,MF,,1949
pyrimidine ribonucleoside triphosphate metabolic process,17,0.401,0.157,1,GO:0009208,BP,,1950
regulation of type I interferon-mediated signaling pathway,25,0.582,0.157,1,GO:0060338,BP,,1951
ear development,182,0.53,0.157,1,GO:0043583,BP,,1952
"DNA-directed RNA polymerase II, core complex",14,0.391,0.158,1,GO:0005665,CC,,1953
regulation of inositol phosphate biosynthetic process,12,0.382,0.158,1,GO:0010919,BP,,1954
relaxation of cardiac muscle,17,0.599,0.158,1,GO:0055119,BP,,1955
"transcription factor activity, RNA polymerase II core promoter sequence-specific",21,0.589,0.158,1,GO:0000983,MF,,1956
ionotropic glutamate receptor activity,18,0.404,0.158,1,GO:0004970,MF,,1957
glutamate receptor signaling pathway,73,0.452,0.158,1,GO:0007215,BP,,1958
histone phosphorylation,32,0.428,0.158,1,GO:0016572,BP,,1959
transcription elongation from RNA polymerase II promoter,84,0.455,0.158,1,GO:0006368,BP,,1960
axoneme assembly,48,0.441,0.159,1,GO:0035082,BP,,1961
"regulation of protein import into nucleus, translocation",17,0.599,0.159,1,GO:0033158,BP,,1962
entrainment of circadian clock,24,0.583,0.159,1,GO:0009649,BP,,1963
regulation of vascular permeability,25,0.419,0.159,1,GO:0043114,BP,,1964
coenzyme catabolic process,11,0.377,0.159,1,GO:0009109,BP,,1965
neural crest cell migration,31,0.573,0.16,1,GO:0001755,BP,,1966
ubiquinone biosynthetic process,13,0.387,0.16,1,"GO:0006744,GO:1901663",BP,quinone biosynthetic process,1967
macromolecule deacylation,94,0.542,0.16,1,GO:0098732,BP,,1968
prostate gland epithelium morphogenesis,21,0.589,0.16,1,GO:0060740,BP,,1969
negative regulation of cell growth,147,0.534,0.161,1,GO:0030308,BP,,1970
L-ascorbic acid binding,20,0.591,0.161,1,GO:0031418,MF,,1971
ATP generation from ADP,61,0.448,0.161,1,GO:0006757,BP,,1972
nucleosome binding,44,0.561,0.161,1,GO:0031491,MF,,1973
ESCRT complex disassembly,10,0.372,0.161,1,"GO:1904896,GO:1904903",BP,ESCRT III complex disassembly,1974
platelet degranulation,112,0.462,0.162,1,GO:0002576,BP,,1975
store-operated calcium entry,12,0.383,0.162,1,GO:0002115,BP,,1976
positive regulation of cell cycle G1/S phase transition,27,0.422,0.162,1,GO:1902808,BP,,1977
dendritic cell differentiation,33,0.43,0.162,1,GO:0097028,BP,,1978
antigen binding,52,0.556,0.162,1,GO:0003823,MF,,1979
regulation of sodium ion transmembrane transport,54,0.445,0.162,1,GO:1902305,BP,,1980
regulation of peptidyl-threonine phosphorylation,36,0.433,0.162,1,GO:0010799,BP,,1981
cyclic-nucleotide-mediated signaling,48,0.442,0.162,1,GO:0019935,BP,,1982
regulation of gluconeogenesis,32,0.571,0.162,1,GO:0006111,BP,,1983
2'-deoxyribonucleotide metabolic process,27,0.422,0.162,1,GO:0009394,BP,,1984
intrinsic component of the cytoplasmic side of the plasma membrane,12,0.617,0.162,1,GO:0031235,CC,,1985
regulation of astrocyte differentiation,22,0.586,0.162,1,GO:0048710,BP,,1986
heterochromatin,60,0.552,0.163,1,GO:0000792,CC,,1987
small nuclear ribonucleoprotein complex,61,0.448,0.163,1,GO:0030532,CC,,1988
"transferase activity, transferring sulfur-containing groups",57,0.447,0.163,1,GO:0016782,MF,,1989
RNA stabilization,31,0.572,0.163,1,GO:0043489,BP,,1990
regulation of extracellular matrix organization,27,0.577,0.164,1,GO:1903053,BP,,1991
positive regulation of nitric-oxide synthase biosynthetic process,12,0.616,0.164,1,GO:0051770,BP,,1992
ureteric bud morphogenesis,55,0.554,0.164,1,GO:0060675,BP,,1993
purinergic nucleotide receptor signaling pathway,14,0.392,0.164,1,GO:0035590,BP,,1994
forebrain regionalization,21,0.588,0.164,1,GO:0021871,BP,,1995
negative regulation of Rho protein signal transduction,16,0.6,0.164,1,GO:0035024,BP,,1996
positive regulation of embryonic development,30,0.573,0.164,1,GO:0040019,BP,,1997
GABAergic neuron differentiation,14,0.393,0.164,1,GO:0097154,BP,,1998
regulation of protein homooligomerization,16,0.4,0.165,1,GO:0032462,BP,,1999
exon-exon junction complex,19,0.592,0.165,1,GO:0035145,CC,,2000
ribosomal large subunit assembly,20,0.41,0.165,1,GO:0000027,BP,,2001
"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides",76,0.546,0.165,1,GO:0016811,MF,,2002
extracellular-glutamate-gated ion channel activity,18,0.406,0.166,1,GO:0005234,MF,,2003
neuron-neuron synaptic transmission,122,0.464,0.166,1,GO:0007270,BP,,2004
peroxisomal membrane,55,0.554,0.166,1,"GO:0005778,GO:0031903",CC,microbody membrane,2005
entrainment of circadian clock by photoperiod,19,0.592,0.166,1,GO:0043153,BP,,2006
extrinsic component of cytoplasmic side of plasma membrane,93,0.542,0.166,1,GO:0031234,CC,,2007
cellular response to sterol,14,0.607,0.167,1,GO:0036315,BP,,2008
regulation of protein import into nucleus,151,0.533,0.167,1,GO:0042306,BP,,2009
nuclear transcriptional repressor complex,30,0.573,0.167,1,GO:0090568,CC,,2010
regulation of chromatin organization,134,0.535,0.167,1,GO:1902275,BP,,2011
"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",15,0.603,0.167,1,GO:0000466,BP,,2012
3'-UTR-mediated mRNA stabilization,11,0.62,0.167,1,GO:0070935,BP,,2013
negative regulation of transforming growth factor beta receptor signaling pathway,61,0.551,0.167,1,GO:0030512,BP,,2014
glycosaminoglycan metabolic process,144,0.467,0.167,1,GO:0030203,BP,,2015
membrane hyperpolarization,12,0.385,0.167,1,GO:0060081,BP,,2016
negative regulation of lymphocyte mediated immunity,28,0.575,0.168,1,GO:0002707,BP,,2017
deoxyribonucleotide metabolic process,30,0.427,0.168,1,GO:0009262,BP,,2018
response to hydroperoxide,15,0.397,0.168,1,GO:0033194,BP,,2019
determination of left/right symmetry,105,0.539,0.168,1,GO:0007368,BP,,2020
macrophage activation,44,0.44,0.168,1,GO:0042116,BP,,2021
endocardium development,10,0.626,0.168,1,GO:0003157,BP,,2022
DNA synthesis involved in DNA repair,64,0.55,0.168,1,GO:0000731,BP,,2023
respiratory gaseous exchange,58,0.552,0.169,1,GO:0007585,BP,,2024
regulation of tyrosine phosphorylation of Stat5 protein,10,0.626,0.169,1,GO:0042522,BP,,2025
meiotic cell cycle,177,0.53,0.169,1,GO:0051321,BP,,2026
neurotransmitter biosynthetic process,17,0.404,0.169,1,GO:0042136,BP,,2027
purine ribonucleotide catabolic process,33,0.431,0.169,1,GO:0009154,BP,,2028
branched-chain amino acid metabolic process,22,0.415,0.169,1,GO:0009081,BP,,2029
G-protein coupled purinergic receptor signaling pathway,16,0.401,0.169,1,GO:0035588,BP,,2030
organic acid:sodium symporter activity,21,0.587,0.169,1,GO:0005343,MF,,2031
negative regulation of catecholamine secretion,12,0.385,0.169,1,GO:0033604,BP,,2032
gastrulation,155,0.532,0.169,1,GO:0007369,BP,,2033
Ran GTPase binding,30,0.573,0.169,1,GO:0008536,MF,,2034
regulation of activin receptor signaling pathway,19,0.591,0.169,1,GO:0032925,BP,,2035
spindle midzone,23,0.583,0.17,1,GO:0051233,CC,,2036
"exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters",43,0.561,0.17,1,GO:0016796,MF,,2037
paraxial mesoderm development,17,0.596,0.17,1,GO:0048339,BP,,2038
transition metal ion transport,96,0.459,0.17,1,GO:0000041,BP,,2039
peptide antigen binding,24,0.581,0.17,1,GO:0042605,MF,,2040
regulation of proton transport,13,0.39,0.17,1,GO:0010155,BP,,2041
negative thymic T cell selection,10,0.375,0.17,1,GO:0045060,BP,,2042
negative regulation of GTPase activity,37,0.565,0.17,1,GO:0034260,BP,,2043
positive regulation of mononuclear cell migration,15,0.398,0.17,1,GO:0071677,BP,,2044
cyclic nucleotide catabolic process,22,0.584,0.17,1,GO:0009214,BP,,2045
"phosphotransferase activity, for other substituted phosphate groups",17,0.596,0.17,1,GO:0016780,MF,,2046
negative regulation of interleukin-17 production,10,0.375,0.171,1,GO:0032700,BP,,2047
cellular response to calcium ion,47,0.558,0.171,1,GO:0071277,BP,,2048
peptidyl-proline dioxygenase activity,13,0.61,0.171,1,GO:0031543,MF,,2049
cytokinesis,123,0.536,0.171,1,GO:0000910,BP,,2050
positive regulation of G1/S transition of mitotic cell cycle,22,0.416,0.171,1,GO:1900087,BP,,2051
negative regulation of vasculature development,70,0.547,0.171,1,GO:1901343,BP,,2052
phosphatidylinositol phospholipase C activity,24,0.419,0.171,1,GO:0004435,MF,,2053
copulation,17,0.596,0.171,1,GO:0007620,BP,,2054
phospholipase C activity,26,0.422,0.171,1,GO:0004629,MF,,2055
calcium-mediated signaling,129,0.465,0.171,1,GO:0019722,BP,,2056
positive regulation of inflammatory response,76,0.455,0.171,1,GO:0050729,BP,,2057
fatty acid oxidation,86,0.457,0.171,1,GO:0019395,BP,,2058
glutathione biosynthetic process,15,0.398,0.172,1,GO:0006750,BP,,2059
regulation of glutamate secretion,14,0.395,0.172,1,GO:0014048,BP,,2060
dicarboxylic acid biosynthetic process,12,0.386,0.172,1,GO:0043650,BP,,2061
beta-tubulin binding,31,0.429,0.173,1,GO:0048487,MF,,2062
regulation of kidney development,47,0.558,0.173,1,GO:0090183,BP,,2063
protein O-linked fucosylation,12,0.614,0.173,1,GO:0036066,BP,,2064
negative regulation of lipid biosynthetic process,37,0.565,0.173,1,GO:0051055,BP,,2065
pyrimidine nucleotide metabolic process,45,0.441,0.173,1,GO:0006220,BP,,2066
"oxidoreductase activity, acting on the CH-NH group of donors",27,0.424,0.173,1,GO:0016645,MF,,2067
cardiac muscle cell action potential,62,0.55,0.173,1,GO:0086001,BP,,2068
regulation of protein targeting to membrane,31,0.429,0.173,1,GO:0090313,BP,,2069
negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,27,0.576,0.173,1,GO:0002823,BP,,2070
pseudouridine synthase activity,12,0.386,0.173,1,GO:0009982,MF,,2071
positive regulation of phosphoprotein phosphatase activity,15,0.398,0.173,1,GO:0032516,BP,,2072
protein targeting to vacuole,26,0.577,0.174,1,GO:0006623,BP,,2073
negative regulation of release of sequestered calcium ion into cytosol,13,0.391,0.174,1,GO:0051280,BP,,2074
negative regulation of small GTPase mediated signal transduction,41,0.561,0.174,1,GO:0051058,BP,,2075
sterol binding,37,0.565,0.174,1,GO:0032934,MF,,2076
single-stranded DNA binding,81,0.544,0.174,1,GO:0003697,MF,,2077
1-phosphatidylinositol binding,16,0.598,0.174,1,GO:0005545,MF,,2078
positive regulation of double-strand break repair,12,0.613,0.174,1,GO:2000781,BP,,2079
regulation of IRE1-mediated unfolded protein response,11,0.618,0.174,1,GO:1903894,BP,,2080
"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",15,0.601,0.174,1,"GO:1900151,GO:1900153",BP,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",2081
adrenergic receptor binding,17,0.405,0.175,1,GO:0031690,MF,,2082
positive regulation of cation channel activity,41,0.439,0.175,1,GO:2001259,BP,,2083
planar cell polarity pathway involved in neural tube closure,12,0.613,0.175,1,GO:0090179,BP,,2084
intracellular calcium activated chloride channel activity,14,0.605,0.175,1,"GO:0005229,GO:0061778",MF,intracellular chloride channel activity,2085
glycosylceramide metabolic process,14,0.395,0.175,1,GO:0006677,BP,,2086
negative regulation of hemopoiesis,101,0.539,0.175,1,GO:1903707,BP,,2087
glomerular epithelium development,22,0.583,0.176,1,GO:0072010,BP,,2088
myeloid leukocyte migration,120,0.464,0.176,1,GO:0097529,BP,,2089
T cell selection,31,0.43,0.176,1,GO:0045058,BP,,2090
glutathione binding,10,0.376,0.176,1,GO:0043295,MF,,2091
endodeoxyribonuclease activity,40,0.562,0.176,1,GO:0004520,MF,,2092
vitamin D receptor binding,14,0.604,0.176,1,GO:0042809,MF,,2093
phospholipid catabolic process,29,0.573,0.176,1,GO:0009395,BP,,2094
SRP-dependent cotranslational protein targeting to membrane,85,0.458,0.177,1,GO:0006614,BP,,2095
mitotic G2/M transition checkpoint,19,0.59,0.177,1,GO:0044818,BP,,2096
positive regulation of smooth muscle cell proliferation,63,0.549,0.177,1,GO:0048661,BP,,2097
MAP kinase activity,13,0.392,0.177,1,GO:0004707,MF,,2098
regulation of metanephros development,21,0.585,0.177,1,GO:0072215,BP,,2099
"positive regulation of DNA damage response, signal transduction by p53 class mediator",11,0.618,0.177,1,GO:0043517,BP,,2100
regulation of glycoprotein metabolic process,39,0.563,0.177,1,GO:1903018,BP,,2101
regulation of metallopeptidase activity,12,0.613,0.177,1,GO:1905048,BP,,2102
pre-miRNA processing,12,0.612,0.177,1,GO:0031054,BP,,2103
drug transmembrane transporter activity,16,0.597,0.177,1,GO:0015238,MF,,2104
regulation of delayed rectifier potassium channel activity,14,0.396,0.178,1,GO:1902259,BP,,2105
ion channel inhibitor activity,32,0.431,0.178,1,GO:0008200,MF,,2106
positive regulation of membrane protein ectodomain proteolysis,14,0.604,0.178,1,GO:0051044,BP,,2107
glutamate metabolic process,24,0.421,0.178,1,GO:0006536,BP,,2108
positive regulation of proteasomal ubiquitin-dependent protein catabolic process,73,0.546,0.178,1,GO:0032436,BP,,2109
pyrimidine nucleoside triphosphate metabolic process,23,0.419,0.178,1,GO:0009147,BP,,2110
positive regulation of binding,131,0.534,0.178,1,GO:0051099,BP,,2111
adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,63,0.451,0.178,1,GO:0007193,BP,,2112
maternal behavior,14,0.604,0.178,1,"GO:0042711,GO:0060746",BP,parental behavior,2113
leukocyte apoptotic process,86,0.542,0.178,1,GO:0071887,BP,,2114
fatty acid beta-oxidation using acyl-CoA oxidase,12,0.388,0.179,1,GO:0033540,BP,,2115
lipid oxidation,88,0.459,0.179,1,GO:0034440,BP,,2116
Golgi cisterna,86,0.458,0.179,1,GO:0031985,CC,,2117
DNA replication-independent nucleosome assembly,35,0.566,0.179,1,GO:0006336,BP,,2118
euchromatin,27,0.575,0.179,1,GO:0000791,CC,,2119
positive regulation of phospholipid metabolic process,37,0.436,0.179,1,GO:1903727,BP,,2120
endopeptidase regulator activity,129,0.534,0.18,1,GO:0061135,MF,,2121
nuclear cyclin-dependent protein kinase holoenzyme complex,15,0.6,0.18,1,GO:0019908,CC,,2122
regulation of potassium ion transport,75,0.455,0.18,1,GO:0043266,BP,,2123
muscle organ morphogenesis,62,0.549,0.18,1,GO:0048644,BP,,2124
calcium-activated potassium channel activity,16,0.403,0.18,1,GO:0015269,MF,,2125
neurotransmitter:sodium symporter activity,17,0.594,0.18,1,GO:0005328,MF,,2126
regulation of cell size,144,0.532,0.18,1,GO:0008361,BP,,2127
regulation of epithelial cell differentiation involved in kidney development,16,0.597,0.18,1,GO:2000696,BP,,2128
regulation of cardiocyte differentiation,32,0.432,0.18,1,GO:1905207,BP,,2129
muscle tissue morphogenesis,59,0.55,0.181,1,GO:0060415,BP,,2130
regulation of reproductive process,97,0.539,0.181,1,GO:2000241,BP,,2131
gap junction assembly,11,0.616,0.181,1,GO:0016264,BP,,2132
extracellular matrix binding,43,0.559,0.181,1,GO:0050840,MF,,2133
translational initiation,172,0.47,0.181,1,GO:0006413,BP,,2134
clathrin-sculpted vesicle,12,0.389,0.181,1,GO:0060198,CC,,2135
behavioral response to pain,12,0.611,0.181,1,GO:0048266,BP,,2136
cardiac epithelial to mesenchymal transition,30,0.57,0.182,1,GO:0060317,BP,,2137
ammonium transmembrane transport,17,0.594,0.182,1,GO:0072488,BP,,2138
regulation of DNA replication,98,0.461,0.182,1,GO:0006275,BP,,2139
negative regulation of synaptic transmission,58,0.551,0.182,1,GO:0050805,BP,,2140
immunoglobulin binding,16,0.404,0.182,1,GO:0019865,MF,,2141
regulation of RNA polymerase II transcriptional preinitiation complex assembly,12,0.389,0.182,1,GO:0045898,BP,,2142
signaling adaptor activity,68,0.547,0.182,1,GO:0035591,MF,,2143
intrinsic component of synaptic vesicle membrane,16,0.404,0.183,1,GO:0098563,CC,,2144
organophosphate ester transmembrane transporter activity,17,0.407,0.183,1,GO:0015605,MF,,2145
dolichol-linked oligosaccharide biosynthetic process,19,0.412,0.183,1,GO:0006488,BP,,2146
midbrain dopaminergic neuron differentiation,15,0.599,0.183,1,GO:1904948,BP,,2147
positive regulation of protein localization to nucleus,112,0.536,0.183,1,GO:1900182,BP,,2148
hydrogen peroxide-mediated programmed cell death,12,0.389,0.183,1,"GO:0010421,GO:0097468",BP,programmed cell death in response to reactive oxygen species,2149
ligand-dependent nuclear receptor transcription coactivator activity,51,0.446,0.183,1,GO:0030374,MF,,2150
zymogen granule,13,0.607,0.184,1,GO:0042588,CC,,2151
regulation of response to endoplasmic reticulum stress,67,0.547,0.184,1,GO:1905897,BP,,2152
notochord development,16,0.596,0.184,1,GO:0030903,BP,,2153
phosphatidylinositol 3-kinase signaling,142,0.532,0.184,1,GO:0014065,BP,,2154
regulation of interleukin-2 biosynthetic process,14,0.603,0.184,1,GO:0045076,BP,,2155
glucuronosyltransferase activity,15,0.401,0.185,1,GO:0015020,MF,,2156
glucosamine-containing compound metabolic process,18,0.41,0.185,1,GO:1901071,BP,,2157
response to dopamine,13,0.606,0.185,1,"GO:1903350,GO:1903351",BP,cellular response to dopamine,2158
negative regulation of neuron death,162,0.47,0.185,1,GO:1901215,BP,,2159
HOPS complex,14,0.398,0.185,1,GO:0030897,CC,,2160
regulation of protein maturation,68,0.546,0.185,1,GO:1903317,BP,,2161
protein tyrosine kinase binding,57,0.551,0.186,1,GO:1990782,MF,,2162
metallopeptidase activity,155,0.531,0.186,1,GO:0008237,MF,,2163
four-way junction DNA binding,13,0.606,0.186,1,GO:0000400,MF,,2164
cardiac chamber morphogenesis,105,0.537,0.186,1,GO:0003206,BP,,2165
positive regulation of sprouting angiogenesis,13,0.606,0.186,1,GO:1903672,BP,,2166
iron ion transport,55,0.448,0.187,1,GO:0006826,BP,,2167
mast cell activation involved in immune response,40,0.44,0.187,1,"GO:0002279,GO:0043303",BP,mast cell degranulation,2168
positive regulation of protein export from nucleus,19,0.587,0.187,1,GO:0046827,BP,,2169
vascular smooth muscle contraction,18,0.59,0.187,1,GO:0014829,BP,,2170
AP-2 adaptor complex,13,0.606,0.187,1,GO:0030122,CC,,2171
neural precursor cell proliferation,121,0.535,0.187,1,GO:0061351,BP,,2172
dendritic cell migration,22,0.419,0.187,1,GO:0036336,BP,,2173
vasodilation,29,0.429,0.188,1,GO:0042311,BP,,2174
positive regulation of lamellipodium assembly,14,0.398,0.188,1,GO:0010592,BP,,2175
regulation of cardiac muscle cell differentiation,26,0.425,0.188,1,GO:2000725,BP,,2176
purine nucleotide catabolic process,44,0.443,0.189,1,GO:0006195,BP,,2177
positive regulation of fibroblast migration,11,0.386,0.189,1,GO:0010763,BP,,2178
positive regulation of histone H3-K4 methylation,14,0.601,0.189,1,GO:0051571,BP,,2179
regulation of chromatin binding,19,0.587,0.189,1,GO:0035561,BP,,2180
branching involved in ureteric bud morphogenesis,51,0.553,0.189,1,GO:0001658,BP,,2181
deoxyribonuclease activity,56,0.551,0.19,1,GO:0004536,MF,,2182
adaptation of signaling pathway,16,0.405,0.19,1,GO:0023058,BP,,2183
chromosome organization involved in meiotic cell cycle,51,0.553,0.19,1,GO:0070192,BP,,2184
cleavage furrow,45,0.556,0.19,1,"GO:0032154,GO:0097610",CC,cell surface furrow,2185
"beta-1,3-galactosyltransferase activity",15,0.402,0.19,1,GO:0048531,MF,,2186
interleukin-2 biosynthetic process,17,0.592,0.19,1,GO:0042094,BP,,2187
regulation of cardiac muscle cell proliferation,29,0.57,0.191,1,GO:0060043,BP,,2188
phosphatidylcholine acyl-chain remodeling,22,0.581,0.191,1,GO:0036151,BP,,2189
regulation of T cell tolerance induction,10,0.619,0.191,1,GO:0002664,BP,,2190
sensory perception of taste,38,0.561,0.191,1,GO:0050909,BP,,2191
positive regulation of centrosome cycle,10,0.619,0.191,1,GO:0046607,BP,,2192
negative regulation of dephosphorylation,77,0.543,0.191,1,GO:0035305,BP,,2193
inhibitory postsynaptic potential,12,0.391,0.191,1,GO:0060080,BP,,2194
protein binding involved in protein folding,22,0.42,0.191,1,GO:0044183,MF,,2195
regulation by virus of viral protein levels in host cell,10,0.619,0.191,1,GO:0046719,BP,,2196
establishment or maintenance of monopolar cell polarity,14,0.601,0.192,1,GO:0061339,BP,,2197
cyclic nucleotide binding,32,0.433,0.192,1,GO:0030551,MF,,2198
interferon-alpha production,18,0.589,0.192,1,GO:0032607,BP,,2199
fat cell differentiation,184,0.528,0.192,1,GO:0045444,BP,,2200
dense core granule,12,0.391,0.193,1,GO:0031045,CC,,2201
response to leptin,19,0.586,0.193,1,GO:0044321,BP,,2202
negative regulation of osteoclast differentiation,22,0.58,0.193,1,GO:0045671,BP,,2203
negative regulation of chromosome organization,99,0.538,0.193,1,GO:2001251,BP,,2204
cerebral cortex GABAergic interneuron differentiation,12,0.391,0.193,1,GO:0021892,BP,,2205
regulation of receptor binding,20,0.416,0.193,1,GO:1900120,BP,,2206
"proton-transporting V-type ATPase, V0 domain",10,0.381,0.193,1,GO:0033179,CC,,2207
regulation of phosphorylation of RNA polymerase II C-terminal domain,10,0.619,0.194,1,GO:1901407,BP,,2208
response to laminar fluid shear stress,14,0.6,0.194,1,GO:0034616,BP,,2209
nucleotide-excision repair,91,0.461,0.194,1,GO:0006289,BP,,2210
negative regulation of microtubule polymerization,10,0.381,0.194,1,GO:0031115,BP,,2211
positive regulation of hormone secretion,93,0.461,0.194,1,GO:0046887,BP,,2212
nucleophagy,13,0.396,0.194,1,GO:0044804,BP,,2213
tethering complex,60,0.452,0.194,1,GO:0099023,CC,,2214
cellular response to ionizing radiation,54,0.551,0.195,1,GO:0071479,BP,,2215
regulation of translational elongation,25,0.425,0.195,1,GO:0006448,BP,,2216
ruffle membrane,78,0.543,0.195,1,GO:0032587,CC,,2217
protein tetramerization,111,0.464,0.195,1,GO:0051262,BP,,2218
regulation of rhodopsin mediated signaling pathway,21,0.418,0.195,1,GO:0022400,BP,,2219
meiotic chromosome segregation,67,0.546,0.195,1,GO:0045132,BP,,2220
negative regulation of androgen receptor signaling pathway,12,0.608,0.195,1,GO:0060766,BP,,2221
heart valve development,32,0.566,0.195,1,GO:0003170,BP,,2222
semaphorin-plexin signaling pathway,23,0.578,0.195,1,GO:0071526,BP,,2223
spindle assembly,77,0.543,0.195,1,GO:0051225,BP,,2224
regulation of oligodendrocyte differentiation,27,0.572,0.196,1,GO:0048713,BP,,2225
heart trabecula morphogenesis,32,0.566,0.196,1,GO:0061384,BP,,2226
site of double-strand break,22,0.58,0.196,1,"GO:0035861,GO:0090734",CC,site of DNA damage,2227
response to lead ion,16,0.593,0.196,1,GO:0010288,BP,,2228
phosphoric diester hydrolase activity,81,0.542,0.196,1,GO:0008081,MF,,2229
myeloid dendritic cell differentiation,14,0.4,0.196,1,GO:0043011,BP,,2230
zymogen activation,33,0.435,0.197,1,GO:0031638,BP,,2231
trabecula morphogenesis,44,0.556,0.197,1,GO:0061383,BP,,2232
thyroid hormone receptor binding,25,0.575,0.197,1,GO:0046966,MF,,2233
cell fate determination,33,0.565,0.198,1,GO:0001709,BP,,2234
condensed nuclear chromosome,68,0.545,0.198,1,GO:0000794,CC,,2235
response to dietary excess,19,0.585,0.199,1,GO:0002021,BP,,2236
mucopolysaccharide metabolic process,102,0.463,0.199,1,GO:1903510,BP,,2237
cis-Golgi network,39,0.559,0.199,1,GO:0005801,CC,,2238
complex of collagen trimers,19,0.585,0.199,1,GO:0098644,CC,,2239
cyclic-nucleotide phosphodiesterase activity,24,0.576,0.199,1,GO:0004112,MF,,2240
negative regulation of digestive system process,10,0.383,0.199,1,GO:0060457,BP,,2241
establishment of protein localization to plasma membrane,129,0.533,0.199,1,GO:0090002,BP,,2242
cellular glucose homeostasis,111,0.465,0.199,1,GO:0001678,BP,,2243
protein complex localization,114,0.535,0.199,1,GO:0031503,BP,,2244
negative regulation of transmembrane transport,72,0.456,0.199,1,GO:0034763,BP,,2245
low-density lipoprotein particle receptor binding,13,0.397,0.2,1,GO:0050750,MF,,2246
"positive regulation of protein localization to chromosome, telomeric region",10,0.383,0.2,1,GO:1904816,BP,,2247
regulation of cell killing,43,0.557,0.2,1,GO:0031341,BP,,2248
positive regulation of calcium ion transport,85,0.46,0.2,1,GO:0051928,BP,,2249
nodal signaling pathway,12,0.607,0.201,1,"GO:0038092,GO:0045717",BP,negative regulation of fatty acid biosynthetic process,2250
ATP-dependent DNA helicase activity,29,0.569,0.201,1,GO:0004003,MF,,2251
signal sequence binding,38,0.56,0.201,1,GO:0005048,MF,,2252
striated muscle adaptation,33,0.564,0.201,1,GO:0014888,BP,,2253
positive regulation of neuron apoptotic process,44,0.444,0.201,1,GO:0043525,BP,,2254
positive regulation of receptor-mediated endocytosis,39,0.559,0.201,1,GO:0048260,BP,,2255
metanephros development,78,0.542,0.201,1,GO:0001656,BP,,2256
sodium ion homeostasis,36,0.562,0.202,1,GO:0055078,BP,,2257
regulation of animal organ formation,29,0.569,0.202,1,GO:0003156,BP,,2258
regulation of pathway-restricted SMAD protein phosphorylation,49,0.553,0.202,1,GO:0060393,BP,,2259
glucosyltransferase activity,15,0.595,0.202,1,GO:0046527,MF,,2260
natural killer cell activation involved in immune response,12,0.606,0.203,1,GO:0002323,BP,,2261
social behavior,45,0.555,0.203,1,"GO:0035176,GO:0051703",BP,intraspecies interaction between organisms,2262
regulation of protein processing,67,0.545,0.203,1,GO:0070613,BP,,2263
histone monoubiquitination,22,0.578,0.203,1,GO:0010390,BP,,2264
cGMP-mediated signaling,11,0.389,0.204,1,GO:0019934,BP,,2265
regulation of skeletal muscle cell differentiation,16,0.592,0.204,1,GO:2001014,BP,,2266
specific granule lumen,49,0.447,0.204,1,GO:0035580,CC,,2267
negative regulation of growth,200,0.526,0.204,1,GO:0045926,BP,,2268
regulation of leukocyte migration,122,0.467,0.204,1,GO:0002685,BP,,2269
endoplasmic reticulum organization,40,0.442,0.204,1,GO:0007029,BP,,2270
platelet alpha granule lumen,56,0.451,0.205,1,GO:0031093,CC,,2271
negative regulation of phosphoprotein phosphatase activity,16,0.408,0.205,1,GO:0032515,BP,,2272
synaptic vesicle exocytosis,78,0.458,0.205,1,GO:0016079,BP,,2273
extracellular matrix structural constituent,65,0.546,0.205,1,GO:0005201,MF,,2274
regulation of muscle contraction,134,0.468,0.205,1,GO:0006937,BP,,2275
SH3/SH2 adaptor activity,48,0.553,0.205,1,GO:0005070,MF,,2276
regulation of response to cytokine stimulus,115,0.534,0.205,1,GO:0060759,BP,,2277
ribonucleotide catabolic process,34,0.437,0.206,1,GO:0009261,BP,,2278
muscle alpha-actinin binding,17,0.411,0.206,1,GO:0051371,MF,,2279
inorganic anion transmembrane transport,97,0.537,0.206,1,GO:0098661,BP,,2280
acetylgalactosaminyltransferase activity,32,0.435,0.206,1,GO:0008376,MF,,2281
cell proliferation in hindbrain,10,0.385,0.206,1,GO:0021534,BP,,2282
syncytium formation by plasma membrane fusion,39,0.558,0.206,1,GO:0000768,BP,,2283
negative regulation of acute inflammatory response,11,0.39,0.207,1,GO:0002674,BP,,2284
titin binding,12,0.395,0.207,1,GO:0031432,MF,,2285
adult behavior,120,0.467,0.207,1,GO:0030534,BP,,2286
acid secretion,94,0.462,0.207,1,GO:0046717,BP,,2287
nucleotide diphosphatase activity,13,0.399,0.207,1,GO:0004551,MF,,2288
membrane depolarization during cardiac muscle cell action potential,21,0.58,0.207,1,GO:0086012,BP,,2289
intestinal absorption,21,0.42,0.207,1,GO:0050892,BP,,2290
hepaticobiliary system development,120,0.533,0.207,1,GO:0061008,BP,,2291
regulation of DNA repair,71,0.543,0.207,1,GO:0006282,BP,,2292
positive regulation of reactive oxygen species metabolic process,71,0.457,0.207,1,GO:2000379,BP,,2293
negative regulation of cell cycle phase transition,183,0.473,0.207,1,GO:1901988,BP,,2294
positive regulation of interleukin-2 production,22,0.578,0.207,1,GO:0032743,BP,,2295
regulation of voltage-gated calcium channel activity,27,0.43,0.208,1,GO:1901385,BP,,2296
nuclear euchromatin,22,0.578,0.208,1,GO:0005719,CC,,2297
developmental growth involved in morphogenesis,195,0.526,0.208,1,GO:0060560,BP,,2298
mRNA cleavage involved in mRNA processing,10,0.615,0.208,1,GO:0098787,BP,,2299
phosphatidylethanolamine metabolic process,15,0.594,0.208,1,GO:0046337,BP,,2300
Golgi to plasma membrane transport,41,0.557,0.209,1,GO:0006893,BP,,2301
negative regulation of receptor-mediated endocytosis,14,0.597,0.209,1,GO:0048261,BP,,2302
negative regulation of dendrite development,26,0.571,0.209,1,GO:2000171,BP,,2303
cholesterol binding,33,0.563,0.209,1,GO:0015485,MF,,2304
platelet-derived growth factor binding,10,0.615,0.209,1,GO:0048407,MF,,2305
platelet dense granule lumen,10,0.615,0.21,1,GO:0031089,CC,,2306
regulation of reactive oxygen species metabolic process,137,0.469,0.21,1,GO:2000377,BP,,2307
neurotransmitter metabolic process,29,0.433,0.21,1,GO:0042133,BP,,2308
"phosphatidylinositol-4,5-bisphosphate 3-kinase activity",57,0.548,0.211,1,GO:0046934,MF,,2309
regulation of platelet activation,27,0.43,0.211,1,GO:0010543,BP,,2310
paraxial mesoderm morphogenesis,10,0.614,0.211,1,GO:0048340,BP,,2311
GABA receptor complex,14,0.403,0.211,1,GO:1902710,CC,,2312
receptor regulator activity,45,0.446,0.211,1,GO:0030545,MF,,2313
granulocyte differentiation,20,0.419,0.211,1,GO:0030851,BP,,2314
glycolytic process,60,0.453,0.211,1,GO:0006096,BP,,2315
regulation of necroptotic process,17,0.588,0.211,1,GO:0060544,BP,,2316
ligand-gated anion channel activity,11,0.391,0.211,1,GO:0099095,MF,,2317
intracellular transport of virus,61,0.546,0.212,1,GO:0075733,BP,,2318
response to sterol,21,0.579,0.212,1,GO:0036314,BP,,2319
morphogenesis of an epithelial sheet,44,0.554,0.212,1,GO:0002011,BP,,2320
tertiary granule,138,0.469,0.212,1,GO:0070820,CC,,2321
dendritic spine membrane,10,0.386,0.212,1,GO:0032591,CC,,2322
membrane repolarization during ventricular cardiac muscle cell action potential,11,0.391,0.212,1,GO:0098915,BP,,2323
regulation of interleukin-8 secretion,16,0.41,0.213,1,GO:2000482,BP,,2324
perinuclear endoplasmic reticulum,10,0.614,0.213,1,GO:0097038,CC,,2325
adenylate cyclase-activating G-protein coupled receptor signaling pathway,53,0.451,0.213,1,GO:0007189,BP,,2326
T cell differentiation involved in immune response,40,0.557,0.213,1,GO:0002292,BP,,2327
hepatocyte apoptotic process,12,0.604,0.213,1,GO:0097284,BP,,2328
ESC/E(Z) complex,15,0.593,0.213,1,GO:0035098,CC,,2329
monosaccharide biosynthetic process,77,0.459,0.214,1,GO:0046364,BP,,2330
glycosphingolipid metabolic process,56,0.452,0.214,1,GO:0006687,BP,,2331
heterochromatin organization,13,0.6,0.214,1,GO:0070828,BP,,2332
RNA methyltransferase activity,46,0.553,0.214,1,GO:0008173,MF,,2333
SUMO binding,12,0.604,0.214,1,GO:0032183,MF,,2334
low-density lipoprotein particle,10,0.387,0.214,1,GO:0034362,CC,,2335
neurotransmitter receptor transport,14,0.404,0.214,1,GO:0099637,BP,,2336
integrin-mediated signaling pathway,84,0.539,0.215,1,GO:0007229,BP,,2337
positive regulation of nucleotide metabolic process,110,0.466,0.216,1,"GO:0045981,GO:1900544",BP,positive regulation of purine nucleotide metabolic process,2338
granulocyte chemotaxis,74,0.458,0.216,1,GO:0071621,BP,,2339
cellular response to radiation,140,0.53,0.216,1,GO:0071478,BP,,2340
regulation of spindle assembly,15,0.592,0.216,1,GO:0090169,BP,,2341
regulation of transcription elongation from RNA polymerase II promoter,23,0.426,0.217,1,GO:0034243,BP,,2342
regulation of nucleotide biosynthetic process,123,0.468,0.217,1,"GO:0030808,GO:1900371",BP,regulation of purine nucleotide biosynthetic process,2343
neurotransmitter receptor transport to plasma membrane,11,0.393,0.219,1,GO:0098877,BP,,2344
phosphatidate phosphatase activity,12,0.603,0.219,1,GO:0008195,MF,,2345
histone H3-K4 trimethylation,13,0.598,0.219,1,GO:0080182,BP,,2346
SWI/SNF complex,15,0.592,0.22,1,GO:0016514,CC,,2347
positive regulation of mitotic cell cycle phase transition,52,0.451,0.22,1,GO:1901992,BP,,2348
negative regulation of proteolysis involved in cellular protein catabolic process,37,0.558,0.22,1,GO:1903051,BP,,2349
steroid biosynthetic process,131,0.469,0.22,1,GO:0006694,BP,,2350
cellular response to growth hormone stimulus,20,0.579,0.22,1,GO:0071378,BP,,2351
protein palmitoylation,21,0.577,0.22,1,GO:0018345,BP,,2352
TBP-class protein binding,19,0.419,0.22,1,GO:0017025,MF,,2353
substrate adhesion-dependent cell spreading,75,0.541,0.221,1,GO:0034446,BP,,2354
histone H3-K9 trimethylation,14,0.595,0.221,1,GO:0036124,BP,,2355
detection of light stimulus,56,0.453,0.221,1,GO:0009583,BP,,2356
bone development,155,0.529,0.221,1,GO:0060348,BP,,2357
lipoprotein particle receptor binding,16,0.412,0.221,1,GO:0070325,MF,,2358
regulation of branching involved in ureteric bud morphogenesis,20,0.579,0.221,1,GO:0090189,BP,,2359
neuron death in response to oxidative stress,19,0.419,0.221,1,GO:0036475,BP,,2360
regulation of endothelial cell development,10,0.612,0.221,1,"GO:1901550,GO:1903140",BP,regulation of establishment of endothelial barrier,2361
regulation of membrane repolarization,28,0.567,0.222,1,GO:0060306,BP,,2362
aldehyde biosynthetic process,12,0.398,0.222,1,GO:0046184,BP,,2363
aspartic-type endopeptidase activity,19,0.581,0.222,1,"GO:0004190,GO:0070001",MF,aspartic-type peptidase activity,2364
NuRD complex,17,0.586,0.222,1,"GO:0016581,GO:0090545",CC,CHD-type complex,2365
pigment biosynthetic process,46,0.448,0.222,1,GO:0046148,BP,,2366
B cell activation involved in immune response,49,0.55,0.222,1,GO:0002312,BP,,2367
p38MAPK cascade,31,0.563,0.222,1,GO:0038066,BP,,2368
prostate gland development,36,0.559,0.223,1,GO:0030850,BP,,2369
secondary metabolite biosynthetic process,19,0.419,0.223,1,GO:0044550,BP,,2370
lymph vessel development,23,0.573,0.223,1,GO:0001945,BP,,2371
regulation of thymocyte apoptotic process,11,0.606,0.223,1,GO:0070243,BP,,2372
primary active transmembrane transporter activity,102,0.465,0.223,1,"GO:0015399,GO:0015405",MF,P-P-bond-hydrolysis-driven transmembrane transporter activity,2373
negative regulation of muscle cell differentiation,52,0.549,0.223,1,GO:0051148,BP,,2374
cGMP binding,12,0.398,0.223,1,GO:0030553,MF,,2375
"alternative mRNA splicing, via spliceosome",43,0.554,0.223,1,GO:0000380,BP,,2376
lipoprotein metabolic process,170,0.473,0.223,1,GO:0042157,BP,,2377
lymphocyte mediated immunity,165,0.528,0.224,1,GO:0002449,BP,,2378
sensory perception of pain,81,0.461,0.224,1,GO:0019233,BP,,2379
negative regulation of alpha-beta T cell activation,22,0.575,0.224,1,GO:0046636,BP,,2380
type 1 angiotensin receptor binding,10,0.611,0.224,1,GO:0031702,MF,,2381
response to caffeine,15,0.591,0.224,1,GO:0031000,BP,,2382
phototransduction,45,0.448,0.224,1,GO:0007602,BP,,2383
negative regulation of cellular protein localization,130,0.469,0.224,1,GO:1903828,BP,,2384
ammonium transmembrane transporter activity,27,0.568,0.225,1,GO:0008519,MF,,2385
mitochondrial calcium ion transport,13,0.403,0.225,1,GO:0006851,BP,,2386
positive regulation of neurotransmitter secretion,12,0.399,0.225,1,GO:0001956,BP,,2387
T cell apoptotic process,42,0.554,0.225,1,GO:0070231,BP,,2388
glucose metabolic process,175,0.473,0.225,1,GO:0006006,BP,,2389
establishment of planar polarity of embryonic epithelium,16,0.588,0.225,1,GO:0042249,BP,,2390
proline metabolic process,10,0.389,0.225,1,GO:0006560,BP,,2391
positive regulation of synapse assembly,61,0.455,0.225,1,GO:0051965,BP,,2392
leukocyte homeostasis,71,0.542,0.225,1,GO:0001776,BP,,2393
regulation of leukocyte mediated immunity,123,0.532,0.226,1,GO:0002703,BP,,2394
histone acetyltransferase binding,25,0.57,0.226,1,GO:0035035,MF,,2395
COPI-coated vesicle,22,0.425,0.226,1,GO:0030137,CC,,2396
pyrimidine ribonucleoside metabolic process,30,0.436,0.226,1,GO:0046131,BP,,2397
mediator complex,31,0.437,0.226,1,GO:0016592,CC,,2398
lung epithelial cell differentiation,23,0.573,0.226,1,GO:0060487,BP,,2399
oligosaccharyltransferase complex,10,0.611,0.226,1,GO:0008250,CC,,2400
positive regulation of response to biotic stimulus,31,0.437,0.226,1,GO:0002833,BP,,2401
tripartite regional subdivision,10,0.61,0.226,1,"GO:0007351,GO:0008595",BP,"anterior/posterior axis specification, embryo",2402
regulation of cellular response to transforming growth factor beta stimulus,93,0.536,0.226,1,GO:1903844,BP,,2403
transcytosis,12,0.399,0.227,1,GO:0045056,BP,,2404
regulation of granulocyte differentiation,12,0.399,0.227,1,GO:0030852,BP,,2405
glycogen biosynthetic process,42,0.446,0.227,1,"GO:0005978,GO:0009250",BP,glucan biosynthetic process,2406
sequestering of triglyceride,14,0.407,0.227,1,GO:0030730,BP,,2407
phagocytic cup,18,0.418,0.227,1,GO:0001891,CC,,2408
lymphocyte homeostasis,54,0.548,0.227,1,GO:0002260,BP,,2409
T-helper 17 type immune response,11,0.605,0.227,1,GO:0072538,BP,,2410
endoplasmic reticulum mannose trimming,16,0.587,0.227,1,GO:1904380,BP,,2411
cellular response to ammonium ion,56,0.453,0.228,1,GO:0071242,BP,,2412
"endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters",17,0.585,0.228,1,GO:0016894,MF,,2413
T-tubule,44,0.553,0.228,1,GO:0030315,CC,,2414
"nucleotide-excision repair, preincision complex stabilization",19,0.42,0.228,1,"GO:0006293,GO:0006295",BP,"nucleotide-excision repair, DNA incision, 3'-to lesion",2415
detection of visible light,42,0.446,0.228,1,GO:0009584,BP,,2416
"signal transducer activity, downstream of receptor",132,0.53,0.229,1,GO:0005057,MF,,2417
regulation of receptor-mediated endocytosis,71,0.541,0.229,1,GO:0048259,BP,,2418
regulation of calcium ion transport,178,0.474,0.229,1,GO:0051924,BP,,2419
spinal cord patterning,20,0.578,0.229,1,GO:0021511,BP,,2420
beta-catenin-TCF complex assembly,32,0.561,0.23,1,GO:1904837,BP,,2421
internal peptidyl-lysine acetylation,132,0.53,0.23,1,GO:0018393,BP,,2422
isoprenoid biosynthetic process,23,0.428,0.23,1,GO:0008299,BP,,2423
negative regulation of epithelial to mesenchymal transition,23,0.572,0.23,1,GO:0010719,BP,,2424
cartilage morphogenesis,10,0.61,0.23,1,GO:0060536,BP,,2425
histone acetyltransferase activity,50,0.549,0.23,1,GO:0004402,MF,,2426
macromolecule transmembrane transporter activity,19,0.42,0.23,1,GO:0022884,MF,,2427
hindlimb morphogenesis,29,0.564,0.231,1,GO:0035137,BP,,2428
growth cone part,17,0.416,0.231,1,GO:0090723,CC,,2429
mesoderm development,105,0.534,0.231,1,GO:0007498,BP,,2430
icosanoid biosynthetic process,39,0.445,0.232,1,"GO:0046456,GO:1901570",BP,fatty acid derivative biosynthetic process,2431
monosaccharide transmembrane transporter activity,16,0.586,0.232,1,GO:0015145,MF,,2432
chloride transport,87,0.537,0.232,1,GO:0006821,BP,,2433
inflammatory response to antigenic stimulus,34,0.441,0.232,1,GO:0002437,BP,,2434
centrosome organization,106,0.534,0.232,1,GO:0051297,BP,,2435
regulation of ventricular cardiac muscle cell membrane repolarization,17,0.584,0.232,1,GO:0060307,BP,,2436
positive regulation of transmembrane transport,110,0.467,0.232,1,GO:0034764,BP,,2437
phospholipid dephosphorylation,35,0.558,0.233,1,GO:0046839,BP,,2438
lymphocyte apoptotic process,60,0.545,0.233,1,GO:0070227,BP,,2439
PDZ domain binding,83,0.538,0.233,1,GO:0030165,MF,,2440
myoblast proliferation,12,0.401,0.233,1,GO:0051450,BP,,2441
very-low-density lipoprotein particle,12,0.401,0.233,1,"GO:0034361,GO:0034385",CC,triglyceride-rich plasma lipoprotein particle,2442
cell fate specification,57,0.546,0.234,1,GO:0001708,BP,,2443
regulation of morphogenesis of a branching structure,47,0.55,0.234,1,GO:0060688,BP,,2444
positive regulation of cell growth,135,0.47,0.234,1,GO:0030307,BP,,2445
definitive hemopoiesis,16,0.586,0.234,1,GO:0060216,BP,,2446
lung epithelium development,35,0.558,0.234,1,GO:0060428,BP,,2447
"chemical synaptic transmission, postsynaptic",99,0.465,0.234,1,GO:0099565,BP,,2448
regulation of calcium ion transmembrane transport,108,0.467,0.234,1,GO:1903169,BP,,2449
regulation of receptor activity,120,0.469,0.234,1,GO:0010469,BP,,2450
retinol metabolic process,26,0.433,0.235,1,GO:0042572,BP,,2451
protein self-association,46,0.551,0.235,1,GO:0043621,MF,,2452
regulation of nuclear cell cycle DNA replication,13,0.405,0.235,1,GO:0033262,BP,,2453
poly(A)-specific ribonuclease activity,13,0.595,0.235,1,GO:0004535,MF,,2454
somatic diversification of immunoglobulins,37,0.556,0.235,1,GO:0016445,BP,,2455
negative regulation of actin filament bundle assembly,21,0.575,0.236,1,GO:0032232,BP,,2456
epithelial cell proliferation involved in lung morphogenesis,10,0.608,0.236,1,GO:0060502,BP,,2457
multi-organism behavior,59,0.545,0.236,1,GO:0051705,BP,,2458
embryonic placenta development,74,0.54,0.236,1,GO:0001892,BP,,2459
pyrimidine ribonucleotide biosynthetic process,23,0.429,0.237,1,GO:0009220,BP,,2460
negative regulation of mitotic cell cycle phase transition,178,0.474,0.237,1,GO:1901991,BP,,2461
mitochondrial fusion,21,0.425,0.237,1,GO:0008053,BP,,2462
oligosaccharide-lipid intermediate biosynthetic process,20,0.424,0.237,1,GO:0006490,BP,,2463
placenta blood vessel development,28,0.564,0.238,1,GO:0060674,BP,,2464
positive regulation of DNA recombination,17,0.583,0.238,1,GO:0045911,BP,,2465
cellular response to interleukin-6,23,0.571,0.238,1,GO:0071354,BP,,2466
peptidyl-threonine modification,106,0.467,0.238,1,GO:0018210,BP,,2467
regulation of vasoconstriction,50,0.452,0.238,1,GO:0019229,BP,,2468
alpha-actinin binding,30,0.438,0.238,1,GO:0051393,MF,,2469
positive regulation of protein targeting to membrane,28,0.436,0.238,1,GO:0090314,BP,,2470
meiotic telomere clustering,10,0.608,0.238,1,GO:0045141,BP,,2471
negative regulation of cytokine biosynthetic process,25,0.432,0.239,1,GO:0042036,BP,,2472
histone acetyltransferase complex,76,0.539,0.239,1,GO:0000123,CC,,2473
protein acetylation,157,0.527,0.24,1,GO:0006473,BP,,2474
response to mechanical stimulus,180,0.525,0.24,1,GO:0009612,BP,,2475
anchored component of external side of plasma membrane,21,0.426,0.24,1,GO:0031362,CC,,2476
transcription of nuclear large rRNA transcript from RNA polymerase I promoter,12,0.402,0.24,1,GO:0042790,BP,,2477
collagen metabolic process,93,0.535,0.24,1,GO:0032963,BP,,2478
membrane lipid metabolic process,166,0.526,0.24,1,GO:0006643,BP,,2479
regulation of tube diameter,110,0.468,0.24,1,"GO:0035296,GO:0097746",BP,regulation of blood vessel diameter,2480
regulation of spindle organization,24,0.569,0.241,1,GO:0090224,BP,,2481
inner ear development,162,0.527,0.241,1,GO:0048839,BP,,2482
mesonephric tubule morphogenesis,56,0.545,0.241,1,GO:0072171,BP,,2483
peptidyl-lysine acetylation,136,0.529,0.241,1,GO:0018394,BP,,2484
extrinsic apoptotic signaling pathway,187,0.525,0.241,1,GO:0097191,BP,,2485
ATP-dependent chromatin remodeling,55,0.546,0.241,1,GO:0043044,BP,,2486
proteoglycan biosynthetic process,56,0.455,0.242,1,GO:0030166,BP,,2487
intracellular ligand-gated ion channel activity,24,0.569,0.242,1,GO:0005217,MF,,2488
protein localization to cell surface,50,0.452,0.242,1,GO:0034394,BP,,2489
microtubule nucleation,20,0.576,0.242,1,GO:0007020,BP,,2490
ADP metabolic process,66,0.458,0.242,1,GO:0046031,BP,,2491
regulation of extrinsic apoptotic signaling pathway,136,0.529,0.243,1,GO:2001236,BP,,2492
superoxide metabolic process,50,0.452,0.243,1,GO:0006801,BP,,2493
spliceosomal complex,157,0.527,0.244,1,GO:0005681,CC,,2494
import across plasma membrane,28,0.436,0.244,1,GO:0098739,BP,,2495
calcium ion import into cell,11,0.601,0.244,1,GO:1990035,BP,,2496
sterol transport,67,0.541,0.244,1,GO:0015918,BP,,2497
hepatocyte proliferation,15,0.587,0.245,1,"GO:0072574,GO:0072575",BP,epithelial cell proliferation involved in liver morphogenesis,2498
glycerophospholipid catabolic process,16,0.584,0.245,1,GO:0046475,BP,,2499
Rac GTPase binding,42,0.552,0.245,1,GO:0048365,MF,,2500
specification of symmetry,113,0.532,0.246,1,GO:0009799,BP,,2501
histone H4-K20 methylation,10,0.606,0.246,1,GO:0034770,BP,,2502
bone maturation,17,0.581,0.246,1,GO:0070977,BP,,2503
DNA-dependent ATPase activity,63,0.542,0.246,1,GO:0008094,MF,,2504
endochondral bone growth,19,0.423,0.246,1,GO:0003416,BP,,2505
regulation of neuron migration,27,0.565,0.246,1,GO:2001222,BP,,2506
cellular response to nutrient levels,147,0.528,0.246,1,GO:0031669,BP,,2507
positive regulation of smoothened signaling pathway,23,0.57,0.246,1,GO:0045880,BP,,2508
nucleoid,31,0.44,0.246,1,"GO:0009295,GO:0042645",CC,mitochondrial nucleoid,2509
ubiquitin conjugating enzyme activity,28,0.437,0.247,1,GO:0061631,MF,,2510
monooxygenase activity,67,0.459,0.247,1,GO:0004497,MF,,2511
oligosaccharide biosynthetic process,15,0.414,0.247,1,GO:0009312,BP,,2512
regulation of necrotic cell death,23,0.57,0.247,1,GO:0010939,BP,,2513
positive regulation of long-term synaptic potentiation,11,0.601,0.247,1,GO:1900273,BP,,2514
lipopolysaccharide-mediated signaling pathway,42,0.448,0.247,1,GO:0031663,BP,,2515
eosinophil migration,12,0.404,0.248,1,GO:0072677,BP,,2516
ossification involved in bone maturation,16,0.583,0.248,1,GO:0043931,BP,,2517
npBAF complex,12,0.596,0.248,1,GO:0071564,CC,,2518
transforming growth factor beta production,26,0.565,0.248,1,GO:0071604,BP,,2519
hematopoietic progenitor cell differentiation,78,0.538,0.249,1,GO:0002244,BP,,2520
spliceosomal tri-snRNP complex assembly,11,0.4,0.249,1,GO:0000244,BP,,2521
brain morphogenesis,31,0.56,0.249,1,GO:0048854,BP,,2522
mitogen-activated protein kinase kinase binding,13,0.408,0.249,1,GO:0031434,MF,,2523
sulfur compound transport,29,0.562,0.249,1,GO:0072348,BP,,2524
cytoplasmic microtubule organization,43,0.551,0.249,1,GO:0031122,BP,,2525
mesodermal cell differentiation,29,0.562,0.249,1,GO:0048333,BP,,2526
glutamate secretion,42,0.449,0.249,1,GO:0014047,BP,,2527
sodium ion transmembrane transporter activity,123,0.53,0.25,1,GO:0015081,MF,,2528
protein methylation,152,0.527,0.25,1,"GO:0006479,GO:0008213",BP,protein alkylation,2529
regulation of interferon-alpha production,17,0.581,0.25,1,GO:0032647,BP,,2530
positive regulation of ERAD pathway,13,0.592,0.25,1,GO:1904294,BP,,2531
excitatory extracellular ligand-gated ion channel activity,41,0.448,0.25,1,GO:0005231,MF,,2532
negative regulation of T cell mediated immunity,13,0.592,0.25,1,GO:0002710,BP,,2533
myeloid dendritic cell activation,21,0.428,0.251,1,GO:0001773,BP,,2534
double-stranded RNA binding,55,0.545,0.251,1,GO:0003725,MF,,2535
protein O-linked glycosylation,86,0.536,0.251,1,GO:0006493,BP,,2536
phosphatidylethanolamine biosynthetic process,12,0.596,0.251,1,GO:0006646,BP,,2537
DNA-templated transcriptional preinitiation complex assembly,31,0.44,0.251,1,GO:0070897,BP,,2538
positive regulation of steroid metabolic process,18,0.578,0.251,1,GO:0045940,BP,,2539
antigen processing and presentation of endogenous antigen,10,0.605,0.251,1,GO:0019883,BP,,2540
interferon-gamma-mediated signaling pathway,80,0.537,0.251,1,GO:0060333,BP,,2541
oligosaccharide metabolic process,47,0.452,0.252,1,GO:0009311,BP,,2542
regulation of pri-miRNA transcription from RNA polymerase II promoter,26,0.565,0.253,1,GO:1902893,BP,,2543
negative regulation of angiogenesis,63,0.542,0.253,1,GO:0016525,BP,,2544
benzene-containing compound metabolic process,16,0.417,0.253,1,GO:0042537,BP,,2545
modification of morphology or physiology of other organism involved in symbiotic interaction,73,0.539,0.253,1,GO:0051817,BP,,2546
inner dynein arm assembly,13,0.409,0.253,1,GO:0036159,BP,,2547
T cell migration,29,0.439,0.253,1,GO:0072678,BP,,2548
translation initiation factor activity,46,0.451,0.254,1,GO:0003743,MF,,2549
nucleoside triphosphate catabolic process,11,0.401,0.255,1,GO:0009143,BP,,2550
neuropeptide receptor binding,22,0.43,0.255,1,GO:0071855,MF,,2551
cell proliferation involved in kidney development,16,0.582,0.255,1,GO:0072111,BP,,2552
invadopodium,11,0.599,0.256,1,GO:0071437,CC,,2553
phosphorylation of RNA polymerase II C-terminal domain,16,0.582,0.256,1,GO:0070816,BP,,2554
"retrograde transport, endosome to plasma membrane",17,0.421,0.257,1,GO:1990126,BP,,2555
cytoplasmic stress granule,36,0.555,0.257,1,GO:0010494,CC,,2556
positive regulation of angiogenesis,106,0.532,0.257,1,GO:0045766,BP,,2557
regulation of respiratory gaseous exchange by neurological system process,10,0.604,0.257,1,GO:0002087,BP,,2558
regulation of synaptic vesicle recycling,14,0.412,0.257,1,GO:1903421,BP,,2559
FMN binding,12,0.406,0.257,1,GO:0010181,MF,,2560
positive regulation of cell cycle phase transition,59,0.457,0.257,1,GO:1901989,BP,,2561
regulation of release of sequestered calcium ion into cytosol,64,0.459,0.257,1,GO:0051279,BP,,2562
"positive regulation of gene expression, epigenetic",57,0.543,0.257,1,GO:0045815,BP,,2563
spinal cord dorsal/ventral patterning,18,0.577,0.257,1,GO:0021513,BP,,2564
NAD-dependent histone deacetylase activity,14,0.587,0.257,1,"GO:0017136,GO:0034979",MF,NAD-dependent protein deacetylase activity,2565
positive regulation of ion transmembrane transporter activity,66,0.46,0.257,1,GO:0032414,BP,,2566
negative regulation of osteoblast differentiation,38,0.553,0.257,1,GO:0045668,BP,,2567
regulation of organic acid transport,44,0.451,0.257,1,GO:0032890,BP,,2568
positive regulation of amine transport,30,0.44,0.258,1,GO:0051954,BP,,2569
positive regulation of tyrosine phosphorylation of Stat3 protein,24,0.567,0.258,1,GO:0042517,BP,,2570
norepinephrine transport,19,0.425,0.258,1,GO:0015874,BP,,2571
negative regulation of systemic arterial blood pressure,13,0.409,0.258,1,GO:0003085,BP,,2572
phosphatidylinositol 3-kinase complex,15,0.584,0.258,1,GO:0005942,CC,,2573
forebrain neuron development,31,0.441,0.258,1,GO:0021884,BP,,2574
tyrosine phosphorylation of Stat1 protein,14,0.587,0.259,1,GO:0042508,BP,,2575
positive regulation of JNK cascade,101,0.533,0.259,1,GO:0046330,BP,,2576
response to insecticide,10,0.397,0.259,1,GO:0017085,BP,,2577
regulation of polysaccharide biosynthetic process,30,0.44,0.259,1,GO:0032885,BP,,2578
regulation of intrinsic apoptotic signaling pathway in response to DNA damage,33,0.557,0.259,1,GO:1902229,BP,,2579
cytoplasmic sequestering of protein,37,0.554,0.259,1,GO:0051220,BP,,2580
"transcriptional activator activity, RNA polymerase II transcription factor binding",47,0.548,0.26,1,"GO:0001190,GO:0098811",MF,"transcriptional repressor activity, RNA polymerase II activating transcription factor binding",2581
acetylcholine receptor signaling pathway,22,0.431,0.26,1,"GO:0095500,GO:1903831,GO:1905144,GO:1905145",BP,"signal transduction involved in cellular response to ammonium ion,response to acetylcholine,cellular response to acetylcholine",2582
negative regulation of homotypic cell-cell adhesion,11,0.598,0.26,1,GO:0034111,BP,,2583
cellular extravasation,40,0.449,0.26,1,GO:0045123,BP,,2584
axonal growth cone,17,0.579,0.261,1,GO:0044295,CC,,2585
positive regulation of renal sodium excretion,13,0.59,0.261,1,GO:0035815,BP,,2586
platelet morphogenesis,16,0.581,0.261,1,GO:0036344,BP,,2587
primary alcohol metabolic process,41,0.449,0.261,1,GO:0034308,BP,,2588
UDP-glycosyltransferase activity,111,0.469,0.261,1,GO:0008194,MF,,2589
cellular response to cholesterol,11,0.598,0.261,1,GO:0071397,BP,,2590
"phagocytosis, recognition",14,0.587,0.261,1,GO:0006910,BP,,2591
long-chain fatty acid binding,10,0.397,0.261,1,GO:0036041,MF,,2592
cellular response to leptin stimulus,15,0.584,0.262,1,GO:0044320,BP,,2593
keratinocyte migration,13,0.59,0.262,1,GO:0051546,BP,,2594
mitotic sister chromatid segregation,117,0.53,0.262,1,GO:0000070,BP,,2595
plasma lipoprotein particle,28,0.439,0.262,1,"GO:0034358,GO:1990777",CC,lipoprotein particle,2596
ruffle,150,0.527,0.262,1,GO:0001726,CC,,2597
magnesium ion binding,178,0.524,0.262,1,GO:0000287,MF,,2598
stem cell differentiation,136,0.528,0.262,1,GO:0048863,BP,,2599
negative regulation of blood vessel morphogenesis,64,0.541,0.262,1,GO:2000181,BP,,2600
glycoprotein binding,89,0.534,0.263,1,GO:0001948,MF,,2601
phosphatidylinositol dephosphorylation,24,0.566,0.263,1,GO:0046856,BP,,2602
renal sodium excretion,20,0.572,0.264,1,"GO:0035812,GO:0035813",BP,regulation of renal sodium excretion,2603
regulation of circadian rhythm,88,0.535,0.264,1,GO:0042752,BP,,2604
RISC complex,10,0.602,0.264,1,GO:0016442,CC,,2605
regulation of Arp2/3 complex-mediated actin nucleation,16,0.419,0.264,1,GO:0034315,BP,,2606
triglyceride lipase activity,13,0.411,0.264,1,GO:0004806,MF,,2607
negative regulation of cellular response to insulin stimulus,31,0.558,0.265,1,GO:1900077,BP,,2608
protein-lipid complex,30,0.441,0.265,1,GO:0032994,CC,,2609
cellular response to virus,34,0.555,0.265,1,GO:0098586,BP,,2610
positive regulation of macroautophagy,52,0.545,0.265,1,GO:0016239,BP,,2611
insulin-like growth factor receptor signaling pathway,32,0.557,0.265,1,GO:0048009,BP,,2612
liver development,117,0.53,0.265,1,GO:0001889,BP,,2613
neuron fate specification,20,0.572,0.265,1,GO:0048665,BP,,2614
iron ion import,13,0.589,0.265,1,GO:0097286,BP,,2615
regulation of DNA biosynthetic process,83,0.465,0.265,1,GO:2000278,BP,,2616
secondary lysosome,13,0.589,0.265,1,GO:0005767,CC,,2617
peptide cross-linking,30,0.559,0.265,1,GO:0018149,BP,,2618
cation-transporting ATPase complex,11,0.597,0.266,1,GO:0090533,CC,,2619
response to acidic pH,18,0.424,0.266,1,GO:0010447,BP,,2620
regulation of mitophagy,46,0.453,0.266,1,GO:1903146,BP,,2621
anchored component of membrane,127,0.471,0.266,1,GO:0031225,CC,,2622
regulation of transforming growth factor beta receptor signaling pathway,91,0.534,0.266,1,GO:0017015,BP,,2623
positive regulation of calcium ion-dependent exocytosis,20,0.428,0.266,1,GO:0045956,BP,,2624
"protein import into nucleus, translocation",43,0.549,0.266,1,GO:0000060,BP,,2625
determination of bilateral symmetry,112,0.53,0.266,1,GO:0009855,BP,,2626
somatic recombination of immunoglobulin gene segments,33,0.556,0.267,1,GO:0016447,BP,,2627
actin nucleation,43,0.451,0.267,1,GO:0045010,BP,,2628
negative regulation of transcription regulatory region DNA binding,17,0.422,0.268,1,GO:2000678,BP,,2629
protein heterooligomerization,93,0.533,0.268,1,GO:0051291,BP,,2630
negative regulation of protein serine/threonine kinase activity,112,0.47,0.268,1,GO:0071901,BP,,2631
negative regulation of protein kinase B signaling,34,0.445,0.269,1,GO:0051898,BP,,2632
regulation of protein import,154,0.526,0.269,1,GO:1904589,BP,,2633
cyclin-dependent protein kinase holoenzyme complex,39,0.551,0.269,1,GO:0000307,CC,,2634
cellular protein complex localization,27,0.561,0.269,1,GO:0034629,BP,,2635
"preribosome, small subunit precursor",10,0.601,0.269,1,GO:0030688,CC,,2636
diterpenoid metabolic process,75,0.463,0.269,1,GO:0016101,BP,,2637
regulation of lipoprotein particle clearance,10,0.601,0.27,1,GO:0010984,BP,,2638
androgen receptor signaling pathway,63,0.54,0.27,1,GO:0030521,BP,,2639
PERK-mediated unfolded protein response,21,0.57,0.27,1,GO:0036499,BP,,2640
regulation of viral entry into host cell,25,0.564,0.27,1,GO:0046596,BP,,2641
nucleoside bisphosphate metabolic process,28,0.44,0.27,1,"GO:0033865,GO:0033875,GO:0034032",BP,"ribonucleoside bisphosphate metabolic process,purine nucleoside bisphosphate metabolic process",2642
positive regulation of mitochondrial calcium ion concentration,10,0.399,0.27,1,GO:0051561,BP,,2643
positive regulation of catecholamine secretion,12,0.408,0.27,1,GO:0033605,BP,,2644
neuropeptide binding,15,0.418,0.27,1,GO:0042923,MF,,2645
regulation of protein localization to cell surface,29,0.441,0.27,1,GO:2000008,BP,,2646
response to potassium ion,11,0.596,0.271,1,GO:0035864,BP,,2647
megakaryocyte development,14,0.585,0.271,1,GO:0035855,BP,,2648
striated muscle hypertrophy,60,0.541,0.271,1,GO:0014897,BP,,2649
intrinsic apoptotic signaling pathway in response to DNA damage,88,0.534,0.271,1,GO:0008630,BP,,2650
homotypic cell-cell adhesion,64,0.54,0.271,1,GO:0034109,BP,,2651
regulation of type I interferon production,106,0.469,0.271,1,GO:0032479,BP,,2652
presynaptic process involved in chemical synaptic transmission,143,0.473,0.272,1,GO:0099531,BP,,2653
very long-chain fatty acid-CoA ligase activity,10,0.4,0.272,1,GO:0031957,MF,,2654
tetrapyrrole metabolic process,47,0.454,0.272,1,GO:0033013,BP,,2655
cellular response to antibiotic,14,0.585,0.272,1,GO:0071236,BP,,2656
UV-damage excision repair,10,0.6,0.273,1,GO:0070914,BP,,2657
T cell chemotaxis,12,0.409,0.273,1,GO:0010818,BP,,2658
positive regulation of chemotaxis,99,0.468,0.274,1,GO:0050921,BP,,2659
regulation of fertilization,17,0.577,0.274,1,GO:0080154,BP,,2660
positive regulation of stress-activated MAPK cascade,116,0.529,0.274,1,GO:0032874,BP,,2661
positive regulation of cilium assembly,18,0.574,0.274,1,GO:0045724,BP,,2662
glomerular epithelial cell differentiation,19,0.572,0.275,1,GO:0072311,BP,,2663
myoblast differentiation,68,0.538,0.275,1,GO:0045445,BP,,2664
carboxylic acid transmembrane transporter activity,107,0.531,0.275,1,GO:0046943,MF,,2665
calcium-dependent protein kinase activity,12,0.409,0.275,1,GO:0010857,MF,,2666
ligand-gated cation channel activity,74,0.463,0.275,1,GO:0099094,MF,,2667
negative regulation of macrophage derived foam cell differentiation,12,0.591,0.275,1,GO:0010745,BP,,2668
lipoprotein transport,12,0.409,0.275,1,"GO:0042953,GO:0044872",BP,lipoprotein localization,2669
activation of GTPase activity,74,0.537,0.275,1,GO:0090630,BP,,2670
serine hydrolase activity,151,0.474,0.275,1,GO:0017171,MF,,2671
epithelial to mesenchymal transition involved in endocardial cushion formation,17,0.576,0.275,1,GO:0003198,BP,,2672
vesicle fusion,138,0.473,0.276,1,GO:0006906,BP,,2673
keratin filament,39,0.55,0.276,1,GO:0045095,CC,,2674
establishment of skin barrier,14,0.584,0.276,1,GO:0061436,BP,,2675
acetylglucosaminyltransferase activity,44,0.453,0.276,1,GO:0008375,MF,,2676
lamellar body,13,0.413,0.276,1,GO:0042599,CC,,2677
autophagosome,74,0.537,0.276,1,GO:0005776,CC,,2678
organic acid transmembrane transporter activity,113,0.53,0.276,1,GO:0005342,MF,,2679
integrin binding,94,0.533,0.277,1,GO:0005178,MF,,2680
positive regulation of hormone metabolic process,10,0.599,0.277,1,GO:0032352,BP,,2681
regulation of sensory perception of pain,26,0.438,0.277,1,"GO:0051930,GO:0051931",BP,regulation of sensory perception,2682
renal filtration cell differentiation,18,0.574,0.277,1,"GO:0061318,GO:0072112",BP,glomerular visceral epithelial cell differentiation,2683
post-Golgi vesicle-mediated transport,80,0.535,0.278,1,GO:0006892,BP,,2684
negative regulation of cyclin-dependent protein kinase activity,21,0.568,0.278,1,GO:1904030,BP,,2685
regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,28,0.441,0.278,1,GO:1902175,BP,,2686
pyrimidine-containing compound metabolic process,73,0.463,0.278,1,GO:0072527,BP,,2687
guanosine-containing compound metabolic process,45,0.453,0.278,1,GO:1901068,BP,,2688
ammonium ion metabolic process,173,0.476,0.278,1,GO:0097164,BP,,2689
detection of chemical stimulus involved in sensory perception of smell,121,0.529,0.278,1,"GO:0050911,GO:0004984",BP,olfactory receptor activity,2690
cerebellar Purkinje cell layer development,25,0.437,0.279,1,GO:0021680,BP,,2691
mammary gland epithelial cell proliferation,19,0.428,0.279,1,GO:0033598,BP,,2692
negative regulation of bone remodeling,12,0.59,0.279,1,GO:0046851,BP,,2693
positive regulation of viral life cycle,81,0.465,0.28,1,GO:1903902,BP,,2694
regulation of actin polymerization or depolymerization,140,0.473,0.28,1,GO:0008064,BP,,2695
positive regulation of lymphocyte apoptotic process,14,0.583,0.28,1,GO:0070230,BP,,2696
regulation of histone deacetylation,23,0.565,0.28,1,GO:0031063,BP,,2697
alpha-tubulin binding,22,0.566,0.281,1,GO:0043014,MF,,2698
positive regulation of steroid biosynthetic process,13,0.586,0.281,1,GO:0010893,BP,,2699
epithelial cell fate commitment,14,0.583,0.281,1,GO:0072148,BP,,2700
regulation of cell projection assembly,136,0.527,0.281,1,GO:0060491,BP,,2701
cellular response to interleukin-1,65,0.539,0.281,1,GO:0071347,BP,,2702
inner cell mass cell proliferation,10,0.402,0.281,1,GO:0001833,BP,,2703
intrinsic component of external side of plasma membrane,26,0.439,0.281,1,GO:0031233,CC,,2704
mitochondrial outer membrane,143,0.474,0.282,1,GO:0005741,CC,,2705
peptide transmembrane transporter activity,25,0.438,0.282,1,GO:1904680,MF,,2706
cGMP biosynthetic process,36,0.448,0.282,1,GO:0006182,BP,,2707
muscle fiber development,45,0.546,0.282,1,GO:0048747,BP,,2708
U2-type prespliceosome,14,0.583,0.282,1,GO:0071004,CC,,2709
N-acetylglucosamine metabolic process,15,0.42,0.283,1,GO:0006044,BP,,2710
"phototransduction, visible light",30,0.443,0.283,1,GO:0007603,BP,,2711
regulation of smooth muscle contraction,52,0.457,0.283,1,GO:0006940,BP,,2712
spliceosomal snRNP complex,54,0.458,0.283,1,GO:0097525,CC,,2713
positive regulation of interleukin-12 production,26,0.561,0.283,1,GO:0032735,BP,,2714
steroid hormone receptor binding,84,0.534,0.283,1,GO:0035258,MF,,2715
cytoplasmic mRNA processing body assembly,20,0.569,0.283,1,GO:0033962,BP,,2716
response to estradiol,106,0.53,0.283,1,GO:0032355,BP,,2717
pyrimidine-containing compound biosynthetic process,41,0.452,0.283,1,GO:0072528,BP,,2718
misfolded protein binding,13,0.414,0.283,1,GO:0051787,MF,,2719
gland morphogenesis,105,0.53,0.284,1,GO:0022612,BP,,2720
oocyte maturation,19,0.429,0.284,1,GO:0001556,BP,,2721
cysteine-type endopeptidase inhibitor activity involved in apoptotic process,21,0.568,0.284,1,GO:0043027,MF,,2722
protein targeting to peroxisome,13,0.414,0.285,1,"GO:0006625,GO:0072662,GO:0072663",BP,"protein localization to peroxisome,establishment of protein localization to peroxisome",2723
positive regulation of striated muscle cell differentiation,45,0.454,0.285,1,GO:0051155,BP,,2724
neurotransmitter secretion,134,0.473,0.285,1,"GO:0007269,GO:0099643",BP,signal release from synapse,2725
chondrocyte development,25,0.438,0.285,1,GO:0002063,BP,,2726
regulation of antigen receptor-mediated signaling pathway,42,0.452,0.285,1,GO:0050854,BP,,2727
regulation of gene silencing by miRNA,29,0.557,0.285,1,GO:0060964,BP,,2728
regulation of G1/S transition of mitotic cell cycle,122,0.528,0.286,1,GO:2000045,BP,,2729
monovalent inorganic anion homeostasis,13,0.586,0.286,1,GO:0055083,BP,,2730
GABA receptor activity,17,0.425,0.286,1,GO:0016917,MF,,2731
somatic diversification of immune receptors via somatic mutation,10,0.597,0.286,1,"GO:0002566,GO:0016446",BP,somatic hypermutation of immunoglobulin genes,2732
cellular response to epinephrine stimulus,13,0.415,0.287,1,GO:0071872,BP,,2733
anchored component of plasma membrane,43,0.453,0.287,1,GO:0046658,CC,,2734
hormone receptor binding,144,0.526,0.287,1,GO:0051427,MF,,2735
regulation of myoblast differentiation,41,0.548,0.287,1,GO:0045661,BP,,2736
regulation of oxidative stress-induced neuron death,18,0.428,0.287,1,GO:1903203,BP,,2737
cell-cell adhesion mediated by cadherin,11,0.593,0.288,1,GO:0044331,BP,,2738
purine-containing compound salvage,13,0.415,0.288,1,GO:0043101,BP,,2739
trans-Golgi network transport vesicle membrane,14,0.418,0.288,1,GO:0012510,CC,,2740
peptidyl-threonine dephosphorylation,11,0.593,0.288,1,GO:0035970,BP,,2741
pyrimidine nucleotide biosynthetic process,31,0.445,0.288,1,GO:0006221,BP,,2742
embryonic placenta morphogenesis,19,0.57,0.288,1,GO:0060669,BP,,2743
positive regulation of ion transmembrane transport,104,0.47,0.288,1,GO:0034767,BP,,2744
positive regulation of axon extension,38,0.45,0.288,1,GO:0045773,BP,,2745
serotonin transport,15,0.421,0.288,1,GO:0006837,BP,,2746
sodium ion transport,190,0.522,0.288,1,GO:0006814,BP,,2747
transmembrane receptor protein serine/threonine kinase binding,13,0.585,0.288,1,GO:0070696,MF,,2748
negative regulation of carbohydrate metabolic process,35,0.448,0.288,1,GO:0045912,BP,,2749
negative regulation of antigen receptor-mediated signaling pathway,20,0.431,0.289,1,GO:0050858,BP,,2750
positive regulation of Notch signaling pathway,30,0.444,0.289,1,GO:0045747,BP,,2751
microtubule polymerization or depolymerization,73,0.536,0.289,1,GO:0031109,BP,,2752
cell recognition,113,0.471,0.289,1,GO:0008037,BP,,2753
midbrain development,81,0.534,0.289,1,GO:0030901,BP,,2754
positive regulation of protein localization to cell surface,11,0.408,0.289,1,GO:2000010,BP,,2755
peptide-lysine-N-acetyltransferase activity,51,0.543,0.289,1,GO:0061733,MF,,2756
calcium-dependent protein binding,55,0.459,0.289,1,GO:0048306,MF,,2757
cellular response to follicle-stimulating hormone stimulus,11,0.408,0.289,1,GO:0071372,BP,,2758
negative regulation of nitric oxide biosynthetic process,10,0.597,0.289,1,"GO:0045019,GO:1904406",BP,negative regulation of nitric oxide metabolic process,2759
positive regulation of vasculature development,120,0.528,0.289,1,GO:1904018,BP,,2760
positive regulation of viral process,91,0.468,0.29,1,GO:0048524,BP,,2761
regulation of extracellular matrix assembly,11,0.592,0.29,1,GO:1901201,BP,,2762
organelle membrane contact site,10,0.403,0.29,1,GO:0044232,CC,,2763
uropod,13,0.415,0.291,1,"GO:0001931,GO:0031254",CC,cell trailing edge,2764
dopamine biosynthetic process,12,0.412,0.291,1,GO:0042416,BP,,2765
mitotic cell cycle arrest,13,0.584,0.292,1,GO:0071850,BP,,2766
negative regulation of cardiac muscle cell apoptotic process,13,0.584,0.292,1,GO:0010667,BP,,2767
DNA replication checkpoint,11,0.408,0.292,1,GO:0000076,BP,,2768
angiogenesis involved in wound healing,17,0.574,0.292,1,GO:0060055,BP,,2769
bundle of His cell to Purkinje myocyte communication,12,0.588,0.292,1,GO:0086069,BP,,2770
embryonic hindlimb morphogenesis,24,0.562,0.292,1,GO:0035116,BP,,2771
regulation of lipid biosynthetic process,112,0.529,0.292,1,GO:0046890,BP,,2772
glutamate receptor activity,26,0.44,0.292,1,GO:0008066,MF,,2773
inositol tetrakisphosphate phosphatase activity,11,0.592,0.292,1,GO:0052743,MF,,2774
multicellular organism aging,21,0.566,0.293,1,GO:0010259,BP,,2775
NAD+ ADP-ribosyltransferase activity,18,0.572,0.293,1,GO:0003950,MF,,2776
maturation of 5.8S rRNA,24,0.562,0.293,1,GO:0000460,BP,,2777
male meiosis I,11,0.408,0.293,1,GO:0007141,BP,,2778
complement activation,45,0.455,0.293,1,GO:0006956,BP,,2779
mammary gland development,112,0.529,0.293,1,GO:0030879,BP,,2780
protein kinase inhibitor activity,87,0.467,0.293,1,GO:0004860,MF,,2781
extrinsic component of organelle membrane,24,0.438,0.293,1,GO:0031312,CC,,2782
muscle myosin complex,19,0.43,0.294,1,GO:0005859,CC,,2783
proline-rich region binding,17,0.574,0.294,1,GO:0070064,MF,,2784
positive regulation of regulatory T cell differentiation,10,0.596,0.294,1,GO:0045591,BP,,2785
endoribonuclease activity,39,0.451,0.294,1,GO:0004521,MF,,2786
cellular response to nitric oxide,14,0.581,0.294,1,GO:0071732,BP,,2787
digestive tract morphogenesis,40,0.548,0.294,1,GO:0048546,BP,,2788
Cul4A-RING E3 ubiquitin ligase complex,10,0.404,0.294,1,GO:0031464,CC,,2789
regulation of removal of superoxide radicals,10,0.404,0.294,1,GO:2000121,BP,,2790
digestive tract development,107,0.529,0.294,1,GO:0048565,BP,,2791
negative regulation of phosphatase activity,68,0.537,0.294,1,GO:0010923,BP,,2792
establishment of chromosome localization,56,0.459,0.294,1,GO:0051303,BP,,2793
endonuclease activity,97,0.531,0.294,1,GO:0004519,MF,,2794
melanin metabolic process,17,0.427,0.295,1,GO:0006582,BP,,2795
photoperiodism,22,0.565,0.295,1,GO:0009648,BP,,2796
establishment of blood-brain barrier,10,0.596,0.295,1,GO:0060856,BP,,2797
replication fork,58,0.54,0.295,1,GO:0005657,CC,,2798
sphingomyelin metabolic process,13,0.584,0.295,1,GO:0006684,BP,,2799
DNA N-glycosylase activity,10,0.596,0.295,1,GO:0019104,MF,,2800
cellular response to reactive nitrogen species,17,0.573,0.295,1,GO:1902170,BP,,2801
interleukin-6 secretion,23,0.563,0.295,1,GO:0072604,BP,,2802
muscle hypertrophy,62,0.538,0.296,1,GO:0014896,BP,,2803
embryonic viscerocranium morphogenesis,10,0.595,0.296,1,GO:0048703,BP,,2804
Notch receptor processing,16,0.575,0.296,1,GO:0007220,BP,,2805
positive regulation of lymphocyte migration,18,0.429,0.296,1,GO:2000403,BP,,2806
SCF ubiquitin ligase complex,48,0.456,0.296,1,GO:0019005,CC,,2807
proteasome binding,10,0.595,0.296,1,GO:0070628,MF,,2808
positive regulation of p38MAPK cascade,15,0.578,0.297,1,GO:1900745,BP,,2809
regulation of gonadotropin secretion,10,0.405,0.297,1,GO:0032276,BP,,2810
serine-type peptidase activity,149,0.475,0.297,1,GO:0008236,MF,,2811
regulation of protein kinase B signaling,108,0.471,0.297,1,GO:0051896,BP,,2812
regulation of proteasomal ubiquitin-dependent protein catabolic process,103,0.53,0.298,1,GO:0032434,BP,,2813
regulation of mast cell activation involved in immune response,25,0.44,0.298,1,"GO:0033006,GO:0043304",BP,regulation of mast cell degranulation,2814
dentate gyrus development,17,0.573,0.298,1,GO:0021542,BP,,2815
regulation of transcription factor import into nucleus,77,0.534,0.298,1,GO:0042990,BP,,2816
"carbon-nitrogen ligase activity, with glutamine as amido-N-donor",10,0.405,0.298,1,GO:0016884,MF,,2817
norepinephrine secretion,15,0.422,0.298,1,GO:0048243,BP,,2818
positive regulation of transforming growth factor beta production,16,0.575,0.298,1,GO:0071636,BP,,2819
cell chemotaxis,188,0.478,0.299,1,GO:0060326,BP,,2820
carboxy-terminal domain protein kinase complex,20,0.567,0.299,1,GO:0032806,CC,,2821
cellular response to platelet-derived growth factor stimulus,18,0.571,0.299,1,GO:0036120,BP,,2822
ankyrin binding,19,0.569,0.299,1,GO:0030506,MF,,2823
keratinocyte development,11,0.59,0.299,1,GO:0003334,BP,,2824
peroxisomal transport,14,0.42,0.3,1,GO:0043574,BP,,2825
Seh1-associated complex,12,0.414,0.3,1,GO:0035859,CC,,2826
regulation of posttranscriptional gene silencing,31,0.554,0.3,1,"GO:0060147,GO:0060966",BP,regulation of gene silencing by RNA,2827
negative regulation of leukocyte apoptotic process,37,0.549,0.3,1,GO:2000107,BP,,2828
macrophage derived foam cell differentiation,27,0.558,0.3,1,"GO:0010742,GO:0090077",BP,foam cell differentiation,2829
cell surface receptor signaling pathway involved in heart development,26,0.559,0.3,1,GO:0061311,BP,,2830
regulation of systemic arterial blood pressure by circulatory renin-angiotensin,13,0.583,0.3,1,GO:0001991,BP,,2831
axonemal dynein complex assembly,26,0.441,0.301,1,GO:0070286,BP,,2832
toll-like receptor signaling pathway,107,0.529,0.301,1,GO:0002224,BP,,2833
pteridine-containing compound biosynthetic process,16,0.425,0.301,1,GO:0042559,BP,,2834
chloride transmembrane transport,77,0.534,0.301,1,"GO:1902476,GO:0015108",BP,chloride transmembrane transporter activity,2835
regulation of leukocyte apoptotic process,70,0.536,0.301,1,GO:2000106,BP,,2836
regulation of potassium ion transmembrane transport,62,0.462,0.301,1,GO:1901379,BP,,2837
regulation of heart rate by cardiac conduction,32,0.553,0.301,1,GO:0086091,BP,,2838
positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,21,0.435,0.301,1,GO:0051482,BP,,2839
protein ADP-ribosylation,20,0.567,0.302,1,GO:0006471,BP,,2840
phosphatidylinositol phosphate phosphatase activity,28,0.556,0.302,1,GO:0052866,MF,,2841
positive regulation of T cell mediated cytotoxicity,11,0.59,0.302,1,GO:0001916,BP,,2842
nuclear replication fork,39,0.548,0.302,1,GO:0043596,CC,,2843
replisome,28,0.556,0.302,1,GO:0030894,CC,,2844
AP-type membrane coat adaptor complex,42,0.454,0.302,1,GO:0030119,CC,,2845
beta-catenin destruction complex disassembly,20,0.567,0.302,1,GO:1904886,BP,,2846
filopodium tip,12,0.414,0.302,1,GO:0032433,CC,,2847
acetylcholine binding,14,0.42,0.302,1,GO:0042166,MF,,2848
UDP-galactosyltransferase activity,26,0.442,0.303,1,GO:0035250,MF,,2849
deaminase activity,21,0.435,0.303,1,GO:0019239,MF,,2850
hormone binding,58,0.539,0.304,1,GO:0042562,MF,,2851
negative regulation of actin filament depolymerization,34,0.551,0.304,1,GO:0030835,BP,,2852
regulation of synapse assembly,79,0.467,0.304,1,GO:0051963,BP,,2853
positive regulation of cyclic nucleotide metabolic process,86,0.468,0.304,1,GO:0030801,BP,,2854
pyrimidine nucleoside metabolic process,48,0.457,0.304,1,GO:0006213,BP,,2855
regulation of synaptic plasticity,141,0.475,0.304,1,GO:0048167,BP,,2856
nuclear envelope reassembly,15,0.423,0.304,1,GO:0031468,BP,,2857
atrial cardiac muscle cell membrane repolarization,10,0.406,0.305,1,GO:0099624,BP,,2858
co-receptor binding,10,0.594,0.305,1,GO:0039706,MF,,2859
vascular endothelial growth factor receptor binding,10,0.594,0.305,1,GO:0005172,MF,,2860
ventricular cardiac muscle cell action potential,28,0.556,0.305,1,GO:0086005,BP,,2861
Cul4-RING E3 ubiquitin ligase complex,24,0.439,0.305,1,GO:0080008,CC,,2862
toll-like receptor 9 signaling pathway,16,0.574,0.305,1,GO:0034162,BP,,2863
regulation of viral genome replication,69,0.536,0.305,1,GO:0045069,BP,,2864
microtubule motor activity,66,0.537,0.305,1,GO:0003777,MF,,2865
stem cell division,31,0.553,0.305,1,GO:0017145,BP,,2866
regulation of activated T cell proliferation,30,0.554,0.305,1,GO:0046006,BP,,2867
negative regulation of MAP kinase activity,64,0.463,0.306,1,GO:0043407,BP,,2868
regulation of microvillus organization,11,0.589,0.306,1,GO:0032530,BP,,2869
endochondral ossification,24,0.56,0.306,1,"GO:0001958,GO:0036075",BP,replacement ossification,2870
chromosome localization,57,0.461,0.306,1,GO:0050000,BP,,2871
excitatory postsynaptic potential,88,0.468,0.307,1,GO:0060079,BP,,2872
transcription from RNA polymerase I promoter,54,0.46,0.307,1,GO:0006360,BP,,2873
regulation of defense response to virus,73,0.465,0.308,1,GO:0050688,BP,,2874
regulation of JAK-STAT cascade,103,0.529,0.308,1,"GO:0046425,GO:1904892",BP,regulation of STAT cascade,2875
"oxidoreductase activity, acting on the CH-CH group of donors",50,0.458,0.308,1,GO:0016627,MF,,2876
type I interferon production,107,0.471,0.309,1,GO:0032606,BP,,2877
terpenoid biosynthetic process,11,0.411,0.309,1,GO:0016114,BP,,2878
cardiac cell fate commitment,11,0.589,0.309,1,GO:0060911,BP,,2879
regulation of lyase activity,75,0.466,0.309,1,GO:0051339,BP,,2880
skeletal muscle acetylcholine-gated channel clustering,10,0.407,0.309,1,GO:0071340,BP,,2881
viral RNA genome replication,19,0.433,0.309,1,"GO:0039694,GO:0039703",BP,RNA replication,2882
positive regulation of behavior,16,0.573,0.309,1,GO:0048520,BP,,2883
positive regulation of ossification,76,0.534,0.309,1,GO:0045778,BP,,2884
ATP-dependent microtubule motor activity,19,0.567,0.309,1,GO:1990939,MF,,2885
positive regulation of kidney development,35,0.55,0.309,1,GO:0090184,BP,,2886
positive regulation of transcription factor import into nucleus,41,0.546,0.309,1,GO:0042993,BP,,2887
phosphotyrosine binding,34,0.55,0.31,1,GO:0001784,MF,,2888
calcium channel complex,58,0.461,0.31,1,GO:0034704,CC,,2889
nonribosomal peptide biosynthetic process,17,0.429,0.311,1,GO:0019184,BP,,2890
low-density lipoprotein particle binding,12,0.416,0.311,1,GO:0030169,MF,,2891
reactive nitrogen species metabolic process,62,0.463,0.312,1,GO:2001057,BP,,2892
positive regulation of regulated secretory pathway,38,0.453,0.312,1,GO:1903307,BP,,2893
positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,82,0.532,0.312,1,GO:0090100,BP,,2894
regulation of actin filament length,141,0.475,0.312,1,GO:0030832,BP,,2895
B cell proliferation,56,0.539,0.313,1,GO:0042100,BP,,2896
"protein localization to chromosome, centromeric region",15,0.575,0.313,1,GO:0071459,BP,,2897
E-box binding,32,0.552,0.313,1,GO:0070888,MF,,2898
regulation of DNA-dependent DNA replication,42,0.455,0.313,1,GO:0090329,BP,,2899
regulation of odontogenesis,20,0.565,0.314,1,GO:0042481,BP,,2900
NADPH binding,12,0.416,0.314,1,GO:0070402,MF,,2901
response to cholesterol,18,0.569,0.314,1,GO:0070723,BP,,2902
5'-nucleotidase activity,10,0.408,0.314,1,GO:0008253,MF,,2903
podosome,29,0.554,0.315,1,GO:0002102,CC,,2904
negative regulation of calcium ion transmembrane transporter activity,25,0.442,0.315,1,GO:1901020,BP,,2905
granulocyte macrophage colony-stimulating factor production,11,0.412,0.315,1,"GO:0032604,GO:0032645",BP,regulation of granulocyte macrophage colony-stimulating factor production,2906
regulation of cyclic nucleotide biosynthetic process,114,0.473,0.315,1,GO:0030802,BP,,2907
establishment of protein localization to vacuole,29,0.554,0.315,1,GO:0072666,BP,,2908
reproductive behavior,29,0.446,0.315,1,GO:0019098,BP,,2909
negative regulation of axon extension,24,0.559,0.315,1,GO:0030517,BP,,2910
regulation of intracellular steroid hormone receptor signaling pathway,60,0.538,0.315,1,GO:0033143,BP,,2911
pyridine-containing compound biosynthetic process,31,0.448,0.315,1,GO:0072525,BP,,2912
activation of JUN kinase activity,32,0.551,0.315,1,GO:0007257,BP,,2913
astrocyte development,23,0.561,0.315,1,GO:0014002,BP,,2914
positive regulation of glycogen biosynthetic process,13,0.58,0.315,1,GO:0045725,BP,,2915
negative regulation of cation channel activity,27,0.444,0.316,1,GO:2001258,BP,,2916
cAMP-mediated signaling,39,0.454,0.316,1,GO:0019933,BP,,2917
cellular metabolic compound salvage,33,0.45,0.316,1,GO:0043094,BP,,2918
negative regulation of double-strand break repair,11,0.587,0.317,1,GO:2000780,BP,,2919
regulation of actin filament bundle assembly,79,0.533,0.317,1,GO:0032231,BP,,2920
GABA-A receptor complex,13,0.42,0.317,1,GO:1902711,CC,,2921
chromosome localization to nuclear envelope involved in homologous chromosome segregation,11,0.587,0.318,1,GO:0090220,BP,,2922
RNA polymerase II transcription cofactor activity,83,0.532,0.318,1,GO:0001104,MF,,2923
mRNA 5'-UTR binding,17,0.43,0.318,1,GO:0048027,MF,,2924
negative regulation of transporter activity,55,0.461,0.319,1,GO:0032410,BP,,2925
cyclin-dependent protein kinase activity,26,0.557,0.319,1,GO:0097472,MF,,2926
regulation of sequestering of triglyceride,11,0.413,0.319,1,GO:0010889,BP,,2927
drug transmembrane transport,19,0.566,0.319,1,GO:0006855,BP,,2928
AMP metabolic process,12,0.417,0.319,1,GO:0046033,BP,,2929
negative regulation of B cell activation,26,0.556,0.319,1,GO:0050869,BP,,2930
"positive regulation of mRNA splicing, via spliceosome",13,0.58,0.32,1,GO:0048026,BP,,2931
modification by host of symbiont morphology or physiology,45,0.543,0.32,1,GO:0051851,BP,,2932
histone deacetylase complex,58,0.538,0.32,1,GO:0000118,CC,,2933
positive regulation of interferon-gamma production,48,0.459,0.32,1,GO:0032729,BP,,2934
"regulation of synaptic transmission, dopaminergic",15,0.426,0.32,1,GO:0032225,BP,,2935
cardiac muscle hypertrophy,59,0.537,0.321,1,GO:0003300,BP,,2936
telomere localization,12,0.583,0.321,1,GO:0034397,BP,,2937
sarcoplasmic reticulum membrane,35,0.549,0.321,1,GO:0033017,CC,,2938
lymphangiogenesis,15,0.574,0.321,1,GO:0001946,BP,,2939
retinoid metabolic process,68,0.465,0.321,1,GO:0001523,BP,,2940
regulation of autophagosome assembly,32,0.449,0.321,1,GO:2000785,BP,,2941
"DNA binding, bending",17,0.569,0.321,1,GO:0008301,MF,,2942
negative regulation of adaptive immune response,29,0.553,0.321,1,GO:0002820,BP,,2943
cellular response to fluid shear stress,17,0.569,0.321,1,GO:0071498,BP,,2944
sulfate transport,12,0.583,0.321,1,GO:0008272,BP,,2945
cell division site,53,0.539,0.322,1,"GO:0032153,GO:0032155",CC,cell division site part,2946
neuron to neuron synapse,200,0.52,0.322,1,GO:0098984,CC,,2947
negative regulation of calcium ion transmembrane transport,28,0.446,0.322,1,GO:1903170,BP,,2948
inclusion body,70,0.534,0.322,1,GO:0016234,CC,,2949
"DNA-templated transcription, elongation",108,0.472,0.322,1,GO:0006354,BP,,2950
positive regulation of vasoconstriction,25,0.443,0.322,1,GO:0045907,BP,,2951
GDP metabolic process,13,0.421,0.323,1,GO:0046710,BP,,2952
negative regulation of ryanodine-sensitive calcium-release channel activity,11,0.414,0.323,1,GO:0060315,BP,,2953
negative regulation of MAPK cascade,134,0.475,0.323,1,GO:0043409,BP,,2954
polyubiquitin binding,38,0.546,0.323,1,GO:0031593,MF,,2955
ear morphogenesis,99,0.529,0.323,1,GO:0042471,BP,,2956
diacylglycerol kinase activity,11,0.586,0.323,1,GO:0004143,MF,,2957
regulation of calcineurin-NFAT signaling cascade,16,0.429,0.323,1,GO:0070884,BP,,2958
regulation of mitotic spindle assembly,14,0.576,0.324,1,GO:1901673,BP,,2959
growth plate cartilage development,14,0.424,0.324,1,GO:0003417,BP,,2960
costamere,19,0.565,0.325,1,GO:0043034,CC,,2961
dendritic cell chemotaxis,18,0.433,0.325,1,GO:0002407,BP,,2962
regulation of tumor necrosis factor-mediated signaling pathway,43,0.543,0.325,1,GO:0010803,BP,,2963
cardioblast differentiation,13,0.579,0.325,1,GO:0010002,BP,,2964
lysosomal lumen,82,0.469,0.325,1,GO:0043202,CC,,2965
calcium ion regulated exocytosis,100,0.471,0.325,1,GO:0017156,BP,,2966
single-organism membrane fusion,177,0.478,0.325,1,GO:0044801,BP,,2967
translation initiation factor binding,25,0.443,0.325,1,GO:0031369,MF,,2968
intercellular bridge,38,0.546,0.325,1,GO:0045171,CC,,2969
B cell apoptotic process,19,0.565,0.325,1,GO:0001783,BP,,2970
protein phosphatase 1 binding,17,0.569,0.325,1,GO:0008157,MF,,2971
positive regulation of nucleotide biosynthetic process,88,0.47,0.325,1,"GO:0030810,GO:1900373",BP,positive regulation of purine nucleotide biosynthetic process,2972
potassium ion binding,13,0.421,0.325,1,GO:0030955,MF,,2973
mitotic recombination,42,0.544,0.325,1,GO:0006312,BP,,2974
regulation of receptor biosynthetic process,16,0.571,0.326,1,GO:0010869,BP,,2975
nucleotide transport,19,0.435,0.326,1,GO:0006862,BP,,2976
neutrophil migration,64,0.464,0.326,1,GO:1990266,BP,,2977
protein localization to endosome,13,0.579,0.326,1,GO:0036010,BP,,2978
regulation of mesonephros development,22,0.56,0.326,1,GO:0061217,BP,,2979
positive regulation of translational initiation,18,0.433,0.327,1,GO:0045948,BP,,2980
postreplication repair,49,0.541,0.327,1,GO:0006301,BP,,2981
"CD4-positive, alpha-beta T cell differentiation",45,0.542,0.327,1,GO:0043367,BP,,2982
peptide catabolic process,27,0.554,0.327,1,GO:0043171,BP,,2983
O-glycan processing,45,0.458,0.327,1,GO:0016266,BP,,2984
cell separation after cytokinesis,14,0.424,0.328,1,GO:0000920,BP,,2985
membrane fission,12,0.582,0.328,1,GO:0090148,BP,,2986
MyD88-independent toll-like receptor signaling pathway,27,0.554,0.328,1,GO:0002756,BP,,2987
chemokine-mediated signaling pathway,49,0.46,0.328,1,GO:0070098,BP,,2988
positive regulation of stress-activated protein kinase signaling cascade,117,0.526,0.328,1,GO:0070304,BP,,2989
negative regulation of ERBB signaling pathway,48,0.541,0.328,1,GO:1901185,BP,,2990
nucleobase biosynthetic process,15,0.427,0.328,1,GO:0046112,BP,,2991
regulation of macrophage migration,15,0.427,0.328,1,GO:1905521,BP,,2992
inner ear morphogenesis,84,0.531,0.328,1,GO:0042472,BP,,2993
"3',5'-cyclic-nucleotide phosphodiesterase activity",23,0.559,0.329,1,GO:0004114,MF,,2994
neurotrophin TRK receptor signaling pathway,23,0.559,0.329,1,GO:0048011,BP,,2995
histone H3-K9 acetylation,10,0.589,0.329,1,GO:0043970,BP,,2996
lens development in camera-type eye,52,0.539,0.329,1,GO:0002088,BP,,2997
"ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism",30,0.449,0.329,1,GO:0015662,MF,,2998
negative regulation of oxidative stress-induced neuron death,15,0.427,0.329,1,GO:1903204,BP,,2999
TRIF-dependent toll-like receptor signaling pathway,23,0.559,0.329,1,GO:0035666,BP,,3000
calcium ion transmembrane transporter activity,119,0.526,0.33,1,GO:0015085,MF,,3001
RNA polymerase II transcriptional preinitiation complex assembly,26,0.445,0.331,1,GO:0051123,BP,,3002
ATPase activator activity,20,0.563,0.331,1,GO:0001671,MF,,3003
regulation of DNA methylation,16,0.57,0.331,1,GO:0044030,BP,,3004
positive regulation of lipid kinase activity,30,0.449,0.331,1,GO:0090218,BP,,3005
peptidyl-arginine N-methylation,10,0.411,0.331,1,"GO:0035246,GO:0016273,GO:0016274",BP,"arginine N-methyltransferase activity,protein-arginine N-methyltransferase activity",3006
positive regulation of endothelial cell proliferation,62,0.536,0.331,1,GO:0001938,BP,,3007
regulation of neuronal synaptic plasticity,49,0.46,0.332,1,GO:0048168,BP,,3008
negative regulation of peptidyl-tyrosine phosphorylation,39,0.545,0.332,1,GO:0050732,BP,,3009
positive regulation of branching involved in ureteric bud morphogenesis,18,0.566,0.332,1,GO:0090190,BP,,3010
regulation of mitotic spindle organization,23,0.558,0.332,1,GO:0060236,BP,,3011
phosphatidylcholine biosynthetic process,32,0.55,0.332,1,GO:0006656,BP,,3012
negative regulation of calcium ion import,19,0.436,0.333,1,GO:0090281,BP,,3013
hepatocyte growth factor receptor signaling pathway,14,0.575,0.333,1,GO:0048012,BP,,3014
animal organ maturation,20,0.563,0.333,1,GO:0048799,BP,,3015
positive regulation of protein sumoylation,11,0.584,0.333,1,GO:0033235,BP,,3016
cyclic nucleotide biosynthetic process,124,0.475,0.333,1,GO:0009190,BP,,3017
positive regulation of TOR signaling,32,0.451,0.333,1,GO:0032008,BP,,3018
"ATP-dependent microtubule motor activity, plus-end-directed",14,0.575,0.334,1,GO:0008574,MF,,3019
histone H4 acetylation,56,0.537,0.334,1,GO:0043967,BP,,3020
insemination,11,0.584,0.334,1,GO:0007320,BP,,3021
mRNA cleavage factor complex,16,0.57,0.335,1,GO:0005849,CC,,3022
carnitine shuttle,11,0.416,0.335,1,GO:0006853,BP,,3023
sodium ion import across plasma membrane,12,0.42,0.335,1,"GO:0098719,GO:1990118",BP,sodium ion import into cell,3024
positive regulation of sequestering of calcium ion,14,0.426,0.335,1,GO:0051284,BP,,3025
striated muscle contraction,146,0.477,0.335,1,GO:0006941,BP,,3026
IRES-dependent translational initiation,11,0.584,0.335,1,GO:0002192,BP,,3027
extrinsic apoptotic signaling pathway via death domain receptors,65,0.535,0.335,1,GO:0008625,BP,,3028
otic vesicle morphogenesis,10,0.588,0.335,1,GO:0071600,BP,,3029
DNA replication initiation,37,0.454,0.335,1,GO:0006270,BP,,3030
"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines",25,0.444,0.336,1,GO:0016814,MF,,3031
mast cell activation,49,0.46,0.336,1,GO:0045576,BP,,3032
cardiac muscle cell development,51,0.461,0.336,1,GO:0055013,BP,,3033
regulation of lipid storage,38,0.545,0.336,1,GO:0010883,BP,,3034
H4 histone acetyltransferase complex,33,0.548,0.336,1,GO:1902562,CC,,3035
regulation of humoral immune response,37,0.454,0.337,1,GO:0002920,BP,,3036
positive regulation of fibroblast proliferation,48,0.46,0.337,1,GO:0048146,BP,,3037
liver regeneration,27,0.553,0.337,1,GO:0097421,BP,,3038
cellular response to thyroid hormone stimulus,14,0.574,0.337,1,GO:0097067,BP,,3039
pericardium development,18,0.565,0.337,1,GO:0060039,BP,,3040
ion channel regulator activity,82,0.469,0.337,1,GO:0099106,MF,,3041
regulation of anion transmembrane transport,28,0.552,0.337,1,GO:1903959,BP,,3042
lateral mesoderm development,12,0.58,0.338,1,GO:0048368,BP,,3043
pancreas development,59,0.536,0.338,1,GO:0031016,BP,,3044
Rab guanyl-nucleotide exchange factor activity,47,0.46,0.338,1,GO:0017112,MF,,3045
contractile ring,10,0.587,0.338,1,GO:0070938,CC,,3046
myosin filament organization,14,0.426,0.339,1,GO:0031033,BP,,3047
autonomic nervous system development,36,0.546,0.339,1,GO:0048483,BP,,3048
positive regulation of leukocyte mediated cytotoxicity,22,0.559,0.339,1,GO:0001912,BP,,3049
muscle adaptation,73,0.532,0.339,1,GO:0043500,BP,,3050
motor activity,110,0.526,0.339,1,GO:0003774,MF,,3051
L-glutamate transport,22,0.441,0.34,1,GO:0015813,BP,,3052
skeletal muscle adaptation,19,0.563,0.34,1,GO:0043501,BP,,3053
fibrillar collagen trimer,11,0.583,0.34,1,"GO:0005583,GO:0098643",CC,banded collagen fibril,3054
cysteine-type endopeptidase activity involved in execution phase of apoptosis,12,0.579,0.341,1,GO:0097200,MF,,3055
neuromuscular process controlling balance,45,0.541,0.341,1,GO:0050885,BP,,3056
regulation of hormone biosynthetic process,16,0.569,0.341,1,GO:0046885,BP,,3057
fibrinolysis,20,0.439,0.341,1,GO:0042730,BP,,3058
membrane raft localization,10,0.587,0.341,1,GO:0051665,BP,,3059
nuclear replisome,27,0.553,0.341,1,GO:0043601,CC,,3060
apical dendrite,13,0.424,0.342,1,GO:0097440,CC,,3061
negative regulation of ERK1 and ERK2 cascade,51,0.461,0.342,1,GO:0070373,BP,,3062
negative regulation of cardiac muscle hypertrophy,14,0.427,0.342,1,GO:0010614,BP,,3063
intronic transcription regulatory region sequence-specific DNA binding,10,0.587,0.342,1,"GO:0001161,GO:0044213",MF,intronic transcription regulatory region DNA binding,3064
phosphatidylglycerol metabolic process,24,0.556,0.342,1,GO:0046471,BP,,3065
positive regulation of potassium ion transmembrane transport,26,0.446,0.342,1,GO:1901381,BP,,3066
cholesterol efflux,29,0.551,0.342,1,GO:0033344,BP,,3067
regulation of excretion,22,0.558,0.342,1,GO:0044062,BP,,3068
dopamine receptor signaling pathway,38,0.455,0.342,1,GO:0007212,BP,,3069
female gonad development,77,0.531,0.343,1,GO:0008585,BP,,3070
very long-chain fatty acid metabolic process,25,0.555,0.343,1,GO:0000038,BP,,3071
cell cortex region,14,0.573,0.343,1,GO:0099738,CC,,3072
central nervous system neuron development,69,0.467,0.343,1,GO:0021954,BP,,3073
"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen",24,0.444,0.343,1,GO:0016709,MF,,3074
regulation of fatty acid oxidation,26,0.446,0.344,1,GO:0046320,BP,,3075
negative regulation of ion transmembrane transport,66,0.466,0.344,1,GO:0034766,BP,,3076
epithelial cell maturation,11,0.582,0.344,1,GO:0002070,BP,,3077
"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen",22,0.442,0.344,1,"GO:0016701,GO:0016702",MF,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen",3078
heme metabolic process,25,0.445,0.344,1,GO:0042168,BP,,3079
regulation of energy homeostasis,18,0.564,0.344,1,GO:2000505,BP,,3080
androgen receptor binding,40,0.543,0.345,1,GO:0050681,MF,,3081
sarcoplasm,62,0.535,0.345,1,GO:0016528,CC,,3082
sarcoplasmic reticulum,55,0.537,0.345,1,GO:0016529,CC,,3083
mannose binding,14,0.573,0.345,1,GO:0005537,MF,,3084
NADP metabolic process,29,0.449,0.345,1,GO:0006739,BP,,3085
acrosomal vesicle,79,0.531,0.345,1,GO:0001669,CC,,3086
actin-mediated cell contraction,90,0.471,0.345,1,GO:0070252,BP,,3087
negative regulation of oligodendrocyte differentiation,11,0.582,0.345,1,GO:0048715,BP,,3088
microtubule associated complex,127,0.524,0.345,1,GO:0005875,CC,,3089
regulation of protein oligomerization,30,0.45,0.346,1,GO:0032459,BP,,3090
phosphatidylinositol bisphosphate kinase activity,59,0.536,0.346,1,GO:0052813,MF,,3091
STAGA complex,12,0.421,0.346,1,GO:0030914,CC,,3092
asymmetric synapse,198,0.519,0.346,1,GO:0032279,CC,,3093
regulation of NMDA receptor activity,16,0.432,0.346,1,GO:2000310,BP,,3094
osteoblast development,14,0.427,0.346,1,GO:0002076,BP,,3095
negative regulation of interleukin-10 production,11,0.582,0.347,1,GO:0032693,BP,,3096
calcium ion import,142,0.477,0.347,1,GO:0070509,BP,,3097
platelet formation,15,0.57,0.347,1,GO:0030220,BP,,3098
dopaminergic neuron differentiation,28,0.551,0.347,1,GO:0071542,BP,,3099
autophagosome membrane,25,0.554,0.347,1,GO:0000421,CC,,3100
tryptophan metabolic process,11,0.418,0.347,1,GO:0006568,BP,,3101
UMP biosynthetic process,10,0.414,0.348,1,"GO:0006222,GO:0009173,GO:0009174,GO:0046049",BP,"pyrimidine ribonucleoside monophosphate metabolic process,pyrimidine ribonucleoside monophosphate biosynthetic process,UMP metabolic process",3102
peptidyl-glutamic acid modification,27,0.448,0.349,1,GO:0018200,BP,,3103
regulation of muscle adaptation,64,0.534,0.349,1,GO:0043502,BP,,3104
tRNA binding,43,0.459,0.349,1,GO:0000049,MF,,3105
positive regulation of Wnt signaling pathway,144,0.477,0.349,1,GO:0030177,BP,,3106
purinergic receptor signaling pathway,22,0.442,0.35,1,GO:0035587,BP,,3107
hyaluronic acid binding,17,0.435,0.35,1,GO:0005540,MF,,3108
response to alkaloid,123,0.476,0.35,1,GO:0043279,BP,,3109
regulation of DNA damage checkpoint,14,0.428,0.35,1,GO:2000001,BP,,3110
interleukin-8 production,53,0.463,0.351,1,GO:0032637,BP,,3111
Lys48-specific deubiquitinase activity,10,0.585,0.351,1,GO:1990380,MF,,3112
actinin binding,37,0.456,0.351,1,GO:0042805,MF,,3113
regulation of hepatocyte proliferation,12,0.578,0.351,1,GO:2000345,BP,,3114
branch elongation of an epithelium,16,0.567,0.351,1,GO:0060602,BP,,3115
phosphatidylinositol-5-phosphate binding,11,0.419,0.351,1,GO:0010314,MF,,3116
"CD4-positive, alpha-beta T cell differentiation involved in immune response",36,0.545,0.351,1,GO:0002294,BP,,3117
protein processing,187,0.52,0.351,1,GO:0016485,BP,,3118
fat-soluble vitamin metabolic process,32,0.452,0.352,1,GO:0006775,BP,,3119
cell proliferation in forebrain,25,0.554,0.352,1,GO:0021846,BP,,3120
"regulation of alternative mRNA splicing, via spliceosome",32,0.547,0.353,1,GO:0000381,BP,,3121
chloride channel complex,42,0.541,0.353,1,GO:0034707,CC,,3122
leucine zipper domain binding,11,0.419,0.353,1,GO:0043522,MF,,3123
"phosphotransferase activity, phosphate group as acceptor",39,0.457,0.353,1,GO:0016776,MF,,3124
GDP-dissociation inhibitor activity,13,0.426,0.353,1,GO:0005092,MF,,3125
T cell activation involved in immune response,58,0.535,0.353,1,GO:0002286,BP,,3126
cellular response to lithium ion,12,0.423,0.353,1,GO:0071285,BP,,3127
regulation of lysosomal lumen pH,10,0.415,0.353,1,GO:0035751,BP,,3128
mesoderm morphogenesis,63,0.534,0.354,1,GO:0048332,BP,,3129
non-recombinational repair,56,0.536,0.354,1,GO:0000726,BP,,3130
response to interleukin-1,88,0.529,0.355,1,GO:0070555,BP,,3131
protease binding,96,0.527,0.355,1,GO:0002020,MF,,3132
retinoid X receptor binding,13,0.426,0.355,1,GO:0046965,MF,,3133
dynactin binding,10,0.415,0.355,1,GO:0034452,MF,,3134
heterotrimeric G-protein complex,31,0.548,0.355,1,"GO:0005834,GO:1905360",CC,GTPase complex,3135
regulation of transcription from RNA polymerase III promoter,24,0.445,0.355,1,GO:0006359,BP,,3136
negative regulation of glial cell differentiation,22,0.557,0.355,1,GO:0045686,BP,,3137
centrosome separation,14,0.429,0.355,1,GO:0051299,BP,,3138
organelle membrane fusion,143,0.478,0.355,1,GO:0090174,BP,,3139
metanephric mesenchyme development,14,0.571,0.355,1,GO:0072075,BP,,3140
carboxylic acid transmembrane transport,87,0.529,0.356,1,GO:1905039,BP,,3141
oligosaccharide catabolic process,10,0.416,0.357,1,GO:0009313,BP,,3142
spectrin binding,25,0.553,0.357,1,GO:0030507,MF,,3143
T-helper 17 cell differentiation,10,0.584,0.357,1,GO:0072539,BP,,3144
positive regulation of release of sequestered calcium ion into cytosol,30,0.451,0.357,1,GO:0051281,BP,,3145
cytosolic small ribosomal subunit,42,0.459,0.357,1,GO:0022627,CC,,3146
desensitization of G-protein coupled receptor protein signaling pathway,14,0.429,0.357,1,"GO:0002029,GO:0022401",BP,negative adaptation of signaling pathway,3147
RNA modification,107,0.526,0.357,1,GO:0009451,BP,,3148
sprouting angiogenesis,64,0.533,0.357,1,GO:0002040,BP,,3149
regulation of neuron apoptotic process,177,0.48,0.357,1,GO:0043523,BP,,3150
nicotinamide nucleotide biosynthetic process,28,0.45,0.357,1,"GO:0019359,GO:0019363",BP,pyridine nucleotide biosynthetic process,3151
cytoplasmic translation,45,0.54,0.357,1,GO:0002181,BP,,3152
organic acid transmembrane transport,93,0.528,0.358,1,GO:1903825,BP,,3153
regulation of phosphatidylinositol 3-kinase signaling,126,0.524,0.358,1,GO:0014066,BP,,3154
hexose transmembrane transporter activity,15,0.569,0.358,1,GO:0015149,MF,,3155
granulocyte migration,81,0.47,0.358,1,GO:0097530,BP,,3156
cellular response to light stimulus,93,0.528,0.358,1,GO:0071482,BP,,3157
positive regulation of neuroblast proliferation,17,0.564,0.358,1,GO:0002052,BP,,3158
gamma-delta T cell activation,12,0.577,0.358,1,GO:0046629,BP,,3159
voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization,11,0.42,0.358,1,GO:0086008,MF,,3160
positive regulation of leukocyte migration,88,0.472,0.359,1,GO:0002687,BP,,3161
tongue development,18,0.562,0.359,1,GO:0043586,BP,,3162
negative regulation of NF-kappaB import into nucleus,19,0.561,0.359,1,GO:0042347,BP,,3163
negative regulation of hormone secretion,56,0.465,0.359,1,GO:0046888,BP,,3164
negative regulation of intracellular protein transport,80,0.47,0.359,1,GO:0090317,BP,,3165
replicative senescence,11,0.42,0.359,1,GO:0090399,BP,,3166
contractile actin filament bundle assembly,78,0.53,0.36,1,"GO:0030038,GO:0043149",BP,stress fiber assembly,3167
Golgi to plasma membrane protein transport,27,0.551,0.36,1,GO:0043001,BP,,3168
ubiquitin-like protein conjugating enzyme activity,29,0.451,0.36,1,GO:0061650,MF,,3169
cellular response to zinc ion,17,0.436,0.36,1,GO:0071294,BP,,3170
fructose metabolic process,14,0.429,0.36,1,GO:0006000,BP,,3171
regulation of glycogen metabolic process,26,0.448,0.36,1,GO:0070873,BP,,3172
organ growth,124,0.524,0.361,1,GO:0035265,BP,,3173
atrial cardiac muscle cell action potential,18,0.438,0.361,1,"GO:0086014,GO:0086026,GO:0086066",BP,"atrial cardiac muscle cell to AV node cell signaling,atrial cardiac muscle cell to AV node cell communication",3174
embryonic camera-type eye formation,11,0.58,0.361,1,GO:0060900,BP,,3175
'de novo' posttranslational protein folding,18,0.438,0.361,1,GO:0051084,BP,,3176
midbody,138,0.523,0.361,1,GO:0030496,CC,,3177
defense response to bacterium,135,0.477,0.362,1,GO:0042742,BP,,3178
cap-independent translational initiation,14,0.57,0.362,1,GO:0002190,BP,,3179
negative regulation of gliogenesis,35,0.545,0.362,1,GO:0014014,BP,,3180
negative regulation of insulin receptor signaling pathway,30,0.548,0.362,1,GO:0046627,BP,,3181
U2-type spliceosomal complex,28,0.55,0.362,1,GO:0005684,CC,,3182
proteoglycan metabolic process,78,0.47,0.363,1,GO:0006029,BP,,3183
kinase inhibitor activity,91,0.472,0.363,1,GO:0019210,MF,,3184
T-helper cell differentiation,35,0.544,0.363,1,GO:0042093,BP,,3185
sarcoplasmic reticulum calcium ion transport,32,0.454,0.363,1,GO:0070296,BP,,3186
regulation of erythrocyte differentiation,33,0.546,0.363,1,GO:0045646,BP,,3187
pseudopodium assembly,13,0.573,0.363,1,GO:0031269,BP,,3188
regulation of insulin secretion involved in cellular response to glucose stimulus,42,0.459,0.363,1,GO:0061178,BP,,3189
positive regulation of mRNA processing,20,0.559,0.363,1,GO:0050685,BP,,3190
cyclic purine nucleotide metabolic process,123,0.476,0.364,1,GO:0052652,BP,,3191
bile acid biosynthetic process,28,0.55,0.364,1,GO:0006699,BP,,3192
prespliceosome,16,0.566,0.364,1,GO:0071010,CC,,3193
cellular response to iron ion,10,0.583,0.364,1,GO:0071281,BP,,3194
feeding behavior,90,0.472,0.365,1,GO:0007631,BP,,3195
activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,10,0.583,0.365,1,GO:0097296,BP,,3196
regulation of circadian sleep/wake cycle,17,0.564,0.365,1,GO:0042749,BP,,3197
positive regulation of collagen metabolic process,20,0.559,0.365,1,"GO:0010714,GO:0032967,GO:0044253",BP,"positive regulation of collagen biosynthetic process,positive regulation of multicellular organismal metabolic process",3198
transforming growth factor beta receptor binding,40,0.541,0.365,1,GO:0005160,MF,,3199
regulation of androgen receptor signaling pathway,26,0.551,0.366,1,GO:0060765,BP,,3200
negative regulation of cellular response to oxidative stress,38,0.458,0.366,1,"GO:1900408,GO:1902883,GO:1903202",BP,"negative regulation of response to oxidative stress,negative regulation of oxidative stress-induced cell death",3201
negative regulation of muscle tissue development,37,0.543,0.366,1,GO:1901862,BP,,3202
negative regulation of phagocytosis,12,0.425,0.366,1,GO:0050765,BP,,3203
polysome,41,0.459,0.367,1,GO:0005844,CC,,3204
negative regulation of ERAD pathway,12,0.575,0.367,1,GO:1904293,BP,,3205
exosome (RNase complex),18,0.561,0.367,1,"GO:0000178,GO:1905354",CC,exoribonuclease complex,3206
COPII vesicle coat,10,0.418,0.367,1,GO:0030127,CC,,3207
amino sugar biosynthetic process,11,0.421,0.367,1,GO:0046349,BP,,3208
regulation of fat cell differentiation,99,0.526,0.368,1,GO:0045598,BP,,3209
regulation of epithelial cell migration,158,0.521,0.368,1,GO:0010632,BP,,3210
protein K63-linked ubiquitination,38,0.458,0.368,1,GO:0070534,BP,,3211
MyD88-dependent toll-like receptor signaling pathway,32,0.546,0.368,1,GO:0002755,BP,,3212
XY body,10,0.582,0.368,1,GO:0001741,CC,,3213
hindbrain development,128,0.523,0.368,1,GO:0030902,BP,,3214
sterol metabolic process,116,0.476,0.368,1,GO:0016125,BP,,3215
positive regulation of epithelial cell proliferation,137,0.522,0.368,1,GO:0050679,BP,,3216
trachea development,17,0.563,0.368,1,GO:0060438,BP,,3217
melanin biosynthetic process,16,0.435,0.369,1,GO:0042438,BP,,3218
arylsulfatase activity,10,0.418,0.369,1,GO:0004065,MF,,3219
negative regulation of bone resorption,10,0.582,0.369,1,GO:0045779,BP,,3220
retina layer formation,20,0.442,0.369,1,GO:0010842,BP,,3221
regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,28,0.549,0.369,1,GO:1902235,BP,,3222
genitalia development,34,0.545,0.369,1,GO:0048806,BP,,3223
toll-like receptor 3 signaling pathway,15,0.433,0.369,1,GO:0034138,BP,,3224
glomerulus development,59,0.534,0.369,1,GO:0032835,BP,,3225
cellular response to alcohol,47,0.538,0.37,1,GO:0097306,BP,,3226
axon regeneration,40,0.541,0.37,1,GO:0031103,BP,,3227
regulation of cardiac conduction,64,0.468,0.371,1,GO:1903779,BP,,3228
positive regulation of lipid metabolic process,109,0.475,0.371,1,GO:0045834,BP,,3229
viral genome replication,94,0.527,0.371,1,GO:0019079,BP,,3230
cardiac atrium development,27,0.55,0.371,1,GO:0003230,BP,,3231
nuclear hormone receptor binding,127,0.523,0.372,1,GO:0035257,MF,,3232
calcium channel activity,101,0.526,0.372,1,GO:0005262,MF,,3233
mitotic spindle assembly checkpoint,24,0.447,0.372,1,GO:0007094,BP,,3234
regulation of high voltage-gated calcium channel activity,10,0.419,0.372,1,GO:1901841,BP,,3235
negative regulation of glucose transport,14,0.431,0.372,1,GO:0010829,BP,,3236
outflow tract septum morphogenesis,19,0.559,0.372,1,GO:0003148,BP,,3237
negative regulation of chemokine production,12,0.574,0.373,1,GO:0032682,BP,,3238
endocytic vesicle lumen,14,0.431,0.373,1,GO:0071682,CC,,3239
hyaluronan biosynthetic process,12,0.426,0.373,1,GO:0030213,BP,,3240
Leydig cell differentiation,10,0.581,0.373,1,GO:0033327,BP,,3241
heparin binding,124,0.523,0.374,1,GO:0008201,MF,,3242
sensory perception of smell,139,0.522,0.374,1,GO:0007608,BP,,3243
regulation of lamellipodium assembly,26,0.45,0.375,1,GO:0010591,BP,,3244
regulation of reactive oxygen species biosynthetic process,59,0.533,0.375,1,GO:1903426,BP,,3245
"positive regulation of DNA-templated transcription, elongation",22,0.445,0.375,1,GO:0032786,BP,,3246
flavin adenine dinucleotide binding,67,0.469,0.375,1,GO:0050660,MF,,3247
sphingolipid metabolic process,125,0.523,0.375,1,GO:0006665,BP,,3248
peptidyl-cysteine modification,26,0.55,0.375,1,GO:0018198,BP,,3249
cellular response to glucocorticoid stimulus,50,0.536,0.375,1,GO:0071385,BP,,3250
mitochondrial protein processing,10,0.419,0.375,1,GO:0034982,BP,,3251
ketone biosynthetic process,30,0.453,0.376,1,GO:0042181,BP,,3252
cysteine-type endopeptidase inhibitor activity,41,0.54,0.376,1,GO:0004869,MF,,3253
forebrain generation of neurons,60,0.467,0.376,1,GO:0021872,BP,,3254
lipase activity,100,0.474,0.376,1,GO:0016298,MF,,3255
transcription factor import into nucleus,78,0.529,0.376,1,GO:0042991,BP,,3256
cellular sodium ion homeostasis,13,0.571,0.376,1,GO:0006883,BP,,3257
positive regulation of peptidyl-serine phosphorylation,70,0.469,0.377,1,GO:0033138,BP,,3258
hexose biosynthetic process,72,0.47,0.377,1,GO:0019319,BP,,3259
negative regulation of inflammatory response,84,0.472,0.377,1,GO:0050728,BP,,3260
positive regulation of cell killing,24,0.552,0.377,1,GO:0031343,BP,,3261
positive regulation of monocyte chemotaxis,11,0.423,0.377,1,GO:0090026,BP,,3262
chaperone binding,80,0.471,0.378,1,GO:0051087,MF,,3263
apical protein localization,11,0.577,0.378,1,GO:0045176,BP,,3264
attachment of spindle microtubules to kinetochore,26,0.45,0.378,1,GO:0008608,BP,,3265
lactation,36,0.542,0.378,1,GO:0007595,BP,,3266
multicellular organismal macromolecule metabolic process,97,0.526,0.379,1,GO:0044259,BP,,3267
mature B cell differentiation involved in immune response,15,0.566,0.379,1,GO:0002313,BP,,3268
postsynaptic membrane organization,29,0.547,0.379,1,GO:0001941,BP,,3269
heat generation,15,0.566,0.379,1,GO:0031649,BP,,3270
negative regulation of muscle organ development,37,0.542,0.379,1,GO:0048635,BP,,3271
positive regulation of stem cell proliferation,32,0.545,0.379,1,GO:2000648,BP,,3272
cytokine activity,138,0.478,0.38,1,GO:0005125,MF,,3273
GMP metabolic process,19,0.442,0.38,1,GO:0046037,BP,,3274
alpha-beta T cell activation involved in immune response,37,0.542,0.38,1,"GO:0002287,GO:0002293",BP,alpha-beta T cell differentiation involved in immune response,3275
L-amino acid transport,57,0.466,0.38,1,GO:0015807,BP,,3276
eye morphogenesis,123,0.523,0.38,1,GO:0048592,BP,,3277
calmodulin binding,172,0.519,0.38,1,GO:0005516,MF,,3278
14-3-3 protein binding,23,0.447,0.381,1,GO:0071889,MF,,3279
response to interleukin-6,26,0.55,0.381,1,GO:0070741,BP,,3280
transition metal ion homeostasis,98,0.474,0.381,1,GO:0055076,BP,,3281
neurotransmitter receptor transport to postsynaptic membrane,10,0.42,0.381,1,"GO:0098969,GO:1903539,GO:1903540",BP,"protein localization to postsynaptic membrane,establishment of protein localization to postsynaptic membrane",3282
peptide hormone processing,25,0.551,0.381,1,GO:0016486,BP,,3283
positive regulation of intrinsic apoptotic signaling pathway,48,0.537,0.381,1,GO:2001244,BP,,3284
organelle outer membrane,159,0.48,0.381,1,GO:0031968,CC,,3285
Notch binding,20,0.443,0.381,1,GO:0005112,MF,,3286
cilium movement,57,0.466,0.381,1,GO:0003341,BP,,3287
regulation of transcription initiation from RNA polymerase II promoter,22,0.446,0.381,1,GO:0060260,BP,,3288
negative regulation of G-protein coupled receptor protein signaling pathway,34,0.457,0.382,1,GO:0045744,BP,,3289
photoreceptor inner segment,33,0.544,0.382,1,GO:0001917,CC,,3290
vacuolar transport,90,0.473,0.382,1,GO:0007034,BP,,3291
negative regulation of receptor activity,32,0.545,0.382,1,GO:2000272,BP,,3292
auditory receptor cell differentiation,27,0.549,0.382,1,GO:0042491,BP,,3293
cochlea morphogenesis,20,0.556,0.382,1,GO:0090103,BP,,3294
platelet alpha granule membrane,16,0.563,0.382,1,GO:0031092,CC,,3295
negative regulation of protein depolymerization,48,0.536,0.383,1,GO:1901880,BP,,3296
hair cell differentiation,34,0.543,0.383,1,GO:0035315,BP,,3297
maternal placenta development,30,0.546,0.383,1,GO:0001893,BP,,3298
C21-steroid hormone biosynthetic process,19,0.442,0.383,1,GO:0006700,BP,,3299
positive regulation of signal transduction by p53 class mediator,16,0.563,0.383,1,GO:1901798,BP,,3300
positive regulation of peptidyl-lysine acetylation,27,0.451,0.383,1,GO:2000758,BP,,3301
embryonic digestive tract development,27,0.452,0.383,1,GO:0048566,BP,,3302
regulation of cholesterol homeostasis,10,0.58,0.383,1,GO:2000188,BP,,3303
regulation of actin filament polymerization,122,0.477,0.383,1,GO:0030833,BP,,3304
pseudopodium organization,14,0.567,0.383,1,GO:0031268,BP,,3305
fatty acid transport,79,0.472,0.384,1,GO:0015908,BP,,3306
negative regulation of heart rate,10,0.58,0.384,1,GO:0010459,BP,,3307
humoral immune response mediated by circulating immunoglobulin,37,0.459,0.384,1,GO:0002455,BP,,3308
negative regulation of viral release from host cell,14,0.567,0.384,1,GO:1902187,BP,,3309
somatic recombination of immunoglobulin genes involved in immune response,30,0.546,0.384,1,"GO:0002204,GO:0002208,GO:0045190",BP,"somatic diversification of immunoglobulins involved in immune response,isotype switching",3310
inner ear receptor cell differentiation,49,0.536,0.385,1,GO:0060113,BP,,3311
regulation of vascular smooth muscle cell proliferation,22,0.554,0.385,1,"GO:1904705,GO:1990874",BP,vascular smooth muscle cell proliferation,3312
regulation of interleukin-12 production,37,0.541,0.385,1,GO:0032655,BP,,3313
inositol phosphate catabolic process,11,0.576,0.385,1,GO:0071545,BP,,3314
neural crest cell differentiation,59,0.533,0.385,1,GO:0014033,BP,,3315
positive regulation of interleukin-8 secretion,10,0.421,0.385,1,GO:2000484,BP,,3316
negative regulation of steroid biosynthetic process,16,0.563,0.385,1,"GO:0010894,GO:0045939",BP,negative regulation of steroid metabolic process,3317
plasminogen activation,16,0.437,0.385,1,GO:0031639,BP,,3318
receptor serine/threonine kinase binding,14,0.567,0.386,1,GO:0033612,MF,,3319
response to fatty acid,66,0.469,0.386,1,GO:0070542,BP,,3320
nuclear ubiquitin ligase complex,30,0.546,0.386,1,GO:0000152,CC,,3321
lamellipodium,166,0.52,0.386,1,GO:0030027,CC,,3322
neuronal action potential,31,0.455,0.387,1,GO:0019228,BP,,3323
extrinsic component of plasma membrane,130,0.522,0.387,1,GO:0019897,CC,,3324
ubiquitin-like protein binding,108,0.524,0.387,1,GO:0032182,MF,,3325
regulation of leukocyte degranulation,32,0.456,0.387,1,GO:0043300,BP,,3326
cAMP catabolic process,19,0.557,0.387,1,GO:0006198,BP,,3327
neuron migration,124,0.523,0.387,1,GO:0001764,BP,,3328
actin filament capping,30,0.546,0.388,1,GO:0051693,BP,,3329
negative regulation of cytokine production involved in immune response,17,0.561,0.388,1,GO:0002719,BP,,3330
filopodium membrane,17,0.56,0.388,1,GO:0031527,CC,,3331
negative regulation of peptide secretion,95,0.474,0.388,1,GO:0002792,BP,,3332
positive regulation of immune effector process,127,0.478,0.388,1,GO:0002699,BP,,3333
regulation of histone H3-K9 methylation,19,0.557,0.388,1,GO:0051570,BP,,3334
interaction with symbiont,49,0.536,0.389,1,GO:0051702,BP,,3335
extracellular matrix disassembly,70,0.53,0.389,1,GO:0022617,BP,,3336
regulation of mRNA 3'-end processing,17,0.56,0.389,1,GO:0031440,BP,,3337
dopamine uptake involved in synaptic transmission,11,0.425,0.389,1,"GO:0051583,GO:0051934,GO:0090493,GO:0090494",BP,"catecholamine uptake involved in synaptic transmission,catecholamine uptake,dopamine uptake",3338
regulation of mitochondrial fission,21,0.446,0.389,1,GO:0090140,BP,,3339
regulation of hematopoietic progenitor cell differentiation,15,0.564,0.389,1,GO:1901532,BP,,3340
T cell proliferation,142,0.521,0.39,1,GO:0042098,BP,,3341
positive regulation of morphogenesis of an epithelium,26,0.549,0.39,1,GO:1905332,BP,,3342
Wnt signaling pathway involved in heart development,10,0.579,0.39,1,GO:0003306,BP,,3343
regulation of interleukin-13 production,13,0.569,0.39,1,GO:0032656,BP,,3344
production of molecular mediator of immune response,127,0.522,0.39,1,GO:0002440,BP,,3345
potassium ion import,25,0.45,0.391,1,GO:0010107,BP,,3346
kidney mesenchyme development,16,0.562,0.391,1,GO:0072074,BP,,3347
negative regulation of peptidyl-serine phosphorylation,24,0.449,0.391,1,GO:0033137,BP,,3348
modified amino acid transmembrane transporter activity,13,0.431,0.392,1,GO:0072349,MF,,3349
regulation of cell maturation,16,0.438,0.392,1,GO:1903429,BP,,3350
sialylation,20,0.445,0.392,1,"GO:0097503,GO:0008373",BP,sialyltransferase activity,3351
prenyltransferase activity,15,0.436,0.392,1,GO:0004659,MF,,3352
"3',5'-cyclic-AMP phosphodiesterase activity",15,0.564,0.392,1,GO:0004115,MF,,3353
peptidyl-serine dephosphorylation,12,0.571,0.392,1,GO:0070262,BP,,3354
synaptic vesicle fusion to presynaptic active zone membrane,15,0.436,0.393,1,"GO:0031629,GO:0099500",BP,vesicle fusion to plasma membrane,3355
response to ischemia,33,0.457,0.393,1,GO:0002931,BP,,3356
acrosome assembly,12,0.571,0.393,1,GO:0001675,BP,,3357
regulation of natural killer cell mediated cytotoxicity,25,0.549,0.394,1,GO:0042269,BP,,3358
regulation of T-helper cell differentiation,19,0.557,0.394,1,GO:0045622,BP,,3359
inorganic cation import into cell,33,0.543,0.394,1,"GO:0098659,GO:0099587",BP,inorganic ion import into cell,3360
regulation of transforming growth factor beta production,25,0.549,0.394,1,GO:0071634,BP,,3361
negative regulation of transcription factor import into nucleus,35,0.542,0.394,1,GO:0042992,BP,,3362
organ induction,17,0.56,0.395,1,GO:0001759,BP,,3363
p53 binding,62,0.531,0.395,1,GO:0002039,MF,,3364
positive regulation of interleukin-6 secretion,15,0.563,0.395,1,GO:2000778,BP,,3365
cAMP binding,21,0.446,0.396,1,GO:0030552,MF,,3366
biological phase,11,0.426,0.396,1,GO:0044848,BP,,3367
positive regulation of transporter activity,73,0.471,0.396,1,GO:0032411,BP,,3368
positive regulation of microtubule polymerization or depolymerization,20,0.555,0.396,1,GO:0031112,BP,,3369
regulation of peroxisome proliferator activated receptor signaling pathway,11,0.574,0.396,1,GO:0035358,BP,,3370
negative regulation of protein transport,168,0.481,0.396,1,GO:0051224,BP,,3371
response to platelet-derived growth factor,19,0.556,0.397,1,GO:0036119,BP,,3372
regulation of myeloid cell differentiation,145,0.52,0.397,1,GO:0045637,BP,,3373
trabecula formation,22,0.448,0.397,1,GO:0060343,BP,,3374
cobalamin metabolic process,16,0.439,0.398,1,GO:0009235,BP,,3375
glomerulus vasculature development,22,0.552,0.398,1,GO:0072012,BP,,3376
positive regulation of natural killer cell mediated cytotoxicity,13,0.568,0.398,1,GO:0045954,BP,,3377
histone-lysine N-methyltransferase activity,40,0.539,0.398,1,GO:0018024,MF,,3378
tricarboxylic acid cycle enzyme complex,11,0.427,0.399,1,GO:0045239,CC,,3379
regulation of cellular extravasation,19,0.444,0.399,1,GO:0002691,BP,,3380
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,14,0.565,0.399,1,GO:2001269,BP,,3381
chromatoid body,10,0.423,0.399,1,GO:0033391,CC,,3382
metallocarboxypeptidase activity,22,0.552,0.399,1,GO:0004181,MF,,3383
sperm part,133,0.521,0.399,1,GO:0097223,CC,,3384
blastoderm segmentation,13,0.567,0.4,1,GO:0007350,BP,,3385
mitotic centrosome separation,13,0.433,0.4,1,GO:0007100,BP,,3386
regulation of blood coagulation,69,0.471,0.401,1,"GO:0030193,GO:1900046",BP,regulation of hemostasis,3387
presynaptic active zone,32,0.543,0.401,1,GO:0048786,CC,,3388
collagen trimer,81,0.527,0.401,1,GO:0005581,CC,,3389
chaperone mediated protein folding requiring cofactor,13,0.433,0.401,1,GO:0051085,BP,,3390
inositol phosphate biosynthetic process,18,0.443,0.401,1,GO:0032958,BP,,3391
G-protein coupled acetylcholine receptor signaling pathway,16,0.439,0.401,1,GO:0007213,BP,,3392
female sex differentiation,92,0.525,0.401,1,GO:0046660,BP,,3393
protein exit from endoplasmic reticulum,34,0.542,0.402,1,GO:0032527,BP,,3394
regulation of keratinocyte proliferation,26,0.548,0.402,1,GO:0010837,BP,,3395
lipopolysaccharide binding,18,0.443,0.402,1,GO:0001530,MF,,3396
cellular copper ion homeostasis,12,0.43,0.402,1,GO:0006878,BP,,3397
carbohydrate transmembrane transport,19,0.555,0.403,1,GO:0034219,BP,,3398
"RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding",42,0.537,0.403,1,"GO:0004879,GO:0098531",MF,"transcription factor activity, direct ligand regulated sequence-specific DNA binding",3399
cytokine production involved in immune response,61,0.531,0.403,1,GO:0002367,BP,,3400
regulation of defense response to bacterium,12,0.57,0.403,1,GO:1900424,BP,,3401
serine-type endopeptidase activity,129,0.479,0.403,1,GO:0004252,MF,,3402
basic amino acid transport,12,0.43,0.403,1,GO:0015802,BP,,3403
S100 protein binding,13,0.567,0.403,1,GO:0044548,MF,,3404
regulation of T cell differentiation,94,0.525,0.403,1,GO:0045580,BP,,3405
positive regulation of cholesterol efflux,12,0.57,0.404,1,GO:0010875,BP,,3406
regulation of bone remodeling,37,0.54,0.404,1,GO:0046850,BP,,3407
mating,33,0.458,0.404,1,GO:0007618,BP,,3408
protein acetyltransferase complex,84,0.526,0.404,1,"GO:0031248,GO:1902493",CC,acetyltransferase complex,3409
cell cycle DNA replication,34,0.459,0.405,1,GO:0044786,BP,,3410
exit from mitosis,27,0.454,0.405,1,GO:0010458,BP,,3411
positive regulation of inositol phosphate biosynthetic process,10,0.424,0.405,1,GO:0060732,BP,,3412
negative regulation of TOR signaling,36,0.54,0.405,1,GO:0032007,BP,,3413
translesion synthesis,39,0.539,0.405,1,GO:0019985,BP,,3414
monocarboxylic acid transmembrane transporter activity,29,0.545,0.406,1,GO:0008028,MF,,3415
Rap protein signal transduction,13,0.567,0.406,1,GO:0032486,BP,,3416
activation of phospholipase C activity,20,0.446,0.406,1,GO:0007202,BP,,3417
positive regulation of transcription elongation from RNA polymerase II promoter,14,0.436,0.406,1,GO:0032968,BP,,3418
ruffle assembly,28,0.545,0.406,1,GO:0097178,BP,,3419
release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,29,0.455,0.407,1,GO:0014808,BP,,3420
regulation of epidermis development,61,0.531,0.407,1,GO:0045682,BP,,3421
inclusion body assembly,19,0.555,0.407,1,GO:0070841,BP,,3422
positive regulation of isotype switching,14,0.564,0.408,1,GO:0045830,BP,,3423
protein serine/threonine/tyrosine kinase activity,37,0.539,0.408,1,GO:0004712,MF,,3424
alpha-beta T cell activation,92,0.525,0.408,1,GO:0046631,BP,,3425
regulation of steroid metabolic process,59,0.531,0.408,1,GO:0019218,BP,,3426
aminoglycan catabolic process,54,0.467,0.408,1,GO:0006026,BP,,3427
Sin3-type complex,16,0.56,0.409,1,GO:0070822,CC,,3428
telomerase holoenzyme complex,20,0.447,0.409,1,GO:0005697,CC,,3429
metalloexopeptidase activity,49,0.534,0.41,1,GO:0008235,MF,,3430
positive regulation of blood vessel endothelial cell migration,26,0.453,0.41,1,GO:0043536,BP,,3431
post-anal tail morphogenesis,15,0.561,0.41,1,GO:0036342,BP,,3432
cellular response to ATP,12,0.431,0.41,1,GO:0071318,BP,,3433
regulation of synapse organization,115,0.478,0.41,1,GO:0050807,BP,,3434
lymphocyte migration,53,0.467,0.411,1,GO:0072676,BP,,3435
positive regulation of viral genome replication,26,0.453,0.411,1,GO:0045070,BP,,3436
negative regulation of interleukin-8 production,15,0.439,0.411,1,GO:0032717,BP,,3437
neurotransmitter binding,18,0.444,0.412,1,GO:0042165,MF,,3438
negative regulation of humoral immune response,10,0.575,0.412,1,GO:0002921,BP,,3439
thymic T cell selection,16,0.441,0.412,1,GO:0045061,BP,,3440
peptidase activator activity,35,0.54,0.413,1,GO:0016504,MF,,3441
positive regulation of blood circulation,53,0.467,0.413,1,GO:1903524,BP,,3442
regulation of macrophage chemotaxis,13,0.434,0.413,1,GO:0010758,BP,,3443
clathrin vesicle coat,24,0.548,0.413,1,GO:0030125,CC,,3444
vascular endothelial growth factor receptor signaling pathway,88,0.525,0.413,1,GO:0048010,BP,,3445
response to arsenic-containing substance,25,0.547,0.413,1,GO:0046685,BP,,3446
"hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances",98,0.476,0.413,1,GO:0016820,MF,,3447
glycoprotein catabolic process,14,0.437,0.413,1,GO:0006516,BP,,3448
hair follicle maturation,15,0.439,0.413,1,GO:0048820,BP,,3449
positive regulation of lamellipodium organization,20,0.447,0.413,1,GO:1902745,BP,,3450
negative regulation of RNA splicing,20,0.553,0.414,1,GO:0033119,BP,,3451
positive regulation of non-canonical Wnt signaling pathway,10,0.575,0.414,1,GO:2000052,BP,,3452
cargo receptor activity,53,0.468,0.414,1,GO:0038024,MF,,3453
histone deacetylase activity (H3-K14 specific),11,0.571,0.414,1,"GO:0031078,GO:0032041",MF,NAD-dependent histone deacetylase activity (H3-K14 specific),3454
loop of Henle development,10,0.575,0.414,1,GO:0072070,BP,,3455
regulation of chromosome segregation,72,0.528,0.414,1,GO:0051983,BP,,3456
membrane protein intracellular domain proteolysis,15,0.561,0.415,1,GO:0031293,BP,,3457
nucleotide catabolic process,61,0.47,0.415,1,GO:0009166,BP,,3458
development of primary female sexual characteristics,81,0.526,0.415,1,GO:0046545,BP,,3459
postsynapse assembly,12,0.568,0.415,1,GO:0099068,BP,,3460
endonucleolytic cleavage involved in rRNA processing,12,0.568,0.415,1,"GO:0000478,GO:0000479",BP,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",3461
regulation of dopamine receptor signaling pathway,10,0.426,0.415,1,GO:0060159,BP,,3462
protein localization to lysosome,27,0.545,0.416,1,GO:0061462,BP,,3463
negative regulation of calcium ion transport into cytosol,16,0.441,0.416,1,GO:0010523,BP,,3464
NuA4 histone acetyltransferase complex,17,0.557,0.416,1,"GO:0035267,GO:0043189",CC,H4/H2A histone acetyltransferase complex,3465
negative regulation of myotube differentiation,12,0.568,0.416,1,GO:0010832,BP,,3466
regulation of synapse maturation,12,0.568,0.416,1,GO:0090128,BP,,3467
negative regulation of cyclin-dependent protein serine/threonine kinase activity,20,0.552,0.416,1,GO:0045736,BP,,3468
response to ethanol,108,0.477,0.417,1,GO:0045471,BP,,3469
regulation of response to food,16,0.441,0.417,1,GO:0032095,BP,,3470
peroxisome,112,0.478,0.417,1,"GO:0005777,GO:0042579",CC,microbody,3471
positive regulation of histone acetylation,26,0.454,0.418,1,GO:0035066,BP,,3472
G-protein coupled peptide receptor activity,89,0.475,0.418,1,GO:0008528,MF,,3473
pyrimidine deoxyribonucleotide catabolic process,10,0.426,0.418,1,GO:0009223,BP,,3474
glucocorticoid biosynthetic process,12,0.568,0.418,1,GO:0006704,BP,,3475
long-chain fatty acid transport,56,0.469,0.419,1,GO:0015909,BP,,3476
drug transporter activity,19,0.554,0.419,1,GO:0090484,MF,,3477
retinoic acid metabolic process,16,0.442,0.419,1,GO:0042573,BP,,3478
clathrin-coated vesicle membrane,102,0.477,0.419,1,GO:0030665,CC,,3479
mRNA transcription,22,0.55,0.419,1,GO:0009299,BP,,3480
positive regulation of protein kinase B signaling,69,0.472,0.419,1,GO:0051897,BP,,3481
cardiac myofibril assembly,14,0.438,0.419,1,GO:0055003,BP,,3482
cell maturation,130,0.479,0.42,1,GO:0048469,BP,,3483
morphogenesis of an epithelial bud,15,0.56,0.42,1,GO:0060572,BP,,3484
sulfuric ester hydrolase activity,14,0.438,0.421,1,GO:0008484,MF,,3485
histone methyltransferase complex,59,0.53,0.421,1,GO:0035097,CC,,3486
regulation of p38MAPK cascade,25,0.546,0.421,1,GO:1900744,BP,,3487
amide transmembrane transporter activity,30,0.458,0.422,1,GO:0042887,MF,,3488
cytoplasmic pattern recognition receptor signaling pathway in response to virus,20,0.552,0.422,1,GO:0039528,BP,,3489
interleukin-5 production,12,0.567,0.422,1,"GO:0032634,GO:0032674",BP,regulation of interleukin-5 production,3490
renal system vasculature development,24,0.547,0.423,1,"GO:0061437,GO:0061440",BP,kidney vasculature development,3491
negative regulation of epidermal growth factor receptor signaling pathway,36,0.539,0.423,1,GO:0042059,BP,,3492
response to cold,37,0.538,0.423,1,GO:0009409,BP,,3493
outer membrane,161,0.482,0.423,1,GO:0019867,CC,,3494
homologous chromosome segregation,45,0.535,0.423,1,GO:0045143,BP,,3495
bone morphogenesis,73,0.527,0.423,1,GO:0060349,BP,,3496
cytoplasmic sequestering of transcription factor,18,0.554,0.424,1,GO:0042994,BP,,3497
negative regulation of T cell activation,75,0.527,0.424,1,GO:0050868,BP,,3498
substrate-dependent cell migration,28,0.544,0.424,1,GO:0006929,BP,,3499
nuclear-transcribed mRNA catabolic process,182,0.517,0.424,1,GO:0000956,BP,,3500
regulation of RNA binding,10,0.573,0.424,1,GO:1905214,BP,,3501
heme binding,96,0.476,0.424,1,GO:0020037,MF,,3502
regulation of centrosome duplication,36,0.538,0.425,1,GO:0010824,BP,,3503
cardiac muscle tissue development,163,0.518,0.425,1,GO:0048738,BP,,3504
oligopeptide binding,11,0.43,0.425,1,GO:1900750,MF,,3505
cyclin-dependent protein serine/threonine kinase activity,25,0.546,0.425,1,GO:0004693,MF,,3506
regulation of pH,92,0.476,0.425,1,GO:0006885,BP,,3507
spinal cord motor neuron differentiation,24,0.547,0.425,1,GO:0021522,BP,,3508
myosin II complex,25,0.454,0.426,1,GO:0016460,CC,,3509
purine-containing compound catabolic process,50,0.467,0.426,1,GO:0072523,BP,,3510
negative regulation of peptidase activity,183,0.517,0.426,1,GO:0010466,BP,,3511
positive regulation of bone resorption,12,0.434,0.426,1,"GO:0045780,GO:0046852",BP,positive regulation of bone remodeling,3512
negative regulation of cellular protein catabolic process,47,0.534,0.426,1,GO:1903363,BP,,3513
regulation of insulin secretion,145,0.481,0.426,1,GO:0050796,BP,,3514
positive regulation of epidermal cell differentiation,18,0.554,0.426,1,GO:0045606,BP,,3515
centromere complex assembly,36,0.538,0.427,1,GO:0034508,BP,,3516
negative regulation of smooth muscle cell migration,17,0.556,0.427,1,GO:0014912,BP,,3517
serine-type endopeptidase inhibitor activity,70,0.527,0.427,1,GO:0004867,MF,,3518
positive regulation of epidermal growth factor receptor signaling pathway,32,0.459,0.427,1,GO:0045742,BP,,3519
positive regulation of antigen receptor-mediated signaling pathway,17,0.444,0.427,1,GO:0050857,BP,,3520
columnar/cuboidal epithelial cell differentiation,86,0.525,0.427,1,GO:0002065,BP,,3521
positive regulation of phagocytosis,36,0.462,0.428,1,GO:0050766,BP,,3522
positive regulation of protein oligomerization,18,0.446,0.428,1,GO:0032461,BP,,3523
peptidyl-threonine phosphorylation,102,0.477,0.428,1,GO:0018107,BP,,3524
regulation of actin nucleation,24,0.453,0.428,1,GO:0051125,BP,,3525
"endoribonuclease activity, producing 5'-phosphomonoesters",21,0.45,0.429,1,GO:0016891,MF,,3526
regulation of striated muscle cell differentiation,75,0.474,0.429,1,GO:0051153,BP,,3527
glial cell migration,42,0.535,0.429,1,GO:0008347,BP,,3528
regulation of systemic arterial blood pressure mediated by a chemical signal,36,0.462,0.43,1,GO:0003044,BP,,3529
regulation of cardiac muscle cell membrane repolarization,21,0.55,0.43,1,GO:0099623,BP,,3530
negative regulation of protein autophosphorylation,11,0.431,0.43,1,GO:0031953,BP,,3531
steroid dehydrogenase activity,20,0.449,0.431,1,GO:0016229,MF,,3532
regulation of production of small RNA involved in gene silencing by RNA,15,0.559,0.431,1,GO:0070920,BP,,3533
high-density lipoprotein particle remodeling,12,0.566,0.431,1,GO:0034375,BP,,3534
sodium ion transmembrane transport,127,0.48,0.431,1,GO:0035725,BP,,3535
regulation of phosphatase activity,102,0.523,0.431,1,GO:0010921,BP,,3536
pre-autophagosomal structure,25,0.455,0.431,1,GO:0000407,CC,,3537
female gamete generation,87,0.524,0.431,1,GO:0007292,BP,,3538
detection of light stimulus involved in visual perception,11,0.432,0.432,1,"GO:0050908,GO:0050962",BP,detection of light stimulus involved in sensory perception,3539
purine nucleoside metabolic process,67,0.472,0.432,1,GO:0042278,BP,,3540
gamma-aminobutyric acid signaling pathway,21,0.45,0.432,1,GO:0007214,BP,,3541
Golgi ribbon formation,10,0.572,0.432,1,GO:0090161,BP,,3542
alpha-beta T cell differentiation,69,0.527,0.432,1,GO:0046632,BP,,3543
"regulation of DNA-templated transcription, elongation",38,0.463,0.432,1,GO:0032784,BP,,3544
regulation of cell cycle G1/S phase transition,133,0.52,0.433,1,GO:1902806,BP,,3545
mesonephros development,90,0.524,0.433,1,GO:0001823,BP,,3546
forebrain neuron fate commitment,10,0.428,0.433,1,GO:0021877,BP,,3547
insulin secretion involved in cellular response to glucose stimulus,47,0.467,0.433,1,GO:0035773,BP,,3548
mechanoreceptor differentiation,52,0.531,0.433,1,GO:0042490,BP,,3549
cellular response to epidermal growth factor stimulus,38,0.537,0.433,1,GO:0071364,BP,,3550
pituitary gland development,37,0.537,0.433,1,GO:0021983,BP,,3551
Derlin-1 retrotranslocation complex,11,0.568,0.433,1,GO:0036513,CC,,3552
negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator,19,0.552,0.433,1,GO:1902254,BP,,3553
cysteine-type endopeptidase activity involved in apoptotic process,14,0.56,0.434,1,GO:0097153,MF,,3554
non-motile cilium,104,0.478,0.434,1,GO:0097730,CC,,3555
positive regulation of phospholipase C activity,29,0.458,0.434,1,GO:0010863,BP,,3556
activation of transmembrane receptor protein tyrosine kinase activity,12,0.435,0.434,1,GO:0007171,BP,,3557
positive regulation of pseudopodium assembly,10,0.571,0.434,1,GO:0031274,BP,,3558
postsynaptic density,194,0.516,0.434,1,GO:0014069,CC,,3559
regulation of alpha-beta T cell activation,58,0.53,0.435,1,GO:0046634,BP,,3560
regulation of sprouting angiogenesis,27,0.543,0.435,1,GO:1903670,BP,,3561
ER-nucleus signaling pathway,43,0.534,0.435,1,GO:0006984,BP,,3562
RIG-I signaling pathway,15,0.558,0.436,1,GO:0039529,BP,,3563
regulation of mitotic cell cycle spindle assembly checkpoint,12,0.435,0.436,1,"GO:0090266,GO:1903504",BP,regulation of mitotic spindle checkpoint,3564
internal protein amino acid acetylation,137,0.519,0.436,1,GO:0006475,BP,,3565
peptidyl-arginine modification,20,0.45,0.436,1,GO:0018195,BP,,3566
negative regulation of telomere maintenance via telomerase,15,0.442,0.436,1,GO:0032211,BP,,3567
endoplasmic reticulum tubular network,15,0.442,0.437,1,GO:0071782,CC,,3568
angiotensin receptor binding,11,0.568,0.437,1,GO:0031701,MF,,3569
ionotropic glutamate receptor binding,21,0.451,0.438,1,GO:0035255,MF,,3570
positive regulation of DNA repair,39,0.536,0.438,1,GO:0045739,BP,,3571
Wnt signalosome,11,0.568,0.438,1,GO:1990909,CC,,3572
negative regulation of tumor necrosis factor production,34,0.462,0.438,1,GO:0032720,BP,,3573
regulation of protein tyrosine kinase activity,62,0.528,0.438,1,GO:0061097,BP,,3574
positive regulation of heart growth,28,0.542,0.439,1,GO:0060421,BP,,3575
regulation of alcohol biosynthetic process,27,0.457,0.44,1,GO:1902930,BP,,3576
tolerance induction,21,0.549,0.44,1,GO:0002507,BP,,3577
glycerolipid catabolic process,42,0.466,0.44,1,GO:0046503,BP,,3578
positive regulation of amino acid transport,15,0.442,0.441,1,GO:0051957,BP,,3579
lateral ventricle development,11,0.433,0.441,1,GO:0021670,BP,,3580
regulation of cyclic nucleotide metabolic process,129,0.48,0.441,1,GO:0030799,BP,,3581
intermediate filament cytoskeleton,142,0.519,0.441,1,GO:0045111,CC,,3582
glial cell proliferation,30,0.459,0.441,1,GO:0014009,BP,,3583
spleen development,30,0.541,0.441,1,GO:0048536,BP,,3584
olfactory bulb interneuron differentiation,12,0.436,0.441,1,GO:0021889,BP,,3585
negative regulation of leukocyte mediated immunity,37,0.537,0.441,1,GO:0002704,BP,,3586
neuromuscular process controlling posture,15,0.557,0.441,1,GO:0050884,BP,,3587
photoreceptor connecting cilium,29,0.459,0.441,1,GO:0032391,CC,,3588
positive regulation of sodium ion transport,29,0.541,0.441,1,GO:0010765,BP,,3589
pyrimidine ribonucleotide metabolic process,25,0.456,0.442,1,GO:0009218,BP,,3590
endoplasmic reticulum calcium ion homeostasis,20,0.45,0.442,1,GO:0032469,BP,,3591
negative regulation of phosphatidylinositol 3-kinase signaling,10,0.57,0.442,1,GO:0014067,BP,,3592
negative regulation of interleukin-2 production,16,0.444,0.442,1,GO:0032703,BP,,3593
neuroepithelial cell differentiation,43,0.534,0.442,1,GO:0060563,BP,,3594
positive regulation of action potential,10,0.43,0.442,1,GO:0045760,BP,,3595
calcium-mediated signaling using intracellular calcium source,15,0.443,0.442,1,GO:0035584,BP,,3596
ganglioside metabolic process,12,0.436,0.442,1,GO:0001573,BP,,3597
tumor necrosis factor superfamily cytokine production,92,0.523,0.442,1,GO:0071706,BP,,3598
"ATPase activity, coupled to transmembrane movement of substances",96,0.477,0.442,1,GO:0042626,MF,,3599
positive regulation of neurotransmitter transport,15,0.443,0.442,1,GO:0051590,BP,,3600
T cell tolerance induction,11,0.567,0.442,1,GO:0002517,BP,,3601
positive regulation of sterol transport,16,0.555,0.442,1,"GO:0032373,GO:0032376",BP,positive regulation of cholesterol transport,3602
regulation of skeletal muscle contraction,10,0.43,0.443,1,GO:0014819,BP,,3603
negative regulation of striated muscle tissue development,36,0.537,0.443,1,GO:0045843,BP,,3604
regulation of fatty acid transport,19,0.551,0.443,1,GO:2000191,BP,,3605
retina morphogenesis in camera-type eye,42,0.466,0.443,1,GO:0060042,BP,,3606
UDP-N-acetylglucosamine metabolic process,13,0.439,0.444,1,GO:0006047,BP,,3607
regulation of vacuole organization,42,0.466,0.444,1,GO:0044088,BP,,3608
response to auditory stimulus,17,0.554,0.444,1,GO:0010996,BP,,3609
positive regulation of type I interferon production,64,0.472,0.444,1,GO:0032481,BP,,3610
negative regulation of organelle assembly,30,0.54,0.444,1,GO:1902116,BP,,3611
negative regulation of lipid catabolic process,19,0.449,0.445,1,GO:0050995,BP,,3612
heterotypic cell-cell adhesion,40,0.535,0.445,1,GO:0034113,BP,,3613
single-stranded telomeric DNA binding,10,0.43,0.445,1,"GO:0043047,GO:0098847",MF,sequence-specific single stranded DNA binding,3614
metanephric nephron epithelium development,21,0.548,0.445,1,GO:0072243,BP,,3615
positive regulation of cyclic nucleotide biosynthetic process,81,0.475,0.445,1,GO:0030804,BP,,3616
voltage-gated chloride channel activity,10,0.57,0.446,1,GO:0005247,MF,,3617
negative regulation of macroautophagy,24,0.455,0.447,1,GO:0016242,BP,,3618
positive regulation of execution phase of apoptosis,10,0.569,0.447,1,GO:1900119,BP,,3619
negative regulation of ion transport,109,0.479,0.447,1,GO:0043271,BP,,3620
anatomical structure arrangement,16,0.555,0.447,1,GO:0048532,BP,,3621
negative regulation of cyclase activity,21,0.452,0.447,1,GO:0031280,BP,,3622
detection of calcium ion,12,0.437,0.448,1,GO:0005513,BP,,3623
apolipoprotein binding,14,0.559,0.448,1,GO:0034185,MF,,3624
interleukin-12 production,39,0.535,0.448,1,GO:0032615,BP,,3625
negative regulation of neurological system process,12,0.563,0.448,1,GO:0031645,BP,,3626
cellular modified amino acid metabolic process,151,0.482,0.448,1,GO:0006575,BP,,3627
bone resorption,42,0.466,0.448,1,GO:0045453,BP,,3628
ureter development,11,0.566,0.449,1,GO:0072189,BP,,3629
negative regulation of histone modification,33,0.538,0.449,1,GO:0031057,BP,,3630
clathrin coat of trans-Golgi network vesicle,12,0.437,0.45,1,GO:0030130,CC,,3631
positive regulation of nuclear division,50,0.469,0.45,1,GO:0051785,BP,,3632
alpha-beta T cell proliferation,23,0.546,0.45,1,GO:0046633,BP,,3633
oocyte development,34,0.463,0.45,1,GO:0048599,BP,,3634
response to glucagon,42,0.534,0.45,1,GO:0033762,BP,,3635
hyaluronan catabolic process,14,0.442,0.45,1,GO:0030214,BP,,3636
"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor",18,0.449,0.45,1,GO:0033764,MF,,3637
negative regulation of blood circulation,29,0.541,0.45,1,GO:1903523,BP,,3638
cerebral cortex radial glia guided migration,23,0.546,0.45,1,"GO:0021801,GO:0022030",BP,telencephalon glial cell migration,3639
cellular response to extracellular stimulus,173,0.517,0.45,1,GO:0031668,BP,,3640
negative regulation of protein secretion,89,0.477,0.451,1,GO:0050709,BP,,3641
primary amino compound metabolic process,14,0.442,0.451,1,GO:1901160,BP,,3642
immune response to tumor cell,12,0.563,0.452,1,GO:0002418,BP,,3643
transcription export complex,13,0.44,0.452,1,GO:0000346,CC,,3644
regulation of inclusion body assembly,13,0.56,0.452,1,GO:0090083,BP,,3645
negative regulation of cell migration,187,0.516,0.452,1,GO:0030336,BP,,3646
cellular defense response,37,0.464,0.452,1,GO:0006968,BP,,3647
nuclear DNA replication,25,0.457,0.453,1,GO:0033260,BP,,3648
lysosome organization,54,0.47,0.453,1,"GO:0007040,GO:0080171",BP,lytic vacuole organization,3649
regulation of production of miRNAs involved in gene silencing by miRNA,14,0.558,0.453,1,GO:1903798,BP,,3650
oocyte differentiation,37,0.464,0.453,1,GO:0009994,BP,,3651
negative regulation of establishment of protein localization,178,0.484,0.453,1,GO:1904950,BP,,3652
T-helper 1 cell differentiation,12,0.562,0.454,1,GO:0045063,BP,,3653
response to vitamin,77,0.525,0.454,1,GO:0033273,BP,,3654
myotube cell development,29,0.46,0.454,1,GO:0014904,BP,,3655
positive regulation of telomere capping,14,0.558,0.454,1,GO:1904355,BP,,3656
glycine metabolic process,14,0.558,0.454,1,GO:0006544,BP,,3657
mesoderm formation,61,0.528,0.454,1,GO:0001707,BP,,3658
protein kinase A catalytic subunit binding,14,0.442,0.454,1,GO:0034236,MF,,3659
positive regulation of protein localization to membrane,98,0.478,0.454,1,GO:1905477,BP,,3660
indole-containing compound metabolic process,24,0.456,0.454,1,GO:0042430,BP,,3661
negative regulation of endothelial cell apoptotic process,19,0.55,0.455,1,GO:2000352,BP,,3662
thyroid hormone generation,12,0.562,0.456,1,GO:0006590,BP,,3663
positive regulation of cytokine-mediated signaling pathway,28,0.541,0.456,1,GO:0001961,BP,,3664
protein insertion into mitochondrial membrane,29,0.46,0.456,1,GO:0051204,BP,,3665
ventral spinal cord interneuron fate commitment,12,0.562,0.456,1,"GO:0060579,GO:0060581",BP,cell fate commitment involved in pattern specification,3666
negative regulation of response to biotic stimulus,32,0.538,0.456,1,GO:0002832,BP,,3667
regulation of cardiac muscle contraction by calcium ion signaling,23,0.545,0.457,1,GO:0010882,BP,,3668
modulation by host of viral genome replication,11,0.565,0.457,1,GO:0044827,BP,,3669
porphyrin-containing compound metabolic process,31,0.461,0.457,1,GO:0006778,BP,,3670
synaptonemal complex,24,0.544,0.457,1,"GO:0000795,GO:0099086",CC,synaptonemal structure,3671
chloride channel regulator activity,16,0.554,0.457,1,GO:0017081,MF,,3672
positive regulation of T cell differentiation,60,0.528,0.457,1,GO:0045582,BP,,3673
CDP-diacylglycerol biosynthetic process,13,0.56,0.458,1,GO:0016024,BP,,3674
myosin complex,57,0.528,0.458,1,GO:0016459,CC,,3675
"blood coagulation, intrinsic pathway",13,0.441,0.458,1,GO:0007597,BP,,3676
cellular response to X-ray,10,0.568,0.458,1,GO:0071481,BP,,3677
negative regulation of striated muscle cell apoptotic process,16,0.554,0.458,1,GO:0010664,BP,,3678
centriolar satellite,25,0.543,0.458,1,GO:0034451,CC,,3679
response to prostaglandin,25,0.457,0.458,1,GO:0034694,BP,,3680
nucleoside metabolic process,112,0.48,0.459,1,GO:0009116,BP,,3681
telomere maintenance via recombination,31,0.538,0.46,1,GO:0000722,BP,,3682
Cul3-RING ubiquitin ligase complex,60,0.472,0.46,1,GO:0031463,CC,,3683
negative regulation of platelet-derived growth factor receptor signaling pathway,15,0.555,0.46,1,GO:0010642,BP,,3684
embryonic digestive tract morphogenesis,14,0.443,0.46,1,GO:0048557,BP,,3685
regulation of protein localization to nucleus,194,0.515,0.461,1,GO:1900180,BP,,3686
regulation of secondary metabolic process,11,0.436,0.461,1,GO:0043455,BP,,3687
L-amino acid import,15,0.445,0.461,1,GO:0043092,BP,,3688
synapse maturation,18,0.55,0.461,1,GO:0060074,BP,,3689
interleukin-8 biosynthetic process,10,0.433,0.461,1,"GO:0042228,GO:0045414",BP,regulation of interleukin-8 biosynthetic process,3690
positive regulation of smooth muscle contraction,24,0.457,0.461,1,GO:0045987,BP,,3691
formation of primary germ layer,105,0.521,0.462,1,GO:0001704,BP,,3692
negative regulation of lipase activity,11,0.564,0.462,1,GO:0060192,BP,,3693
retinal ganglion cell axon guidance,18,0.45,0.463,1,GO:0031290,BP,,3694
"nucleotide-excision repair, DNA incision, 5'-to lesion",32,0.462,0.463,1,GO:0006296,BP,,3695
regulation of establishment of protein localization to plasma membrane,42,0.533,0.463,1,GO:0090003,BP,,3696
immunoglobulin production,69,0.526,0.463,1,GO:0002377,BP,,3697
endosome to lysosome transport,36,0.465,0.463,1,GO:0008333,BP,,3698
mesonephric epithelium development,88,0.523,0.463,1,"GO:0072163,GO:0072164",BP,mesonephric tubule development,3699
regulation of JNK cascade,143,0.518,0.463,1,GO:0046328,BP,,3700
kinetochore,109,0.48,0.463,1,GO:0000776,CC,,3701
protein kinase regulator activity,166,0.483,0.464,1,GO:0019887,MF,,3702
negative regulation of response to endoplasmic reticulum stress,36,0.535,0.464,1,GO:1903573,BP,,3703
"ligase activity, forming carbon-nitrogen bonds",47,0.469,0.464,1,GO:0016879,MF,,3704
regulation of chemotaxis,137,0.482,0.465,1,GO:0050920,BP,,3705
calcium ion transport from endoplasmic reticulum to cytosol,30,0.461,0.465,1,GO:1903514,BP,,3706
indolalkylamine metabolic process,16,0.447,0.465,1,GO:0006586,BP,,3707
regulation of response to biotic stimulus,115,0.48,0.466,1,GO:0002831,BP,,3708
phosphatidylcholine binding,14,0.444,0.466,1,"GO:0031210,GO:0050997",MF,quaternary ammonium group binding,3709
response to hydrogen peroxide,114,0.48,0.466,1,GO:0042542,BP,,3710
"regulation of synaptic transmission, glutamatergic",50,0.53,0.466,1,GO:0051966,BP,,3711
tau-protein kinase activity,11,0.437,0.466,1,GO:0050321,MF,,3712
positive regulation of glycolytic process,11,0.563,0.467,1,GO:0045821,BP,,3713
rRNA transcription,28,0.46,0.467,1,GO:0009303,BP,,3714
mitotic spindle checkpoint,26,0.459,0.467,1,GO:0071174,BP,,3715
water transport,13,0.558,0.467,1,GO:0006833,BP,,3716
protein mannosylation,18,0.549,0.468,1,GO:0035268,BP,,3717
sulfur amino acid metabolic process,35,0.465,0.468,1,GO:0000096,BP,,3718
ammonium transport,81,0.477,0.468,1,GO:0015696,BP,,3719
positive regulation of mesonephros development,20,0.547,0.468,1,GO:0061213,BP,,3720
response to epidermal growth factor,42,0.532,0.469,1,GO:0070849,BP,,3721
"phosphatidylinositol-3,4,5-trisphosphate binding",31,0.538,0.469,1,GO:0005547,MF,,3722
tetrapyrrole binding,103,0.479,0.469,1,GO:0046906,MF,,3723
regulation of pseudopodium assembly,11,0.563,0.469,1,GO:0031272,BP,,3724
heart valve formation,11,0.563,0.47,1,GO:0003188,BP,,3725
"blood coagulation, fibrin clot formation",19,0.452,0.47,1,GO:0072378,BP,,3726
response to monoamine,36,0.535,0.47,1,"GO:0071867,GO:0071869",BP,response to catecholamine,3727
DNA secondary structure binding,18,0.549,0.47,1,GO:0000217,MF,,3728
regulation of peptidyl-serine phosphorylation,100,0.479,0.471,1,GO:0033135,BP,,3729
peptidyl-proline modification,46,0.469,0.471,1,GO:0018208,BP,,3730
sugar:proton symporter activity,14,0.556,0.471,1,"GO:0005351,GO:0005402",MF,cation:sugar symporter activity,3731
rRNA-containing ribonucleoprotein complex export from nucleus,13,0.558,0.471,1,GO:0071428,BP,,3732
interstrand cross-link repair,43,0.532,0.471,1,GO:0036297,BP,,3733
receptor catabolic process,22,0.456,0.472,1,GO:0032801,BP,,3734
T cell differentiation in thymus,61,0.527,0.472,1,GO:0033077,BP,,3735
chondroitin sulfate catabolic process,12,0.44,0.472,1,GO:0030207,BP,,3736
positive regulation of organic acid transport,24,0.458,0.472,1,GO:0032892,BP,,3737
"tRNA splicing, via endonucleolytic cleavage and ligation",14,0.444,0.472,1,GO:0006388,BP,,3738
antiporter activity,74,0.524,0.472,1,GO:0015297,MF,,3739
G-protein coupled receptor internalization,11,0.437,0.472,1,GO:0002031,BP,,3740
positive regulation of interleukin-1 beta secretion,20,0.454,0.472,1,GO:0050718,BP,,3741
mitotic chromosome condensation,13,0.442,0.472,1,GO:0007076,BP,,3742
ribonucleoprotein complex binding,87,0.478,0.472,1,GO:0043021,MF,,3743
L-ascorbic acid metabolic process,10,0.434,0.472,1,GO:0019852,BP,,3744
chromatin-mediated maintenance of transcription,10,0.566,0.472,1,GO:0048096,BP,,3745
"wound healing, spreading of cells",23,0.543,0.473,1,"GO:0044319,GO:0090505",BP,epiboly involved in wound healing,3746
ephrin receptor activity,18,0.451,0.473,1,GO:0005003,MF,,3747
mitochondrial depolarization,22,0.456,0.473,1,GO:0051882,BP,,3748
positive regulation of receptor recycling,14,0.555,0.474,1,GO:0001921,BP,,3749
positive regulation of ERBB signaling pathway,34,0.465,0.474,1,GO:1901186,BP,,3750
error-free translesion synthesis,18,0.451,0.475,1,GO:0070987,BP,,3751
negative regulation of glycoprotein biosynthetic process,10,0.565,0.475,1,GO:0010561,BP,,3752
regulation of hydrogen peroxide-mediated programmed cell death,10,0.435,0.475,1,GO:1901298,BP,,3753
regulation of epidermal cell differentiation,41,0.532,0.476,1,GO:0045604,BP,,3754
cleavage involved in rRNA processing,20,0.546,0.476,1,GO:0000469,BP,,3755
secondary alcohol metabolic process,106,0.48,0.476,1,GO:1902652,BP,,3756
regulation of gastrulation,32,0.536,0.476,1,GO:0010470,BP,,3757
kinetochore assembly,12,0.441,0.476,1,GO:0051382,BP,,3758
positive regulation of viral release from host cell,14,0.445,0.476,1,GO:1902188,BP,,3759
regulation of norepinephrine secretion,14,0.445,0.476,1,GO:0014061,BP,,3760
cAMP response element binding,13,0.557,0.476,1,GO:0035497,MF,,3761
nephric duct morphogenesis,10,0.565,0.476,1,GO:0072178,BP,,3762
peptide receptor activity,90,0.478,0.476,1,GO:0001653,MF,,3763
establishment or maintenance of transmembrane electrochemical gradient,10,0.565,0.476,1,GO:0010248,BP,,3764
amino acid transmembrane transport,56,0.528,0.477,1,GO:0003333,BP,,3765
cellular response to lipoprotein particle stimulus,14,0.445,0.477,1,GO:0071402,BP,,3766
negative regulation of leukocyte mediated cytotoxicity,12,0.559,0.477,1,GO:0001911,BP,,3767
fucose metabolic process,14,0.445,0.477,1,GO:0006004,BP,,3768
parasympathetic nervous system development,14,0.555,0.477,1,GO:0048486,BP,,3769
ventricular cardiac muscle cell membrane repolarization,21,0.545,0.477,1,GO:0099625,BP,,3770
gamma-tubulin complex,18,0.452,0.478,1,GO:0000930,CC,,3771
regulation of deoxyribonuclease activity,10,0.565,0.478,1,GO:0032070,BP,,3772
dendrite cytoplasm,20,0.454,0.478,1,GO:0032839,CC,,3773
regulation of retinoic acid receptor signaling pathway,14,0.555,0.478,1,GO:0048385,BP,,3774
Fanconi anaemia nuclear complex,13,0.557,0.478,1,GO:0043240,CC,,3775
regulation of interleukin-8 production,49,0.471,0.478,1,GO:0032677,BP,,3776
subpallium development,21,0.455,0.478,1,GO:0021544,BP,,3777
regulation of ketone biosynthetic process,12,0.559,0.479,1,GO:0010566,BP,,3778
spermatid nucleus differentiation,13,0.557,0.479,1,GO:0007289,BP,,3779
vitamin transport,25,0.541,0.479,1,GO:0051180,BP,,3780
histone deacetylase activity,39,0.533,0.48,1,"GO:0004407,GO:0033558",MF,protein deacetylase activity,3781
retinol dehydrogenase activity,15,0.447,0.48,1,GO:0004745,MF,,3782
cardiac muscle cell differentiation,84,0.478,0.48,1,GO:0055007,BP,,3783
response to activity,54,0.528,0.48,1,GO:0014823,BP,,3784
regulation of odontogenesis of dentin-containing tooth,10,0.564,0.48,1,GO:0042487,BP,,3785
alpha-catenin binding,10,0.564,0.481,1,GO:0045294,MF,,3786
spindle pole,122,0.519,0.481,1,GO:0000922,CC,,3787
"DNA-templated transcription, termination",91,0.479,0.481,1,GO:0006353,BP,,3788
negative regulation of leukocyte migration,24,0.458,0.481,1,GO:0002686,BP,,3789
vitamin D metabolic process,13,0.444,0.482,1,GO:0042359,BP,,3790
metanephric nephron tubule development,18,0.548,0.482,1,GO:0072234,BP,,3791
meiotic cell cycle process,143,0.517,0.482,1,GO:1903046,BP,,3792
sensory perception of mechanical stimulus,137,0.517,0.483,1,GO:0050954,BP,,3793
mRNA cap binding complex,11,0.439,0.483,1,GO:0005845,CC,,3794
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,28,0.538,0.483,1,GO:1902042,BP,,3795
pigment cell differentiation,31,0.464,0.483,1,GO:0050931,BP,,3796
regulation of neurotransmitter secretion,51,0.472,0.483,1,GO:0046928,BP,,3797
myeloid leukocyte differentiation,153,0.484,0.483,1,GO:0002573,BP,,3798
regulation of clathrin-dependent endocytosis,20,0.545,0.483,1,GO:2000369,BP,,3799
glucose 6-phosphate metabolic process,22,0.457,0.483,1,GO:0051156,BP,,3800
regulation of histone modification,112,0.519,0.484,1,GO:0031056,BP,,3801
positive regulation of ATP metabolic process,24,0.459,0.484,1,GO:1903580,BP,,3802
regeneration,153,0.516,0.485,1,GO:0031099,BP,,3803
sulfation,10,0.436,0.485,1,GO:0051923,BP,,3804
cellular response to estradiol stimulus,26,0.46,0.485,1,GO:0071392,BP,,3805
multicellular organismal catabolic process,59,0.526,0.485,1,GO:0044243,BP,,3806
amyloid precursor protein catabolic process,21,0.456,0.485,1,GO:0042987,BP,,3807
regulation of immunoglobulin production,38,0.533,0.485,1,GO:0002637,BP,,3808
middle ear morphogenesis,15,0.448,0.485,1,GO:0042474,BP,,3809
antibacterial humoral response,22,0.457,0.486,1,GO:0019731,BP,,3810
cellular response to amino acid starvation,33,0.465,0.486,1,GO:0034198,BP,,3811
positive regulation of pri-miRNA transcription from RNA polymerase II promoter,18,0.547,0.486,1,GO:1902895,BP,,3812
negative regulation of histone methylation,16,0.55,0.486,1,GO:0031061,BP,,3813
cell death in response to oxidative stress,69,0.476,0.486,1,GO:0036473,BP,,3814
diacylglycerol metabolic process,13,0.556,0.486,1,GO:0046339,BP,,3815
U5 snRNP,18,0.453,0.487,1,GO:0005682,CC,,3816
nucleotide-excision repair complex,13,0.444,0.487,1,GO:0000109,CC,,3817
negative regulation of blood vessel diameter,70,0.476,0.487,1,GO:0097756,BP,,3818
amino acid transmembrane transporter activity,66,0.525,0.487,1,GO:0015171,MF,,3819
"regulation of DNA damage response, signal transduction by p53 class mediator",27,0.539,0.488,1,GO:0043516,BP,,3820
organ or tissue specific immune response,17,0.549,0.488,1,GO:0002251,BP,,3821
positive regulation of telomerase activity,30,0.537,0.489,1,GO:0051973,BP,,3822
cholesterol transport,61,0.526,0.489,1,GO:0030301,BP,,3823
mechanosensory behavior,11,0.56,0.489,1,GO:0007638,BP,,3824
muscle cell cellular homeostasis,17,0.548,0.489,1,GO:0046716,BP,,3825
regulation of vasculogenesis,11,0.56,0.49,1,GO:2001212,BP,,3826
inner ear receptor stereocilium organization,24,0.541,0.49,1,GO:0060122,BP,,3827
regulation of B cell differentiation,22,0.457,0.49,1,GO:0045577,BP,,3828
calcium channel regulator activity,32,0.535,0.491,1,GO:0005246,MF,,3829
snRNA metabolic process,72,0.476,0.491,1,GO:0016073,BP,,3830
Ino80 complex,10,0.437,0.491,1,"GO:0031011,GO:0033202",CC,DNA helicase complex,3831
actomyosin,61,0.526,0.491,1,GO:0042641,CC,,3832
response to starvation,139,0.517,0.491,1,GO:0042594,BP,,3833
intermediate filament,111,0.519,0.491,1,GO:0005882,CC,,3834
palmitoyltransferase activity,33,0.535,0.492,1,GO:0016409,MF,,3835
positive regulation of myeloid leukocyte differentiation,37,0.467,0.492,1,GO:0002763,BP,,3836
negative regulation of keratinocyte proliferation,14,0.553,0.492,1,GO:0010839,BP,,3837
response to corticosteroid,134,0.483,0.493,1,GO:0031960,BP,,3838
forelimb morphogenesis,30,0.536,0.493,1,GO:0035136,BP,,3839
myoblast fusion,31,0.536,0.493,1,GO:0007520,BP,,3840
cytokine receptor activity,67,0.524,0.493,1,GO:0004896,MF,,3841
dendritic spine maintenance,12,0.443,0.493,1,GO:0097062,BP,,3842
segment specification,12,0.557,0.494,1,GO:0007379,BP,,3843
parturition,17,0.452,0.494,1,GO:0007567,BP,,3844
membrane repolarization,39,0.532,0.494,1,GO:0086009,BP,,3845
DNA-directed RNA polymerase complex,105,0.481,0.494,1,"GO:0000428,GO:0055029",CC,nuclear DNA-directed RNA polymerase complex,3846
cardiac cell development,56,0.474,0.494,1,GO:0055006,BP,,3847
cardiac muscle cell membrane repolarization,31,0.536,0.494,1,GO:0099622,BP,,3848
magnesium ion homeostasis,11,0.56,0.494,1,GO:0010960,BP,,3849
regulation of phospholipase activity,48,0.471,0.494,1,GO:0010517,BP,,3850
rRNA modification,29,0.463,0.495,1,GO:0000154,BP,,3851
regulation of glomerulus development,12,0.557,0.495,1,GO:0090192,BP,,3852
cerebellar cortex formation,20,0.456,0.496,1,GO:0021697,BP,,3853
mitochondrial genome maintenance,26,0.461,0.496,1,GO:0000002,BP,,3854
collagen-activated signaling pathway,11,0.559,0.497,1,GO:0038065,BP,,3855
L-glutamate transmembrane transport,13,0.446,0.497,1,"GO:0089711,GO:0005313,GO:0015172",BP,"L-glutamate transmembrane transporter activity,acidic amino acid transmembrane transporter activity",3856
beta-catenin destruction complex,11,0.441,0.497,1,GO:0030877,CC,,3857
4-hydroxyproline metabolic process,12,0.557,0.497,1,GO:0019471,BP,,3858
RNA polymerase binding,43,0.53,0.497,1,GO:0070063,MF,,3859
misfolded or incompletely synthesized protein catabolic process,21,0.543,0.498,1,GO:0006515,BP,,3860
positive regulation of cyclin-dependent protein serine/threonine kinase activity,31,0.535,0.498,1,GO:0045737,BP,,3861
regulation of transcription regulatory region DNA binding,36,0.467,0.498,1,GO:2000677,BP,,3862
myosin filament assembly,13,0.446,0.499,1,GO:0031034,BP,,3863
anion channel activity,77,0.522,0.499,1,GO:0005253,MF,,3864
negative regulation of microtubule polymerization or depolymerization,24,0.46,0.499,1,GO:0031111,BP,,3865
metanephric epithelium development,24,0.54,0.499,1,GO:0072207,BP,,3866
alpha-amino acid biosynthetic process,59,0.475,0.5,1,GO:1901607,BP,,3867
positive regulation of Ras protein signal transduction,37,0.468,0.5,1,GO:0046579,BP,,3868
prostaglandin transport,14,0.448,0.5,1,GO:0015732,BP,,3869
exploration behavior,23,0.541,0.5,1,GO:0035640,BP,,3870
flagellated sperm motility,61,0.475,0.5,1,GO:0030317,BP,,3871
C4-dicarboxylate transport,11,0.559,0.501,1,GO:0015740,BP,,3872
spliceosomal complex assembly,48,0.528,0.501,1,GO:0000245,BP,,3873
regulation of amyloid precursor protein catabolic process,13,0.446,0.501,1,GO:1902991,BP,,3874
protein tyrosine/serine/threonine phosphatase activity,39,0.469,0.501,1,GO:0008138,MF,,3875
dermatan sulfate biosynthetic process,11,0.559,0.501,1,GO:0030208,BP,,3876
positive regulation of phosphatidylinositol 3-kinase activity,27,0.463,0.501,1,GO:0043552,BP,,3877
lateral sprouting from an epithelium,11,0.559,0.501,1,GO:0060601,BP,,3878
cellular transition metal ion homeostasis,71,0.477,0.501,1,GO:0046916,BP,,3879
membrane raft assembly,10,0.561,0.502,1,GO:0001765,BP,,3880
regulation of alpha-beta T cell proliferation,19,0.545,0.502,1,GO:0046640,BP,,3881
striated muscle myosin thick filament assembly,12,0.444,0.502,1,GO:0071688,BP,,3882
regulation of mast cell activation,33,0.466,0.502,1,GO:0033003,BP,,3883
O-acyltransferase activity,39,0.531,0.502,1,GO:0008374,MF,,3884
postsynaptic specialization,196,0.514,0.502,1,GO:0099572,CC,,3885
fibroblast growth factor binding,23,0.54,0.503,1,GO:0017134,MF,,3886
negative regulation of tissue remodeling,17,0.547,0.503,1,GO:0034104,BP,,3887
cysteine-type endopeptidase activator activity involved in apoptotic process,16,0.452,0.503,1,GO:0008656,MF,,3888
regulation of skeletal muscle tissue development,43,0.53,0.503,1,GO:0048641,BP,,3889
negative regulation of necroptotic process,10,0.561,0.503,1,GO:0060546,BP,,3890
kinesin binding,35,0.467,0.503,1,GO:0019894,MF,,3891
nitric-oxide synthase binding,16,0.548,0.504,1,GO:0050998,MF,,3892
positive regulation of triglyceride biosynthetic process,10,0.439,0.505,1,GO:0010867,BP,,3893
GPI anchor metabolic process,26,0.538,0.505,1,GO:0006505,BP,,3894
histone H2A acetylation,14,0.551,0.505,1,GO:0043968,BP,,3895
endoplasmic reticulum quality control compartment,21,0.542,0.505,1,GO:0044322,CC,,3896
negative regulation of endopeptidase activity,176,0.515,0.505,1,GO:0010951,BP,,3897
secondary active sulfate transmembrane transporter activity,11,0.558,0.505,1,"GO:0008271,GO:0015116",MF,sulfate transmembrane transporter activity,3898
positive regulation of erythrocyte differentiation,21,0.542,0.505,1,GO:0045648,BP,,3899
"phosphatidylinositol-4,5-bisphosphate binding",51,0.473,0.506,1,GO:0005546,MF,,3900
negative regulation of wound healing,54,0.474,0.506,1,GO:0061045,BP,,3901
annealing activity,12,0.445,0.506,1,GO:0097617,MF,,3902
interleukin-13 production,14,0.551,0.506,1,GO:0032616,BP,,3903
peptide hormone secretion,195,0.486,0.507,1,GO:0030072,BP,,3904
ncRNA catabolic process,17,0.547,0.507,1,GO:0034661,BP,,3905
positive regulation of cellular amide metabolic process,106,0.481,0.507,1,GO:0034250,BP,,3906
positive regulation by host of viral process,12,0.555,0.507,1,GO:0044794,BP,,3907
viral transcription,160,0.515,0.507,1,GO:0019083,BP,,3908
negative regulation of myeloid cell differentiation,65,0.524,0.507,1,GO:0045638,BP,,3909
lipase inhibitor activity,10,0.439,0.507,1,GO:0055102,MF,,3910
drug binding,88,0.48,0.508,1,GO:0008144,MF,,3911
positive regulation of chromosome organization,134,0.517,0.508,1,GO:2001252,BP,,3912
amino acid transport,124,0.483,0.508,1,GO:0006865,BP,,3913
base-excision repair,32,0.534,0.508,1,GO:0006284,BP,,3914
microtubule depolymerization,23,0.54,0.508,1,GO:0007019,BP,,3915
regulation of systemic arterial blood pressure,69,0.477,0.509,1,GO:0003073,BP,,3916
regulation of cofactor metabolic process,47,0.472,0.509,1,"GO:0051193,GO:0051196",BP,regulation of coenzyme metabolic process,3917
SNARE binding,105,0.481,0.509,1,GO:0000149,MF,,3918
regulation of interferon-gamma production,69,0.477,0.509,1,GO:0032649,BP,,3919
hormone activity,77,0.478,0.509,1,GO:0005179,MF,,3920
negative regulation of mitotic metaphase/anaphase transition,27,0.463,0.509,1,"GO:0045841,GO:1902100,GO:1905819,GO:2000816",BP,"negative regulation of metaphase/anaphase transition of cell cycle,negative regulation of chromosome separation,negative regulation of mitotic sister chromatid separation",3921
gamma-tubulin binding,23,0.54,0.51,1,GO:0043015,MF,,3922
response to antibiotic,41,0.53,0.51,1,GO:0046677,BP,,3923
regulation of interleukin-2 production,40,0.53,0.51,1,GO:0032663,BP,,3924
negative regulation of blood coagulation,39,0.47,0.51,1,"GO:0030195,GO:1900047",BP,negative regulation of hemostasis,3925
neurotransmitter transport,179,0.486,0.51,1,GO:0006836,BP,,3926
lipoprotein biosynthetic process,123,0.483,0.51,1,GO:0042158,BP,,3927
response to UV-B,16,0.548,0.51,1,GO:0010224,BP,,3928
regulation of lipid catabolic process,45,0.472,0.511,1,GO:0050994,BP,,3929
regulation of cholesterol biosynthetic process,11,0.557,0.511,1,GO:0045540,BP,,3930
pinocytosis,18,0.545,0.511,1,GO:0006907,BP,,3931
syntaxin binding,74,0.478,0.511,1,GO:0019905,MF,,3932
"chromosome, telomeric region",132,0.517,0.511,1,GO:0000781,CC,,3933
regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,15,0.451,0.511,1,GO:0039531,BP,,3934
nitric oxide metabolic process,59,0.475,0.511,1,GO:0046209,BP,,3935
regulation of protein autophosphorylation,39,0.47,0.512,1,GO:0031952,BP,,3936
hindbrain morphogenesis,36,0.532,0.512,1,GO:0021575,BP,,3937
regulation of organ growth,71,0.523,0.512,1,GO:0046620,BP,,3938
regulation of muscle tissue development,107,0.518,0.512,1,GO:1901861,BP,,3939
central nervous system projection neuron axonogenesis,22,0.54,0.512,1,GO:0021952,BP,,3940
pericentric heterochromatin,17,0.546,0.512,1,GO:0005721,CC,,3941
glutamine metabolic process,23,0.461,0.513,1,GO:0006541,BP,,3942
active ion transmembrane transporter activity,102,0.481,0.513,1,GO:0022853,MF,,3943
icosanoid receptor activity,13,0.448,0.513,1,GO:0004953,MF,,3944
laminin binding,24,0.539,0.513,1,GO:0043236,MF,,3945
positive regulation of apoptotic signaling pathway,159,0.515,0.514,1,GO:2001235,BP,,3946
sulfur compound transmembrane transporter activity,25,0.538,0.514,1,GO:1901682,MF,,3947
"hydrolase activity, acting on glycosyl bonds",85,0.52,0.515,1,GO:0016798,MF,,3948
regulation of cardiac muscle contraction,66,0.523,0.515,1,GO:0055117,BP,,3949
leukocyte mediated cytotoxicity,58,0.525,0.515,1,GO:0001909,BP,,3950
carbohydrate phosphorylation,20,0.542,0.516,1,GO:0046835,BP,,3951
ubiquitin protein ligase activity involved in ERAD pathway,13,0.552,0.516,1,GO:1904264,MF,,3952
keratinization,113,0.518,0.516,1,GO:0031424,BP,,3953
negative regulation of protein localization to cell surface,11,0.557,0.516,1,GO:2000009,BP,,3954
positive regulation of natural killer cell mediated immunity,15,0.548,0.516,1,GO:0002717,BP,,3955
response to growth hormone,32,0.533,0.516,1,GO:0060416,BP,,3956
dermatan sulfate proteoglycan biosynthetic process,13,0.552,0.517,1,GO:0050651,BP,,3957
histone ubiquitination,35,0.532,0.517,1,GO:0016574,BP,,3958
viral gene expression,170,0.514,0.517,1,GO:0019080,BP,,3959
acyl-CoA metabolic process,86,0.48,0.517,1,"GO:0006637,GO:0035383",BP,thioester metabolic process,3960
regulation of biomineral tissue development,63,0.524,0.517,1,GO:0070167,BP,,3961
retina homeostasis,55,0.525,0.517,1,GO:0001895,BP,,3962
insulin-like growth factor binding,27,0.536,0.517,1,GO:0005520,MF,,3963
gluconeogenesis,69,0.477,0.517,1,GO:0006094,BP,,3964
negative regulation of myoblast differentiation,19,0.543,0.518,1,GO:0045662,BP,,3965
positive regulation of protein exit from endoplasmic reticulum,10,0.441,0.518,1,GO:0070863,BP,,3966
neuron remodeling,11,0.556,0.518,1,GO:0016322,BP,,3967
blood microparticle,89,0.48,0.518,1,GO:0072562,CC,,3968
gonadotropin secretion,13,0.448,0.518,1,GO:0032274,BP,,3969
tetrapyrrole biosynthetic process,24,0.462,0.518,1,GO:0033014,BP,,3970
positive regulation of cardiac muscle tissue growth,24,0.538,0.518,1,GO:0055023,BP,,3971
peptide N-acetyltransferase activity,59,0.524,0.518,1,GO:0034212,MF,,3972
branching involved in salivary gland morphogenesis,21,0.459,0.519,1,GO:0060445,BP,,3973
negative regulation of lyase activity,23,0.461,0.519,1,GO:0051350,BP,,3974
NAD+ binding,12,0.554,0.52,1,GO:0070403,MF,,3975
lamellipodium membrane,18,0.544,0.52,1,GO:0031258,CC,,3976
negative regulation of TORC1 signaling,11,0.556,0.521,1,GO:1904262,BP,,3977
regulation of growth hormone secretion,10,0.559,0.521,1,GO:0060123,BP,,3978
clathrin-dependent endocytosis,56,0.475,0.521,1,GO:0072583,BP,,3979
pyrimidine nucleoside biosynthetic process,32,0.467,0.521,1,GO:0046134,BP,,3980
chloride channel activity,68,0.523,0.521,1,GO:0005254,MF,,3981
regulation of response to oxidative stress,70,0.478,0.521,1,GO:1902882,BP,,3982
ribonucleoside biosynthetic process,38,0.47,0.521,1,GO:0042455,BP,,3983
regulation of macrophage activation,22,0.461,0.522,1,GO:0043030,BP,,3984
chromatin remodeling at centromere,29,0.534,0.522,1,GO:0031055,BP,,3985
negative regulation of response to reactive oxygen species,16,0.454,0.522,1,"GO:1901032,GO:1903206",BP,negative regulation of hydrogen peroxide-induced cell death,3986
cellular response to nerve growth factor stimulus,40,0.529,0.522,1,GO:1990090,BP,,3987
prostanoid metabolic process,29,0.466,0.522,1,"GO:0006692,GO:0006693",BP,prostaglandin metabolic process,3988
insulin secretion,169,0.486,0.522,1,GO:0030073,BP,,3989
nucleobase metabolic process,34,0.468,0.523,1,GO:0009112,BP,,3990
actin polymerization or depolymerization,163,0.485,0.523,1,GO:0008154,BP,,3991
immunoglobulin secretion,14,0.451,0.523,1,GO:0048305,BP,,3992
regulation of B cell activation,92,0.519,0.524,1,GO:0050864,BP,,3993
regulation of cellular pH,85,0.48,0.524,1,GO:0030641,BP,,3994
positive regulation of vascular smooth muscle cell proliferation,15,0.548,0.524,1,GO:1904707,BP,,3995
negative regulation of T cell receptor signaling pathway,17,0.455,0.524,1,GO:0050860,BP,,3996
positive regulation of protein acetylation,31,0.467,0.524,1,GO:1901985,BP,,3997
regulation of microtubule polymerization or depolymerization,48,0.527,0.524,1,GO:0031110,BP,,3998
acetyl-CoA metabolic process,32,0.467,0.524,1,GO:0006084,BP,,3999
positive regulation of B cell differentiation,13,0.449,0.524,1,GO:0045579,BP,,4000
positive regulation of supramolecular fiber organization,150,0.485,0.525,1,GO:1902905,BP,,4001
"protein binding, bridging",143,0.515,0.525,1,GO:0030674,MF,,4002
glucocorticoid receptor binding,13,0.449,0.525,1,GO:0035259,MF,,4003
negative regulation of tumor necrosis factor superfamily cytokine production,36,0.469,0.525,1,GO:1903556,BP,,4004
positive regulation of dendritic spine development,35,0.531,0.526,1,GO:0060999,BP,,4005
regulation of sister chromatid segregation,58,0.524,0.526,1,GO:0033045,BP,,4006
mast cell migration,13,0.551,0.526,1,GO:0097531,BP,,4007
positive regulation of protein deacetylation,20,0.541,0.526,1,GO:0090312,BP,,4008
peptidyl-tyrosine autophosphorylation,46,0.527,0.526,1,GO:0038083,BP,,4009
phosphatidylglycerol acyl-chain remodeling,13,0.551,0.527,1,GO:0036148,BP,,4010
transcription factor TFIID complex,29,0.466,0.527,1,GO:0005669,CC,,4011
regulation of protein polyubiquitination,13,0.551,0.527,1,GO:1902914,BP,,4012
intracellular sterol transport,17,0.544,0.527,1,"GO:0032366,GO:0032367",BP,intracellular cholesterol transport,4013
drug transport,24,0.537,0.527,1,GO:0015893,BP,,4014
negative regulation of extrinsic apoptotic signaling pathway,86,0.52,0.527,1,GO:2001237,BP,,4015
RNA phosphodiester bond hydrolysis,107,0.518,0.528,1,GO:0090501,BP,,4016
regulation of multicellular organismal metabolic process,31,0.533,0.528,1,GO:0044246,BP,,4017
negative regulation of fat cell differentiation,37,0.53,0.528,1,GO:0045599,BP,,4018
negative regulation of striated muscle cell differentiation,25,0.536,0.528,1,GO:0051154,BP,,4019
preganglionic parasympathetic fiber development,13,0.551,0.528,1,GO:0021783,BP,,4020
regulation of cyclase activity,75,0.479,0.528,1,GO:0031279,BP,,4021
cell differentiation in hindbrain,18,0.457,0.528,1,GO:0021533,BP,,4022
cellular response to vitamin,22,0.539,0.528,1,GO:0071295,BP,,4023
frizzled binding,31,0.467,0.528,1,GO:0005109,MF,,4024
peptide alpha-N-acetyltransferase activity,10,0.442,0.528,1,GO:0004596,MF,,4025
acetylcholine receptor activity,19,0.458,0.529,1,GO:0015464,MF,,4026
aminopeptidase activity,36,0.53,0.53,1,GO:0004177,MF,,4027
protein K48-linked deubiquitination,27,0.535,0.53,1,GO:0071108,BP,,4028
negative regulation of protein localization to membrane,23,0.462,0.53,1,GO:1905476,BP,,4029
positive regulation of potassium ion transport,33,0.468,0.53,1,GO:0043268,BP,,4030
calcium-dependent protein serine/threonine kinase activity,11,0.445,0.53,1,GO:0009931,MF,,4031
positive regulation of actin nucleation,13,0.55,0.53,1,GO:0051127,BP,,4032
negative regulation of proteasomal ubiquitin-dependent protein catabolic process,21,0.54,0.53,1,GO:0032435,BP,,4033
sodium:amino acid symporter activity,11,0.555,0.53,1,GO:0005283,MF,,4034
acidic amino acid transport,24,0.463,0.531,1,GO:0015800,BP,,4035
intramolecular oxidoreductase activity,43,0.472,0.531,1,GO:0016860,MF,,4036
establishment of mitochondrion localization,18,0.543,0.532,1,GO:0051654,BP,,4037
ribonucleoprotein complex subunit organization,183,0.487,0.532,1,GO:0071826,BP,,4038
positive regulation of leukocyte apoptotic process,24,0.537,0.532,1,GO:2000108,BP,,4039
regulation of fibroblast migration,29,0.467,0.533,1,GO:0010762,BP,,4040
methionine biosynthetic process,12,0.552,0.533,1,GO:0009086,BP,,4041
regulation of proteasomal protein catabolic process,136,0.484,0.533,1,GO:0061136,BP,,4042
regulation of respiratory burst,10,0.443,0.533,1,GO:0060263,BP,,4043
negative regulation of peptide hormone secretion,39,0.471,0.533,1,GO:0090278,BP,,4044
DNA polymerase complex,15,0.546,0.533,1,GO:0042575,CC,,4045
cornification,57,0.476,0.533,1,GO:0070268,BP,,4046
regulation of histone H3-K4 methylation,21,0.539,0.534,1,GO:0051569,BP,,4047
cellular response to gamma radiation,21,0.539,0.534,1,GO:0071480,BP,,4048
binding of sperm to zona pellucida,23,0.462,0.534,1,GO:0007339,BP,,4049
lamellipodium assembly,54,0.476,0.534,1,GO:0030032,BP,,4050
negative regulation of protein oligomerization,12,0.448,0.534,1,GO:0032460,BP,,4051
regulation of lymphocyte apoptotic process,45,0.527,0.534,1,GO:0070228,BP,,4052
inhibitory synapse,10,0.557,0.534,1,GO:0060077,CC,,4053
embryo implantation,39,0.529,0.534,1,GO:0007566,BP,,4054
calcium activated cation channel activity,25,0.464,0.535,1,GO:0005227,MF,,4055
protein phosphatase type 1 complex,10,0.443,0.535,1,GO:0000164,CC,,4056
positive regulation of myeloid leukocyte mediated immunity,14,0.452,0.535,1,GO:0002888,BP,,4057
regulation of T cell differentiation in thymus,22,0.538,0.535,1,GO:0033081,BP,,4058
superoxide anion generation,21,0.461,0.535,1,GO:0042554,BP,,4059
skeletal muscle contraction,30,0.467,0.535,1,GO:0003009,BP,,4060
chemokine biosynthetic process,10,0.443,0.535,1,"GO:0042033,GO:0050755",BP,chemokine metabolic process,4061
arachidonic acid secretion,22,0.462,0.535,1,"GO:0050482,GO:1903963",BP,arachidonate transport,4062
monocarboxylic acid biosynthetic process,161,0.514,0.535,1,GO:0072330,BP,,4063
spindle assembly checkpoint,25,0.464,0.536,1,GO:0071173,BP,,4064
regulation of lymphocyte differentiation,116,0.517,0.536,1,GO:0045619,BP,,4065
NADP binding,42,0.472,0.536,1,GO:0050661,MF,,4066
ceramide metabolic process,70,0.521,0.536,1,GO:0006672,BP,,4067
regulation of systemic arterial blood pressure by renin-angiotensin,17,0.543,0.536,1,GO:0003081,BP,,4068
alcohol binding,60,0.523,0.536,1,GO:0043178,MF,,4069
interleukin-2 production,47,0.526,0.536,1,GO:0032623,BP,,4070
neuron maturation,39,0.529,0.536,1,GO:0042551,BP,,4071
positive regulation of filopodium assembly,27,0.534,0.536,1,GO:0051491,BP,,4072
positive regulation of tissue remodeling,22,0.462,0.536,1,GO:0034105,BP,,4073
vesicle docking involved in exocytosis,42,0.472,0.536,1,GO:0006904,BP,,4074
azole transport,15,0.546,0.537,1,GO:0045117,BP,,4075
acute-phase response,30,0.533,0.537,1,GO:0006953,BP,,4076
eukaryotic translation initiation factor 3 complex,14,0.452,0.537,1,GO:0005852,CC,,4077
fatty acid synthase activity,10,0.556,0.537,1,GO:0004312,MF,,4078
transcription initiation from RNA polymerase II promoter,149,0.485,0.537,1,GO:0006367,BP,,4079
negative regulation of viral transcription,20,0.54,0.537,1,GO:0032897,BP,,4080
inositol trisphosphate kinase activity,11,0.554,0.537,1,GO:0051766,MF,,4081
toll-like receptor 4 signaling pathway,25,0.464,0.537,1,GO:0034142,BP,,4082
cellular response to glucose starvation,32,0.531,0.538,1,GO:0042149,BP,,4083
regulation of T cell apoptotic process,28,0.534,0.538,1,GO:0070232,BP,,4084
aspartate metabolic process,10,0.444,0.538,1,GO:0006531,BP,,4085
nuclear outer membrane,17,0.543,0.538,1,GO:0005640,CC,,4086
activation of MAPK activity,128,0.484,0.538,1,GO:0000187,BP,,4087
phosphatidylinositol phosphate binding,116,0.517,0.539,1,GO:1901981,MF,,4088
intra-S DNA damage checkpoint,12,0.551,0.539,1,GO:0031573,BP,,4089
pyrimidine nucleotide catabolic process,11,0.446,0.539,1,GO:0006244,BP,,4090
negative regulation of leukocyte differentiation,70,0.521,0.539,1,GO:1902106,BP,,4091
negative regulation of muscle hypertrophy,16,0.456,0.539,1,GO:0014741,BP,,4092
thioester biosynthetic process,60,0.477,0.539,1,"GO:0035384,GO:0071616",BP,acyl-CoA biosynthetic process,4093
regulation of synapse structure or activity,119,0.484,0.539,1,GO:0050803,BP,,4094
translation repressor activity,23,0.537,0.539,1,GO:0030371,MF,,4095
regulation of lipoprotein metabolic process,14,0.547,0.54,1,GO:0050746,BP,,4096
"translation factor activity, RNA binding",77,0.48,0.54,1,GO:0008135,MF,,4097
regulation of natural killer cell mediated immunity,27,0.534,0.54,1,GO:0002715,BP,,4098
regulation of endocrine process,35,0.47,0.54,1,GO:0044060,BP,,4099
interleukin-4 production,24,0.536,0.54,1,GO:0032633,BP,,4100
telencephalon cell migration,55,0.524,0.54,1,GO:0022029,BP,,4101
vesicle-mediated transport between endosomal compartments,36,0.471,0.541,1,GO:0098927,BP,,4102
"hydrolase activity, hydrolyzing O-glycosyl compounds",66,0.522,0.541,1,GO:0004553,MF,,4103
cytosolic transport,119,0.516,0.541,1,GO:0016482,BP,,4104
transmission of nerve impulse,61,0.477,0.541,1,GO:0019226,BP,,4105
fatty acid transporter activity,13,0.451,0.541,1,GO:0015245,MF,,4106
TOR complex,13,0.451,0.542,1,GO:0038201,CC,,4107
positive regulation of Rho protein signal transduction,20,0.461,0.542,1,GO:0035025,BP,,4108
fatty-acyl-CoA biosynthetic process,40,0.472,0.542,1,GO:0046949,BP,,4109
membrane depolarization,92,0.518,0.543,1,GO:0051899,BP,,4110
regulation of translational initiation by eIF2 alpha phosphorylation,10,0.556,0.543,1,GO:0010998,BP,,4111
cyclin binding,22,0.537,0.543,1,GO:0030332,MF,,4112
negative regulation of protein complex disassembly,51,0.525,0.544,1,GO:0043242,BP,,4113
embryonic forelimb morphogenesis,24,0.536,0.544,1,GO:0035115,BP,,4114
positive regulation of muscle cell differentiation,79,0.52,0.544,1,GO:0051149,BP,,4115
interleukin-17 production,19,0.46,0.544,1,GO:0032620,BP,,4116
serine family amino acid metabolic process,37,0.529,0.544,1,GO:0009069,BP,,4117
receptor recycling,29,0.467,0.545,1,GO:0001881,BP,,4118
ureteric bud development,87,0.519,0.545,1,GO:0001657,BP,,4119
clathrin-coated endocytic vesicle membrane,48,0.475,0.545,1,GO:0030669,CC,,4120
histone H2B ubiquitination,10,0.555,0.545,1,GO:0033523,BP,,4121
neuronal stem cell division,12,0.55,0.545,1,"GO:0036445,GO:0055057",BP,neuroblast division,4122
glycolipid binding,13,0.548,0.545,1,GO:0051861,MF,,4123
pronucleus,12,0.55,0.545,1,GO:0045120,CC,,4124
positive regulation of lymphocyte differentiation,71,0.521,0.546,1,GO:0045621,BP,,4125
Set1C/COMPASS complex,12,0.45,0.546,1,GO:0048188,CC,,4126
response to ionizing radiation,127,0.516,0.546,1,GO:0010212,BP,,4127
muscle cell development,134,0.515,0.546,1,GO:0055001,BP,,4128
endosome lumen,20,0.539,0.546,1,GO:0031904,CC,,4129
regulation of type B pancreatic cell proliferation,10,0.555,0.547,1,GO:0061469,BP,,4130
positive regulation of protein processing,19,0.46,0.547,1,GO:0010954,BP,,4131
phagocytosis,191,0.487,0.548,1,GO:0006909,BP,,4132
"positive regulation of CD4-positive, alpha-beta T cell activation",22,0.537,0.548,1,GO:2000516,BP,,4133
protein lipidation,117,0.484,0.548,1,GO:0006497,BP,,4134
positive regulation of MAP kinase activity,194,0.487,0.548,1,GO:0043406,BP,,4135
dicarboxylic acid transport,81,0.481,0.548,1,GO:0006835,BP,,4136
regulation of the force of heart contraction,23,0.536,0.548,1,GO:0002026,BP,,4137
positive regulation of T cell apoptotic process,11,0.552,0.549,1,GO:0070234,BP,,4138
protein localization to centrosome,23,0.464,0.549,1,"GO:0071539,GO:1905508",BP,protein localization to microtubule organizing center,4139
cellular response to hydrogen peroxide,76,0.48,0.549,1,GO:0070301,BP,,4140
photoreceptor outer segment membrane,10,0.555,0.55,1,GO:0042622,CC,,4141
protein O-linked mannosylation,12,0.45,0.55,1,GO:0035269,BP,,4142
telencephalon regionalization,10,0.555,0.55,1,GO:0021978,BP,,4143
nucleotide kinase activity,22,0.463,0.55,1,GO:0019201,MF,,4144
ribonucleoprotein complex assembly,172,0.487,0.55,1,GO:0022618,BP,,4145
positive regulation of interleukin-8 production,35,0.471,0.551,1,GO:0032757,BP,,4146
JNK cascade,167,0.513,0.551,1,GO:0007254,BP,,4147
positive regulation of lyase activity,53,0.476,0.551,1,GO:0051349,BP,,4148
MAP kinase tyrosine/serine/threonine phosphatase activity,12,0.55,0.551,1,GO:0017017,MF,,4149
kinase regulator activity,184,0.487,0.551,1,GO:0019207,MF,,4150
negative regulation of mast cell activation,10,0.446,0.551,1,GO:0033004,BP,,4151
poly(U) RNA binding,16,0.543,0.551,1,GO:0008266,MF,,4152
mitogen-activated protein kinase kinase kinase binding,14,0.454,0.551,1,GO:0031435,MF,,4153
response to copper ion,21,0.462,0.552,1,GO:0046688,BP,,4154
microtubule anchoring,18,0.54,0.552,1,GO:0034453,BP,,4155
serine phosphorylation of STAT protein,12,0.451,0.553,1,GO:0042501,BP,,4156
regulation of integrin-mediated signaling pathway,12,0.451,0.553,1,GO:2001044,BP,,4157
platelet activation,140,0.515,0.553,1,GO:0030168,BP,,4158
negative regulation of organ growth,20,0.538,0.553,1,GO:0046621,BP,,4159
interferon-gamma production,76,0.48,0.553,1,GO:0032609,BP,,4160
zinc II ion transmembrane transport,19,0.461,0.554,1,GO:0071577,BP,,4161
L-amino acid transmembrane transporter activity,46,0.475,0.554,1,GO:0015179,MF,,4162
positive regulation of T cell activation,170,0.487,0.554,1,GO:0050870,BP,,4163
histone H4-K5 acetylation,15,0.544,0.554,1,"GO:0043981,GO:0043982",BP,histone H4-K8 acetylation,4164
negative regulation of protein polymerization,54,0.477,0.555,1,GO:0032272,BP,,4165
modification by symbiont of host morphology or physiology,35,0.529,0.555,1,GO:0044003,BP,,4166
positive regulation of translation,90,0.482,0.555,1,GO:0045727,BP,,4167
actin filament polymerization,136,0.485,0.555,1,GO:0030041,BP,,4168
sterol transporter activity,20,0.538,0.555,1,GO:0015248,MF,,4169
negative regulation of dendrite morphogenesis,14,0.546,0.555,1,GO:0050774,BP,,4170
cranial nerve morphogenesis,23,0.536,0.555,1,GO:0021602,BP,,4171
G-protein beta/gamma-subunit complex binding,15,0.544,0.555,1,GO:0031683,MF,,4172
negative regulation of cardiac muscle tissue growth,13,0.453,0.555,1,"GO:0055022,GO:0061117",BP,negative regulation of heart growth,4173
negative regulation of leukocyte cell-cell adhesion,81,0.519,0.556,1,GO:1903038,BP,,4174
"retrograde transport, endosome to Golgi",64,0.521,0.556,1,GO:0042147,BP,,4175
fatty acid transmembrane transport,16,0.457,0.556,1,GO:1902001,BP,,4176
axoneme,85,0.481,0.556,1,"GO:0005930,GO:0097014",CC,ciliary plasm,4177
neuron projection regeneration,47,0.525,0.556,1,GO:0031102,BP,,4178
"retrograde protein transport, ER to cytosol",24,0.535,0.556,1,"GO:0030970,GO:1903513",BP,endoplasmic reticulum to cytosol transport,4179
ATPase complex,18,0.54,0.556,1,GO:1904949,CC,,4180
hippocampus development,74,0.52,0.556,1,GO:0021766,BP,,4181
adult walking behavior,26,0.467,0.557,1,GO:0007628,BP,,4182
oxalate transport,10,0.554,0.557,1,"GO:0019532,GO:1902358,GO:0019531",BP,"sulfate transmembrane transport,oxalate transmembrane transporter activity",4183
detection of mechanical stimulus involved in sensory perception,23,0.535,0.557,1,GO:0050974,BP,,4184
"synaptic transmission, glutamatergic",67,0.479,0.557,1,GO:0035249,BP,,4185
regulation of mitochondrial depolarization,19,0.461,0.557,1,GO:0051900,BP,,4186
GABA-A receptor activity,15,0.456,0.558,1,GO:0004890,MF,,4187
regulation of lipid transport,76,0.519,0.558,1,GO:0032368,BP,,4188
positive regulation of cytoskeleton organization,170,0.487,0.558,1,GO:0051495,BP,,4189
"regulation of synaptic transmission, GABAergic",29,0.531,0.559,1,GO:0032228,BP,,4190
gastric acid secretion,14,0.455,0.559,1,GO:0001696,BP,,4191
pyrimidine-containing compound transmembrane transport,10,0.553,0.559,1,GO:0072531,BP,,4192
positive T cell selection,20,0.462,0.56,1,GO:0043368,BP,,4193
metanephric tubule development,20,0.538,0.56,1,GO:0072170,BP,,4194
polypeptide N-acetylgalactosaminyltransferase activity,19,0.461,0.56,1,GO:0004653,MF,,4195
regulation of renal system process,31,0.53,0.561,1,GO:0098801,BP,,4196
phosphatidylinositol bisphosphate phosphatase activity,25,0.534,0.561,1,GO:0034593,MF,,4197
RNA stem-loop binding,10,0.447,0.561,1,GO:0035613,MF,,4198
tau protein binding,10,0.447,0.562,1,GO:0048156,MF,,4199
"negative regulation of mRNA splicing, via spliceosome",16,0.542,0.562,1,GO:0048025,BP,,4200
regulation of execution phase of apoptosis,17,0.541,0.562,1,GO:1900117,BP,,4201
fatty acid biosynthetic process,104,0.516,0.562,1,GO:0006633,BP,,4202
clathrin-coated vesicle,164,0.513,0.562,1,GO:0030136,CC,,4203
regulation of natural killer cell activation,20,0.537,0.562,1,GO:0032814,BP,,4204
regulation of digestive system process,28,0.468,0.562,1,GO:0044058,BP,,4205
forebrain neuron differentiation,53,0.477,0.563,1,GO:0021879,BP,,4206
interleukin-1 receptor binding,14,0.545,0.563,1,GO:0005149,MF,,4207
mononuclear cell proliferation,200,0.512,0.563,1,GO:0032943,BP,,4208
positive regulation of protein polymerization,98,0.483,0.563,1,GO:0032273,BP,,4209
negative regulation of regulated secretory pathway,20,0.537,0.563,1,GO:1903306,BP,,4210
microtubule bundle formation,68,0.48,0.564,1,GO:0001578,BP,,4211
microtubule plus-end,15,0.543,0.564,1,GO:0035371,CC,,4212
positive regulation of catenin import into nucleus,11,0.55,0.564,1,GO:0035413,BP,,4213
positive regulation of leukocyte cell-cell adhesion,178,0.487,0.564,1,GO:1903039,BP,,4214
positive regulation of cell morphogenesis involved in differentiation,123,0.515,0.564,1,GO:0010770,BP,,4215
positive regulation of glycogen metabolic process,14,0.544,0.565,1,GO:0070875,BP,,4216
positive regulation of chromatin organization,79,0.519,0.565,1,GO:1905269,BP,,4217
smooth muscle cell apoptotic process,13,0.454,0.565,1,"GO:0034390,GO:0034391",BP,regulation of smooth muscle cell apoptotic process,4218
regulation of centrosome cycle,47,0.524,0.565,1,GO:0046605,BP,,4219
rRNA methylation,19,0.538,0.565,1,GO:0031167,BP,,4220
SAGA-type complex,26,0.467,0.565,1,GO:0070461,CC,,4221
genitalia morphogenesis,10,0.553,0.565,1,GO:0035112,BP,,4222
chaperone-mediated protein complex assembly,18,0.461,0.565,1,GO:0051131,BP,,4223
regulation of cytokine production involved in inflammatory response,18,0.539,0.566,1,GO:1900015,BP,,4224
5'-3' exonuclease activity,12,0.548,0.566,1,GO:0008409,MF,,4225
cellular response to misfolded protein,20,0.537,0.566,1,GO:0071218,BP,,4226
cytoplasmic translational initiation,21,0.536,0.567,1,GO:0002183,BP,,4227
U1 snRNP,17,0.54,0.567,1,GO:0005685,CC,,4228
negative regulation of lipid metabolic process,61,0.521,0.567,1,GO:0045833,BP,,4229
Golgi organization,88,0.518,0.567,1,GO:0007030,BP,,4230
mRNA modification,12,0.548,0.567,1,GO:0016556,BP,,4231
maintenance of cell polarity,16,0.541,0.568,1,GO:0030011,BP,,4232
regulation of ERBB signaling pathway,85,0.518,0.568,1,GO:1901184,BP,,4233
actin cytoskeleton reorganization,79,0.481,0.568,1,GO:0031532,BP,,4234
phosphatidylinositol 3-kinase binding,30,0.53,0.568,1,GO:0043548,MF,,4235
RNA polymerase complex,107,0.484,0.568,1,GO:0030880,CC,,4236
beta-amyloid formation,14,0.544,0.568,1,GO:0034205,BP,,4237
negative regulation of adenylate cyclase activity,20,0.463,0.569,1,GO:0007194,BP,,4238
monovalent cation:proton antiporter activity,13,0.454,0.569,1,GO:0005451,MF,,4239
regulation of muscle system process,186,0.488,0.569,1,GO:0090257,BP,,4240
platelet dense granule,16,0.541,0.569,1,GO:0042827,CC,,4241
"4 iron, 4 sulfur cluster binding",35,0.528,0.57,1,GO:0051539,MF,,4242
negative regulation of DNA binding,45,0.525,0.57,1,GO:0043392,BP,,4243
positive regulation of endothelial cell chemotaxis,12,0.453,0.57,1,GO:2001028,BP,,4244
clathrin-coated pit,67,0.52,0.57,1,GO:0005905,CC,,4245
positive regulation of lipid storage,20,0.463,0.57,1,GO:0010884,BP,,4246
regulation of plasminogen activation,10,0.448,0.57,1,GO:0010755,BP,,4247
regulation of microtubule polymerization,30,0.53,0.57,1,GO:0031113,BP,,4248
positive regulation of phosphatase activity,26,0.468,0.57,1,GO:0010922,BP,,4249
cyclin-dependent protein serine/threonine kinase inhibitor activity,11,0.451,0.571,1,GO:0004861,MF,,4250
histone mRNA metabolic process,20,0.463,0.571,1,GO:0008334,BP,,4251
S-adenosylmethionine-dependent methyltransferase activity,127,0.515,0.571,1,GO:0008757,MF,,4252
negative regulation of DNA repair,13,0.545,0.571,1,GO:0045738,BP,,4253
condensed chromosome outer kinetochore,10,0.552,0.571,1,GO:0000940,CC,,4254
grooming behavior,16,0.541,0.571,1,GO:0007625,BP,,4255
endoplasmic reticulum-Golgi intermediate compartment membrane,52,0.477,0.572,1,GO:0033116,CC,,4256
polyol metabolic process,93,0.517,0.572,1,GO:0019751,BP,,4257
"oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor",10,0.448,0.572,1,GO:0016671,MF,,4258
smooth muscle cell differentiation,46,0.524,0.572,1,GO:0051145,BP,,4259
positive regulation of nuclease activity,14,0.544,0.572,1,GO:0032075,BP,,4260
scavenger receptor activity,34,0.472,0.572,1,GO:0005044,MF,,4261
regulation of nucleobase-containing compound transport,11,0.549,0.572,1,GO:0032239,BP,,4262
nucleoside catabolic process,26,0.468,0.572,1,GO:0009164,BP,,4263
negative regulation of gluconeogenesis,11,0.549,0.573,1,GO:0045721,BP,,4264
cerebellum morphogenesis,34,0.528,0.573,1,GO:0021587,BP,,4265
regulation of cAMP-dependent protein kinase activity,14,0.456,0.573,1,GO:2000479,BP,,4266
SMAD protein complex assembly,13,0.455,0.573,1,GO:0007183,BP,,4267
syntaxin-1 binding,19,0.537,0.573,1,GO:0017075,MF,,4268
regulation of response to interferon-gamma,20,0.536,0.574,1,GO:0060330,BP,,4269
regulation of synaptic vesicle exocytosis,27,0.469,0.574,1,GO:2000300,BP,,4270
negative regulation of cellular carbohydrate metabolic process,32,0.471,0.574,1,GO:0010677,BP,,4271
regulation of tyrosine phosphorylation of Stat1 protein,12,0.547,0.575,1,GO:0042510,BP,,4272
regulation of interferon-gamma-mediated signaling pathway,19,0.537,0.575,1,GO:0060334,BP,,4273
H4 histone acetyltransferase activity,15,0.542,0.575,1,GO:0010485,MF,,4274
regulation of toll-like receptor signaling pathway,42,0.525,0.575,1,GO:0034121,BP,,4275
phosphatidylinositol bisphosphate binding,73,0.481,0.575,1,GO:1902936,MF,,4276
post-translational protein modification,83,0.482,0.575,1,GO:0043687,BP,,4277
cilium movement involved in cell motility,17,0.461,0.576,1,GO:0060294,BP,,4278
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,13,0.455,0.576,1,GO:2001241,BP,,4279
megakaryocyte differentiation,33,0.528,0.576,1,GO:0030219,BP,,4280
regulation of acyl-CoA biosynthetic process,13,0.455,0.576,1,GO:0050812,BP,,4281
reverse cholesterol transport,12,0.547,0.576,1,GO:0043691,BP,,4282
vasoconstriction,66,0.48,0.577,1,GO:0042310,BP,,4283
fear response,31,0.471,0.577,1,GO:0042596,BP,,4284
pancreatic juice secretion,11,0.549,0.577,1,GO:0030157,BP,,4285
phosphatidylserine binding,36,0.473,0.577,1,GO:0001786,MF,,4286
organophosphate ester transport,70,0.519,0.577,1,GO:0015748,BP,,4287
"complement activation, classical pathway",28,0.47,0.577,1,GO:0006958,BP,,4288
protein-cysteine S-palmitoyltransferase activity,22,0.534,0.577,1,"GO:0019706,GO:0019707",MF,protein-cysteine S-acyltransferase activity,4289
regulation of cell proliferation involved in kidney development,10,0.551,0.577,1,GO:1901722,BP,,4290
ubiquitin binding,93,0.517,0.577,1,GO:0043130,MF,,4291
epithelial structure maintenance,18,0.538,0.578,1,GO:0010669,BP,,4292
myeloid cell development,48,0.523,0.578,1,GO:0061515,BP,,4293
"establishment of mitochondrion localization, microtubule-mediated",16,0.54,0.578,1,"GO:0034643,GO:0047497",BP,mitochondrion transport along microtubule,4294
positive regulation of natural killer cell activation,13,0.545,0.579,1,GO:0032816,BP,,4295
bone growth,21,0.465,0.579,1,GO:0098868,BP,,4296
regulation of cell projection size,11,0.452,0.579,1,GO:0032536,BP,,4297
regulation of transcription involved in cell fate commitment,14,0.543,0.579,1,GO:0060850,BP,,4298
protein transport along microtubule,47,0.523,0.58,1,"GO:0098840,GO:0099118",BP,microtubule-based protein transport,4299
carbon-oxygen lyase activity,59,0.479,0.58,1,GO:0016835,MF,,4300
embryonic body morphogenesis,10,0.551,0.58,1,GO:0010172,BP,,4301
synaptonemal complex organization,17,0.461,0.58,1,GO:0070193,BP,,4302
sodium ion import,13,0.456,0.58,1,GO:0097369,BP,,4303
regulation of tyrosine phosphorylation of Stat3 protein,31,0.529,0.58,1,GO:0042516,BP,,4304
Z disc,107,0.515,0.581,1,GO:0030018,CC,,4305
glyceraldehyde-3-phosphate metabolic process,20,0.464,0.581,1,GO:0019682,BP,,4306
nucleotidase activity,12,0.454,0.581,1,GO:0008252,MF,,4307
positive regulation of calcium ion transmembrane transport,49,0.477,0.582,1,GO:1904427,BP,,4308
positive regulation of myeloid leukocyte cytokine production involved in immune response,11,0.452,0.582,1,GO:0061081,BP,,4309
negative regulation of cell motility,198,0.511,0.582,1,GO:2000146,BP,,4310
G-protein activated inward rectifier potassium channel activity,10,0.45,0.582,1,GO:0015467,MF,,4311
clathrin coat,46,0.477,0.582,1,GO:0030118,CC,,4312
ER overload response,11,0.452,0.583,1,GO:0006983,BP,,4313
retinoic acid binding,12,0.454,0.583,1,GO:0001972,MF,,4314
ventral spinal cord development,34,0.527,0.583,1,GO:0021517,BP,,4315
regulation of membrane depolarization,40,0.475,0.583,1,GO:0003254,BP,,4316
autophagosome organization,69,0.481,0.583,1,GO:1905037,BP,,4317
regulation of T cell receptor signaling pathway,32,0.472,0.583,1,GO:0050856,BP,,4318
phospholipase A2 activity,25,0.468,0.584,1,GO:0004623,MF,,4319
protein kinase B binding,11,0.452,0.584,1,GO:0043422,MF,,4320
central nervous system neuron axonogenesis,27,0.53,0.584,1,GO:0021955,BP,,4321
condensed chromosome,169,0.512,0.584,1,GO:0000793,CC,,4322
positive regulation of macrophage derived foam cell differentiation,11,0.452,0.584,1,GO:0010744,BP,,4323
nucleoside phosphate catabolic process,66,0.481,0.584,1,GO:1901292,BP,,4324
positive regulation of cofactor metabolic process,12,0.546,0.585,1,"GO:0051194,GO:0051197",BP,positive regulation of coenzyme metabolic process,4325
guanylate kinase activity,12,0.454,0.585,1,GO:0004385,MF,,4326
translation elongation factor activity,14,0.542,0.585,1,GO:0003746,MF,,4327
"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor",18,0.463,0.585,1,GO:0016646,MF,,4328
negative regulation of signal transduction in absence of ligand,27,0.53,0.585,1,"GO:1901099,GO:2001240",BP,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,4329
regulation of heat generation,11,0.547,0.586,1,GO:0031650,BP,,4330
lymphoid progenitor cell differentiation,16,0.539,0.586,1,GO:0002320,BP,,4331
regulation of response to extracellular stimulus,20,0.465,0.586,1,"GO:0032104,GO:0032107",BP,regulation of response to nutrient levels,4332
mesenchymal cell development,56,0.521,0.586,1,GO:0014031,BP,,4333
intermediate filament organization,18,0.463,0.586,1,GO:0045109,BP,,4334
regulation of neurotransmitter transport,61,0.48,0.587,1,GO:0051588,BP,,4335
positive regulation of epithelial cell migration,100,0.516,0.588,1,GO:0010634,BP,,4336
modulation by symbiont of host cellular process,20,0.535,0.588,1,GO:0044068,BP,,4337
immunoglobulin production involved in immunoglobulin mediated immune response,35,0.526,0.588,1,GO:0002381,BP,,4338
cytoplasmic dynein complex,22,0.533,0.588,1,GO:0005868,CC,,4339
intraciliary transport,46,0.523,0.588,1,GO:0042073,BP,,4340
regulation of sodium ion transport,78,0.482,0.588,1,GO:0002028,BP,,4341
regulation of viral life cycle,151,0.513,0.588,1,GO:1903900,BP,,4342
negative regulation of necrotic cell death,12,0.545,0.589,1,GO:0060547,BP,,4343
nucleosome disassembly,15,0.54,0.589,1,GO:0006337,BP,,4344
glycosaminoglycan catabolic process,52,0.478,0.589,1,GO:0006027,BP,,4345
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,38,0.525,0.589,1,GO:0007157,BP,,4346
fibroblast proliferation,77,0.482,0.589,1,GO:0048144,BP,,4347
cell adhesion mediated by integrin,50,0.522,0.589,1,GO:0033627,BP,,4348
mitochondrial DNA replication,12,0.455,0.589,1,GO:0006264,BP,,4349
zinc II ion transport,22,0.467,0.589,1,GO:0006829,BP,,4350
kinetochore organization,15,0.46,0.59,1,GO:0051383,BP,,4351
negative regulation of T cell proliferation,45,0.523,0.59,1,GO:0042130,BP,,4352
regulation of vascular endothelial growth factor signaling pathway,10,0.451,0.591,1,"GO:1900746,GO:1902547",BP,regulation of cellular response to vascular endothelial growth factor stimulus,4353
forebrain cell migration,58,0.52,0.591,1,GO:0021885,BP,,4354
developmental pigmentation,38,0.475,0.591,1,GO:0048066,BP,,4355
positive regulation of myoblast differentiation,17,0.538,0.591,1,GO:0045663,BP,,4356
regulation of muscle organ development,106,0.515,0.591,1,GO:0048634,BP,,4357
stereocilium bundle,41,0.524,0.591,1,GO:0032421,CC,,4358
cardiac muscle tissue growth,58,0.52,0.591,1,GO:0055017,BP,,4359
negative regulation of muscle cell apoptotic process,25,0.531,0.593,1,GO:0010656,BP,,4360
lymphocyte proliferation,198,0.511,0.593,1,GO:0046651,BP,,4361
epithelial cilium movement,19,0.465,0.593,1,GO:0003351,BP,,4362
regulation of systemic arterial blood pressure by hormone,27,0.53,0.593,1,GO:0001990,BP,,4363
cell-cell recognition,47,0.477,0.594,1,GO:0009988,BP,,4364
positive regulation of circadian rhythm,15,0.54,0.594,1,GO:0042753,BP,,4365
epithelial cell-cell adhesion,15,0.46,0.594,1,GO:0090136,BP,,4366
ncRNA transcription,94,0.484,0.594,1,GO:0098781,BP,,4367
cartilage condensation,15,0.46,0.595,1,GO:0001502,BP,,4368
cellular response to cadmium ion,29,0.471,0.595,1,GO:0071276,BP,,4369
DNA polymerase binding,12,0.544,0.595,1,GO:0070182,MF,,4370
endothelial cell chemotaxis,25,0.469,0.596,1,GO:0035767,BP,,4371
regulation of sphingolipid biosynthetic process,13,0.543,0.596,1,"GO:0090153,GO:1905038,GO:2000303",BP,"regulation of membrane lipid metabolic process,regulation of ceramide biosynthetic process",4372
nuclear inclusion body,10,0.548,0.596,1,GO:0042405,CC,,4373
nitric oxide biosynthetic process,54,0.479,0.596,1,GO:0006809,BP,,4374
regulation of syncytium formation by plasma membrane fusion,19,0.535,0.596,1,GO:0060142,BP,,4375
phosphatase regulator activity,78,0.517,0.596,1,GO:0019208,MF,,4376
regulation of exit from mitosis,17,0.463,0.597,1,GO:0007096,BP,,4377
regulation of phospholipase C activity,31,0.473,0.597,1,GO:1900274,BP,,4378
positive regulation of phospholipase activity,40,0.476,0.598,1,GO:0010518,BP,,4379
chromatin disassembly,17,0.537,0.598,1,GO:0031498,BP,,4380
Fc receptor mediated stimulatory signaling pathway,77,0.517,0.598,1,GO:0002431,BP,,4381
membrane repolarization during cardiac muscle cell action potential,20,0.466,0.598,1,GO:0086013,BP,,4382
Notch signaling pathway,145,0.513,0.598,1,GO:0007219,BP,,4383
branching involved in mammary gland duct morphogenesis,22,0.468,0.599,1,GO:0060444,BP,,4384
collagen catabolic process,55,0.521,0.599,1,GO:0030574,BP,,4385
regulation of B cell apoptotic process,14,0.541,0.599,1,GO:0002902,BP,,4386
protein autoubiquitination,47,0.522,0.599,1,GO:0051865,BP,,4387
olfactory bulb development,31,0.473,0.599,1,GO:0021772,BP,,4388
pro-B cell differentiation,10,0.548,0.599,1,GO:0002328,BP,,4389
negative regulation of protein complex assembly,103,0.485,0.6,1,GO:0031333,BP,,4390
modulation by host of viral process,20,0.534,0.6,1,GO:0044788,BP,,4391
regulation of neural precursor cell proliferation,70,0.518,0.6,1,GO:2000177,BP,,4392
protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,28,0.471,0.6,1,GO:0001844,BP,,4393
regulation of intracellular pH,84,0.483,0.6,1,GO:0051453,BP,,4394
folic acid metabolic process,18,0.464,0.6,1,GO:0046655,BP,,4395
U6 snRNA binding,10,0.452,0.6,1,GO:0017070,MF,,4396
"regulation of circadian sleep/wake cycle, sleep",16,0.538,0.6,1,GO:0045187,BP,,4397
brush border,78,0.517,0.601,1,GO:0005903,CC,,4398
anion homeostasis,33,0.526,0.601,1,GO:0055081,BP,,4399
retinal binding,12,0.456,0.601,1,GO:0016918,MF,,4400
"RNA phosphodiester bond hydrolysis, endonucleolytic",51,0.479,0.601,1,GO:0090502,BP,,4401
collecting duct development,12,0.544,0.601,1,GO:0072044,BP,,4402
regulation of cytoplasmic transport,19,0.465,0.602,1,GO:1903649,BP,,4403
purine ribonucleoside metabolic process,64,0.481,0.602,1,GO:0046128,BP,,4404
positive regulation of nitric oxide biosynthetic process,33,0.474,0.602,1,"GO:0045429,GO:1904407",BP,positive regulation of nitric oxide metabolic process,4405
unsaturated fatty acid biosynthetic process,35,0.525,0.602,1,GO:0006636,BP,,4406
chemokine receptor binding,37,0.525,0.602,1,GO:0042379,MF,,4407
response to cAMP,85,0.516,0.602,1,GO:0051591,BP,,4408
negative regulation of cell killing,14,0.54,0.602,1,GO:0031342,BP,,4409
modification of morphology or physiology of other organism,82,0.517,0.603,1,GO:0035821,BP,,4410
positive regulation of metanephros development,13,0.542,0.603,1,GO:0072216,BP,,4411
regulation of alpha-beta T cell differentiation,39,0.524,0.603,1,GO:0046637,BP,,4412
regulation of endocytosis,179,0.489,0.603,1,GO:0030100,BP,,4413
labyrinthine layer morphogenesis,16,0.538,0.603,1,GO:0060713,BP,,4414
suckling behavior,11,0.455,0.603,1,GO:0001967,BP,,4415
death receptor binding,15,0.539,0.603,1,GO:0005123,MF,,4416
organic hydroxy compound catabolic process,45,0.478,0.603,1,GO:1901616,BP,,4417
calcineurin-NFAT signaling cascade,22,0.468,0.604,1,"GO:0033173,GO:0097720",BP,calcineurin-mediated signaling,4418
"DNA-templated transcription, initiation",190,0.489,0.604,1,GO:0006352,BP,,4419
TORC2 complex,11,0.455,0.604,1,GO:0031932,CC,,4420
JAK-STAT cascade involved in growth hormone signaling pathway,12,0.543,0.604,1,GO:0060397,BP,,4421
regulation of cilium assembly,40,0.524,0.604,1,GO:1902017,BP,,4422
regulation of extent of cell growth,88,0.516,0.604,1,GO:0061387,BP,,4423
cellular response to metal ion,130,0.487,0.604,1,GO:0071248,BP,,4424
negative regulation of protein dephosphorylation,23,0.469,0.604,1,GO:0035308,BP,,4425
positive regulation of hemopoiesis,136,0.513,0.604,1,GO:1903708,BP,,4426
locomotory behavior,170,0.488,0.605,1,GO:0007626,BP,,4427
ovulation cycle,90,0.484,0.605,1,GO:0042698,BP,,4428
amino acid import,17,0.464,0.607,1,GO:0043090,BP,,4429
negative regulation of T cell apoptotic process,14,0.54,0.608,1,GO:0070233,BP,,4430
regulation of postsynaptic membrane potential,121,0.486,0.608,1,GO:0060078,BP,,4431
P-body,92,0.516,0.608,1,GO:0000932,CC,,4432
RNA-dependent DNA biosynthetic process,54,0.48,0.608,1,GO:0006278,BP,,4433
coreceptor activity,33,0.526,0.609,1,GO:0015026,MF,,4434
fucosylation,22,0.532,0.609,1,GO:0036065,BP,,4435
long-term memory,28,0.472,0.609,1,GO:0007616,BP,,4436
response to progesterone,36,0.525,0.609,1,GO:0032570,BP,,4437
neutral lipid metabolic process,95,0.485,0.609,1,GO:0006638,BP,,4438
tissue regeneration,49,0.521,0.61,1,GO:0042246,BP,,4439
meiosis I,78,0.517,0.61,1,GO:0007127,BP,,4440
hexose transmembrane transport,14,0.539,0.61,1,"GO:0035428,GO:1904659,GO:1905950,GO:0005355",BP,"glucose transmembrane transport,monosaccharide transmembrane transport,glucose transmembrane transporter activity",4441
phosphatidylinositol phosphate 4-phosphatase activity,10,0.453,0.61,1,GO:0034596,MF,,4442
"transferase activity, transferring acyl groups other than amino-acyl groups",183,0.511,0.61,1,GO:0016747,MF,,4443
regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,25,0.471,0.61,1,GO:0010880,BP,,4444
protein tyrosine kinase activator activity,16,0.463,0.61,1,GO:0030296,MF,,4445
negative regulation of stem cell differentiation,17,0.536,0.612,1,GO:2000737,BP,,4446
negative regulation of autophagy,55,0.48,0.612,1,GO:0010507,BP,,4447
CoA-ligase activity,10,0.546,0.612,1,GO:0016405,MF,,4448
ribosomal subunit export from nucleus,11,0.544,0.612,1,"GO:0000054,GO:0033750,GO:0033753",BP,"ribosome localization,establishment of ribosome localization",4449
response to water,13,0.541,0.613,1,GO:0009415,BP,,4450
retinal metabolic process,12,0.542,0.613,1,GO:0042574,BP,,4451
carbohydrate derivative transport,43,0.478,0.614,1,GO:1901264,BP,,4452
negative regulation of purine nucleotide metabolic process,55,0.48,0.614,1,GO:1900543,BP,,4453
negative regulation of sequence-specific DNA binding transcription factor activity,120,0.513,0.615,1,GO:0043433,BP,,4454
succinate metabolic process,11,0.456,0.615,1,GO:0006105,BP,,4455
regulation of leukocyte chemotaxis,74,0.483,0.615,1,GO:0002688,BP,,4456
endodermal cell fate commitment,14,0.461,0.615,1,GO:0001711,BP,,4457
immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,72,0.517,0.615,1,"GO:0002433,GO:0038096",BP,Fc-gamma receptor signaling pathway involved in phagocytosis,4458
lymphocyte chemotaxis,33,0.475,0.616,1,GO:0048247,BP,,4459
metalloendopeptidase activity,90,0.515,0.616,1,GO:0004222,MF,,4460
positive regulation of mitotic nuclear division,42,0.478,0.616,1,GO:0045840,BP,,4461
vesicle docking,60,0.481,0.616,1,GO:0048278,BP,,4462
somatic stem cell population maintenance,63,0.482,0.616,1,GO:0035019,BP,,4463
detection of temperature stimulus,18,0.466,0.616,1,GO:0016048,BP,,4464
cadherin binding involved in cell-cell adhesion,17,0.465,0.616,1,GO:0098641,MF,,4465
regulation of phospholipid biosynthetic process,12,0.542,0.617,1,GO:0071071,BP,,4466
regulation of filopodium assembly,39,0.477,0.617,1,GO:0051489,BP,,4467
brown fat cell differentiation,33,0.525,0.617,1,GO:0050873,BP,,4468
negative regulation of nucleocytoplasmic transport,65,0.482,0.617,1,GO:0046823,BP,,4469
regulation of lipid localization,100,0.514,0.617,1,GO:1905952,BP,,4470
response to salt,11,0.544,0.617,1,GO:1902074,BP,,4471
alditol metabolic process,16,0.464,0.617,1,GO:0019400,BP,,4472
ribosomal small subunit binding,11,0.543,0.617,1,GO:0043024,MF,,4473
regulation of developmental pigmentation,13,0.54,0.618,1,GO:0048070,BP,,4474
inflammatory cell apoptotic process,15,0.537,0.618,1,GO:0006925,BP,,4475
osteoclast development,15,0.463,0.618,1,GO:0036035,BP,,4476
"positive regulation of synaptic transmission, glutamatergic",19,0.533,0.618,1,GO:0051968,BP,,4477
growth cone,142,0.488,0.618,1,GO:0030426,CC,,4478
acute inflammatory response,100,0.486,0.619,1,GO:0002526,BP,,4479
forebrain morphogenesis,12,0.541,0.619,1,GO:0048853,BP,,4480
regulation of phospholipid metabolic process,54,0.48,0.62,1,GO:1903725,BP,,4481
Rac protein signal transduction,31,0.526,0.62,1,GO:0016601,BP,,4482
cellular hormone metabolic process,84,0.484,0.62,1,GO:0034754,BP,,4483
endocrine system development,102,0.514,0.62,1,GO:0035270,BP,,4484
negative regulation of lymphocyte activation,101,0.514,0.62,1,GO:0051250,BP,,4485
positive regulation of calcium ion transmembrane transporter activity,28,0.473,0.62,1,GO:1901021,BP,,4486
icosanoid transport,35,0.476,0.62,1,"GO:0071715,GO:1901571",BP,fatty acid derivative transport,4487
oogenesis,60,0.481,0.62,1,GO:0048477,BP,,4488
"endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters",27,0.472,0.621,1,GO:0016893,MF,,4489
response to prostaglandin E,21,0.469,0.621,1,GO:0034695,BP,,4490
ion channel binding,108,0.486,0.621,1,GO:0044325,MF,,4491
cellular response to arsenic-containing substance,12,0.541,0.621,1,GO:0071243,BP,,4492
"oxidoreductase activity, oxidizing metal ions",13,0.46,0.621,1,GO:0016722,MF,,4493
heat shock protein binding,86,0.515,0.621,1,GO:0031072,MF,,4494
long-chain fatty-acyl-CoA biosynthetic process,39,0.477,0.622,1,GO:0035338,BP,,4495
retinol binding,10,0.455,0.622,1,GO:0019841,MF,,4496
nuclear nucleosome,13,0.54,0.622,1,GO:0000788,CC,,4497
negative regulation of potassium ion transport,24,0.471,0.622,1,GO:0043267,BP,,4498
"nucleotide-excision repair, DNA gap filling",20,0.532,0.622,1,GO:0006297,BP,,4499
tumor necrosis factor production,87,0.515,0.623,1,GO:0032640,BP,,4500
regulation of neuron projection regeneration,25,0.472,0.623,1,GO:0070570,BP,,4501
calcium:cation antiporter activity,10,0.545,0.623,1,GO:0015368,MF,,4502
cartilage development involved in endochondral bone morphogenesis,20,0.468,0.623,1,GO:0060351,BP,,4503
high voltage-gated calcium channel activity,12,0.541,0.623,1,GO:0008331,MF,,4504
purine nucleobase metabolic process,17,0.466,0.623,1,GO:0006144,BP,,4505
"DNA-directed RNA polymerase II, holoenzyme",85,0.485,0.623,1,GO:0016591,CC,,4506
serine family amino acid biosynthetic process,15,0.537,0.623,1,GO:0009070,BP,,4507
intermediate filament-based process,35,0.476,0.623,1,"GO:0045103,GO:0045104",BP,intermediate filament cytoskeleton organization,4508
sodium channel activity,42,0.478,0.624,1,GO:0005272,MF,,4509
negative regulation of ATP metabolic process,19,0.467,0.624,1,GO:1903579,BP,,4510
negative regulation of insulin secretion,34,0.476,0.624,1,GO:0046676,BP,,4511
response to glucose,151,0.488,0.624,1,GO:0009749,BP,,4512
response to interleukin-4,30,0.526,0.624,1,GO:0070670,BP,,4513
positive regulation of exosomal secretion,13,0.539,0.624,1,GO:1903543,BP,,4514
pyramidal neuron differentiation,10,0.545,0.625,1,GO:0021859,BP,,4515
vascular endothelial growth factor production,30,0.474,0.625,1,GO:0010573,BP,,4516
sequestering of metal ion,106,0.486,0.625,1,GO:0051238,BP,,4517
regulation of telomere capping,20,0.532,0.625,1,GO:1904353,BP,,4518
synaptic vesicle priming,13,0.461,0.625,1,GO:0016082,BP,,4519
glycerol metabolic process,13,0.461,0.625,1,GO:0006071,BP,,4520
"regulation of development, heterochronic",11,0.542,0.626,1,GO:0040034,BP,,4521
negative regulation of anion transport,21,0.531,0.626,1,GO:1903792,BP,,4522
cell differentiation in spinal cord,37,0.523,0.626,1,GO:0021515,BP,,4523
temperature homeostasis,32,0.525,0.626,1,GO:0001659,BP,,4524
nucleobase-containing compound transmembrane transporter activity,30,0.474,0.626,1,GO:0015932,MF,,4525
meiotic nuclear division,136,0.512,0.626,1,GO:0007126,BP,,4526
positive regulation of T cell receptor signaling pathway,10,0.456,0.627,1,GO:0050862,BP,,4527
regulation of glucose metabolic process,84,0.515,0.627,1,GO:0010906,BP,,4528
positive regulation of cell-matrix adhesion,43,0.479,0.628,1,GO:0001954,BP,,4529
receptor internalization,78,0.484,0.629,1,GO:0031623,BP,,4530
mannosylation,28,0.474,0.629,1,GO:0097502,BP,,4531
short-term memory,10,0.544,0.629,1,GO:0007614,BP,,4532
protein kinase A signaling,27,0.473,0.629,1,GO:0010737,BP,,4533
chondroitin sulfate metabolic process,37,0.523,0.629,1,GO:0030204,BP,,4534
regulation of histone H4 acetylation,11,0.458,0.63,1,GO:0090239,BP,,4535
early endosome to late endosome transport,33,0.476,0.63,1,GO:0045022,BP,,4536
hyaluronan metabolic process,32,0.475,0.63,1,GO:0030212,BP,,4537
blastocyst formation,25,0.528,0.63,1,GO:0001825,BP,,4538
response to food,34,0.476,0.631,1,GO:0032094,BP,,4539
sperm midpiece,11,0.458,0.631,1,GO:0097225,CC,,4540
"regulation of CD4-positive, alpha-beta T cell differentiation",25,0.528,0.631,1,GO:0043370,BP,,4541
mammary gland morphogenesis,42,0.521,0.631,1,GO:0060443,BP,,4542
epiboly,24,0.528,0.631,1,GO:0090504,BP,,4543
lens morphogenesis in camera-type eye,16,0.535,0.632,1,GO:0002089,BP,,4544
myeloid cell apoptotic process,23,0.471,0.632,1,GO:0033028,BP,,4545
receptor biosynthetic process,19,0.532,0.632,1,GO:0032800,BP,,4546
chondroitin sulfate biosynthetic process,23,0.471,0.632,1,GO:0030206,BP,,4547
cardiac muscle cell apoptotic process,23,0.529,0.633,1,GO:0010659,BP,,4548
regulation of ATPase activity,56,0.482,0.633,1,GO:0043462,BP,,4549
cyclooxygenase pathway,11,0.458,0.633,1,GO:0019371,BP,,4550
negative regulation of muscle contraction,21,0.47,0.633,1,GO:0045932,BP,,4551
cytokine production involved in inflammatory response,20,0.531,0.633,1,GO:0002534,BP,,4552
mesenchymal cell apoptotic process,10,0.544,0.634,1,GO:0097152,BP,,4553
mRNA cleavage and polyadenylation specificity factor complex,11,0.541,0.634,1,GO:0005847,CC,,4554
chemokine production,56,0.482,0.635,1,GO:0032602,BP,,4555
positive regulation of blood vessel diameter,50,0.481,0.635,1,GO:0097755,BP,,4556
neurotrophin signaling pathway,31,0.525,0.635,1,GO:0038179,BP,,4557
odorant binding,35,0.523,0.636,1,GO:0005549,MF,,4558
positive regulation of protein maturation,20,0.469,0.636,1,GO:1903319,BP,,4559
decidualization,19,0.531,0.636,1,GO:0046697,BP,,4560
striated muscle cell apoptotic process,25,0.527,0.636,1,GO:0010658,BP,,4561
protein monoubiquitination,52,0.519,0.636,1,GO:0006513,BP,,4562
dermatan sulfate metabolic process,12,0.539,0.636,1,GO:0030205,BP,,4563
positive regulation of adherens junction organization,23,0.528,0.636,1,GO:1903393,BP,,4564
regulation of protein polymerization,154,0.489,0.636,1,GO:0032271,BP,,4565
negative regulation of fibroblast growth factor receptor signaling pathway,10,0.457,0.637,1,GO:0040037,BP,,4566
morphogenesis of an epithelial fold,21,0.53,0.637,1,GO:0060571,BP,,4567
chemokine binding,16,0.534,0.637,1,GO:0019956,MF,,4568
signal transduction involved in regulation of gene expression,14,0.464,0.637,1,GO:0023019,BP,,4569
connexin complex,16,0.534,0.637,1,GO:0005922,CC,,4570
semi-lunar valve development,12,0.539,0.637,1,GO:1905314,BP,,4571
regulation of peptide hormone secretion,162,0.489,0.637,1,GO:0090276,BP,,4572
long term synaptic depression,22,0.529,0.638,1,GO:0060292,BP,,4573
lens fiber cell differentiation,24,0.472,0.638,1,GO:0070306,BP,,4574
phosphoprotein binding,71,0.516,0.638,1,GO:0051219,MF,,4575
heparan sulfate proteoglycan biosynthetic process,24,0.472,0.638,1,GO:0015012,BP,,4576
long-chain fatty acid-CoA ligase activity,13,0.538,0.638,1,GO:0004467,MF,,4577
alcohol catabolic process,35,0.523,0.638,1,GO:0046164,BP,,4578
estrous cycle,13,0.462,0.639,1,GO:0044849,BP,,4579
protein kinase A regulatory subunit binding,17,0.533,0.639,1,GO:0034237,MF,,4580
telomeric loop disassembly,10,0.457,0.639,1,GO:0090657,BP,,4581
protein-lipid complex assembly,16,0.534,0.639,1,GO:0065005,BP,,4582
negative regulation of skeletal muscle tissue development,11,0.459,0.639,1,GO:0048642,BP,,4583
positive regulation of neural precursor cell proliferation,41,0.521,0.64,1,GO:2000179,BP,,4584
germ cell development,183,0.51,0.64,1,GO:0007281,BP,,4585
phospholipase binding,15,0.465,0.64,1,GO:0043274,MF,,4586
cellular response to lipopolysaccharide,121,0.488,0.64,1,GO:0071222,BP,,4587
immunological synapse,31,0.476,0.64,1,GO:0001772,CC,,4588
positive regulation of response to cytokine stimulus,29,0.525,0.64,1,GO:0060760,BP,,4589
nuclear pore outer ring,10,0.543,0.641,1,GO:0031080,CC,,4590
neuron apoptotic process,200,0.49,0.641,1,GO:0051402,BP,,4591
excretion,55,0.482,0.641,1,GO:0007588,BP,,4592
dermatan sulfate proteoglycan metabolic process,14,0.536,0.641,1,GO:0050655,BP,,4593
response to magnesium ion,16,0.466,0.641,1,GO:0032026,BP,,4594
innervation,24,0.473,0.641,1,GO:0060384,BP,,4595
regulation of striated muscle tissue development,105,0.513,0.641,1,GO:0016202,BP,,4596
keratinocyte proliferation,36,0.522,0.641,1,GO:0043616,BP,,4597
negative regulation of cytokine-mediated signaling pathway,30,0.525,0.642,1,GO:0001960,BP,,4598
CENP-A containing nucleosome assembly,26,0.526,0.642,1,"GO:0034080,GO:0061641",BP,CENP-A containing chromatin organization,4599
regulation of adenylate cyclase activity,63,0.483,0.642,1,GO:0045761,BP,,4600
neuron projection extension,135,0.488,0.642,1,GO:1990138,BP,,4601
regulation of NF-kappaB import into nucleus,39,0.522,0.642,1,"GO:0042345,GO:0042348",BP,NF-kappaB import into nucleus,4602
sperm motility,63,0.483,0.643,1,GO:0097722,BP,,4603
telomere capping,38,0.478,0.643,1,GO:0016233,BP,,4604
endoplasmic reticulum tubular network organization,12,0.461,0.643,1,GO:0071786,BP,,4605
regulation of fibroblast proliferation,76,0.485,0.644,1,GO:0048145,BP,,4606
regulation of receptor recycling,22,0.472,0.644,1,GO:0001919,BP,,4607
positive regulation of carbohydrate metabolic process,57,0.518,0.645,1,GO:0045913,BP,,4608
semaphorin receptor activity,11,0.54,0.645,1,GO:0017154,MF,,4609
positive regulation of osteoblast differentiation,53,0.518,0.645,1,GO:0045669,BP,,4610
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,69,0.484,0.645,1,GO:0043154,BP,,4611
telomere maintenance via telomerase,52,0.482,0.645,1,GO:0007004,BP,,4612
INO80-type complex,17,0.532,0.645,1,GO:0097346,CC,,4613
folic acid-containing compound biosynthetic process,11,0.46,0.645,1,GO:0009396,BP,,4614
protein K63-linked deubiquitination,26,0.526,0.645,1,GO:0070536,BP,,4615
glucocorticoid receptor signaling pathway,15,0.466,0.646,1,GO:0042921,BP,,4616
cholesterol metabolic process,103,0.487,0.646,1,GO:0008203,BP,,4617
chaperone-mediated autophagy,11,0.46,0.646,1,GO:0061684,BP,,4618
pyrimidine nucleoside catabolic process,18,0.469,0.646,1,GO:0046135,BP,,4619
ARF protein signal transduction,16,0.533,0.646,1,"GO:0032011,GO:0032012",BP,regulation of ARF protein signal transduction,4620
phosphatidylinositol phosphate 5-phosphatase activity,12,0.538,0.646,1,GO:0034595,MF,,4621
"phosphatidylinositol-3,5-bisphosphate binding",19,0.53,0.647,1,GO:0080025,MF,,4622
axon extension involved in axon guidance,21,0.471,0.647,1,"GO:0048846,GO:1902284",BP,neuron projection extension involved in neuron projection guidance,4623
regulation of osteoclast differentiation,49,0.519,0.647,1,GO:0045670,BP,,4624
regulation of intrinsic apoptotic signaling pathway by p53 class mediator,23,0.527,0.648,1,GO:1902253,BP,,4625
"protein localization to chromosome, telomeric region",23,0.473,0.648,1,GO:0070198,BP,,4626
lysine N-methyltransferase activity,52,0.518,0.649,1,GO:0016278,MF,,4627
chondroitin sulfate proteoglycan metabolic process,39,0.521,0.649,1,GO:0050654,BP,,4628
macromolecular complex remodeling,17,0.468,0.649,1,"GO:0034367,GO:0034368,GO:0034369",BP,"protein-lipid complex remodeling,plasma lipoprotein particle remodeling",4629
response to hexose,156,0.489,0.649,1,GO:0009746,BP,,4630
phospholipase activity,82,0.485,0.649,1,GO:0004620,MF,,4631
positive regulation of peptidase activity,136,0.511,0.649,1,GO:0010952,BP,,4632
induction of positive chemotaxis,11,0.54,0.649,1,GO:0050930,BP,,4633
heparan sulfate proteoglycan metabolic process,30,0.476,0.65,1,GO:0030201,BP,,4634
"positive regulation of DNA-templated transcription, initiation",21,0.471,0.65,1,GO:2000144,BP,,4635
response to cocaine,43,0.48,0.65,1,GO:0042220,BP,,4636
triglyceride metabolic process,82,0.485,0.65,1,GO:0006641,BP,,4637
protein localization to chromosome,60,0.517,0.65,1,GO:0034502,BP,,4638
histone H2A monoubiquitination,11,0.54,0.65,1,GO:0035518,BP,,4639
positive regulation of B cell activation,61,0.517,0.65,1,GO:0050871,BP,,4640
long-chain fatty-acyl-CoA metabolic process,43,0.48,0.65,1,GO:0035336,BP,,4641
metanephric tubule morphogenesis,10,0.541,0.65,1,GO:0072173,BP,,4642
transmembrane receptor protein tyrosine kinase activity,61,0.517,0.65,1,GO:0004714,MF,,4643
positive regulation of interleukin-1 secretion,21,0.471,0.65,1,GO:0050716,BP,,4644
venous blood vessel development,14,0.535,0.651,1,GO:0060841,BP,,4645
organophosphate catabolic process,109,0.513,0.651,1,GO:0046434,BP,,4646
regulation of anoikis,22,0.528,0.652,1,GO:2000209,BP,,4647
regulation of transmission of nerve impulse,11,0.539,0.652,1,GO:0051969,BP,,4648
cysteine-type endopeptidase regulator activity involved in apoptotic process,38,0.521,0.652,1,GO:0043028,MF,,4649
inositol phosphate-mediated signaling,31,0.477,0.652,1,GO:0048016,BP,,4650
neural crest cell development,52,0.518,0.653,1,GO:0014032,BP,,4651
cysteine metabolic process,12,0.462,0.653,1,GO:0006534,BP,,4652
nephron tubule formation,17,0.532,0.653,1,GO:0072079,BP,,4653
condensed chromosome kinetochore,86,0.486,0.653,1,GO:0000777,CC,,4654
solute:cation antiporter activity,32,0.523,0.653,1,GO:0015298,MF,,4655
sequestering of calcium ion,97,0.487,0.654,1,GO:0051208,BP,,4656
TORC1 signaling,24,0.474,0.654,1,GO:0038202,BP,,4657
positive regulation of sodium ion transmembrane transport,17,0.531,0.654,1,GO:1902307,BP,,4658
regulation of urine volume,18,0.53,0.654,1,GO:0035809,BP,,4659
heparan sulfate sulfotransferase activity,13,0.464,0.655,1,GO:0034483,MF,,4660
cardiac muscle cell contraction,54,0.518,0.655,1,GO:0086003,BP,,4661
negative regulation of peptidyl-lysine acetylation,17,0.531,0.656,1,GO:2000757,BP,,4662
negative regulation of response to DNA damage stimulus,51,0.518,0.656,1,GO:2001021,BP,,4663
positive regulation of skeletal muscle tissue development,21,0.528,0.656,1,GO:0048643,BP,,4664
protein localization to cell junction,10,0.541,0.656,1,GO:1902414,BP,,4665
bronchus development,10,0.459,0.656,1,GO:0060433,BP,,4666
regulation of interleukin-1 secretion,27,0.525,0.657,1,GO:0050704,BP,,4667
lipid storage,57,0.517,0.657,1,GO:0019915,BP,,4668
eye photoreceptor cell development,24,0.474,0.657,1,GO:0042462,BP,,4669
serotonin metabolic process,11,0.461,0.657,1,GO:0042428,BP,,4670
regulation of telomere maintenance via telomerase,39,0.479,0.658,1,GO:0032210,BP,,4671
amelogenesis,18,0.53,0.658,1,GO:0097186,BP,,4672
sperm-egg recognition,31,0.477,0.658,1,GO:0035036,BP,,4673
regulation of sulfur metabolic process,20,0.529,0.658,1,GO:0042762,BP,,4674
type B pancreatic cell development,19,0.529,0.659,1,GO:0003323,BP,,4675
endodermal cell differentiation,40,0.48,0.659,1,GO:0035987,BP,,4676
positive regulation of cell adhesion mediated by integrin,15,0.467,0.659,1,GO:0033630,BP,,4677
regulation of podosome assembly,12,0.463,0.659,1,GO:0071801,BP,,4678
receptor metabolic process,140,0.489,0.66,1,GO:0043112,BP,,4679
plasma lipoprotein particle clearance,25,0.525,0.66,1,GO:0034381,BP,,4680
site of polarized growth,146,0.489,0.66,1,GO:0030427,CC,,4681
co-SMAD binding,10,0.54,0.661,1,GO:0070410,MF,,4682
spindle microtubule,44,0.481,0.661,1,GO:0005876,CC,,4683
microtubule polymerization,52,0.518,0.661,1,GO:0046785,BP,,4684
negative regulation of reproductive process,38,0.521,0.661,1,GO:2000242,BP,,4685
low-density lipoprotein receptor particle metabolic process,11,0.462,0.662,1,GO:0032799,BP,,4686
regulation of potassium ion transmembrane transporter activity,40,0.52,0.662,1,GO:1901016,BP,,4687
cyclase activity,18,0.47,0.662,1,GO:0009975,MF,,4688
regulation of neutrophil migration,27,0.524,0.662,1,GO:1902622,BP,,4689
male sex determination,13,0.535,0.662,1,GO:0030238,BP,,4690
axoneme part,23,0.526,0.662,1,GO:0044447,CC,,4691
negative regulation of NF-kappaB transcription factor activity,61,0.484,0.662,1,GO:0032088,BP,,4692
protein heterotetramerization,24,0.526,0.662,1,GO:0051290,BP,,4693
positive chemotaxis,46,0.481,0.662,1,GO:0050918,BP,,4694
potassium channel regulator activity,41,0.48,0.662,1,GO:0015459,MF,,4695
solute:proton symporter activity,26,0.525,0.662,1,GO:0015295,MF,,4696
CCR chemokine receptor binding,21,0.472,0.662,1,GO:0048020,MF,,4697
NF-kappaB binding,26,0.525,0.662,1,GO:0051059,MF,,4698
GABA receptor binding,12,0.464,0.663,1,GO:0050811,MF,,4699
prepulse inhibition,13,0.465,0.664,1,GO:0060134,BP,,4700
myosin filament,16,0.469,0.664,1,GO:0032982,CC,,4701
structural constituent of muscle,40,0.48,0.665,1,GO:0008307,MF,,4702
tumor necrosis factor receptor superfamily binding,35,0.521,0.665,1,GO:0032813,MF,,4703
ERBB2 signaling pathway,36,0.521,0.665,1,GO:0038128,BP,,4704
negative regulation of intrinsic apoptotic signaling pathway,81,0.486,0.665,1,GO:2001243,BP,,4705
negative regulation of proteasomal protein catabolic process,27,0.524,0.665,1,GO:1901799,BP,,4706
regulation of coagulation,73,0.485,0.665,1,GO:0050818,BP,,4707
regulation of cell cycle checkpoint,31,0.478,0.665,1,GO:1901976,BP,,4708
"circadian sleep/wake cycle, sleep",20,0.472,0.666,1,GO:0050802,BP,,4709
negative regulation of nucleotide metabolic process,56,0.483,0.666,1,GO:0045980,BP,,4710
positive regulation of oligodendrocyte differentiation,13,0.535,0.666,1,GO:0048714,BP,,4711
regulation of natural killer cell differentiation,10,0.539,0.667,1,GO:0032823,BP,,4712
monovalent inorganic cation homeostasis,128,0.489,0.667,1,GO:0055067,BP,,4713
ATP-dependent helicase activity,89,0.513,0.667,1,"GO:0008026,GO:0070035",MF,purine NTP-dependent helicase activity,4714
optic nerve development,12,0.536,0.667,1,GO:0021554,BP,,4715
negative regulation of glycoprotein metabolic process,13,0.534,0.667,1,GO:1903019,BP,,4716
fibroblast migration,37,0.52,0.667,1,GO:0010761,BP,,4717
nucleotidyltransferase activity,110,0.512,0.668,1,GO:0016779,MF,,4718
ERAD pathway,82,0.514,0.668,1,GO:0036503,BP,,4719
protein stabilization,133,0.489,0.668,1,GO:0050821,BP,,4720
"chromosome, centromeric region",157,0.51,0.668,1,GO:0000775,CC,,4721
positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,34,0.479,0.669,1,GO:1901030,BP,,4722
cellular response to hepatocyte growth factor stimulus,11,0.463,0.669,1,GO:0035729,BP,,4723
regulation of hair cycle,24,0.525,0.669,1,GO:0042634,BP,,4724
positive regulation of DNA metabolic process,174,0.491,0.67,1,GO:0051054,BP,,4725
"phagocytosis, engulfment",29,0.477,0.67,1,GO:0006911,BP,,4726
protein kinase C-activating G-protein coupled receptor signaling pathway,26,0.476,0.67,1,GO:0007205,BP,,4727
negative regulation of telomere maintenance,26,0.524,0.67,1,GO:0032205,BP,,4728
negative regulation of behavior,10,0.461,0.671,1,GO:0048521,BP,,4729
regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,18,0.529,0.671,1,GO:0010881,BP,,4730
receptor localization to synapse,14,0.533,0.671,1,GO:0097120,BP,,4731
regulation of membrane permeability,68,0.515,0.672,1,GO:0090559,BP,,4732
positive regulation of meiotic cell cycle,10,0.461,0.672,1,GO:0051446,BP,,4733
spermatid differentiation,108,0.512,0.672,1,GO:0048515,BP,,4734
regulation of ER to Golgi vesicle-mediated transport,11,0.463,0.672,1,GO:0060628,BP,,4735
sodium-independent organic anion transport,20,0.473,0.672,1,GO:0043252,BP,,4736
uterus development,14,0.533,0.673,1,GO:0060065,BP,,4737
lipid homeostasis,89,0.513,0.673,1,GO:0055088,BP,,4738
positive regulation of chemokine production,37,0.48,0.673,1,GO:0032722,BP,,4739
T cell homeostasis,33,0.521,0.673,1,GO:0043029,BP,,4740
methyl-CpG binding,17,0.47,0.673,1,GO:0008327,MF,,4741
cellular response to unfolded protein,118,0.489,0.674,1,GO:0034620,BP,,4742
natural killer cell activation,43,0.519,0.674,1,GO:0030101,BP,,4743
multicellular organismal water homeostasis,49,0.517,0.674,1,GO:0050891,BP,,4744
barbed-end actin filament capping,15,0.531,0.674,1,GO:0051016,BP,,4745
"ligase activity, forming carbon-sulfur bonds",36,0.52,0.674,1,GO:0016877,MF,,4746
sensory perception of temperature stimulus,19,0.472,0.675,1,GO:0050951,BP,,4747
positive regulation of homeostatic process,176,0.491,0.675,1,GO:0032846,BP,,4748
macrolide binding,13,0.466,0.675,1,"GO:0005527,GO:0005528",MF,FK506 binding,4749
inner ear receptor cell development,37,0.52,0.675,1,GO:0060119,BP,,4750
myosin V binding,16,0.47,0.675,1,GO:0031489,MF,,4751
mucosal immune response,16,0.53,0.675,1,GO:0002385,BP,,4752
phosphatidylinositol acyl-chain remodeling,13,0.534,0.675,1,GO:0036149,BP,,4753
telomere maintenance via telomere lengthening,60,0.484,0.675,1,GO:0010833,BP,,4754
tyrosine phosphorylation of Stat3 protein,32,0.521,0.676,1,GO:0042503,BP,,4755
negative regulation of interleukin-1 beta production,10,0.462,0.676,1,GO:0032691,BP,,4756
mitochondrial outer membrane permeabilization,50,0.483,0.676,1,GO:0097345,BP,,4757
positive regulation of wound healing,36,0.52,0.676,1,GO:0090303,BP,,4758
regulation of relaxation of muscle,10,0.538,0.677,1,GO:1901077,BP,,4759
regulation of calcium ion transport into cytosol,77,0.486,0.677,1,GO:0010522,BP,,4760
deoxyribonucleotide biosynthetic process,11,0.536,0.677,1,GO:0009263,BP,,4761
trophectodermal cell differentiation,12,0.535,0.677,1,GO:0001829,BP,,4762
regulation of cellular response to oxidative stress,63,0.485,0.678,1,GO:1900407,BP,,4763
ER-associated misfolded protein catabolic process,11,0.464,0.678,1,GO:0071712,BP,,4764
long-term synaptic potentiation,54,0.516,0.678,1,GO:0060291,BP,,4765
negative regulation of JUN kinase activity,12,0.535,0.678,1,GO:0043508,BP,,4766
interleukin-1 secretion,32,0.521,0.678,1,GO:0050701,BP,,4767
sperm flagellum,61,0.485,0.678,1,"GO:0036126,GO:0097729",CC,9+2 motile cilium,4768
cluster of actin-based cell projections,113,0.511,0.678,1,GO:0098862,CC,,4769
cell death in response to hydrogen peroxide,24,0.476,0.678,1,GO:0036474,BP,,4770
response to iron ion,31,0.521,0.679,1,GO:0010039,BP,,4771
cellular response to interleukin-4,27,0.523,0.679,1,GO:0071353,BP,,4772
regulation of early endosome to late endosome transport,15,0.469,0.679,1,GO:2000641,BP,,4773
endoribonuclease complex,24,0.476,0.68,1,"GO:1902555,GO:1905348",CC,endonuclease complex,4774
regulation of water loss via skin,16,0.53,0.68,1,GO:0033561,BP,,4775
apoptotic cell clearance,31,0.521,0.68,1,GO:0043277,BP,,4776
error-prone translesion synthesis,19,0.527,0.681,1,GO:0042276,BP,,4777
cholesterol storage,14,0.468,0.681,1,GO:0010878,BP,,4778
regulation of lipopolysaccharide-mediated signaling pathway,15,0.531,0.681,1,GO:0031664,BP,,4779
organic cation transmembrane transporter activity,14,0.468,0.682,1,GO:0015101,MF,,4780
regulation of long-term synaptic potentiation,20,0.474,0.682,1,GO:1900271,BP,,4781
regulation of macrophage derived foam cell differentiation,23,0.525,0.682,1,GO:0010743,BP,,4782
pyrimidine-containing compound catabolic process,28,0.478,0.683,1,GO:0072529,BP,,4783
positive regulation of heart contraction,30,0.478,0.683,1,GO:0045823,BP,,4784
regulation of stress-activated MAPK cascade,174,0.509,0.683,1,GO:0032872,BP,,4785
homeostasis of number of cells within a tissue,27,0.523,0.683,1,GO:0048873,BP,,4786
protein N-linked glycosylation,59,0.515,0.683,1,GO:0006487,BP,,4787
asymmetric cell division,16,0.529,0.684,1,GO:0008356,BP,,4788
positive regulation of anion transport,35,0.48,0.684,1,GO:1903793,BP,,4789
regulation of type 2 immune response,19,0.527,0.684,1,GO:0002828,BP,,4790
cerebral cortex cell migration,42,0.518,0.684,1,GO:0021795,BP,,4791
bone cell development,29,0.522,0.684,1,GO:0098751,BP,,4792
liposaccharide metabolic process,95,0.488,0.684,1,GO:1903509,BP,,4793
positive regulation of mitotic cell cycle,113,0.489,0.684,1,GO:0045931,BP,,4794
regulation of neurotrophin TRK receptor signaling pathway,11,0.465,0.685,1,GO:0051386,BP,,4795
intrinsic apoptotic signaling pathway by p53 class mediator,71,0.514,0.685,1,GO:0072332,BP,,4796
positive regulation of potassium ion transmembrane transporter activity,14,0.469,0.685,1,GO:1901018,BP,,4797
lysine catabolic process,12,0.534,0.685,1,GO:0006554,BP,,4798
positive regulation of sodium ion transmembrane transporter activity,12,0.534,0.686,1,GO:2000651,BP,,4799
chemoattractant activity,24,0.476,0.686,1,GO:0042056,MF,,4800
spermatid development,104,0.512,0.686,1,GO:0007286,BP,,4801
amine binding,11,0.465,0.686,1,"GO:0043176,GO:0051378",MF,serotonin binding,4802
regulation of mitochondrial membrane permeability involved in apoptotic process,56,0.484,0.687,1,GO:1902108,BP,,4803
poly-pyrimidine tract binding,18,0.527,0.687,1,GO:0008187,MF,,4804
phosphatidic acid binding,16,0.471,0.687,1,GO:0070300,MF,,4805
neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential,16,0.471,0.687,1,"GO:0099529,GO:1904315",MF,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,4806
regulation of Rac protein signal transduction,12,0.534,0.687,1,GO:0035020,BP,,4807
platelet alpha granule,78,0.487,0.688,1,GO:0031091,CC,,4808
regulation of protein localization to membrane,132,0.49,0.688,1,GO:1905475,BP,,4809
motile cilium assembly,22,0.525,0.688,1,GO:0044458,BP,,4810
stem cell development,56,0.515,0.689,1,GO:0048864,BP,,4811
GPI anchor biosynthetic process,25,0.523,0.689,1,GO:0006506,BP,,4812
endocrine hormone secretion,37,0.481,0.69,1,GO:0060986,BP,,4813
myeloid leukocyte cytokine production,21,0.525,0.69,1,GO:0061082,BP,,4814
retinoic acid receptor signaling pathway,27,0.522,0.69,1,GO:0048384,BP,,4815
negative regulation of nucleotide biosynthetic process,36,0.481,0.691,1,"GO:0030809,GO:1900372",BP,negative regulation of purine nucleotide biosynthetic process,4816
negative regulation of cytokine secretion,36,0.519,0.691,1,GO:0050710,BP,,4817
cellular response to low-density lipoprotein particle stimulus,12,0.467,0.691,1,GO:0071404,BP,,4818
neuron fate commitment,52,0.516,0.691,1,GO:0048663,BP,,4819
response to dexamethasone,36,0.519,0.692,1,GO:0071548,BP,,4820
regulation of carbohydrate biosynthetic process,72,0.486,0.692,1,GO:0043255,BP,,4821
regulation of cell aging,31,0.521,0.692,1,GO:0090342,BP,,4822
epoxygenase P450 pathway,12,0.533,0.692,1,GO:0019373,BP,,4823
collagen biosynthetic process,32,0.52,0.692,1,GO:0032964,BP,,4824
methyltransferase complex,75,0.513,0.693,1,GO:0034708,CC,,4825
blood vessel endothelial cell proliferation involved in sprouting angiogenesis,11,0.466,0.693,1,GO:0002043,BP,,4826
aspartate family amino acid biosynthetic process,20,0.525,0.694,1,GO:0009067,BP,,4827
histone H3-K27 methylation,13,0.532,0.694,1,GO:0070734,BP,,4828
maintenance of apical/basal cell polarity,11,0.534,0.694,1,"GO:0035090,GO:0045199",BP,maintenance of epithelial cell apical/basal polarity,4829
negative regulation of mononuclear cell proliferation,55,0.485,0.694,1,"GO:0032945,GO:0050672",BP,negative regulation of lymphocyte proliferation,4830
skeletal muscle tissue regeneration,27,0.478,0.694,1,GO:0043403,BP,,4831
"nuclear chromosome, telomeric region",98,0.512,0.694,1,GO:0000784,CC,,4832
negative regulation of pri-miRNA transcription from RNA polymerase II promoter,10,0.536,0.694,1,GO:1902894,BP,,4833
cytoskeletal adaptor activity,11,0.534,0.694,1,GO:0008093,MF,,4834
heart trabecula formation,13,0.469,0.695,1,GO:0060347,BP,,4835
regulation of response to tumor cell,11,0.534,0.695,1,"GO:0002834,GO:0002837",BP,regulation of immune response to tumor cell,4836
peptidyl-asparagine modification,38,0.482,0.696,1,GO:0018196,BP,,4837
mammary gland duct morphogenesis,30,0.521,0.696,1,GO:0060603,BP,,4838
ATPase dependent transmembrane transport complex,17,0.527,0.696,1,GO:0098533,CC,,4839
myofibril,180,0.492,0.697,1,GO:0030016,CC,,4840
omega peptidase activity,11,0.466,0.697,1,GO:0008242,MF,,4841
stress fiber,49,0.516,0.697,1,"GO:0001725,GO:0097517",CC,contractile actin filament bundle,4842
response to retinoic acid,97,0.511,0.697,1,GO:0032526,BP,,4843
tissue homeostasis,167,0.509,0.697,1,GO:0001894,BP,,4844
negative regulation of DNA replication,30,0.479,0.698,1,GO:0008156,BP,,4845
negative regulation of secretion by cell,149,0.491,0.698,1,GO:1903531,BP,,4846
camera-type eye morphogenesis,93,0.512,0.698,1,GO:0048593,BP,,4847
synaptonemal complex assembly,15,0.471,0.698,1,GO:0007130,BP,,4848
protein-chromophore linkage,10,0.465,0.698,1,GO:0018298,BP,,4849
tRNA-specific ribonuclease activity,12,0.468,0.698,1,GO:0004549,MF,,4850
glucocorticoid metabolic process,18,0.474,0.698,1,GO:0008211,BP,,4851
histone H3 acetylation,50,0.516,0.699,1,GO:0043966,BP,,4852
positive regulation of histone deacetylation,16,0.528,0.699,1,GO:0031065,BP,,4853
protein-lysine N-methyltransferase activity,51,0.516,0.7,1,GO:0016279,MF,,4854
regulation of long-term neuronal synaptic plasticity,23,0.477,0.7,1,GO:0048169,BP,,4855
regulation of cytokinesis,55,0.485,0.7,1,GO:0032465,BP,,4856
positive regulation of defense response to virus by host,14,0.47,0.7,1,GO:0002230,BP,,4857
ventricular cardiac muscle cell development,11,0.466,0.7,1,GO:0055015,BP,,4858
regulation of lymphocyte proliferation,158,0.491,0.701,1,GO:0050670,BP,,4859
acrosome reaction,24,0.523,0.701,1,GO:0007340,BP,,4860
negative regulation of exocytosis,28,0.521,0.701,1,GO:0045920,BP,,4861
cellular response to cAMP,46,0.484,0.702,1,GO:0071320,BP,,4862
acylglycerol homeostasis,24,0.523,0.702,1,"GO:0055090,GO:0070328",BP,triglyceride homeostasis,4863
phosphatase activator activity,10,0.465,0.702,1,GO:0019211,MF,,4864
nucleotide-activated protein kinase complex,10,0.465,0.702,1,GO:0031588,CC,,4865
regulation of neurotransmitter uptake,12,0.468,0.702,1,GO:0051580,BP,,4866
columnar/cuboidal epithelial cell development,50,0.484,0.702,1,GO:0002066,BP,,4867
regulation of macrophage differentiation,17,0.527,0.703,1,GO:0045649,BP,,4868
negative regulation of platelet activation,16,0.472,0.703,1,GO:0010544,BP,,4869
opsonin binding,11,0.533,0.703,1,GO:0001846,MF,,4870
integrin complex,30,0.52,0.704,1,"GO:0008305,GO:0098636",CC,protein complex involved in cell adhesion,4871
hexosaminidase activity,12,0.532,0.704,1,GO:0015929,MF,,4872
negative regulation of astrocyte differentiation,11,0.533,0.705,1,GO:0048712,BP,,4873
cardiac muscle cell action potential involved in contraction,45,0.516,0.706,1,GO:0086002,BP,,4874
cellular zinc ion homeostasis,20,0.476,0.706,1,GO:0006882,BP,,4875
regulation of tumor necrosis factor superfamily cytokine production,88,0.512,0.706,1,GO:1903555,BP,,4876
regulation of protein exit from endoplasmic reticulum,20,0.524,0.706,1,GO:0070861,BP,,4877
negative regulation of interferon-beta production,11,0.533,0.706,1,GO:0032688,BP,,4878
platelet dense tubular network,11,0.533,0.707,1,GO:0031094,CC,,4879
T-helper 1 type immune response,25,0.478,0.707,1,GO:0042088,BP,,4880
double-strand break repair via nonhomologous end joining,50,0.515,0.707,1,GO:0006303,BP,,4881
positive regulation of transcription from RNA polymerase I promoter,18,0.526,0.708,1,GO:0045943,BP,,4882
peptide disulfide oxidoreductase activity,12,0.469,0.708,1,GO:0015037,MF,,4883
response to thyroid hormone,21,0.524,0.708,1,GO:0097066,BP,,4884
DNA ligation,19,0.475,0.708,1,GO:0006266,BP,,4885
endocytic vesicle membrane,159,0.491,0.708,1,GO:0030666,CC,,4886
host cell part,10,0.466,0.709,1,GO:0033643,CC,,4887
purine nucleobase biosynthetic process,10,0.466,0.709,1,GO:0009113,BP,,4888
cellular response to ketone,78,0.512,0.709,1,GO:1901655,BP,,4889
photoreceptor cell maintenance,30,0.48,0.709,1,GO:0045494,BP,,4890
Fc-gamma receptor signaling pathway,74,0.513,0.709,1,GO:0038094,BP,,4891
cellular response to exogenous dsRNA,11,0.532,0.709,1,GO:0071360,BP,,4892
mitotic spindle assembly,46,0.516,0.71,1,GO:0090307,BP,,4893
response to nutrient,146,0.491,0.71,1,GO:0007584,BP,,4894
negative regulation of coagulation,42,0.483,0.71,1,GO:0050819,BP,,4895
zinc ion transmembrane transporter activity,18,0.475,0.71,1,GO:0005385,MF,,4896
negative regulation of glucose import,11,0.468,0.71,1,GO:0046325,BP,,4897
acylglycerol metabolic process,94,0.489,0.711,1,GO:0006639,BP,,4898
sarcomere,161,0.492,0.711,1,GO:0030017,CC,,4899
atrial septum morphogenesis,10,0.534,0.711,1,GO:0060413,BP,,4900
vesicle-mediated transport to the plasma membrane,63,0.514,0.711,1,GO:0098876,BP,,4901
negative regulation of peptidyl-threonine phosphorylation,15,0.472,0.711,1,GO:0010801,BP,,4902
negative regulation of lymphocyte apoptotic process,23,0.522,0.711,1,GO:0070229,BP,,4903
regulation of calcium ion transmembrane transporter activity,67,0.487,0.711,1,GO:1901019,BP,,4904
regulation of sequestering of calcium ion,94,0.489,0.711,1,GO:0051282,BP,,4905
regulation of blood pressure,139,0.491,0.712,1,GO:0008217,BP,,4906
UV protection,12,0.531,0.712,1,GO:0009650,BP,,4907
negative regulation of centrosome duplication,10,0.534,0.712,1,"GO:0010826,GO:0046606",BP,negative regulation of centrosome cycle,4908
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,27,0.479,0.712,1,"GO:1900739,GO:1900740",BP,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,4909
I band,118,0.51,0.712,1,GO:0031674,CC,,4910
striatum development,16,0.473,0.712,1,GO:0021756,BP,,4911
protein C-terminus binding,165,0.508,0.712,1,GO:0008022,MF,,4912
regulation of hair follicle development,17,0.474,0.712,1,GO:0051797,BP,,4913
protein K48-linked ubiquitination,45,0.516,0.712,1,GO:0070936,BP,,4914
regulation of keratinocyte differentiation,24,0.522,0.712,1,GO:0045616,BP,,4915
cellular response to acid chemical,171,0.492,0.712,1,GO:0071229,BP,,4916
calcium ion transmembrane transport via high voltage-gated calcium channel,10,0.466,0.713,1,GO:0061577,BP,,4917
regulation of meiotic nuclear division,16,0.473,0.713,1,GO:0040020,BP,,4918
cerebellar cortex morphogenesis,29,0.48,0.713,1,GO:0021696,BP,,4919
regulation of vesicle fusion,59,0.486,0.713,1,GO:0031338,BP,,4920
sperm capacitation,17,0.474,0.713,1,GO:0048240,BP,,4921
regulation of lipid kinase activity,43,0.516,0.713,1,GO:0043550,BP,,4922
regulation of cholesterol metabolic process,19,0.524,0.713,1,GO:0090181,BP,,4923
telomeric DNA binding,29,0.52,0.714,1,GO:0042162,MF,,4924
regulation of extrinsic apoptotic signaling pathway in absence of ligand,40,0.483,0.714,1,GO:2001239,BP,,4925
"transcription factor activity, transcription factor recruiting",12,0.47,0.715,1,GO:0001134,MF,,4926
precatalytic spliceosome,21,0.477,0.715,1,GO:0071011,CC,,4927
protein methyltransferase activity,74,0.488,0.715,1,GO:0008276,MF,,4928
cell communication by electrical coupling involved in cardiac conduction,22,0.477,0.715,1,GO:0086064,BP,,4929
regulation of collagen metabolic process,30,0.519,0.715,1,GO:0010712,BP,,4930
lipoprotein particle binding,20,0.476,0.715,1,"GO:0071813,GO:0071814",MF,protein-lipid complex binding,4931
response to immobilization stress,21,0.477,0.716,1,GO:0035902,BP,,4932
positive regulation of cell junction assembly,28,0.52,0.716,1,GO:1901890,BP,,4933
ubiquitin-protein transferase regulator activity,11,0.468,0.716,1,GO:0055106,MF,,4934
folic acid-containing compound metabolic process,26,0.521,0.716,1,GO:0006760,BP,,4935
transcription elongation factor complex,46,0.516,0.716,1,GO:0008023,CC,,4936
endoderm development,67,0.513,0.716,1,GO:0007492,BP,,4937
autophagosome assembly,66,0.487,0.717,1,GO:0000045,BP,,4938
endochondral bone morphogenesis,45,0.516,0.717,1,GO:0060350,BP,,4939
negative regulation of neural precursor cell proliferation,18,0.525,0.717,1,GO:2000178,BP,,4940
ethanol metabolic process,12,0.47,0.717,1,GO:0006067,BP,,4941
positive regulation of macrophage differentiation,10,0.533,0.718,1,GO:0045651,BP,,4942
central nervous system neuron differentiation,153,0.508,0.718,1,GO:0021953,BP,,4943
"transferase activity, transferring nitrogenous groups",19,0.524,0.718,1,GO:0016769,MF,,4944
potassium ion antiporter activity,14,0.472,0.718,1,GO:0022821,MF,,4945
positive regulation of cardiac muscle hypertrophy,22,0.522,0.718,1,"GO:0010613,GO:0014742",BP,positive regulation of muscle hypertrophy,4946
response to electrical stimulus,37,0.517,0.718,1,GO:0051602,BP,,4947
negative regulation of interleukin-6 production,30,0.481,0.719,1,GO:0032715,BP,,4948
female genitalia development,12,0.53,0.719,1,GO:0030540,BP,,4949
sensory perception of sound,123,0.509,0.719,1,GO:0007605,BP,,4950
tropomyosin binding,12,0.47,0.719,1,GO:0005523,MF,,4951
poly-purine tract binding,16,0.526,0.719,1,GO:0070717,MF,,4952
negative regulation of glycolytic process,11,0.531,0.719,1,"GO:0045820,GO:0051195,GO:0051198",BP,"negative regulation of cofactor metabolic process,negative regulation of coenzyme metabolic process",4953
protein homotrimerization,23,0.478,0.719,1,GO:0070207,BP,,4954
negative regulation of epidermis development,13,0.529,0.719,1,GO:0045683,BP,,4955
brush border membrane,40,0.484,0.719,1,GO:0031526,CC,,4956
regulation of translational initiation in response to stress,15,0.473,0.72,1,GO:0043558,BP,,4957
lysosomal transport,70,0.512,0.721,1,GO:0007041,BP,,4958
behavioral fear response,29,0.481,0.721,1,"GO:0001662,GO:0002209",BP,behavioral defense response,4959
fibroblast apoptotic process,16,0.474,0.721,1,GO:0044346,BP,,4960
rRNA methyltransferase activity,14,0.472,0.721,1,GO:0008649,MF,,4961
regulation of bone resorption,29,0.519,0.722,1,GO:0045124,BP,,4962
neuromuscular process,87,0.511,0.722,1,GO:0050905,BP,,4963
"transferase activity, transferring one-carbon groups",192,0.493,0.722,1,GO:0016741,MF,,4964
positive regulation of exocytosis,65,0.487,0.722,1,GO:0045921,BP,,4965
potassium ion homeostasis,13,0.471,0.722,1,GO:0055075,BP,,4966
regulation of axon guidance,20,0.477,0.722,1,GO:1902667,BP,,4967
Wnt-protein binding,29,0.519,0.722,1,GO:0017147,MF,,4968
positive regulation of neutrophil migration,23,0.521,0.722,1,GO:1902624,BP,,4969
positive regulation of NF-kappaB import into nucleus,21,0.522,0.722,1,GO:0042346,BP,,4970
negative regulation of reactive oxygen species metabolic process,43,0.516,0.723,1,GO:2000378,BP,,4971
outward rectifier potassium channel activity,11,0.469,0.724,1,GO:0015271,MF,,4972
regulation of leukocyte differentiation,195,0.507,0.725,1,GO:1902105,BP,,4973
adrenergic receptor signaling pathway,20,0.477,0.725,1,GO:0071875,BP,,4974
dopamine receptor binding,15,0.526,0.725,1,GO:0050780,MF,,4975
filopodium,91,0.511,0.726,1,GO:0030175,CC,,4976
positive regulation of osteoclast differentiation,17,0.475,0.726,1,GO:0045672,BP,,4977
response to increased oxygen levels,17,0.475,0.726,1,"GO:0036296,GO:0055093",BP,response to hyperoxia,4978
regulation of hormone metabolic process,23,0.521,0.726,1,GO:0032350,BP,,4979
glycolipid metabolic process,94,0.49,0.727,1,GO:0006664,BP,,4980
positive regulation of alpha-beta T cell proliferation,15,0.526,0.727,1,GO:0046641,BP,,4981
regulation of protein kinase A signaling,20,0.477,0.728,1,GO:0010738,BP,,4982
kinesin complex,46,0.515,0.728,1,GO:0005871,CC,,4983
progesterone metabolic process,11,0.47,0.728,1,GO:0042448,BP,,4984
regulation of extracellular matrix disassembly,14,0.473,0.729,1,GO:0010715,BP,,4985
thalamus development,14,0.527,0.729,1,GO:0021794,BP,,4986
structural constituent of eye lens,11,0.47,0.729,1,GO:0005212,MF,,4987
regulation of transcription involved in G1/S transition of mitotic cell cycle,23,0.479,0.729,1,GO:0000083,BP,,4988
prostaglandin biosynthetic process,21,0.478,0.729,1,"GO:0001516,GO:0046457",BP,prostanoid biosynthetic process,4989
voltage-gated calcium channel activity,39,0.516,0.729,1,GO:0005245,MF,,4990
cellular response to molecule of bacterial origin,127,0.491,0.729,1,GO:0071219,BP,,4991
nuclear body organization,10,0.532,0.73,1,GO:0030575,BP,,4992
camera-type eye photoreceptor cell differentiation,13,0.472,0.73,1,GO:0060219,BP,,4993
positive regulation of cytokine biosynthetic process,43,0.515,0.73,1,GO:0042108,BP,,4994
response to protozoan,14,0.527,0.73,1,GO:0001562,BP,,4995
multi-multicellular organism process,170,0.508,0.73,1,GO:0044706,BP,,4996
endoplasmic reticulum unfolded protein response,115,0.491,0.731,1,GO:0030968,BP,,4997
activation of protein kinase A activity,15,0.526,0.731,1,GO:0034199,BP,,4998
regulation of intrinsic apoptotic signaling pathway,135,0.509,0.731,1,GO:2001242,BP,,4999
regulation of telomere maintenance via telomere lengthening,45,0.485,0.731,1,GO:1904356,BP,,5000
positive regulation of cell division,69,0.512,0.731,1,GO:0051781,BP,,5001
type B pancreatic cell differentiation,20,0.522,0.732,1,GO:0003309,BP,,5002
positive regulation of insulin-like growth factor receptor signaling pathway,10,0.531,0.732,1,GO:0043568,BP,,5003
scaffold protein binding,47,0.514,0.732,1,GO:0097110,MF,,5004
positive regulation of cytokine production involved in immune response,27,0.519,0.732,1,GO:0002720,BP,,5005
protein kinase B signaling,131,0.491,0.732,1,GO:0043491,BP,,5006
regulation of leukocyte proliferation,165,0.492,0.733,1,GO:0070663,BP,,5007
macrophage cytokine production,13,0.527,0.733,1,GO:0010934,BP,,5008
specific granule membrane,77,0.511,0.733,1,GO:0035579,CC,,5009
negative regulation of cell migration involved in sprouting angiogenesis,10,0.469,0.733,1,GO:0090051,BP,,5010
proton-transporting two-sector ATPase complex assembly,12,0.472,0.733,1,GO:0070071,BP,,5011
regulation of stem cell differentiation,31,0.482,0.734,1,GO:2000736,BP,,5012
regulation of cholesterol storage,12,0.472,0.734,1,GO:0010885,BP,,5013
cGMP metabolic process,50,0.486,0.735,1,GO:0046068,BP,,5014
positive regulation of interleukin-4 production,17,0.476,0.735,1,GO:0032753,BP,,5015
"inositol-1,4,5-trisphosphate 3-kinase activity",10,0.531,0.735,1,GO:0008440,MF,,5016
cell aggregation,16,0.476,0.735,1,GO:0098743,BP,,5017
spinal cord development,81,0.511,0.735,1,GO:0021510,BP,,5018
protein-DNA complex assembly,170,0.508,0.735,1,GO:0065004,BP,,5019
response to unfolded protein,155,0.492,0.735,1,GO:0006986,BP,,5020
intraciliary transport particle B,19,0.522,0.735,1,GO:0030992,CC,,5021
regulation of mononuclear cell proliferation,159,0.492,0.736,1,GO:0032944,BP,,5022
positive regulation of BMP signaling pathway,27,0.519,0.736,1,GO:0030513,BP,,5023
positive regulation of chondrocyte differentiation,17,0.476,0.736,1,GO:0032332,BP,,5024
negative regulation of cytokine production,181,0.493,0.736,1,GO:0001818,BP,,5025
positive regulation of autophagosome assembly,10,0.469,0.736,1,GO:2000786,BP,,5026
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,15,0.525,0.736,1,GO:0043162,BP,,5027
regulation of peptidyl-tyrosine phosphorylation,181,0.507,0.737,1,GO:0050730,BP,,5028
limbic system development,96,0.51,0.737,1,GO:0021761,BP,,5029
FAD binding,15,0.525,0.737,1,GO:0071949,MF,,5030
regulation of RIG-I signaling pathway,12,0.472,0.738,1,GO:0039535,BP,,5031
positive regulation of lipid biosynthetic process,53,0.487,0.738,1,GO:0046889,BP,,5032
response to interferon-beta,21,0.521,0.738,1,GO:0035456,BP,,5033
lysophospholipase activity,17,0.477,0.739,1,GO:0004622,MF,,5034
sex determination,21,0.521,0.739,1,GO:0007530,BP,,5035
regulation of wound healing,106,0.491,0.739,1,GO:0061041,BP,,5036
spindle checkpoint,31,0.517,0.74,1,GO:0031577,BP,,5037
leukocyte tethering or rolling,19,0.478,0.74,1,GO:0050901,BP,,5038
membranous septum morphogenesis,10,0.47,0.74,1,GO:0003149,BP,,5039
hormone metabolic process,143,0.492,0.74,1,GO:0042445,BP,,5040
fatty-acyl-CoA metabolic process,45,0.486,0.74,1,GO:0035337,BP,,5041
regulation of response to wounding,128,0.491,0.74,1,GO:1903034,BP,,5042
negative regulation of pathway-restricted SMAD protein phosphorylation,10,0.53,0.74,1,GO:0060394,BP,,5043
regulation of production of molecular mediator of immune response,86,0.51,0.74,1,GO:0002700,BP,,5044
3'-5' DNA helicase activity,11,0.529,0.741,1,GO:0043138,MF,,5045
heterochromatin assembly,10,0.53,0.741,1,GO:0031507,BP,,5046
regulation of epidermal growth factor-activated receptor activity,23,0.52,0.741,1,GO:0007176,BP,,5047
negative regulation of defense response,127,0.491,0.741,1,GO:0031348,BP,,5048
ciliary transition zone,52,0.487,0.741,1,GO:0035869,CC,,5049
negative regulation of catabolic process,183,0.493,0.741,1,GO:0009895,BP,,5050
juxtaparanode region of axon,10,0.47,0.741,1,GO:0044224,CC,,5051
lamellipodium organization,68,0.512,0.741,1,GO:0097581,BP,,5052
plasma membrane fusion,29,0.518,0.741,1,GO:0045026,BP,,5053
cellular response to electrical stimulus,11,0.529,0.742,1,GO:0071257,BP,,5054
acid-thiol ligase activity,22,0.52,0.743,1,GO:0016878,MF,,5055
negative regulation of circadian rhythm,13,0.474,0.743,1,GO:0042754,BP,,5056
histone kinase activity,16,0.476,0.743,1,GO:0035173,MF,,5057
CDP-diacylglycerol metabolic process,14,0.525,0.743,1,GO:0046341,BP,,5058
acetyltransferase activity,88,0.49,0.743,1,GO:0016407,MF,,5059
negative regulation of chondrocyte differentiation,15,0.524,0.743,1,GO:0032331,BP,,5060
male meiosis,30,0.483,0.743,1,GO:0007140,BP,,5061
regulation of bone mineralization,58,0.512,0.743,1,GO:0030500,BP,,5062
fat-soluble vitamin biosynthetic process,10,0.47,0.743,1,GO:0042362,BP,,5063
response to cadmium ion,51,0.513,0.744,1,GO:0046686,BP,,5064
erythrocyte development,21,0.521,0.744,1,GO:0048821,BP,,5065
monocyte differentiation,31,0.517,0.744,1,"GO:0030224,GO:1903131",BP,mononuclear cell differentiation,5066
N-acyltransferase activity,88,0.49,0.744,1,GO:0016410,MF,,5067
DNA strand elongation,22,0.52,0.744,1,GO:0022616,BP,,5068
positive regulation of interleukin-6 production,54,0.513,0.744,1,GO:0032755,BP,,5069
regulation of defense response to virus by host,23,0.48,0.744,1,GO:0050691,BP,,5070
Golgi localization,12,0.473,0.745,1,"GO:0051645,GO:0015385",BP,sodium:proton antiporter activity,5071
podosome assembly,19,0.478,0.745,1,GO:0071800,BP,,5072
negative regulation of chemotaxis,29,0.483,0.745,1,GO:0050922,BP,,5073
thrombin-activated receptor signaling pathway,11,0.472,0.746,1,GO:0070493,BP,,5074
ciliary membrane,59,0.512,0.746,1,GO:0060170,CC,,5075
response to pH,33,0.484,0.746,1,GO:0009268,BP,,5076
female meiotic division,22,0.52,0.746,1,GO:0007143,BP,,5077
positive regulation of organ growth,38,0.515,0.747,1,GO:0046622,BP,,5078
positive regulation of telomere maintenance,39,0.515,0.747,1,GO:0032206,BP,,5079
"oxidoreductase activity, acting on the CH-NH2 group of donors",18,0.478,0.747,1,GO:0016638,MF,,5080
"transferase activity, transferring hexosyl groups",166,0.493,0.747,1,GO:0016758,MF,,5081
ARF guanyl-nucleotide exchange factor activity,19,0.521,0.748,1,GO:0005086,MF,,5082
lipid particle,64,0.512,0.748,1,GO:0005811,CC,,5083
"DNA damage response, signal transduction resulting in transcription",15,0.476,0.748,1,GO:0042772,BP,,5084
negative regulation of cardiocyte differentiation,14,0.525,0.749,1,GO:1905208,BP,,5085
germ cell nucleus,15,0.476,0.75,1,GO:0043073,CC,,5086
negative regulation of interleukin-1 production,13,0.474,0.75,1,GO:0032692,BP,,5087
programmed cell death involved in cell development,12,0.527,0.75,1,GO:0010623,BP,,5088
peptidyl-methionine modification,10,0.529,0.75,1,GO:0018206,BP,,5089
circadian sleep/wake cycle,23,0.481,0.75,1,GO:0042745,BP,,5090
regulation of stress-activated protein kinase signaling cascade,175,0.507,0.751,1,GO:0070302,BP,,5091
regulation of cholesterol efflux,17,0.522,0.751,1,GO:0010874,BP,,5092
prostaglandin secretion,12,0.474,0.751,1,GO:0032310,BP,,5093
response to X-ray,25,0.518,0.751,1,GO:0010165,BP,,5094
regulation of cell communication by electrical coupling,12,0.526,0.752,1,GO:0010649,BP,,5095
positive regulation of DNA binding,40,0.486,0.752,1,GO:0043388,BP,,5096
osteoclast differentiation,72,0.489,0.753,1,GO:0030316,BP,,5097
regulation of cAMP metabolic process,107,0.491,0.754,1,GO:0030814,BP,,5098
positive regulation of leukocyte degranulation,13,0.525,0.755,1,GO:0043302,BP,,5099
AV node cell to bundle of His cell communication,10,0.471,0.755,1,GO:0086067,BP,,5100
kinase activator activity,66,0.489,0.755,1,GO:0019209,MF,,5101
resolution of meiotic recombination intermediates,12,0.474,0.756,1,GO:0000712,BP,,5102
positive regulation of cyclin-dependent protein kinase activity,34,0.515,0.756,1,GO:1904031,BP,,5103
positive regulation of chromosome segregation,20,0.52,0.756,1,GO:0051984,BP,,5104
steroid catabolic process,17,0.522,0.756,1,GO:0006706,BP,,5105
transcription factor TFTC complex,14,0.476,0.756,1,GO:0033276,CC,,5106
hematopoietic stem cell proliferation,18,0.479,0.757,1,GO:0071425,BP,,5107
regulation of macrophage cytokine production,11,0.473,0.757,1,GO:0010935,BP,,5108
positive regulation of blood coagulation,19,0.48,0.757,1,"GO:0030194,GO:1900048",BP,positive regulation of hemostasis,5109
RNA polymerase II core binding,23,0.481,0.758,1,GO:0000993,MF,,5110
positive regulation of interleukin-13 production,11,0.527,0.758,1,GO:0032736,BP,,5111
negative regulation of stress-activated MAPK cascade,37,0.485,0.758,1,"GO:0032873,GO:0070303",BP,negative regulation of stress-activated protein kinase signaling cascade,5112
regulation of glycogen biosynthetic process,24,0.482,0.759,1,"GO:0005979,GO:0010962",BP,regulation of glucan biosynthetic process,5113
toxin transport,32,0.484,0.759,1,GO:1901998,BP,,5114
animal organ regeneration,65,0.511,0.759,1,GO:0031100,BP,,5115
multicellular organismal response to stress,62,0.511,0.759,1,GO:0033555,BP,,5116
regulation of ryanodine-sensitive calcium-release channel activity,25,0.482,0.759,1,GO:0060314,BP,,5117
cell migration involved in gastrulation,13,0.475,0.759,1,GO:0042074,BP,,5118
protein autoprocessing,11,0.473,0.76,1,GO:0016540,BP,,5119
ionotropic glutamate receptor signaling pathway,24,0.482,0.76,1,GO:0035235,BP,,5120
regulation of tyrosine phosphorylation of STAT protein,45,0.513,0.76,1,GO:0042509,BP,,5121
protein nitrosylation,11,0.473,0.76,1,"GO:0017014,GO:0018119",BP,peptidyl-cysteine S-nitrosylation,5122
positive regulation of cellular carbohydrate metabolic process,45,0.513,0.76,1,GO:0010676,BP,,5123
regulation of heterotypic cell-cell adhesion,15,0.477,0.761,1,GO:0034114,BP,,5124
regulation of protein export from nucleus,36,0.515,0.762,1,GO:0046825,BP,,5125
positive regulation of histone modification,73,0.51,0.762,1,GO:0031058,BP,,5126
regulation of blood vessel endothelial cell migration,50,0.488,0.762,1,GO:0043535,BP,,5127
exodeoxyribonuclease activity,15,0.523,0.762,1,"GO:0004529,GO:0016895",MF,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters",5128
regulation of epidermal growth factor receptor signaling pathway,72,0.51,0.762,1,GO:0042058,BP,,5129
positive regulation of substrate adhesion-dependent cell spreading,27,0.483,0.762,1,GO:1900026,BP,,5130
"binding, bridging",160,0.507,0.762,1,GO:0060090,MF,,5131
intra-Golgi vesicle-mediated transport,40,0.514,0.763,1,GO:0006891,BP,,5132
zinc ion homeostasis,22,0.481,0.763,1,GO:0055069,BP,,5133
"nucleotide-excision repair, DNA incision",34,0.485,0.764,1,GO:0033683,BP,,5134
myoblast migration,10,0.527,0.764,1,GO:0051451,BP,,5135
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,25,0.483,0.764,1,GO:0016339,BP,,5136
activation of NF-kappaB-inducing kinase activity,15,0.522,0.765,1,GO:0007250,BP,,5137
regulation of glial cell proliferation,22,0.482,0.765,1,GO:0060251,BP,,5138
ganglion development,11,0.526,0.765,1,GO:0061548,BP,,5139
regulation of monocyte differentiation,18,0.48,0.766,1,GO:0045655,BP,,5140
regulation of B cell mediated immunity,34,0.515,0.767,1,"GO:0002712,GO:0002889",BP,regulation of immunoglobulin mediated immune response,5141
regulation of skeletal muscle adaptation,11,0.526,0.767,1,GO:0014733,BP,,5142
phosphate ion binding,10,0.527,0.768,1,GO:0042301,MF,,5143
ribonuclease activity,74,0.51,0.768,1,GO:0004540,MF,,5144
regulation of tissue remodeling,58,0.511,0.768,1,GO:0034103,BP,,5145
potassium:proton antiporter activity,10,0.473,0.769,1,GO:0015386,MF,,5146
secretory granule organization,28,0.516,0.769,1,GO:0033363,BP,,5147
B cell receptor signaling pathway,39,0.514,0.769,1,GO:0050853,BP,,5148
regulation of collagen biosynthetic process,26,0.517,0.769,1,GO:0032965,BP,,5149
cellular monovalent inorganic cation homeostasis,99,0.491,0.769,1,GO:0030004,BP,,5150
protein-DNA complex subunit organization,196,0.506,0.769,1,GO:0071824,BP,,5151
transport along microtubule,119,0.492,0.77,1,"GO:0010970,GO:0099111",BP,microtubule-based transport,5152
regulation of B cell proliferation,44,0.513,0.77,1,GO:0030888,BP,,5153
iron ion homeostasis,64,0.489,0.771,1,GO:0055072,BP,,5154
regulation of fibroblast apoptotic process,13,0.477,0.771,1,GO:2000269,BP,,5155
defense response to protozoan,13,0.523,0.771,1,GO:0042832,BP,,5156
ER to Golgi transport vesicle,71,0.51,0.771,1,GO:0030134,CC,,5157
protein N-linked glycosylation via asparagine,37,0.486,0.772,1,GO:0018279,BP,,5158
MHC class I protein binding,17,0.48,0.772,1,GO:0042288,MF,,5159
protein trimerization,43,0.513,0.772,1,GO:0070206,BP,,5160
regulation of protein depolymerization,59,0.489,0.772,1,GO:1901879,BP,,5161
transmembrane receptor protein tyrosine phosphatase activity,16,0.521,0.772,1,"GO:0005001,GO:0019198",MF,transmembrane receptor protein phosphatase activity,5162
regulation of tumor necrosis factor production,85,0.509,0.773,1,GO:0032680,BP,,5163
protein kinase C signaling,25,0.517,0.773,1,GO:0070528,BP,,5164
cellular amino acid biosynthetic process,74,0.49,0.773,1,GO:0008652,BP,,5165
negative regulation of histone H3-K9 methylation,10,0.474,0.773,1,GO:0051573,BP,,5166
myosin binding,49,0.512,0.773,1,GO:0017022,MF,,5167
neuromuscular synaptic transmission,24,0.483,0.773,1,GO:0007274,BP,,5168
phagocytic vesicle membrane,68,0.51,0.774,1,GO:0030670,CC,,5169
"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator",14,0.478,0.774,1,GO:0006978,BP,,5170
negative regulation of protein binding,74,0.49,0.774,1,GO:0032091,BP,,5171
negative regulation of DNA metabolic process,101,0.508,0.774,1,GO:0051053,BP,,5172
fatty acid homeostasis,11,0.475,0.774,1,GO:0055089,BP,,5173
regulation of sterol transport,32,0.515,0.774,1,"GO:0032371,GO:0032374",BP,regulation of cholesterol transport,5174
regulation of regulatory T cell differentiation,15,0.521,0.774,1,GO:0045589,BP,,5175
regulation of interleukin-10 production,31,0.515,0.774,1,GO:0032653,BP,,5176
regulation of mammary gland epithelial cell proliferation,11,0.475,0.774,1,GO:0033599,BP,,5177
regulation of cellular senescence,27,0.516,0.774,1,GO:2000772,BP,,5178
purine ribonucleoside bisphosphate metabolic process,14,0.522,0.775,1,"GO:0034035,GO:0050427",BP,3'-phosphoadenosine 5'-phosphosulfate metabolic process,5179
sarcomere organization,38,0.513,0.775,1,GO:0045214,BP,,5180
negative regulation of cysteine-type endopeptidase activity,73,0.49,0.776,1,GO:2000117,BP,,5181
endoplasmic reticulum-Golgi intermediate compartment,96,0.492,0.776,1,GO:0005793,CC,,5182
cellular response to drug,61,0.489,0.776,1,GO:0035690,BP,,5183
acetylcholine-gated cation-selective channel activity,13,0.477,0.776,1,GO:0022848,MF,,5184
meiotic spindle organization,10,0.474,0.776,1,GO:0000212,BP,,5185
inactivation of MAPK activity,21,0.518,0.777,1,GO:0000188,BP,,5186
mammary gland epithelium development,57,0.511,0.777,1,GO:0061180,BP,,5187
signal transduction in absence of ligand,60,0.511,0.778,1,"GO:0038034,GO:0097192",BP,extrinsic apoptotic signaling pathway in absence of ligand,5188
I-kappaB phosphorylation,14,0.478,0.778,1,GO:0007252,BP,,5189
cellular response to retinoic acid,63,0.51,0.778,1,GO:0071300,BP,,5190
axon extension,97,0.508,0.778,1,GO:0048675,BP,,5191
response to ketone,160,0.506,0.779,1,GO:1901654,BP,,5192
positive regulation of establishment of protein localization to plasma membrane,29,0.485,0.779,1,GO:0090004,BP,,5193
G-protein coupled chemoattractant receptor activity,14,0.478,0.779,1,"GO:0001637,GO:0004950",MF,chemokine receptor activity,5194
regulation of exosomal secretion,14,0.522,0.779,1,GO:1903541,BP,,5195
response to ATP,27,0.484,0.779,1,GO:0033198,BP,,5196
ubiquitin-ubiquitin ligase activity,13,0.522,0.779,1,GO:0034450,MF,,5197
negative regulation of secretion,166,0.494,0.779,1,GO:0051048,BP,,5198
ATP hydrolysis coupled anion transmembrane transport,11,0.524,0.78,1,"GO:0099133,GO:0043225",BP,ATPase-coupled anion transmembrane transporter activity,5199
walking behavior,27,0.484,0.78,1,GO:0090659,BP,,5200
myotube differentiation,84,0.509,0.78,1,GO:0014902,BP,,5201
actin filament network formation,10,0.475,0.78,1,GO:0051639,BP,,5202
peptidyl-lysine dimethylation,14,0.522,0.78,1,GO:0018027,BP,,5203
regulation of NFAT protein import into nucleus,13,0.478,0.78,1,GO:0051532,BP,,5204
protein depolymerization,78,0.509,0.781,1,GO:0051261,BP,,5205
mitochondrial DNA metabolic process,17,0.481,0.781,1,GO:0032042,BP,,5206
cytokine binding,77,0.509,0.781,1,GO:0019955,MF,,5207
regulation of interleukin-17 production,17,0.481,0.781,1,GO:0032660,BP,,5208
glycosphingolipid biosynthetic process,15,0.521,0.782,1,GO:0006688,BP,,5209
activation-induced cell death of T cells,11,0.476,0.782,1,GO:0006924,BP,,5210
ciliary basal body docking,90,0.508,0.782,1,GO:0097711,BP,,5211
photoreceptor cell differentiation,47,0.512,0.783,1,GO:0046530,BP,,5212
Hsp70 protein binding,33,0.486,0.783,1,GO:0030544,MF,,5213
"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor",14,0.479,0.783,1,GO:0050664,MF,,5214
negative regulation of B cell apoptotic process,10,0.525,0.783,1,GO:0002903,BP,,5215
regulation of mitotic sister chromatid segregation,48,0.511,0.784,1,GO:0033047,BP,,5216
M band,27,0.485,0.784,1,GO:0031430,CC,,5217
positive regulation of cyclase activity,54,0.489,0.784,1,GO:0031281,BP,,5218
positive regulation of T cell differentiation in thymus,10,0.525,0.784,1,GO:0033089,BP,,5219
renal system process,96,0.508,0.785,1,GO:0003014,BP,,5220
specific granule,133,0.493,0.785,1,GO:0042581,CC,,5221
response to purine-containing compound,130,0.507,0.785,1,GO:0014074,BP,,5222
cellular response to glucagon stimulus,34,0.514,0.785,1,GO:0071377,BP,,5223
intrinsic component of Golgi membrane,52,0.511,0.786,1,GO:0031228,CC,,5224
positive regulation of tyrosine phosphorylation of STAT protein,36,0.513,0.786,1,GO:0042531,BP,,5225
trans-Golgi network,175,0.494,0.786,1,GO:0005802,CC,,5226
regulation of endothelial cell migration,108,0.508,0.786,1,GO:0010594,BP,,5227
renal system process involved in regulation of blood volume,11,0.476,0.787,1,GO:0001977,BP,,5228
cellular response to osmotic stress,23,0.516,0.787,1,GO:0071470,BP,,5229
corticosteroid hormone secretion,12,0.477,0.787,1,"GO:0035930,GO:2000846",BP,regulation of corticosteroid hormone secretion,5230
chemokine secretion,10,0.525,0.787,1,GO:0090195,BP,,5231
cellular response to vitamin D,14,0.521,0.787,1,GO:0071305,BP,,5232
intracellular lipid transport,30,0.486,0.787,1,GO:0032365,BP,,5233
protein localization to vacuole,38,0.513,0.788,1,GO:0072665,BP,,5234
RNA polymerase II transcription factor complex,95,0.492,0.788,1,GO:0090575,CC,,5235
positive regulation of mitochondrial membrane permeability involved in apoptotic process,51,0.489,0.788,1,"GO:1902110,GO:1902686",BP,mitochondrial outer membrane permeabilization involved in programmed cell death,5236
iron ion transmembrane transport,11,0.523,0.788,1,GO:0034755,BP,,5237
vesicle coat,46,0.511,0.788,1,GO:0030120,CC,,5238
negative regulation of blood vessel endothelial cell migration,21,0.517,0.788,1,GO:0043537,BP,,5239
nucleotide salvage,12,0.478,0.788,1,GO:0043173,BP,,5240
cellular response to dexamethasone stimulus,30,0.514,0.789,1,GO:0071549,BP,,5241
body fluid secretion,74,0.491,0.789,1,GO:0007589,BP,,5242
positive regulation of leukocyte differentiation,109,0.507,0.789,1,GO:1902107,BP,,5243
regulation of feeding behavior,14,0.521,0.789,1,GO:0060259,BP,,5244
multivesicular body,32,0.486,0.789,1,GO:0005771,CC,,5245
positive regulation of proteasomal protein catabolic process,86,0.508,0.789,1,GO:1901800,BP,,5246
L-serine metabolic process,10,0.524,0.789,1,GO:0006563,BP,,5247
release of sequestered calcium ion into cytosol,93,0.492,0.789,1,"GO:0051209,GO:0051283",BP,negative regulation of sequestering of calcium ion,5248
production of molecular mediator involved in inflammatory response,34,0.513,0.789,1,GO:0002532,BP,,5249
"CD8-positive, alpha-beta T cell activation",14,0.521,0.789,1,GO:0036037,BP,,5250
positive regulation of phosphatidylinositol 3-kinase signaling,55,0.51,0.79,1,GO:0014068,BP,,5251
Hsp90 protein binding,29,0.514,0.79,1,GO:0051879,MF,,5252
negative regulation of cyclic nucleotide metabolic process,36,0.487,0.79,1,GO:0030800,BP,,5253
isoprenoid binding,25,0.515,0.79,1,GO:0019840,MF,,5254
cellular response to amino acid stimulus,57,0.51,0.791,1,GO:0071230,BP,,5255
ER to Golgi transport vesicle membrane,53,0.511,0.791,1,GO:0012507,CC,,5256
hematopoietic stem cell differentiation,12,0.478,0.791,1,GO:0060218,BP,,5257
regulation of telomerase activity,38,0.512,0.791,1,GO:0051972,BP,,5258
regulation of mesoderm development,14,0.52,0.791,1,GO:2000380,BP,,5259
plasma lipoprotein particle organization,26,0.485,0.791,1,GO:0071827,BP,,5260
thymus development,38,0.488,0.791,1,GO:0048538,BP,,5261
regulation of protein homodimerization activity,17,0.519,0.791,1,GO:0043496,BP,,5262
negative regulation of translational initiation,20,0.483,0.792,1,GO:0045947,BP,,5263
innate immune response in mucosa,11,0.477,0.792,1,GO:0002227,BP,,5264
olfactory lobe development,32,0.487,0.792,1,GO:0021988,BP,,5265
SNARE complex assembly,15,0.48,0.793,1,GO:0035493,BP,,5266
dynein light intermediate chain binding,12,0.478,0.793,1,GO:0051959,MF,,5267
DNA duplex unwinding,64,0.49,0.793,1,GO:0032508,BP,,5268
semaphorin receptor binding,10,0.524,0.793,1,GO:0030215,MF,,5269
N-terminal protein amino acid acetylation,15,0.52,0.793,1,GO:0006474,BP,,5270
positive regulation of myotube differentiation,24,0.485,0.793,1,GO:0010831,BP,,5271
MAP kinase kinase activity,12,0.478,0.793,1,GO:0004708,MF,,5272
regulation of immunoglobulin secretion,11,0.477,0.793,1,GO:0051023,BP,,5273
ATPase binding,75,0.491,0.793,1,GO:0051117,MF,,5274
icosanoid secretion,33,0.487,0.794,1,GO:0032309,BP,,5275
blood vessel remodeling,39,0.512,0.794,1,GO:0001974,BP,,5276
startle response,24,0.485,0.794,1,GO:0001964,BP,,5277
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,16,0.519,0.795,1,GO:1902236,BP,,5278
regulation of megakaryocyte differentiation,16,0.481,0.795,1,GO:0045652,BP,,5279
RNA secondary structure unwinding,41,0.512,0.795,1,GO:0010501,BP,,5280
cellular response to fibroblast growth factor stimulus,123,0.507,0.796,1,GO:0044344,BP,,5281
DNA replication origin binding,10,0.476,0.796,1,GO:0003688,MF,,5282
regulation of beta-amyloid formation,10,0.524,0.796,1,GO:1902003,BP,,5283
structural molecule activity conferring elasticity,15,0.519,0.796,1,GO:0097493,MF,,5284
regulation of microtubule-based movement,16,0.481,0.796,1,GO:0060632,BP,,5285
negative regulation of stem cell proliferation,10,0.524,0.796,1,GO:2000647,BP,,5286
negative regulation of cell activation,135,0.494,0.797,1,GO:0050866,BP,,5287
regulation of acrosome reaction,12,0.521,0.797,1,GO:0060046,BP,,5288
cellular iron ion homeostasis,41,0.488,0.797,1,GO:0006879,BP,,5289
regulation of axon regeneration,22,0.516,0.798,1,GO:0048679,BP,,5290
protein-DNA complex disassembly,17,0.518,0.798,1,GO:0032986,BP,,5291
regulation of homotypic cell-cell adhesion,19,0.517,0.798,1,GO:0034110,BP,,5292
chondrocyte proliferation,12,0.479,0.798,1,GO:0035988,BP,,5293
positive regulation of stress fiber assembly,42,0.511,0.799,1,GO:0051496,BP,,5294
developmental cell growth,175,0.494,0.799,1,GO:0048588,BP,,5295
regulation of axon extension,74,0.509,0.799,1,GO:0030516,BP,,5296
dendritic spine,119,0.507,0.8,1,GO:0043197,CC,,5297
pattern binding,15,0.481,0.8,1,"GO:0001871,GO:0030247",MF,polysaccharide binding,5298
nucleoside salvage,16,0.518,0.8,1,GO:0043174,BP,,5299
positive regulation of fatty acid oxidation,14,0.48,0.8,1,GO:0046321,BP,,5300
negative regulation of apoptotic signaling pathway,179,0.495,0.801,1,GO:2001234,BP,,5301
metanephric glomerulus development,16,0.518,0.801,1,GO:0072224,BP,,5302
negative regulation of defense response to virus,20,0.516,0.801,1,GO:0050687,BP,,5303
pentose metabolic process,11,0.522,0.801,1,GO:0019321,BP,,5304
histone methyltransferase activity (H3-K4 specific),15,0.519,0.801,1,GO:0042800,MF,,5305
actin monomer binding,24,0.485,0.801,1,GO:0003785,MF,,5306
response to zinc ion,43,0.489,0.801,1,GO:0010043,BP,,5307
dendritic shaft,34,0.512,0.801,1,GO:0043198,CC,,5308
cytokine secretion,138,0.506,0.801,1,GO:0050663,BP,,5309
cell-cell signaling involved in cardiac conduction,29,0.487,0.802,1,GO:0086019,BP,,5310
heart growth,64,0.509,0.802,1,GO:0060419,BP,,5311
anoikis,29,0.513,0.802,1,GO:0043276,BP,,5312
regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,42,0.489,0.802,1,GO:1901028,BP,,5313
negative regulation of protein import into nucleus,56,0.49,0.802,1,"GO:0042308,GO:1904590",BP,negative regulation of protein import,5314
microtubule end,20,0.516,0.802,1,GO:1990752,CC,,5315
regulation of smooth muscle cell differentiation,23,0.515,0.802,1,GO:0051150,BP,,5316
positive regulation of activated T cell proliferation,19,0.517,0.802,1,GO:0042104,BP,,5317
heme biosynthetic process,18,0.483,0.803,1,GO:0006783,BP,,5318
negative regulation of innate immune response,31,0.513,0.803,1,GO:0045824,BP,,5319
cellular response to alkaloid,36,0.512,0.803,1,GO:0071312,BP,,5320
exosomal secretion,17,0.483,0.803,1,GO:1990182,BP,,5321
positive regulation of triglyceride metabolic process,13,0.48,0.803,1,GO:0090208,BP,,5322
steroid hydroxylase activity,10,0.523,0.804,1,GO:0008395,MF,,5323
cholesterol transporter activity,11,0.478,0.804,1,GO:0017127,MF,,5324
protein localization to cilium,30,0.513,0.804,1,GO:0061512,BP,,5325
DNA methylation involved in gamete generation,15,0.482,0.805,1,GO:0043046,BP,,5326
cerebellar Purkinje cell layer formation,10,0.523,0.805,1,"GO:0021694,GO:0021702",BP,cerebellar Purkinje cell differentiation,5327
cell migration involved in heart development,13,0.48,0.805,1,GO:0060973,BP,,5328
fertilization,112,0.507,0.806,1,GO:0009566,BP,,5329
positive regulation of cellular extravasation,10,0.478,0.806,1,GO:0002693,BP,,5330
regulation of interleukin-6 biosynthetic process,14,0.481,0.806,1,GO:0045408,BP,,5331
type B pancreatic cell proliferation,19,0.484,0.806,1,GO:0044342,BP,,5332
porphyrin-containing compound biosynthetic process,21,0.485,0.807,1,GO:0006779,BP,,5333
negative regulation of type I interferon production,40,0.489,0.807,1,GO:0032480,BP,,5334
positive regulation of alcohol biosynthetic process,17,0.517,0.807,1,GO:1902932,BP,,5335
response to topologically incorrect protein,173,0.495,0.807,1,GO:0035966,BP,,5336
T-helper 2 cell differentiation,12,0.48,0.808,1,GO:0045064,BP,,5337
snRNA transcription,64,0.491,0.808,1,"GO:0009301,GO:0042795",BP,snRNA transcription from RNA polymerase II promoter,5338
regulation of protein complex disassembly,72,0.492,0.808,1,GO:0043244,BP,,5339
calcium ion transport into cytosol,113,0.507,0.808,1,GO:0060402,BP,,5340
gap junction channel activity,11,0.521,0.808,1,GO:0005243,MF,,5341
positive regulation of leukocyte chemotaxis,63,0.491,0.808,1,GO:0002690,BP,,5342
N-methyltransferase activity,76,0.508,0.808,1,GO:0008170,MF,,5343
regulation of insulin-like growth factor receptor signaling pathway,19,0.516,0.808,1,GO:0043567,BP,,5344
cellular response to gonadotropin stimulus,16,0.482,0.808,1,GO:0071371,BP,,5345
negative regulation of homeostatic process,161,0.506,0.808,1,GO:0032845,BP,,5346
ribonucleoside metabolic process,88,0.493,0.809,1,GO:0009119,BP,,5347
regulation of response to reactive oxygen species,33,0.488,0.809,1,GO:1901031,BP,,5348
main axon,58,0.491,0.809,1,GO:0044304,CC,,5349
receptor inhibitor activity,11,0.479,0.809,1,GO:0030547,MF,,5350
negative regulation of leukocyte proliferation,58,0.491,0.809,1,GO:0070664,BP,,5351
regulation of cilium movement,11,0.521,0.81,1,"GO:0003352,GO:0003356",BP,regulation of cilium beat frequency,5352
hemidesmosome assembly,10,0.478,0.81,1,GO:0031581,BP,,5353
rhythmic behavior,39,0.511,0.81,1,GO:0007622,BP,,5354
Golgi-associated vesicle,77,0.492,0.81,1,GO:0005798,CC,,5355
natural killer cell mediated cytotoxicity,38,0.511,0.81,1,GO:0042267,BP,,5356
regulation of glycolytic process,29,0.513,0.81,1,GO:0006110,BP,,5357
cytolysis,23,0.486,0.811,1,GO:0019835,BP,,5358
negative regulation of B cell proliferation,11,0.521,0.811,1,GO:0030889,BP,,5359
neuron spine,121,0.506,0.812,1,GO:0044309,CC,,5360
positive regulation of focal adhesion assembly,22,0.515,0.812,1,GO:0051894,BP,,5361
positive regulation of response to oxidative stress,16,0.483,0.812,1,GO:1902884,BP,,5362
clathrin adaptor activity,11,0.521,0.813,1,"GO:0035615,GO:0098748",MF,endocytic adaptor activity,5363
negative regulation of tumor necrosis factor-mediated signaling pathway,12,0.52,0.813,1,GO:0010804,BP,,5364
regulation of carbohydrate catabolic process,37,0.489,0.813,1,GO:0043470,BP,,5365
voltage-gated sodium channel activity,22,0.515,0.813,1,"GO:0005248,GO:1905030",MF,voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential,5366
N-acetyltransferase activity,74,0.508,0.813,1,GO:0008080,MF,,5367
response to lipoprotein particle,20,0.485,0.814,1,GO:0055094,BP,,5368
mitochondrion distribution,12,0.48,0.814,1,GO:0048311,BP,,5369
trans-Golgi network membrane,76,0.508,0.814,1,GO:0032588,CC,,5370
response to gonadotropin,25,0.486,0.815,1,GO:0034698,BP,,5371
chemokine activity,28,0.487,0.815,1,GO:0008009,MF,,5372
histone exchange,34,0.512,0.815,1,GO:0043486,BP,,5373
membrane invagination,44,0.49,0.815,1,GO:0010324,BP,,5374
actin filament bundle assembly,123,0.506,0.815,1,GO:0051017,BP,,5375
interleukin-1 beta secretion,29,0.513,0.815,1,GO:0050702,BP,,5376
monocarboxylic acid transport,127,0.494,0.816,1,GO:0015718,BP,,5377
neuromuscular junction development,40,0.511,0.816,1,GO:0007528,BP,,5378
neurotransmitter catabolic process,11,0.48,0.816,1,GO:0042135,BP,,5379
fibroblast activation,10,0.521,0.817,1,GO:0072537,BP,,5380
neural nucleus development,56,0.509,0.817,1,GO:0048857,BP,,5381
regulation of cAMP-mediated signaling,13,0.519,0.817,1,GO:0043949,BP,,5382
blastocyst development,49,0.49,0.817,1,GO:0001824,BP,,5383
mRNA transcription from RNA polymerase II promoter,18,0.516,0.817,1,GO:0042789,BP,,5384
"phosphatidylinositol-3,4-bisphosphate binding",17,0.484,0.818,1,GO:0043325,MF,,5385
reciprocal meiotic recombination,36,0.489,0.818,1,"GO:0007131,GO:0035825",BP,reciprocal DNA recombination,5386
"CD4-positive or CD8-positive, alpha-beta T cell lineage commitment",10,0.479,0.818,1,GO:0043369,BP,,5387
TOR signaling,92,0.493,0.819,1,GO:0031929,BP,,5388
hyperosmotic response,17,0.484,0.82,1,GO:0006972,BP,,5389
acid-amino acid ligase activity,16,0.516,0.82,1,GO:0016881,MF,,5390
somatic stem cell division,20,0.515,0.82,1,GO:0048103,BP,,5391
lymph node development,14,0.518,0.82,1,GO:0048535,BP,,5392
amyloid fibril formation,11,0.52,0.821,1,GO:1990000,BP,,5393
negative regulation of JNK cascade,29,0.488,0.821,1,GO:0046329,BP,,5394
learning,126,0.506,0.821,1,GO:0007612,BP,,5395
positive regulation of interferon-beta production,26,0.513,0.821,1,GO:0032728,BP,,5396
regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,19,0.485,0.822,1,GO:2001267,BP,,5397
maintenance of gastrointestinal epithelium,12,0.519,0.822,1,GO:0030277,BP,,5398
cerebellar Purkinje cell layer morphogenesis,14,0.517,0.822,1,GO:0021692,BP,,5399
tooth mineralization,17,0.516,0.822,1,GO:0034505,BP,,5400
phosphate ion transport,15,0.517,0.822,1,GO:0006817,BP,,5401
negative regulation of organic acid transport,16,0.484,0.822,1,GO:0032891,BP,,5402
meiotic chromosome separation,14,0.483,0.823,1,GO:0051307,BP,,5403
interferon-gamma secretion,12,0.519,0.823,1,GO:0072643,BP,,5404
A band,36,0.511,0.823,1,GO:0031672,CC,,5405
regulation of fibroblast growth factor receptor signaling pathway,24,0.513,0.823,1,GO:0040036,BP,,5406
locomotor rhythm,10,0.52,0.823,1,GO:0045475,BP,,5407
cilium or flagellum-dependent cell motility,26,0.487,0.823,1,GO:0001539,BP,,5408
leading edge membrane,130,0.506,0.823,1,GO:0031256,CC,,5409
neutral amino acid transport,33,0.511,0.824,1,GO:0015804,BP,,5410
positive regulation of oxidative stress-induced cell death,12,0.519,0.824,1,GO:1903209,BP,,5411
positive regulation of receptor internalization,21,0.486,0.825,1,GO:0002092,BP,,5412
eyelid development in camera-type eye,10,0.52,0.825,1,GO:0061029,BP,,5413
ribosome binding,41,0.49,0.825,1,GO:0043022,MF,,5414
positive regulation of reactive oxygen species biosynthetic process,39,0.49,0.825,1,GO:1903428,BP,,5415
cellular response to biotic stimulus,148,0.495,0.825,1,GO:0071216,BP,,5416
one-carbon metabolic process,31,0.489,0.826,1,GO:0006730,BP,,5417
response to estrogen,62,0.508,0.826,1,GO:0043627,BP,,5418
positive regulation of tumor necrosis factor superfamily cytokine production,52,0.509,0.826,1,GO:1903557,BP,,5419
protein phosphatase type 2A complex,20,0.514,0.826,1,GO:0000159,CC,,5420
retinoid binding,23,0.487,0.827,1,GO:0005501,MF,,5421
ruffle organization,38,0.51,0.827,1,GO:0031529,BP,,5422
photoreceptor disc membrane,12,0.482,0.827,1,GO:0097381,CC,,5423
cilium-dependent cell motility,25,0.487,0.827,1,GO:0060285,BP,,5424
heart field specification,10,0.52,0.827,1,GO:0003128,BP,,5425
relaxation of muscle,27,0.512,0.827,1,GO:0090075,BP,,5426
clathrin adaptor complex,29,0.512,0.827,1,GO:0030131,CC,,5427
regulatory T cell differentiation,17,0.515,0.827,1,GO:0045066,BP,,5428
cellular response to corticosteroid stimulus,54,0.509,0.828,1,GO:0071384,BP,,5429
negative regulation of potassium ion transmembrane transporter activity,13,0.483,0.828,1,GO:1901017,BP,,5430
cAMP biosynthetic process,97,0.494,0.828,1,"GO:0006171,GO:0030817",BP,regulation of cAMP biosynthetic process,5431
regulation of myoblast fusion,14,0.517,0.828,1,GO:1901739,BP,,5432
cellular response to estrogen stimulus,11,0.519,0.828,1,GO:0071391,BP,,5433
bioactive lipid receptor activity,11,0.519,0.828,1,GO:0045125,MF,,5434
negative regulation of sprouting angiogenesis,12,0.482,0.829,1,GO:1903671,BP,,5435
small protein activating enzyme activity,10,0.52,0.829,1,GO:0008641,MF,,5436
centriole-centriole cohesion,10,0.52,0.829,1,GO:0010457,BP,,5437
bile acid metabolic process,38,0.49,0.829,1,GO:0008206,BP,,5438
visual behavior,48,0.509,0.829,1,GO:0007632,BP,,5439
lysine metabolic process,13,0.517,0.829,1,GO:0006553,BP,,5440
mast cell chemotaxis,11,0.481,0.83,1,GO:0002551,BP,,5441
positive regulation of cytokinesis,27,0.488,0.83,1,GO:0032467,BP,,5442
glycosaminoglycan binding,162,0.505,0.83,1,GO:0005539,MF,,5443
G-protein coupled glutamate receptor signaling pathway,13,0.517,0.831,1,GO:0007216,BP,,5444
telomere maintenance in response to DNA damage,10,0.52,0.831,1,GO:0043247,BP,,5445
regulation of neurological system process,56,0.492,0.831,1,GO:0031644,BP,,5446
motor neuron axon guidance,24,0.513,0.831,1,GO:0008045,BP,,5447
mitotic sister chromatid separation,43,0.491,0.831,1,GO:0051306,BP,,5448
positive regulation of myoblast fusion,13,0.483,0.831,1,GO:1901741,BP,,5449
negative regulation of cardiac muscle tissue development,21,0.487,0.832,1,GO:0055026,BP,,5450
response to organophosphorus,116,0.506,0.832,1,GO:0046683,BP,,5451
dorsal spinal cord development,15,0.516,0.833,1,GO:0021516,BP,,5452
MHC protein complex,25,0.488,0.833,1,GO:0042611,CC,,5453
intestinal epithelial cell differentiation,12,0.518,0.834,1,GO:0060575,BP,,5454
defense response to Gram-positive bacterium,39,0.49,0.834,1,GO:0050830,BP,,5455
regulation of myotube differentiation,41,0.491,0.834,1,GO:0010830,BP,,5456
mesodermal cell fate specification,12,0.483,0.834,1,GO:0007501,BP,,5457
negative regulation of telomere maintenance via telomere lengthening,21,0.487,0.834,1,GO:1904357,BP,,5458
negative regulation of ossification,65,0.507,0.835,1,GO:0030279,BP,,5459
modified amino acid transport,20,0.513,0.835,1,GO:0072337,BP,,5460
regulation of cardiac muscle tissue growth,39,0.51,0.835,1,GO:0055021,BP,,5461
regulation of hydrogen peroxide metabolic process,12,0.483,0.835,1,GO:0010310,BP,,5462
regulation of appetite,20,0.487,0.836,1,GO:0032098,BP,,5463
COPI-coated vesicle membrane,15,0.515,0.836,1,GO:0030663,CC,,5464
RNA cap binding complex,12,0.483,0.836,1,GO:0034518,CC,,5465
negative regulation of receptor binding,11,0.518,0.836,1,GO:1900121,BP,,5466
negative regulation of sister chromatid segregation,31,0.511,0.837,1,"GO:0033046,GO:0051985",BP,negative regulation of chromosome segregation,5467
phosphoprotein phosphatase activity,164,0.505,0.837,1,GO:0004721,MF,,5468
negative regulation of protein localization to nucleus,69,0.493,0.837,1,GO:1900181,BP,,5469
glycolipid biosynthetic process,46,0.509,0.837,1,GO:0009247,BP,,5470
DNA geometric change,73,0.493,0.837,1,GO:0032392,BP,,5471
neuronal ion channel clustering,10,0.519,0.838,1,GO:0045161,BP,,5472
response to alcohol,158,0.505,0.838,1,GO:0097305,BP,,5473
"phosphotransferase activity, nitrogenous group as acceptor",11,0.482,0.838,1,GO:0016775,MF,,5474
negative regulation of fatty acid metabolic process,19,0.514,0.838,1,GO:0045922,BP,,5475
response to glucocorticoid,118,0.495,0.838,1,GO:0051384,BP,,5476
response to carbohydrate,177,0.496,0.838,1,GO:0009743,BP,,5477
GDP binding,53,0.492,0.838,1,GO:0019003,MF,,5478
translation regulator activity,33,0.51,0.839,1,GO:0045182,MF,,5479
complement binding,14,0.484,0.839,1,GO:0001848,MF,,5480
salivary gland morphogenesis,31,0.489,0.839,1,GO:0007435,BP,,5481
cell migration involved in sprouting angiogenesis,31,0.511,0.839,1,GO:0002042,BP,,5482
regulation of axon extension involved in axon guidance,16,0.485,0.839,1,GO:0048841,BP,,5483
sphingolipid binding,10,0.518,0.84,1,GO:0046625,MF,,5484
DNA-dependent DNA replication,128,0.505,0.84,1,GO:0006261,BP,,5485
phosphatase binding,150,0.505,0.841,1,GO:0019902,MF,,5486
positive regulation of toll-like receptor signaling pathway,15,0.485,0.841,1,GO:0034123,BP,,5487
endocrine process,63,0.493,0.841,1,GO:0050886,BP,,5488
negative regulation of neuron apoptotic process,126,0.495,0.841,1,GO:0043524,BP,,5489
regulation of T cell migration,19,0.513,0.841,1,GO:2000404,BP,,5490
detection of temperature stimulus involved in sensory perception,14,0.485,0.841,1,"GO:0050961,GO:0050965",BP,detection of temperature stimulus involved in sensory perception of pain,5491
GTPase activating protein binding,14,0.485,0.842,1,GO:0032794,MF,,5492
response to muscle activity,18,0.514,0.842,1,GO:0014850,BP,,5493
pyrimidine-containing compound salvage,12,0.517,0.842,1,"GO:0008655,GO:0043097",BP,pyrimidine nucleoside salvage,5494
NAD+ kinase activity,17,0.514,0.842,1,GO:0003951,MF,,5495
regulation of lymphocyte chemotaxis,13,0.484,0.843,1,GO:1901623,BP,,5496
"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",109,0.494,0.843,1,GO:0000184,BP,,5497
motile cilium,115,0.495,0.843,1,GO:0031514,CC,,5498
regulation of transcription from RNA polymerase II promoter in response to oxidative stress,11,0.517,0.844,1,GO:0043619,BP,,5499
regulation of catenin import into nucleus,22,0.488,0.844,1,GO:0035412,BP,,5500
ion antiporter activity,55,0.508,0.844,1,GO:0099516,MF,,5501
cerebral cortex radially oriented cell migration,31,0.51,0.844,1,GO:0021799,BP,,5502
labyrinthine layer blood vessel development,20,0.513,0.845,1,GO:0060716,BP,,5503
organic hydroxy compound transport,178,0.496,0.845,1,GO:0015850,BP,,5504
negative regulation of epithelial cell migration,47,0.508,0.845,1,GO:0010633,BP,,5505
insulin-like growth factor I binding,12,0.516,0.845,1,GO:0031994,MF,,5506
regulation of cell adhesion mediated by integrin,35,0.49,0.846,1,GO:0033628,BP,,5507
metaphase/anaphase transition of mitotic cell cycle,41,0.491,0.846,1,"GO:0007091,GO:0010965,GO:0044784,GO:1905818",BP,"regulation of mitotic sister chromatid separation,metaphase/anaphase transition of cell cycle,regulation of chromosome separation",5508
"3',5'-cyclic-GMP phosphodiesterase activity",13,0.484,0.846,1,GO:0047555,MF,,5509
positive regulation of granulocyte chemotaxis,22,0.488,0.846,1,GO:0071624,BP,,5510
receptor clustering,45,0.508,0.846,1,GO:0043113,BP,,5511
protein serine/threonine phosphatase complex,45,0.508,0.847,1,"GO:0008287,GO:1903293",CC,phosphatase complex,5512
inositol phosphate metabolic process,62,0.493,0.847,1,GO:0043647,BP,,5513
tumor necrosis factor-activated receptor activity,22,0.488,0.847,1,"GO:0005031,GO:0005035",MF,death receptor activity,5514
renal water homeostasis,29,0.49,0.848,1,GO:0003091,BP,,5515
smooth endoplasmic reticulum,29,0.49,0.848,1,GO:0005790,CC,,5516
muscle cell apoptotic process,43,0.508,0.848,1,GO:0010657,BP,,5517
MAP kinase phosphatase activity,13,0.515,0.848,1,GO:0033549,MF,,5518
adult locomotory behavior,67,0.493,0.848,1,GO:0008344,BP,,5519
mitochondrial RNA metabolic process,27,0.489,0.848,1,GO:0000959,BP,,5520
gamma-aminobutyric acid transport,12,0.484,0.849,1,GO:0015812,BP,,5521
positive regulation of tumor necrosis factor production,50,0.508,0.849,1,GO:0032760,BP,,5522
pyrimidine nucleoside monophosphate biosynthetic process,13,0.515,0.849,1,GO:0009130,BP,,5523
auditory receptor cell morphogenesis,12,0.516,0.849,1,GO:0002093,BP,,5524
regulation of cyclin-dependent protein serine/threonine kinase activity,76,0.506,0.85,1,GO:0000079,BP,,5525
negative regulation of oxidoreductase activity,16,0.486,0.85,1,GO:0051354,BP,,5526
response to misfolded protein,23,0.511,0.85,1,GO:0051788,BP,,5527
non-membrane spanning protein tyrosine kinase activity,43,0.492,0.85,1,GO:0004715,MF,,5528
positive regulation of protein autophosphorylation,24,0.489,0.851,1,GO:0031954,BP,,5529
regulation of cytokine production involved in immune response,49,0.508,0.851,1,GO:0002718,BP,,5530
U12-type spliceosomal complex,22,0.488,0.851,1,GO:0005689,CC,,5531
actin filament depolymerization,45,0.508,0.851,1,GO:0030042,BP,,5532
negative regulation of cartilage development,21,0.512,0.851,1,GO:0061037,BP,,5533
regulation of protein binding,163,0.504,0.852,1,GO:0043393,BP,,5534
negative regulation of histone acetylation,15,0.514,0.852,1,GO:0035067,BP,,5535
acetyl-CoA biosynthetic process from pyruvate,14,0.514,0.853,1,GO:0006086,BP,,5536
positive regulation of transcription regulatory region DNA binding,17,0.487,0.853,1,GO:2000679,BP,,5537
lipid phosphatase activity,10,0.517,0.853,1,GO:0042577,MF,,5538
phosphate ion transmembrane transport,10,0.517,0.854,1,"GO:0035435,GO:0015114,GO:1901677",BP,"phosphate ion transmembrane transporter activity,phosphate transmembrane transporter activity",5539
trans-Golgi network transport vesicle,26,0.49,0.854,1,GO:0030140,CC,,5540
polyol biosynthetic process,35,0.491,0.854,1,GO:0046173,BP,,5541
regulation of acetyl-CoA biosynthetic process from pyruvate,12,0.485,0.854,1,GO:0010510,BP,,5542
protein targeting to plasma membrane,23,0.511,0.854,1,GO:0072661,BP,,5543
positive regulation of cytokine secretion,80,0.494,0.855,1,GO:0050715,BP,,5544
regulation of plasma lipoprotein particle levels,45,0.508,0.855,1,GO:0097006,BP,,5545
"positive regulation of CD4-positive, alpha-beta T cell differentiation",18,0.488,0.855,1,GO:0043372,BP,,5546
midgut development,11,0.516,0.855,1,GO:0007494,BP,,5547
protein tyrosine phosphatase activity,94,0.495,0.855,1,GO:0004725,MF,,5548
DNA replication-dependent nucleosome assembly,14,0.486,0.855,1,"GO:0006335,GO:0034723",BP,DNA replication-dependent nucleosome organization,5549
negative regulation of supramolecular fiber organization,99,0.505,0.856,1,GO:1902904,BP,,5550
regulation of substrate adhesion-dependent cell spreading,40,0.508,0.857,1,GO:1900024,BP,,5551
response to ether,11,0.516,0.857,1,GO:0045472,BP,,5552
endoderm formation,48,0.492,0.857,1,GO:0001706,BP,,5553
regulation of chemokine production,50,0.493,0.857,1,GO:0032642,BP,,5554
negative regulation of signal transduction by p53 class mediator,27,0.51,0.858,1,GO:1901797,BP,,5555
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,11,0.484,0.858,1,GO:1990440,BP,,5556
tissue remodeling,124,0.505,0.858,1,GO:0048771,BP,,5557
positive regulation of chromatin binding,10,0.516,0.858,1,GO:0035563,BP,,5558
immunological synapse formation,11,0.516,0.858,1,GO:0001771,BP,,5559
pseudopodium,15,0.487,0.859,1,GO:0031143,CC,,5560
positive regulation of adenylate cyclase activity,43,0.508,0.859,1,GO:0045762,BP,,5561
regulation of lipase activity,61,0.493,0.859,1,GO:0060191,BP,,5562
glial cell fate commitment,11,0.485,0.859,1,"GO:0021781,GO:0016653",BP,"oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor",5563
defense response to virus,181,0.504,0.86,1,GO:0051607,BP,,5564
bone trabecula morphogenesis,10,0.516,0.86,1,GO:0061430,BP,,5565
negative regulation of glial cell proliferation,13,0.486,0.86,1,GO:0060253,BP,,5566
renal system process involved in regulation of systemic arterial blood pressure,16,0.487,0.86,1,GO:0003071,BP,,5567
contractile fiber part,173,0.496,0.86,1,GO:0044449,CC,,5568
regulation of leukocyte adhesion to vascular endothelial cell,10,0.484,0.86,1,GO:1904994,BP,,5569
positive regulation of telomere maintenance via telomere lengthening,28,0.51,0.86,1,GO:1904358,BP,,5570
positive regulation of leukocyte proliferation,106,0.495,0.861,1,GO:0070665,BP,,5571
negative regulation of synapse organization,12,0.485,0.861,1,GO:1905809,BP,,5572
voltage-gated sodium channel complex,13,0.514,0.861,1,GO:0001518,CC,,5573
intraciliary transport particle,29,0.509,0.861,1,GO:0030990,CC,,5574
gap junction,25,0.49,0.862,1,GO:0005921,CC,,5575
drug metabolic process,22,0.489,0.862,1,GO:0017144,BP,,5576
regulation of nuclear division,149,0.496,0.862,1,GO:0051783,BP,,5577
proteoglycan binding,34,0.491,0.862,1,GO:0043394,MF,,5578
regulation of viral release from host cell,28,0.509,0.862,1,GO:1902186,BP,,5579
regulation of spindle checkpoint,15,0.513,0.862,1,GO:0090231,BP,,5580
modulation of excitatory postsynaptic potential,31,0.509,0.862,1,GO:0098815,BP,,5581
negative regulation of microtubule depolymerization,15,0.487,0.862,1,"GO:0007026,GO:0031114",BP,regulation of microtubule depolymerization,5582
regulation of T-helper 1 type immune response,13,0.514,0.862,1,GO:0002825,BP,,5583
"positive regulation of synaptic transmission, GABAergic",11,0.485,0.863,1,GO:0032230,BP,,5584
host,15,0.513,0.863,1,"GO:0018995,GO:0043657",CC,host cell,5585
tumor necrosis factor biosynthetic process,15,0.487,0.863,1,"GO:0042533,GO:0042534",BP,regulation of tumor necrosis factor biosynthetic process,5586
glandular epithelial cell differentiation,39,0.508,0.863,1,GO:0002067,BP,,5587
ovulation cycle process,70,0.506,0.863,1,GO:0022602,BP,,5588
memory,93,0.495,0.864,1,GO:0007613,BP,,5589
positive regulation of syncytium formation by plasma membrane fusion,18,0.512,0.864,1,GO:0060143,BP,,5590
maternal process involved in female pregnancy,51,0.493,0.864,1,GO:0060135,BP,,5591
ciliary basal body,92,0.505,0.864,1,GO:0036064,CC,,5592
9+0 non-motile cilium,79,0.494,0.864,1,"GO:0097731,GO:0097733",CC,photoreceptor cell cilium,5593
retina vasculature development in camera-type eye,16,0.488,0.864,1,GO:0061298,BP,,5594
tRNA wobble base modification,11,0.485,0.865,1,GO:0002097,BP,,5595
muscle hypertrophy in response to stress,16,0.512,0.865,1,"GO:0003299,GO:0014887,GO:0014898",BP,"cardiac muscle adaptation,cardiac muscle hypertrophy in response to stress",5596
response to nicotine,42,0.492,0.865,1,GO:0035094,BP,,5597
protein localization to chromatin,16,0.488,0.865,1,GO:0071168,BP,,5598
protein serine/threonine kinase activator activity,23,0.49,0.865,1,GO:0043539,MF,,5599
positive regulation of excitatory postsynaptic potential,23,0.49,0.865,1,GO:2000463,BP,,5600
Rab GTPase binding,125,0.496,0.865,1,GO:0017137,MF,,5601
ventricular cardiac muscle cell differentiation,15,0.487,0.866,1,GO:0055012,BP,,5602
striated muscle cell development,120,0.496,0.866,1,GO:0055002,BP,,5603
positive regulation of JAK-STAT cascade,48,0.507,0.866,1,"GO:0046427,GO:1904894",BP,positive regulation of STAT cascade,5604
estrogen metabolic process,14,0.487,0.866,1,GO:0008210,BP,,5605
positive regulation of T cell migration,14,0.487,0.866,1,GO:2000406,BP,,5606
regulation of T-helper 2 cell differentiation,10,0.515,0.866,1,GO:0045628,BP,,5607
dynein complex,43,0.507,0.866,1,GO:0030286,CC,,5608
negative regulation of heart contraction,21,0.511,0.866,1,GO:0045822,BP,,5609
"synaptic transmission, GABAergic",36,0.508,0.866,1,GO:0051932,BP,,5610
regulation of interleukin-4 production,20,0.511,0.867,1,GO:0032673,BP,,5611
reactive oxygen species biosynthetic process,77,0.494,0.867,1,GO:1903409,BP,,5612
regulation of receptor internalization,33,0.492,0.867,1,GO:0002090,BP,,5613
protein kinase activator activity,60,0.494,0.867,1,GO:0030295,MF,,5614
anatomical structure maturation,49,0.493,0.867,1,GO:0071695,BP,,5615
activation of cysteine-type endopeptidase activity involved in apoptotic process,71,0.494,0.867,1,GO:0006919,BP,,5616
regulation of telomere maintenance,60,0.506,0.868,1,GO:0032204,BP,,5617
regulation of cyclin-dependent protein kinase activity,79,0.505,0.868,1,GO:1904029,BP,,5618
natural killer cell differentiation,16,0.512,0.87,1,GO:0001779,BP,,5619
methyltransferase activity,181,0.496,0.87,1,GO:0008168,MF,,5620
ciliary tip,44,0.507,0.87,1,GO:0097542,CC,,5621
ferrous iron binding,20,0.489,0.87,1,GO:0008198,MF,,5622
glomerular filtration,15,0.488,0.87,1,GO:0003094,BP,,5623
negative regulation of interferon-gamma production,22,0.49,0.87,1,GO:0032689,BP,,5624
skeletal muscle fiber development,26,0.491,0.87,1,GO:0048741,BP,,5625
cornified envelope,32,0.508,0.87,1,GO:0001533,CC,,5626
positive regulation of vascular endothelial growth factor receptor signaling pathway,14,0.513,0.871,1,GO:0030949,BP,,5627
peroxisome proliferator activated receptor signaling pathway,19,0.511,0.871,1,GO:0035357,BP,,5628
positive regulation of fatty acid metabolic process,27,0.491,0.871,1,GO:0045923,BP,,5629
regulation of toll-like receptor 4 signaling pathway,12,0.486,0.871,1,GO:0034143,BP,,5630
catenin import into nucleus,24,0.51,0.871,1,GO:0035411,BP,,5631
positive regulation of urine volume,12,0.514,0.871,1,GO:0035810,BP,,5632
associative learning,69,0.494,0.871,1,GO:0008306,BP,,5633
regulation of cysteine-type endopeptidase activity,184,0.503,0.871,1,GO:2000116,BP,,5634
neurexin family protein binding,12,0.514,0.871,1,GO:0042043,MF,,5635
growth hormone secretion,14,0.487,0.871,1,GO:0030252,BP,,5636
integral component of Golgi membrane,48,0.507,0.872,1,GO:0030173,CC,,5637
sulfur compound binding,188,0.497,0.872,1,GO:1901681,MF,,5638
deacetylase activity,49,0.507,0.872,1,GO:0019213,MF,,5639
response to angiotensin,15,0.512,0.872,1,GO:1990776,BP,,5640
necroptotic process,33,0.508,0.873,1,GO:0070266,BP,,5641
positive regulation of blood pressure,32,0.508,0.873,1,GO:0045777,BP,,5642
alkali metal ion binding,17,0.511,0.873,1,GO:0031420,MF,,5643
formation of extrachromosomal circular DNA,12,0.487,0.873,1,"GO:0001325,GO:0090656,GO:0090737",BP,"t-circle formation,telomere maintenance via telomere trimming",5644
positive regulation of alpha-beta T cell activation,40,0.507,0.873,1,GO:0046635,BP,,5645
tRNA processing,93,0.505,0.874,1,GO:0008033,BP,,5646
regulation of T cell proliferation,118,0.504,0.874,1,GO:0042129,BP,,5647
protein serine/threonine phosphatase activity,63,0.506,0.874,1,GO:0004722,MF,,5648
regulation of viral transcription,55,0.494,0.874,1,GO:0046782,BP,,5649
detection of external stimulus,108,0.504,0.874,1,GO:0009581,BP,,5650
"condensed chromosome, centromeric region",96,0.495,0.874,1,GO:0000779,CC,,5651
response to nerve growth factor,43,0.507,0.874,1,GO:1990089,BP,,5652
regulation of peptidyl-lysine acetylation,49,0.507,0.875,1,GO:2000756,BP,,5653
positive regulation of cell-cell adhesion,200,0.503,0.875,1,GO:0022409,BP,,5654
phosphatidylinositol-4-phosphate binding,20,0.49,0.875,1,GO:0070273,MF,,5655
cardiocyte differentiation,107,0.496,0.875,1,GO:0035051,BP,,5656
cation:cation antiporter activity,27,0.509,0.875,1,GO:0015491,MF,,5657
calcium-dependent cysteine-type endopeptidase activity,17,0.511,0.875,1,GO:0004198,MF,,5658
response to interferon-gamma,131,0.504,0.875,1,GO:0034341,BP,,5659
regulation of anion transport,87,0.505,0.875,1,GO:0044070,BP,,5660
activation of adenylate cyclase activity,32,0.508,0.876,1,GO:0007190,BP,,5661
iron coordination entity transport,10,0.514,0.876,1,GO:1901678,BP,,5662
cytoskeleton-dependent intracellular transport,135,0.496,0.876,1,GO:0030705,BP,,5663
negative regulation of toll-like receptor signaling pathway,24,0.509,0.877,1,GO:0034122,BP,,5664
S-acyltransferase activity,26,0.509,0.877,1,GO:0016417,MF,,5665
pyrimidine deoxyribonucleotide metabolic process,16,0.489,0.877,1,GO:0009219,BP,,5666
regulation of cartilage development,55,0.494,0.877,1,GO:0061035,BP,,5667
transposition,10,0.514,0.877,1,GO:0032196,BP,,5668
fatty acid ligase activity,17,0.511,0.877,1,GO:0015645,MF,,5669
multi-organism metabolic process,192,0.503,0.877,1,GO:0044033,BP,,5670
azurophil granule membrane,45,0.507,0.877,1,GO:0035577,CC,,5671
endocytic recycling,30,0.508,0.877,1,GO:0032456,BP,,5672
DNA replication factor A complex,14,0.512,0.877,1,GO:0005662,CC,,5673
regulation of timing of cell differentiation,10,0.514,0.878,1,GO:0048505,BP,,5674
regulation of interferon-beta production,41,0.493,0.878,1,GO:0032648,BP,,5675
regulation of muscle hypertrophy,40,0.507,0.878,1,GO:0014743,BP,,5676
multicellular organismal movement,38,0.493,0.878,1,"GO:0050879,GO:0050881",BP,musculoskeletal movement,5677
telomere maintenance,119,0.496,0.878,1,GO:0000723,BP,,5678
adenohypophysis development,11,0.487,0.879,1,GO:0021984,BP,,5679
fibrillar center,110,0.504,0.879,1,GO:0001650,CC,,5680
histone methyltransferase activity,50,0.506,0.879,1,GO:0042054,MF,,5681
positive regulation of actin filament bundle assembly,49,0.494,0.879,1,GO:0032233,BP,,5682
cartilage development,158,0.504,0.879,1,GO:0051216,BP,,5683
positive regulation of endocytosis,95,0.505,0.879,1,GO:0045807,BP,,5684
regulation of myelination,29,0.508,0.88,1,GO:0031641,BP,,5685
inositol trisphosphate phosphatase activity,11,0.487,0.88,1,GO:0046030,MF,,5686
negative regulation of cell fate commitment,10,0.514,0.881,1,GO:0010454,BP,,5687
cAMP metabolic process,121,0.504,0.881,1,GO:0046058,BP,,5688
extracellular exosome biogenesis,18,0.49,0.881,1,GO:0097734,BP,,5689
corpus callosum development,13,0.488,0.882,1,GO:0022038,BP,,5690
cellular response to pH,16,0.511,0.882,1,GO:0071467,BP,,5691
positive regulation of calcium ion transport into cytosol,38,0.493,0.882,1,GO:0010524,BP,,5692
2-oxoglutarate metabolic process,15,0.489,0.883,1,GO:0006103,BP,,5693
"negative regulation of DNA damage response, signal transduction by p53 class mediator",14,0.489,0.883,1,GO:0043518,BP,,5694
positive regulation of keratinocyte differentiation,12,0.488,0.883,1,GO:0045618,BP,,5695
positive regulation of fat cell differentiation,49,0.506,0.883,1,GO:0045600,BP,,5696
MLL1/2 complex,24,0.491,0.883,1,"GO:0044665,GO:0071339",CC,MLL1 complex,5697
viral release from host cell,32,0.493,0.884,1,"GO:0019076,GO:0035890,GO:0035891,GO:0052126,GO:0052192",BP,"exit from host,exit from host cell,movement in host environment,movement in environment of other organism involved in symbiotic interaction",5698
pteridine-containing compound metabolic process,32,0.507,0.884,1,GO:0042558,BP,,5699
renal absorption,13,0.512,0.884,1,GO:0070293,BP,,5700
positive regulation of intracellular steroid hormone receptor signaling pathway,14,0.511,0.884,1,GO:0033145,BP,,5701
filamentous actin,27,0.508,0.884,1,GO:0031941,CC,,5702
natural killer cell mediated immunity,41,0.493,0.884,1,GO:0002228,BP,,5703
synapsis,34,0.507,0.885,1,GO:0007129,BP,,5704
positive regulation of striated muscle tissue development,54,0.494,0.885,1,"GO:0045844,GO:0048636",BP,positive regulation of muscle organ development,5705
phagocytic vesicle,96,0.504,0.885,1,GO:0045335,CC,,5706
MHC protein binding,25,0.492,0.886,1,GO:0042287,MF,,5707
positive regulation of transforming growth factor beta receptor signaling pathway,23,0.509,0.886,1,"GO:0030511,GO:1903846",BP,positive regulation of cellular response to transforming growth factor beta stimulus,5708
adenylate cyclase-activating dopamine receptor signaling pathway,10,0.487,0.887,1,GO:0007191,BP,,5709
heparan sulfate proteoglycan binding,17,0.51,0.887,1,GO:0043395,MF,,5710
ncRNA 3'-end processing,15,0.511,0.888,1,GO:0043628,BP,,5711
response to low-density lipoprotein particle,15,0.489,0.888,1,GO:0055098,BP,,5712
carbonate dehydratase activity,11,0.512,0.888,1,GO:0004089,MF,,5713
response to exogenous dsRNA,30,0.507,0.888,1,GO:0043330,BP,,5714
mitochondrial fission,36,0.493,0.888,1,GO:0000266,BP,,5715
cytokine biosynthetic process,81,0.504,0.889,1,"GO:0042089,GO:0042107",BP,cytokine metabolic process,5716
cofactor transporter activity,16,0.51,0.889,1,GO:0051184,MF,,5717
cardiolipin metabolic process,10,0.513,0.89,1,GO:0032048,BP,,5718
pyrimidine nucleobase metabolic process,18,0.491,0.89,1,GO:0006206,BP,,5719
negative regulation of endothelial cell migration,33,0.507,0.891,1,GO:0010596,BP,,5720
positive regulation of mast cell activation involved in immune response,10,0.513,0.891,1,"GO:0033008,GO:0043306",BP,positive regulation of mast cell degranulation,5721
intraciliary transport involved in cilium assembly,40,0.506,0.891,1,GO:0035735,BP,,5722
triglyceride biosynthetic process,38,0.494,0.892,1,GO:0019432,BP,,5723
synapse assembly,137,0.497,0.892,1,GO:0007416,BP,,5724
thyroid gland development,20,0.491,0.892,1,GO:0030878,BP,,5725
negative regulation of DNA-dependent DNA replication,17,0.49,0.892,1,GO:2000104,BP,,5726
negative regulation of cell division,14,0.49,0.892,1,GO:0051782,BP,,5727
regulation of positive chemotaxis,20,0.509,0.893,1,GO:0050926,BP,,5728
regulation of translation in response to stress,19,0.509,0.893,1,GO:0043555,BP,,5729
ovarian follicle development,47,0.494,0.893,1,GO:0001541,BP,,5730
negative regulation of cyclic nucleotide biosynthetic process,33,0.493,0.893,1,GO:0030803,BP,,5731
response to gamma radiation,42,0.494,0.893,1,GO:0010332,BP,,5732
glandular epithelial cell development,24,0.492,0.893,1,GO:0002068,BP,,5733
serotonin receptor signaling pathway,18,0.491,0.894,1,"GO:0007210,GO:0098664,GO:0004993,GO:0099589",BP,"G-protein coupled serotonin receptor signaling pathway,G-protein coupled serotonin receptor activity,serotonin receptor activity",5734
negative regulation of immune response,96,0.504,0.894,1,GO:0050777,BP,,5735
acyl-CoA dehydrogenase activity,15,0.49,0.894,1,GO:0003995,MF,,5736
negative regulation of protein catabolic process,91,0.504,0.894,1,GO:0042177,BP,,5737
low-density lipoprotein particle clearance,13,0.511,0.894,1,GO:0034383,BP,,5738
salivary gland development,35,0.507,0.894,1,GO:0007431,BP,,5739
acetylcholine-gated channel complex,14,0.51,0.894,1,GO:0005892,CC,,5740
ATF6-mediated unfolded protein response,10,0.488,0.894,1,GO:0036500,BP,,5741
regulation of muscle cell apoptotic process,41,0.494,0.894,1,GO:0010660,BP,,5742
cellular response to monoamine stimulus,33,0.507,0.894,1,"GO:0071868,GO:0071870",BP,cellular response to catecholamine stimulus,5743
positive regulation of interleukin-10 production,22,0.492,0.894,1,GO:0032733,BP,,5744
response to amino acid,96,0.504,0.895,1,GO:0043200,BP,,5745
ventral spinal cord interneuron differentiation,14,0.51,0.895,1,GO:0021514,BP,,5746
protein kinase A binding,42,0.494,0.895,1,GO:0051018,MF,,5747
L-alpha-amino acid transmembrane transport,26,0.493,0.895,1,GO:1902475,BP,,5748
positive regulation of myeloid cell differentiation,63,0.495,0.895,1,GO:0045639,BP,,5749
positive regulation of cellular response to oxidative stress,14,0.49,0.895,1,GO:1900409,BP,,5750
neurological system process involved in regulation of systemic arterial blood pressure,12,0.511,0.896,1,GO:0001976,BP,,5751
negative regulation of intracellular transport,104,0.504,0.896,1,GO:0032387,BP,,5752
ephrin receptor binding,25,0.492,0.896,1,GO:0046875,MF,,5753
fibroblast growth factor receptor signaling pathway,96,0.504,0.897,1,GO:0008543,BP,,5754
programmed necrotic cell death,36,0.494,0.897,1,GO:0097300,BP,,5755
galactosyltransferase activity,30,0.493,0.897,1,GO:0008378,MF,,5756
action potential,121,0.503,0.897,1,GO:0001508,BP,,5757
positive regulation of vacuole organization,17,0.509,0.898,1,GO:0044090,BP,,5758
MKS complex,12,0.489,0.898,1,GO:0036038,CC,,5759
cellular response to interferon-gamma,113,0.504,0.898,1,GO:0071346,BP,,5760
peptide hormone receptor binding,14,0.51,0.898,1,GO:0051428,MF,,5761
positive regulation of interleukin-1 beta production,26,0.493,0.898,1,GO:0032731,BP,,5762
negative regulation of response to extracellular stimulus,11,0.489,0.899,1,"GO:0032105,GO:0032108",BP,negative regulation of response to nutrient levels,5763
regulation of carbohydrate metabolic process,126,0.497,0.899,1,GO:0006109,BP,,5764
adrenal gland development,18,0.509,0.899,1,GO:0030325,BP,,5765
RNA cap binding,15,0.491,0.899,1,GO:0000339,MF,,5766
cardiac muscle contraction,110,0.496,0.899,1,GO:0060048,BP,,5767
positive regulation of T cell proliferation,72,0.496,0.899,1,GO:0042102,BP,,5768
corticosteroid receptor signaling pathway,17,0.491,0.899,1,GO:0031958,BP,,5769
positive regulation of macrophage chemotaxis,10,0.488,0.9,1,GO:0010759,BP,,5770
positive regulation of neutrophil chemotaxis,21,0.492,0.9,1,GO:0090023,BP,,5771
positive regulation of G2/M transition of mitotic cell cycle,19,0.508,0.9,1,GO:0010971,BP,,5772
endothelial cell migration,144,0.503,0.9,1,GO:0043542,BP,,5773
detection of mechanical stimulus involved in sensory perception of sound,11,0.489,0.9,1,GO:0050910,BP,,5774
response to hepatocyte growth factor,13,0.49,0.9,1,GO:0035728,BP,,5775
vitamin transporter activity,18,0.508,0.901,1,GO:0051183,MF,,5776
cell communication involved in cardiac conduction,51,0.495,0.902,1,GO:0086065,BP,,5777
negative regulation of axon guidance,10,0.511,0.903,1,GO:1902668,BP,,5778
high-density lipoprotein particle,17,0.491,0.903,1,GO:0034364,CC,,5779
positive regulation of lipid transport,43,0.505,0.903,1,GO:0032370,BP,,5780
sodium-independent organic anion transmembrane transporter activity,12,0.49,0.903,1,GO:0015347,MF,,5781
protein kinase C activity,16,0.491,0.903,1,GO:0004697,MF,,5782
telomere organization,124,0.503,0.903,1,GO:0032200,BP,,5783
pre-autophagosomal structure membrane,12,0.49,0.904,1,GO:0034045,CC,,5784
anion:anion antiporter activity,28,0.507,0.904,1,GO:0015301,MF,,5785
retinoic acid receptor binding,21,0.492,0.904,1,GO:0042974,MF,,5786
regulation of lymphocyte migration,29,0.494,0.904,1,GO:2000401,BP,,5787
auditory receptor cell development,16,0.491,0.905,1,GO:0060117,BP,,5788
positive regulation of cartilage development,26,0.493,0.905,1,GO:0061036,BP,,5789
ficolin-1-rich granule membrane,53,0.495,0.905,1,GO:0101003,CC,,5790
contractile fiber,187,0.497,0.905,1,GO:0043292,CC,,5791
B cell mediated immunity,83,0.496,0.906,1,GO:0019724,BP,,5792
plasma lipoprotein particle assembly,14,0.509,0.906,1,GO:0034377,BP,,5793
regulation of protein kinase C signaling,14,0.491,0.906,1,GO:0090036,BP,,5794
positive regulation of viral transcription,35,0.494,0.907,1,GO:0050434,BP,,5795
integrin activation,14,0.491,0.907,1,GO:0033622,BP,,5796
calcium ion transmembrane import into cytosol,99,0.497,0.907,1,"GO:0097553,GO:1902656",BP,calcium ion import into cytosol,5797
positive regulation of mitochondrial membrane permeability,53,0.495,0.907,1,GO:0035794,BP,,5798
mature B cell differentiation,19,0.508,0.908,1,GO:0002335,BP,,5799
platelet-derived growth factor receptor binding,14,0.491,0.908,1,GO:0005161,MF,,5800
regulation of protein activation cascade,24,0.493,0.908,1,GO:2000257,BP,,5801
positive regulation of protein tyrosine kinase activity,36,0.494,0.908,1,GO:0061098,BP,,5802
ATP-dependent RNA helicase activity,59,0.496,0.908,1,GO:0004004,MF,,5803
actin filament bundle,56,0.496,0.908,1,GO:0032432,CC,,5804
ubiquitin-specific protease binding,13,0.509,0.908,1,GO:1990381,MF,,5805
interferon-beta production,43,0.495,0.908,1,GO:0032608,BP,,5806
clathrin coat of coated pit,18,0.492,0.908,1,GO:0030132,CC,,5807
renal filtration,16,0.492,0.909,1,GO:0097205,BP,,5808
phosphatase inhibitor activity,35,0.494,0.909,1,GO:0019212,MF,,5809
RNA polymerase II transcription coactivator activity,32,0.506,0.909,1,GO:0001105,MF,,5810
regulation of interleukin-1 production,46,0.505,0.91,1,GO:0032652,BP,,5811
cellular response to mechanical stimulus,70,0.504,0.91,1,GO:0071260,BP,,5812
keratan sulfate catabolic process,10,0.49,0.91,1,GO:0042340,BP,,5813
positive regulation of cAMP metabolic process,68,0.496,0.91,1,GO:0030816,BP,,5814
fucosyltransferase activity,11,0.49,0.91,1,GO:0008417,MF,,5815
negative regulation of cAMP metabolic process,35,0.495,0.91,1,GO:0030815,BP,,5816
arachidonic acid metabolic process,40,0.495,0.911,1,GO:0019369,BP,,5817
phasic smooth muscle contraction,12,0.491,0.911,1,GO:0014821,BP,,5818
chromosome condensation,28,0.494,0.911,1,GO:0030261,BP,,5819
negative regulation of leukocyte activation,118,0.497,0.911,1,GO:0002695,BP,,5820
positive regulation of transcription from RNA polymerase III promoter,10,0.51,0.912,1,GO:0045945,BP,,5821
preassembly of GPI anchor in ER membrane,14,0.491,0.912,1,GO:0016254,BP,,5822
"oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor",14,0.509,0.912,1,GO:0016641,MF,,5823
cellular response to nutrient,31,0.506,0.913,1,GO:0031670,BP,,5824
toxin metabolic process,10,0.49,0.913,1,GO:0009404,BP,,5825
ribonucleoprotein granule,165,0.502,0.913,1,GO:0035770,CC,,5826
positive regulation of positive chemotaxis,19,0.507,0.914,1,GO:0050927,BP,,5827
plasma membrane receptor complex,152,0.503,0.914,1,GO:0098802,CC,,5828
positive regulation of type 2 immune response,12,0.509,0.914,1,GO:0002830,BP,,5829
activation of MAPKKK activity,11,0.491,0.914,1,GO:0000185,BP,,5830
positive regulation of myelination,11,0.509,0.915,1,GO:0031643,BP,,5831
response to osmotic stress,58,0.496,0.915,1,GO:0006970,BP,,5832
negative regulation of response to food,10,0.51,0.915,1,"GO:0032096,GO:0032099",BP,negative regulation of appetite,5833
regulation of phosphatidylinositol 3-kinase activity,35,0.495,0.915,1,GO:0043551,BP,,5834
cell aging,80,0.497,0.915,1,GO:0007569,BP,,5835
regulation of endothelial cell chemotaxis,18,0.507,0.916,1,GO:2001026,BP,,5836
methionine metabolic process,19,0.493,0.916,1,GO:0006555,BP,,5837
regulation of meiotic cell cycle,26,0.506,0.916,1,GO:0051445,BP,,5838
actin filament-based movement,107,0.503,0.916,1,GO:0030048,BP,,5839
regulation of chondrocyte differentiation,39,0.495,0.917,1,GO:0032330,BP,,5840
regulation of cell migration involved in sprouting angiogenesis,18,0.493,0.917,1,GO:0090049,BP,,5841
regulation of interleukin-6 production,84,0.497,0.917,1,GO:0032675,BP,,5842
cellular response to angiotensin,13,0.508,0.918,1,GO:1904385,BP,,5843
termination of RNA polymerase II transcription,59,0.504,0.918,1,GO:0006369,BP,,5844
actin filament,81,0.503,0.918,1,GO:0005884,CC,,5845
tRNA threonylcarbamoyladenosine metabolic process,11,0.491,0.918,1,GO:0070525,BP,,5846
Wnt-activated receptor activity,14,0.508,0.918,1,GO:0042813,MF,,5847
photoreceptor cell development,32,0.495,0.918,1,GO:0042461,BP,,5848
circadian behavior,38,0.505,0.919,1,GO:0048512,BP,,5849
mannosyltransferase activity,20,0.493,0.919,1,GO:0000030,MF,,5850
rough endoplasmic reticulum,61,0.504,0.92,1,GO:0005791,CC,,5851
actin filament bundle organization,126,0.503,0.92,1,GO:0061572,BP,,5852
positive regulation of small GTPase mediated signal transduction,43,0.504,0.92,1,GO:0051057,BP,,5853
sulfur amino acid biosynthetic process,16,0.493,0.92,1,GO:0000097,BP,,5854
regulation of lamellipodium organization,34,0.495,0.92,1,GO:1902743,BP,,5855
unsaturated fatty acid metabolic process,80,0.497,0.92,1,GO:0033559,BP,,5856
regulation of cytokine biosynthetic process,74,0.503,0.92,1,GO:0042035,BP,,5857
substantia nigra development,39,0.495,0.92,1,GO:0021762,BP,,5858
regulation of cell division,115,0.503,0.921,1,GO:0051302,BP,,5859
copper ion transport,17,0.493,0.921,1,GO:0006825,BP,,5860
voltage-gated calcium channel complex,38,0.505,0.921,1,GO:0005891,CC,,5861
negative regulation of response to wounding,65,0.504,0.921,1,GO:1903035,BP,,5862
negative regulation of protein acetylation,18,0.507,0.921,1,GO:1901984,BP,,5863
calcium-transporting ATPase activity,12,0.492,0.921,1,GO:0005388,MF,,5864
positive regulation of DNA-dependent DNA replication,14,0.508,0.922,1,GO:2000105,BP,,5865
modulation by virus of host process,17,0.493,0.922,1,GO:0019054,BP,,5866
male germ cell nucleus,12,0.508,0.922,1,GO:0001673,CC,,5867
regulation of actin filament depolymerization,42,0.496,0.923,1,GO:0030834,BP,,5868
negative regulation of potassium ion transmembrane transport,17,0.507,0.924,1,GO:1901380,BP,,5869
nuclear transcription factor complex,118,0.497,0.924,1,GO:0044798,CC,,5870
interstitial matrix,12,0.492,0.925,1,GO:0005614,CC,,5871
positive regulation of icosanoid secretion,11,0.508,0.926,1,"GO:0032305,GO:2000193",BP,positive regulation of fatty acid transport,5872
sympathetic nervous system development,17,0.493,0.926,1,GO:0048485,BP,,5873
signaling pattern recognition receptor activity,15,0.493,0.926,1,"GO:0008329,GO:0038187",MF,pattern recognition receptor activity,5874
response to axon injury,58,0.497,0.927,1,GO:0048678,BP,,5875
tumor necrosis factor receptor binding,22,0.506,0.927,1,GO:0005164,MF,,5876
regulation of protein acetylation,54,0.504,0.927,1,GO:1901983,BP,,5877
negative regulation of cytoskeleton organization,107,0.503,0.927,1,GO:0051494,BP,,5878
hepatocyte differentiation,11,0.492,0.928,1,GO:0070365,BP,,5879
beta-amyloid metabolic process,23,0.495,0.928,1,GO:0050435,BP,,5880
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,13,0.507,0.928,1,GO:1902166,BP,,5881
positive regulation of immunoglobulin production,26,0.505,0.928,1,GO:0002639,BP,,5882
regulation of heart growth,44,0.504,0.928,1,GO:0060420,BP,,5883
biomineral tissue development,109,0.498,0.929,1,GO:0031214,BP,,5884
receptor agonist activity,18,0.506,0.929,1,GO:0048018,MF,,5885
negative regulation of cellular catabolic process,129,0.502,0.93,1,GO:0031330,BP,,5886
microbody part,82,0.503,0.93,1,"GO:0044438,GO:0044439",CC,peroxisomal part,5887
eye photoreceptor cell differentiation,34,0.496,0.93,1,GO:0001754,BP,,5888
cellular senescence,51,0.496,0.93,1,GO:0090398,BP,,5889
positive regulation of ATPase activity,40,0.496,0.93,1,GO:0032781,BP,,5890
transaminase activity,17,0.494,0.93,1,GO:0008483,MF,,5891
mRNA cleavage,22,0.495,0.93,1,GO:0006379,BP,,5892
regulation of ion homeostasis,172,0.502,0.931,1,GO:2000021,BP,,5893
"guanylate cyclase complex, soluble",15,0.494,0.931,1,"GO:0008074,GO:0004383",CC,guanylate cyclase activity,5894
S-adenosylmethionine metabolic process,12,0.507,0.932,1,GO:0046500,BP,,5895
interferon-gamma biosynthetic process,14,0.493,0.933,1,GO:0042095,BP,,5896
regulation of steroid hormone secretion,13,0.493,0.933,1,GO:2000831,BP,,5897
cytoplasmic microtubule,42,0.504,0.933,1,GO:0005881,CC,,5898
aromatase activity,16,0.494,0.933,1,GO:0070330,MF,,5899
voltage-gated anion channel activity,14,0.506,0.933,1,GO:0008308,MF,,5900
positive regulation of reproductive process,37,0.496,0.934,1,GO:2000243,BP,,5901
craniofacial suture morphogenesis,15,0.494,0.934,1,GO:0097094,BP,,5902
regulation of interferon-gamma biosynthetic process,13,0.507,0.934,1,GO:0045072,BP,,5903
cell differentiation involved in embryonic placenta development,18,0.506,0.935,1,GO:0060706,BP,,5904
cellular response to topologically incorrect protein,134,0.498,0.935,1,GO:0035967,BP,,5905
chromosome separation,60,0.503,0.935,1,GO:0051304,BP,,5906
regulation of antigen processing and presentation,14,0.506,0.936,1,GO:0002577,BP,,5907
cell communication by electrical coupling,26,0.495,0.936,1,GO:0010644,BP,,5908
neutral lipid biosynthetic process,40,0.496,0.936,1,"GO:0046460,GO:0046463",BP,acylglycerol biosynthetic process,5909
steroid hormone secretion,15,0.494,0.936,1,GO:0035929,BP,,5910
clathrin-coated endocytic vesicle,61,0.503,0.937,1,GO:0045334,CC,,5911
negative regulation of myeloid leukocyte differentiation,40,0.496,0.937,1,GO:0002762,BP,,5912
positive regulation of cell size,11,0.507,0.937,1,GO:0045793,BP,,5913
positive regulation of B cell proliferation,32,0.504,0.937,1,GO:0030890,BP,,5914
positive regulation of axonogenesis,71,0.497,0.937,1,GO:0050772,BP,,5915
long-chain fatty acid metabolic process,79,0.503,0.938,1,GO:0001676,BP,,5916
visual learning,43,0.503,0.938,1,GO:0008542,BP,,5917
N-terminal protein amino acid modification,26,0.504,0.938,1,GO:0031365,BP,,5918
protein complex scaffold,68,0.503,0.938,1,GO:0032947,MF,,5919
endosome transport via multivesicular body sorting pathway,11,0.507,0.938,1,GO:0032509,BP,,5920
positive regulation of B cell mediated immunity,23,0.495,0.938,1,"GO:0002714,GO:0002891",BP,positive regulation of immunoglobulin mediated immune response,5921
potassium ion export,11,0.507,0.939,1,GO:0071435,BP,,5922
pyrimidine nucleoside monophosphate metabolic process,14,0.494,0.939,1,GO:0009129,BP,,5923
negative regulation of calcium ion transport,45,0.497,0.939,1,GO:0051926,BP,,5924
regulation of mitochondrial membrane permeability,64,0.497,0.939,1,GO:0046902,BP,,5925
cyclin-dependent protein serine/threonine kinase regulator activity,28,0.504,0.94,1,GO:0016538,MF,,5926
response to pain,26,0.504,0.94,1,GO:0048265,BP,,5927
DNA strand elongation involved in DNA replication,15,0.494,0.941,1,GO:0006271,BP,,5928
positive regulation of telomere maintenance via telomerase,26,0.496,0.941,1,GO:0032212,BP,,5929
peptidase activator activity involved in apoptotic process,19,0.495,0.941,1,GO:0016505,MF,,5930
regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,14,0.506,0.941,1,GO:1902165,BP,,5931
phagolysosome assembly,11,0.506,0.941,1,GO:0001845,BP,,5932
RNA-dependent ATPase activity,60,0.503,0.941,1,GO:0008186,MF,,5933
sodium channel complex,18,0.495,0.941,1,GO:0034706,CC,,5934
neural crest formation,10,0.507,0.941,1,GO:0014029,BP,,5935
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,26,0.504,0.942,1,GO:1902230,BP,,5936
negative regulation of natural killer cell mediated immunity,10,0.507,0.942,1,GO:0002716,BP,,5937
IMP metabolic process,12,0.494,0.942,1,GO:0046040,BP,,5938
integral component of lumenal side of endoplasmic reticulum membrane,28,0.496,0.942,1,"GO:0071556,GO:0098553",CC,lumenal side of endoplasmic reticulum membrane,5939
positive regulation of lipid localization,61,0.497,0.942,1,GO:1905954,BP,,5940
response to fibroblast growth factor,127,0.502,0.942,1,GO:0071774,BP,,5941
melanocyte differentiation,23,0.496,0.942,1,GO:0030318,BP,,5942
protein phosphatase regulator activity,67,0.503,0.942,1,GO:0019888,MF,,5943
chondrocyte differentiation,86,0.498,0.943,1,GO:0002062,BP,,5944
positive regulation of lipase activity,49,0.497,0.943,1,GO:0060193,BP,,5945
hydro-lyase activity,45,0.497,0.943,1,GO:0016836,MF,,5946
presynaptic membrane,66,0.497,0.943,1,GO:0042734,CC,,5947
single fertilization,85,0.498,0.944,1,GO:0007338,BP,,5948
phosphorus-oxygen lyase activity,18,0.505,0.944,1,GO:0016849,MF,,5949
anaphase-promoting complex,17,0.495,0.945,1,GO:0005680,CC,,5950
"RNA splicing, via endonucleolytic cleavage and ligation",17,0.505,0.945,1,GO:0000394,BP,,5951
interleukin-6 biosynthetic process,15,0.505,0.945,1,GO:0042226,BP,,5952
retina development in camera-type eye,125,0.502,0.945,1,GO:0060041,BP,,5953
epithelial cell proliferation involved in prostate gland development,10,0.494,0.945,1,GO:0060767,BP,,5954
response to epinephrine,16,0.495,0.945,1,GO:0071871,BP,,5955
iron ion binding,124,0.498,0.945,1,GO:0005506,MF,,5956
regulation of hydrogen peroxide-induced cell death,22,0.504,0.946,1,GO:1903205,BP,,5957
negative regulation of actin filament polymerization,43,0.503,0.946,1,GO:0030837,BP,,5958
nucleoside bisphosphate biosynthetic process,16,0.495,0.946,1,"GO:0033866,GO:0034030,GO:0034033",BP,"ribonucleoside bisphosphate biosynthetic process,purine nucleoside bisphosphate biosynthetic process",5959
carbohydrate homeostasis,179,0.499,0.946,1,"GO:0033500,GO:0042593",BP,glucose homeostasis,5960
regulation of cell fate commitment,22,0.496,0.946,1,GO:0010453,BP,,5961
import into cell,65,0.502,0.946,1,GO:0098657,BP,,5962
DNA-(apurinic or apyrimidinic site) lyase activity,11,0.494,0.946,1,GO:0003906,MF,,5963
T cell lineage commitment,12,0.494,0.946,1,"GO:0002360,GO:0030126",BP,COPI vesicle coat,5964
regulation of granulocyte chemotaxis,34,0.503,0.946,1,GO:0071622,BP,,5965
histone deubiquitination,21,0.504,0.947,1,GO:0016578,BP,,5966
water homeostasis,52,0.497,0.947,1,GO:0030104,BP,,5967
protein localization to microtubule cytoskeleton,31,0.497,0.947,1,GO:0072698,BP,,5968
embryonic hemopoiesis,17,0.505,0.947,1,GO:0035162,BP,,5969
regulation of platelet aggregation,15,0.495,0.948,1,GO:0090330,BP,,5970
positive regulation of DNA biosynthetic process,55,0.497,0.948,1,GO:2000573,BP,,5971
neurotrophin receptor binding,10,0.494,0.948,1,GO:0005165,MF,,5972
carbohydrate derivative transporter activity,31,0.497,0.948,1,GO:1901505,MF,,5973
chondroitin sulfate proteoglycan biosynthetic process,27,0.496,0.949,1,GO:0050650,BP,,5974
coated vesicle membrane,156,0.499,0.949,1,GO:0030662,CC,,5975
regulation of fatty acid beta-oxidation,14,0.495,0.949,1,GO:0031998,BP,,5976
store-operated calcium channel activity,10,0.494,0.949,1,GO:0015279,MF,,5977
monosaccharide binding,59,0.498,0.949,1,GO:0048029,MF,,5978
phosphatidylinositol phosphate kinase activity,15,0.505,0.949,1,GO:0016307,MF,,5979
enamel mineralization,11,0.506,0.95,1,GO:0070166,BP,,5980
interleukin-1 production,52,0.503,0.95,1,GO:0032612,BP,,5981
axon initial segment,12,0.495,0.95,1,GO:0043194,CC,,5982
circadian sleep/wake cycle process,21,0.496,0.95,1,GO:0022410,BP,,5983
RNA helicase activity,60,0.498,0.95,1,GO:0003724,MF,,5984
protein kinase C binding,40,0.497,0.951,1,GO:0005080,MF,,5985
membrane docking,161,0.499,0.951,1,GO:0022406,BP,,5986
bone remodeling,61,0.498,0.951,1,GO:0046849,BP,,5987
cochlea development,41,0.503,0.951,1,GO:0090102,BP,,5988
actin-dependent ATPase activity,11,0.505,0.951,1,GO:0030898,MF,,5989
nucleoside biosynthetic process,48,0.497,0.951,1,GO:0009163,BP,,5990
necrotic cell death,42,0.503,0.952,1,GO:0070265,BP,,5991
aspartate family amino acid catabolic process,20,0.496,0.952,1,GO:0009068,BP,,5992
positive regulation of epidermis development,30,0.497,0.952,1,GO:0045684,BP,,5993
labyrinthine layer development,41,0.503,0.952,1,GO:0060711,BP,,5994
positive regulation of G-protein coupled receptor protein signaling pathway,22,0.504,0.952,1,GO:0045745,BP,,5995
dicarboxylic acid transmembrane transporter activity,28,0.503,0.953,1,GO:0005310,MF,,5996
left/right pattern formation,19,0.504,0.953,1,GO:0060972,BP,,5997
positive regulation of mononuclear cell proliferation,102,0.502,0.953,1,GO:0032946,BP,,5998
rough endoplasmic reticulum membrane,22,0.504,0.953,1,GO:0030867,CC,,5999
homocysteine metabolic process,13,0.495,0.953,1,GO:0050667,BP,,6000
plasma membrane invagination,37,0.503,0.953,1,GO:0099024,BP,,6001
fibroblast growth factor receptor binding,21,0.496,0.953,1,GO:0005104,MF,,6002
female pregnancy,148,0.501,0.954,1,GO:0007565,BP,,6003
response to manganese ion,14,0.496,0.954,1,"GO:0010042,GO:0060644",BP,mammary gland epithelial cell differentiation,6004
regulation of mitotic nuclear division,137,0.499,0.954,1,GO:0007088,BP,,6005
intermediate filament binding,10,0.495,0.954,1,GO:0019215,MF,,6006
regulation of histone acetylation,46,0.502,0.954,1,GO:0035065,BP,,6007
diacylglycerol binding,10,0.505,0.954,1,GO:0019992,MF,,6008
membrane repolarization during action potential,23,0.497,0.955,1,GO:0086011,BP,,6009
regulation of plasma membrane organization,72,0.498,0.955,1,GO:1903729,BP,,6010
response to vitamin E,12,0.495,0.955,1,GO:0033197,BP,,6011
adenosine receptor signaling pathway,10,0.495,0.955,1,GO:0001973,BP,,6012
regulation of interleukin-1 beta secretion,25,0.503,0.955,1,GO:0050706,BP,,6013
response to vitamin D,27,0.497,0.955,1,GO:0033280,BP,,6014
regulation of vascular endothelial growth factor production,28,0.497,0.956,1,GO:0010574,BP,,6015
photoreceptor outer segment,58,0.502,0.956,1,GO:0001750,CC,,6016
positive regulation of protein localization to plasma membrane,38,0.503,0.956,1,"GO:1903078,GO:1904377",BP,positive regulation of protein localization to cell periphery,6017
LRR domain binding,17,0.496,0.956,1,GO:0030275,MF,,6018
regulation of nitric oxide biosynthetic process,43,0.502,0.956,1,GO:0045428,BP,,6019
chronic inflammatory response,17,0.496,0.956,1,GO:0002544,BP,,6020
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,53,0.502,0.956,1,GO:0070059,BP,,6021
regulation of DNA binding,89,0.498,0.957,1,GO:0051101,BP,,6022
regulation of striated muscle cell apoptotic process,23,0.503,0.957,1,GO:0010662,BP,,6023
peroxisomal matrix,36,0.503,0.957,1,"GO:0005782,GO:0031907",CC,microbody lumen,6024
other organism,16,0.496,0.957,1,"GO:0044215,GO:0044216,GO:0044217",CC,"other organism cell,other organism part",6025
tyrosine phosphorylation of STAT protein,48,0.502,0.957,1,GO:0007260,BP,,6026
response to salt stress,13,0.504,0.957,1,GO:0009651,BP,,6027
filopodium assembly,52,0.502,0.957,1,GO:0046847,BP,,6028
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,39,0.498,0.958,1,GO:0042771,BP,,6029
diencephalon development,66,0.498,0.958,1,GO:0021536,BP,,6030
negative regulation of response to cytokine stimulus,34,0.497,0.958,1,GO:0060761,BP,,6031
macrophage differentiation,30,0.497,0.958,1,GO:0030225,BP,,6032
regulation of oxidative stress-induced cell death,54,0.498,0.959,1,GO:1903201,BP,,6033
exocrine system development,42,0.502,0.959,1,GO:0035272,BP,,6034
positive regulation of coagulation,20,0.503,0.959,1,GO:0050820,BP,,6035
detection of external biotic stimulus,11,0.504,0.96,1,GO:0098581,BP,,6036
protein destabilization,34,0.503,0.96,1,GO:0031648,BP,,6037
ubiquitin-dependent ERAD pathway,65,0.498,0.96,1,GO:0030433,BP,,6038
low-density lipoprotein receptor activity,12,0.504,0.96,1,GO:0005041,MF,,6039
carbohydrate kinase activity,18,0.497,0.96,1,GO:0019200,MF,,6040
myofibril assembly,51,0.498,0.96,1,GO:0030239,BP,,6041
cyclic nucleotide metabolic process,157,0.501,0.96,1,GO:0009187,BP,,6042
cardiac atrium morphogenesis,23,0.503,0.96,1,GO:0003209,BP,,6043
presynapse assembly,16,0.496,0.961,1,GO:0099054,BP,,6044
response to vitamin A,13,0.496,0.961,1,GO:0033189,BP,,6045
blood vessel endothelial cell migration,71,0.498,0.961,1,GO:0043534,BP,,6046
protein localization to cytoskeleton,34,0.498,0.962,1,GO:0044380,BP,,6047
protein phosphatase inhibitor activity,33,0.498,0.962,1,GO:0004864,MF,,6048
cation:amino acid symporter activity,16,0.497,0.962,1,GO:0005416,MF,,6049
"oxidoreductase activity, acting on the aldehyde or oxo group of donors",35,0.498,0.962,1,GO:0016903,MF,,6050
regulation of striated muscle contraction,75,0.498,0.962,1,GO:0006942,BP,,6051
tetrahydrofolate metabolic process,18,0.497,0.963,1,GO:0046653,BP,,6052
cellular response to vascular endothelial growth factor stimulus,35,0.498,0.963,1,GO:0035924,BP,,6053
positive regulation of vascular endothelial growth factor production,25,0.503,0.963,1,GO:0010575,BP,,6054
positive regulation of response to wounding,43,0.498,0.963,1,GO:1903036,BP,,6055
positive regulation of neuron migration,10,0.496,0.964,1,GO:2001224,BP,,6056
vascular smooth muscle cell differentiation,16,0.503,0.964,1,GO:0035886,BP,,6057
immunoglobulin mediated immune response,81,0.499,0.964,1,GO:0016064,BP,,6058
regulation of complement activation,23,0.497,0.964,1,GO:0030449,BP,,6059
male genitalia development,18,0.503,0.964,1,GO:0030539,BP,,6060
positive regulation of fatty acid biosynthetic process,11,0.496,0.965,1,GO:0045723,BP,,6061
Golgi-associated vesicle membrane,46,0.502,0.965,1,GO:0030660,CC,,6062
pentose-phosphate shunt,15,0.497,0.966,1,GO:0006098,BP,,6063
negative regulation of protein localization to cell periphery,18,0.503,0.966,1,GO:1904376,BP,,6064
basal transcription machinery binding,33,0.498,0.966,1,"GO:0001098,GO:0001099",MF,basal RNA polymerase II transcription machinery binding,6065
protein phosphorylated amino acid binding,43,0.498,0.966,1,GO:0045309,MF,,6066
negative regulation of cell cycle arrest,21,0.503,0.967,1,GO:0071157,BP,,6067
ribonucleoprotein complex disassembly,12,0.503,0.967,1,GO:0032988,BP,,6068
positive regulation of heart rate,21,0.503,0.967,1,GO:0010460,BP,,6069
regulation of signal transduction by p53 class mediator,148,0.499,0.967,1,GO:1901796,BP,,6070
positive regulation of gene silencing by miRNA,20,0.503,0.967,1,GO:2000637,BP,,6071
ATPase regulator activity,35,0.498,0.967,1,GO:0060590,MF,,6072
negative regulation of endocytosis,38,0.498,0.967,1,GO:0045806,BP,,6073
DNA repair complex,35,0.502,0.967,1,GO:1990391,CC,,6074
regulation of cardiac muscle cell apoptotic process,21,0.503,0.968,1,GO:0010665,BP,,6075
sodium ion binding,11,0.503,0.968,1,GO:0031402,MF,,6076
interleukin-10 production,32,0.502,0.969,1,GO:0032613,BP,,6077
protein localization to kinetochore,12,0.497,0.97,1,GO:0034501,BP,,6078
interleukin-6 production,89,0.501,0.97,1,GO:0032635,BP,,6079
sleep,30,0.498,0.97,1,GO:0030431,BP,,6080
histone H2A ubiquitination,18,0.497,0.97,1,GO:0033522,BP,,6081
negative regulation of fibroblast proliferation,27,0.498,0.97,1,GO:0048147,BP,,6082
NAD biosynthetic process,24,0.498,0.97,1,GO:0009435,BP,,6083
transition metal ion transmembrane transporter activity,33,0.502,0.971,1,GO:0046915,MF,,6084
localization within membrane,79,0.501,0.971,1,GO:0051668,BP,,6085
C-acyltransferase activity,16,0.497,0.971,1,GO:0016408,MF,,6086
regulation of cysteine-type endopeptidase activity involved in apoptotic process,173,0.501,0.971,1,GO:0043281,BP,,6087
cholesterol catabolic process,10,0.503,0.971,1,"GO:0006707,GO:0016127",BP,sterol catabolic process,6088
RNA polymerase II carboxy-terminal domain kinase activity,14,0.497,0.971,1,GO:0008353,MF,,6089
mitochondrial RNA processing,12,0.503,0.972,1,GO:0000963,BP,,6090
regulation of dephosphorylation,130,0.499,0.972,1,GO:0035303,BP,,6091
postsynaptic neurotransmitter receptor activity,17,0.498,0.972,1,GO:0098960,MF,,6092
positive regulation of cAMP biosynthetic process,65,0.501,0.972,1,GO:0030819,BP,,6093
"regulation of retrograde protein transport, ER to cytosol",12,0.503,0.973,1,GO:1904152,BP,,6094
protein tyrosine kinase activity,162,0.499,0.973,1,GO:0004713,MF,,6095
adhesion of symbiont to host,11,0.497,0.973,1,GO:0044406,BP,,6096
positive regulation of membrane permeability,54,0.499,0.973,1,GO:1905710,BP,,6097
negative regulation of smooth muscle contraction,14,0.503,0.973,1,GO:0045986,BP,,6098
catalytic step 2 spliceosome,84,0.499,0.974,1,GO:0071013,CC,,6099
aspartate family amino acid metabolic process,53,0.499,0.974,1,GO:0009066,BP,,6100
GTP metabolic process,26,0.498,0.974,1,GO:0046039,BP,,6101
regulation of transcription from RNA polymerase I promoter,29,0.502,0.974,1,GO:0006356,BP,,6102
positive regulation of cell-substrate adhesion,98,0.499,0.974,1,GO:0010811,BP,,6103
regulation of fatty acid metabolic process,68,0.501,0.974,1,GO:0019217,BP,,6104
locomotory exploration behavior,12,0.497,0.974,1,GO:0035641,BP,,6105
regulation of TOR signaling,79,0.501,0.974,1,GO:0032006,BP,,6106
poly(A) binding,10,0.497,0.975,1,GO:0008143,MF,,6107
Ral GTPase binding,13,0.503,0.975,1,GO:0017160,MF,,6108
glycosyl compound biosynthetic process,50,0.501,0.975,1,GO:1901659,BP,,6109
ion gated channel activity,38,0.499,0.975,1,GO:0022839,MF,,6110
positive regulation of neurological system process,17,0.502,0.975,1,GO:0031646,BP,,6111
positive regulation of production of molecular mediator of immune response,55,0.501,0.977,1,GO:0002702,BP,,6112
positive regulation of cell cycle G2/M phase transition,20,0.502,0.977,1,GO:1902751,BP,,6113
positive regulation of cardiac muscle tissue development,34,0.501,0.977,1,GO:0055025,BP,,6114
positive regulation of extracellular matrix organization,15,0.502,0.977,1,GO:1903055,BP,,6115
negative regulation of cAMP biosynthetic process,32,0.501,0.978,1,GO:0030818,BP,,6116
layer formation in cerebral cortex,13,0.498,0.978,1,GO:0021819,BP,,6117
response to folic acid,11,0.498,0.978,1,GO:0051593,BP,,6118
metalloaminopeptidase activity,16,0.502,0.978,1,GO:0070006,MF,,6119
positive regulation of interleukin-1 production,30,0.501,0.978,1,GO:0032732,BP,,6120
negative regulation of cardiac muscle cell differentiation,10,0.497,0.978,1,GO:2000726,BP,,6121
ribonucleoside catabolic process,15,0.502,0.978,1,GO:0042454,BP,,6122
"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen",18,0.498,0.979,1,GO:0016712,MF,,6123
lipoprotein particle receptor activity,14,0.498,0.979,1,GO:0030228,MF,,6124
interleukin-1 beta production,45,0.501,0.979,1,GO:0032611,BP,,6125
ephrin receptor signaling pathway,83,0.501,0.979,1,GO:0048013,BP,,6126
positive regulation of alpha-beta T cell differentiation,30,0.501,0.98,1,GO:0046638,BP,,6127
endocrine pancreas development,35,0.499,0.98,1,GO:0031018,BP,,6128
basal lamina,19,0.498,0.981,1,GO:0005605,CC,,6129
regulation of mitotic metaphase/anaphase transition,39,0.499,0.981,1,"GO:0030071,GO:1902099",BP,regulation of metaphase/anaphase transition of cell cycle,6130
regulation of myeloid cell apoptotic process,21,0.501,0.981,1,GO:0033032,BP,,6131
amyloid precursor protein metabolic process,31,0.499,0.981,1,GO:0042982,BP,,6132
negative regulation of mitotic sister chromatid segregation,29,0.499,0.982,1,GO:0033048,BP,,6133
proximal/distal pattern formation,23,0.501,0.982,1,GO:0009954,BP,,6134
cellular modified amino acid biosynthetic process,39,0.499,0.982,1,GO:0042398,BP,,6135
positive regulation of macrophage migration,11,0.502,0.982,1,GO:1905523,BP,,6136
thyroid hormone metabolic process,15,0.502,0.982,1,GO:0042403,BP,,6137
NFAT protein import into nucleus,14,0.502,0.983,1,GO:0051531,BP,,6138
positive regulation of cysteine-type endopeptidase activity,111,0.501,0.983,1,GO:2001056,BP,,6139
regulation of cellular carbohydrate metabolic process,106,0.499,0.984,1,GO:0010675,BP,,6140
regulation of cardiac muscle hypertrophy,38,0.499,0.984,1,GO:0010611,BP,,6141
imidazole-containing compound metabolic process,10,0.498,0.984,1,GO:0052803,BP,,6142
smooth muscle contraction,87,0.501,0.984,1,GO:0006939,BP,,6143
glyoxylate metabolic process,22,0.501,0.984,1,GO:0046487,BP,,6144
cytoplasmic ribonucleoprotein granule,156,0.5,0.984,1,GO:0036464,CC,,6145
negative regulation of protein localization to plasma membrane,17,0.501,0.984,1,GO:1903077,BP,,6146
regulation of vascular endothelial growth factor receptor signaling pathway,24,0.501,0.984,1,GO:0030947,BP,,6147
positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,104,0.499,0.984,1,GO:0043280,BP,,6148
regulation of protein localization to plasma membrane,64,0.499,0.985,1,GO:1903076,BP,,6149
positive regulation of peptidyl-tyrosine phosphorylation,129,0.5,0.985,1,GO:0050731,BP,,6150
extracellular regulation of signal transduction,11,0.498,0.985,1,"GO:1900115,GO:1900116",BP,extracellular negative regulation of signal transduction,6151
cellular response to inorganic substance,152,0.5,0.985,1,GO:0071241,BP,,6152
cytosolic calcium ion transport,124,0.5,0.985,1,GO:0060401,BP,,6153
tertiary granule membrane,59,0.501,0.985,1,GO:0070821,CC,,6154
response to monosaccharide,161,0.5,0.986,1,GO:0034284,BP,,6155
"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds",121,0.5,0.986,1,GO:0016810,MF,,6156
Cajal body,47,0.499,0.986,1,GO:0015030,CC,,6157
bone mineralization,87,0.501,0.986,1,GO:0030282,BP,,6158
protein-lipid complex subunit organization,28,0.501,0.987,1,GO:0071825,BP,,6159
insulin receptor binding,28,0.501,0.987,1,GO:0005158,MF,,6160
Ada2/Gcn5/Ada3 transcription activator complex,13,0.501,0.987,1,GO:0005671,CC,,6161
platelet aggregation,49,0.501,0.988,1,GO:0070527,BP,,6162
retromer complex,20,0.499,0.988,1,GO:0030904,CC,,6163
SH2 domain binding,28,0.501,0.988,1,GO:0042169,MF,,6164
negative regulation of binding,124,0.5,0.988,1,GO:0051100,BP,,6165
IRE1-mediated unfolded protein response,61,0.501,0.988,1,GO:0036498,BP,,6166
negative chemotaxis,21,0.501,0.989,1,GO:0050919,BP,,6167
acetyl-CoA biosynthetic process,19,0.501,0.989,1,GO:0006085,BP,,6168
locomotion involved in locomotory behavior,10,0.501,0.989,1,GO:0031987,BP,,6169
"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor",30,0.501,0.99,1,GO:0016620,MF,,6170
cell killing,69,0.5,0.99,1,GO:0001906,BP,,6171
positive regulation of membrane depolarization,11,0.499,0.99,1,GO:1904181,BP,,6172
detection of biotic stimulus,14,0.501,0.99,1,GO:0009595,BP,,6173
vascular endothelial growth factor signaling pathway,23,0.499,0.99,1,GO:0038084,BP,,6174
aldehyde dehydrogenase (NAD) activity,13,0.501,0.991,1,GO:0004029,MF,,6175
peptidyl-tyrosine dephosphorylation,93,0.5,0.991,1,GO:0035335,BP,,6176
cofactor transport,22,0.499,0.991,1,GO:0051181,BP,,6177
protein folding in endoplasmic reticulum,13,0.501,0.991,1,GO:0034975,BP,,6178
ventricular system development,24,0.501,0.991,1,GO:0021591,BP,,6179
leukocyte adhesion to vascular endothelial cell,22,0.501,0.991,1,GO:0061756,BP,,6180
positive regulation of mast cell activation,13,0.501,0.992,1,GO:0033005,BP,,6181
negative regulation of substrate adhesion-dependent cell spreading,13,0.499,0.992,1,GO:1900025,BP,,6182
positive regulation of developmental growth,143,0.5,0.992,1,GO:0048639,BP,,6183
DNA biosynthetic process,172,0.5,0.992,1,GO:0071897,BP,,6184
solute:proton antiporter activity,19,0.499,0.992,1,GO:0015299,MF,,6185
enteroendocrine cell differentiation,23,0.499,0.992,1,GO:0035883,BP,,6186
negative regulation of nuclear division,40,0.5,0.993,1,GO:0051784,BP,,6187
neurotransmitter reuptake,17,0.501,0.993,1,GO:0098810,BP,,6188
positive regulation of T-helper cell differentiation,13,0.501,0.993,1,GO:0045624,BP,,6189
neurotransmitter uptake,22,0.501,0.993,1,GO:0001504,BP,,6190
detection of abiotic stimulus,111,0.5,0.993,1,GO:0009582,BP,,6191
insulin-like growth factor receptor binding,14,0.499,0.994,1,GO:0005159,MF,,6192
positive regulation of posttranscriptional gene silencing,21,0.5,0.994,1,GO:0060148,BP,,6193
positive regulation of endothelial cell migration,66,0.5,0.994,1,GO:0010595,BP,,6194
protein N-terminus binding,91,0.5,0.994,1,GO:0047485,MF,,6195
RNA polymerase core enzyme binding,30,0.5,0.994,1,GO:0043175,MF,,6196
positive regulation of endopeptidase activity,120,0.5,0.994,1,GO:0010950,BP,,6197
glutamate receptor binding,32,0.5,0.994,1,GO:0035254,MF,,6198
metencephalon development,92,0.5,0.994,1,GO:0022037,BP,,6199
positive regulation of lipid catabolic process,20,0.5,0.995,1,GO:0050996,BP,,6200
regulation of protein localization to cell periphery,65,0.5,0.995,1,GO:1904375,BP,,6201
positive regulation of muscle tissue development,55,0.5,0.995,1,GO:1901863,BP,,6202
cerebellum development,85,0.5,0.995,1,GO:0021549,BP,,6203
regulation of interleukin-1 beta production,39,0.5,0.996,1,GO:0032651,BP,,6204
regulation of myeloid leukocyte differentiation,89,0.5,0.996,1,GO:0002761,BP,,6205
ADP binding,30,0.5,0.996,1,GO:0043531,MF,,6206
regulation of cardiac muscle tissue development,58,0.5,0.996,1,GO:0055024,BP,,6207
mammary gland alveolus development,14,0.5,0.997,1,"GO:0060749,GO:0061377",BP,mammary gland lobule development,6208
bile acid and bile salt transport,22,0.5,0.997,1,GO:0015721,BP,,6209
modulation by virus of host morphology or physiology,28,0.5,0.997,1,GO:0019048,BP,,6210
"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",65,0.5,0.997,1,GO:0000288,BP,,6211
neutral amino acid transmembrane transporter activity,29,0.5,0.997,1,GO:0015175,MF,,6212
type 2 immune response,23,0.5,0.997,1,GO:0042092,BP,,6213
cell fate commitment involved in formation of primary germ layer,29,0.5,0.998,1,GO:0060795,BP,,6214
negative regulation of mitotic nuclear division,36,0.5,0.998,1,GO:0045839,BP,,6215
positive regulation of lymphocyte proliferation,101,0.5,0.998,1,GO:0050671,BP,,6216
regulation of cytokine secretion,121,0.5,0.998,1,GO:0050707,BP,,6217
nBAF complex,14,0.5,0.998,1,GO:0071565,CC,,6218
regulation of icosanoid secretion,13,0.5,0.998,1,GO:0032303,BP,,6219
mesodermal cell fate commitment,16,0.5,0.998,1,GO:0001710,BP,,6220
sodium channel regulator activity,32,0.5,0.998,1,GO:0017080,MF,,6221
regulation of neutrophil chemotaxis,25,0.5,0.998,1,GO:0090022,BP,,6222
Golgi lumen,68,0.5,0.999,1,GO:0005796,CC,,6223
"ATPase activity, coupled to movement of substances",111,0.5,0.999,1,GO:0043492,MF,,6224
regulation of TORC1 signaling,20,0.5,0.999,1,GO:1903432,BP,,6225
snRNA binding,33,0.5,0.999,1,GO:0017069,MF,,6226
"regulation of DNA-templated transcription, initiation",30,0.5,0.999,1,GO:2000142,BP,,6227
chondrocyte differentiation involved in endochondral bone morphogenesis,10,0.5,0.999,1,GO:0003413,BP,,6228
protein phosphatase binding,106,0.5,1,1,GO:0019903,MF,,6229